1	The	DT	O	the	det	3	SENT_1	[p1l491t186r596b247],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l643t173r952b249],
3	ENGLAND	NNP	LOCATION	ENGLAND	_	0	SENT_1	[p1l999t172r1657b249],

1	JOURNAL	NN	O	journal	_	0	SENT_2	[p1l331t297r948b400],
2	of	IN	O	of	_	0	SENT_2	[p1l997t304r1077b392],
3	MEDICINE	NNP	O	MEDICINE	prep_of	1	SENT_2	[p1l1113t297r1816b374],

1	ESTABLISHED	VBN	O	establish	_	0	SENT_3	[p1l355t487r568b505],
2	IN	IN	O	in	_	0	SENT_3	[p1l582t487r618b505],
3	1812	CD	DATE	1812	prep_in	1	SENT_3	[p1l633t487r703b505],

1	JULY	NN	DATE	july	_	0	SENT_4	[p1l936t481r1034b513],
2	14	CD	DATE	14	num	1	SENT_4	[p1l1048t480r1104b510],
3	,	,	DATE	,	_	0	SENT_4	[p1l1048t480r1104b510],
4	2005	CD	DATE	2005	appos	1	SENT_4	[p1l1119t481r1215b506],

1	VOL	NNP	O	VOL	_	0	SENT_5	[p1l1549t487r1617b505],
2	.	.	O	.	_	0	SENT_5	[p1l1549t487r1617b505],

1	353	CD	NUMBER	353	num	2	SENT_6	[p1l1627t487r1679b506],
2	NO.	NN	O	no.	_	0	SENT_6	[p1l1720t487r1775b505],
3	2	CD	NUMBER	2	dep	2	SENT_6	[p1l1786t487r1800b504],

1	Erlotinib	NNP	O	Erlotinib	nsubj	4	SENT_7	[p1l196t595r455b650],
2	in	IN	O	in	prep	1	SENT_7	[p1l473t596r530b649],
3	Previously	RB	DATE	previously	pcomp	2	SENT_7	[p1l546t595r848b665],
4	Treated	VBN	O	treat	_	0	SENT_7	[p1l860t595r1081b650],
5	N	NN	O	n	dobj	4	SENT_7	[p1l1097t600r1149b650],
6	on	IN	O	on	prep	4	SENT_7	[p1l1152t595r1573b650],
7	.	.	O	.	_	0	SENT_7	[p1l1152t595r1573b650],

1	—	NN	O	—	_	0	SENT_8	[p1l1152t595r1573b650],
2	.	.	O	.	_	0	SENT_8	[p1l1152t595r1573b650],

1	Small-Cell	JJ	O	small-cell	amod	3	SENT_9	[p1l1152t595r1573b650],
2	Lung	NN	O	lung	nn	3	SENT_9	[p1l1589t600r1742b665],
3	Cancer	NN	O	cancer	_	0	SENT_9	[p1l1757t599r1964b650],

1	Frances	NNP	PERSON	Frances	nn	3	SENT_10	[p1l215t732r340b760],
2	A.	NNP	PERSON	A.	nn	3	SENT_10	[p1l353t731r385b760],
3	Shepherd	NNP	PERSON	Shepherd	_	0	SENT_10	[p1l400t729r570b769],
4	,	,	O	,	_	0	SENT_10	[p1l400t729r570b769],
5	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l587t732r762b769],
6	,	,	O	,	_	0	SENT_10	[p1l587t732r762b769],
7	José	NNP	PERSON	José	nn	9	SENT_10	[p1l587t732r762b769],
8	Rodrigues	NNP	PERSON	Rodrigues	nn	9	SENT_10	[p1l777t729r945b770],
9	Pereira	NNP	PERSON	Pereira	appos	3	SENT_10	[p1l962t732r1085b766],
10	,	,	O	,	_	0	SENT_10	[p1l962t732r1085b766],
11	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l1103t732r1193b766],
12	,	,	O	,	_	0	SENT_10	[p1l1103t732r1193b766],
13	Tudor	NNP	PERSON	Tudor	nn	14	SENT_10	[p1l1206t729r1305b760],
14	Ciuleanu	NNP	PERSON	Ciuleanu	appos	3	SENT_10	[p1l1317t729r1475b766],
15	,	,	O	,	_	0	SENT_10	[p1l1317t729r1475b766],
16	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l1492t732r1582b766],
17	,	,	O	,	_	0	SENT_10	[p1l1492t732r1582b766],
18	Eng	NNP	PERSON	Eng	nn	20	SENT_10	[p1l1599t732r1661b770],
19	Huat	NNP	PERSON	Huat	nn	20	SENT_10	[p1l1675t732r1758b760],
20	Tan	NNP	PERSON	Tan	appos	3	SENT_10	[p1l1768t732r1836b766],
21	,	,	O	,	_	0	SENT_10	[p1l1768t732r1836b766],
22	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l1854t732r1944b766],
23	,	,	O	,	_	0	SENT_10	[p1l1854t732r1944b766],
24	Vera	NNP	PERSON	Vera	nn	25	SENT_10	[p1l208t781r281b809],
25	Hirsh	NNP	PERSON	Hirsh	appos	3	SENT_10	[p1l297t778r398b815],
26	,	,	O	,	_	0	SENT_10	[p1l297t778r398b815],
27	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l415t781r505b815],
28	,	,	O	,	_	0	SENT_10	[p1l415t781r505b815],
29	Sumitra	NNP	PERSON	Sumitra	nn	30	SENT_10	[p1l520t780r653b809],
30	Thongprasert	NNP	PERSON	Thongprasert	appos	3	SENT_10	[p1l665t778r904b819],
31	,	,	O	,	_	0	SENT_10	[p1l665t778r904b819],
32	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l922t781r1012b815],
33	,	,	O	,	_	0	SENT_10	[p1l922t781r1012b815],
34	Daniel	NNP	PERSON	Daniel	nn	35	SENT_10	[p1l1029t778r1130b809],
35	Campos	NNP	PERSON	Campos	appos	3	SENT_10	[p1l1143t780r1288b818],
36	,	,	O	,	_	0	SENT_10	[p1l1143t780r1288b818],
37	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l1304t781r1393b815],
38	,	,	O	,	_	0	SENT_10	[p1l1304t781r1393b815],
39	Savitree	NNP	PERSON	Savitree	nn	40	SENT_10	[p1l1407t780r1537b809],
40	Maoleekoonpiroj	NNP	PERSON	Maoleekoonpiroj	appos	3	SENT_10	[p1l1552t778r1842b819],
41	,	,	O	,	_	0	SENT_10	[p1l1552t778r1842b819],
42	M.D.	NNP	O	M.D.	appos	3	SENT_10	[p1l1858t781r1946b815],
43	,	,	O	,	_	0	SENT_10	[p1l1858t781r1946b815],
44	Michael	NNP	PERSON	Michael	nn	45	SENT_10	[p1l200t827r325b858],
45	Smylie	NNP	PERSON	Smylie	appos	3	SENT_10	[p1l339t827r454b868],
46	,	,	O	,	_	0	SENT_10	[p1l339t827r454b868],
47	M.B.	NNP	LOCATION	M.B.	appos	3	SENT_10	[p1l469t830r552b864],
48	,	,	O	,	_	0	SENT_10	[p1l469t830r552b864],
49	Ch	NNP	O	Ch	appos	3	SENT_10	[p1l565t827r660b864],
50	.	.	O	.	_	0	SENT_10	[p1l565t827r660b864],

1	B.	NNP	O	B.	_	0	SENT_11	[p1l565t827r660b864],
2	,	,	O	,	_	0	SENT_11	[p1l565t827r660b864],
3	Renato	NNP	PERSON	Renato	nn	4	SENT_11	[p1l675t830r791b858],
4	Martins	NNP	PERSON	Martins	appos	1	SENT_11	[p1l807t830r945b864],
5	,	,	O	,	_	0	SENT_11	[p1l807t830r945b864],
6	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l962t830r1052b864],
7	,	,	O	,	_	0	SENT_11	[p1l962t830r1052b864],
8	Maximiliano	NNP	PERSON	Maximiliano	nn	10	SENT_11	[p1l1069t827r1277b858],
9	van	NNP	PERSON	van	nn	10	SENT_11	[p1l1289t838r1346b858],
10	Kooten	NNP	PERSON	Kooten	appos	1	SENT_11	[p1l1364t830r1490b864],
11	,	,	O	,	_	0	SENT_11	[p1l1364t830r1490b864],
12	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1507t830r1597b864],
13	,	,	O	,	_	0	SENT_11	[p1l1507t830r1597b864],
14	Mircea	NNP	PERSON	Mircea	nn	15	SENT_11	[p1l1615t830r1727b858],
15	Dediu	NNP	PERSON	Dediu	appos	1	SENT_11	[p1l1743t827r1851b864],
16	,	,	O	,	_	0	SENT_11	[p1l1743t827r1851b864],
17	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1868t830r1958b864],
18	,	,	O	,	_	0	SENT_11	[p1l1868t830r1958b864],
19	Brian	NNP	PERSON	Brian	nn	20	SENT_11	[p1l220t879r304b907],
20	Findlay	NNP	PERSON	Findlay	appos	1	SENT_11	[p1l322t876r445b917],
21	,	,	O	,	_	0	SENT_11	[p1l322t876r445b917],
22	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l462t879r553b913],
23	,	,	O	,	_	0	SENT_11	[p1l462t879r553b913],
24	Dongsheng	NNP	PERSON	Dongsheng	nn	25	SENT_11	[p1l570t876r765b917],
25	Tu	NNP	PERSON	Tu	appos	1	SENT_11	[p1l775t879r823b913],
26	,	,	O	,	_	0	SENT_11	[p1l775t879r823b913],
27	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_11	[p1l840t876r940b913],
28	,	,	O	,	_	0	SENT_11	[p1l840t876r940b913],
29	Diannejohnston	NNP	PERSON	Diannejohnston	appos	1	SENT_11	[p1l957t876r1250b916],
30	,	,	O	,	_	0	SENT_11	[p1l957t876r1250b916],
31	Andrea	NNP	PERSON	Andrea	nn	32	SENT_11	[p1l1264t876r1384b907],
32	Bezjak	NNP	PERSON	Bezjak	appos	1	SENT_11	[p1l1401t876r1516b917],
33	,	,	O	,	_	0	SENT_11	[p1l1401t876r1516b917],
34	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1533t879r1623b913],
35	,	,	O	,	_	0	SENT_11	[p1l1533t879r1623b913],
36	Gary	NNP	PERSON	Gary	nn	39	SENT_11	[p1l1638t878r1716b917],
37	Clark	NNP	PERSON	Clark	nn	39	SENT_11	[p1l1728t876r1822b913],
38	,	,	O	,	_	0	SENT_11	[p1l1728t876r1822b913],
39	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_11	[p1l1839t876r1938b913],
40	,	,	O	,	_	0	SENT_11	[p1l1839t876r1938b913],

1	Pedro	NNP	PERSON	Pedro	_	0	SENT_12	[p1l504t925r599b956],
2	Santabarbara	NNP	PERSON	Santabarbara	nn	6	SENT_12	[p1l613t925r847b962],
3	,	,	O	,	_	0	SENT_12	[p1l613t925r847b962],
4	M.D.	NNP	O	M.D.	appos	6	SENT_12	[p1l865t928r955b962],
5	,	,	O	,	_	0	SENT_12	[p1l865t928r955b962],
6	Ph.D.	NNP	O	Ph.D.	dep	1	SENT_12	[p1l972t925r1071b962],
7	,	,	O	,	_	0	SENT_12	[p1l972t925r1071b962],
8	and	CC	O	and	prep	6	SENT_12	[p1l1086t925r1146b956],
9	Lesley	NNP	PERSON	Lesley	nn	14	SENT_12	[p1l1163t925r1263b966],
10	Seymour	NNP	PERSON	Seymour	nn	14	SENT_12	[p1l1276t927r1430b966],
11	,	,	O	,	_	0	SENT_12	[p1l1276t927r1430b966],
12	M.D.	NNP	O	M.D.	appos	14	SENT_12	[p1l1447t928r1538b962],
13	,	,	O	,	_	0	SENT_12	[p1l1447t928r1538b962],
14	Ph.D.	NNP	O	Ph.D.	dep	8	SENT_12	[p1l1555t925r1654b962],
15	,	,	O	,	_	0	SENT_12	[p1l1555t925r1654b962],
16	for	IN	O	for	_	0	SENT_12	[p1l522t974r569b1005],
17	the	DT	O	the	det	21	SENT_12	[p1l579t974r632b1005],
18	National	NNP	ORGANIZATION	National	nn	21	SENT_12	[p1l647t974r789b1005],
19	Cancer	NNP	ORGANIZATION	Cancer	nn	21	SENT_12	[p1l804t977r920b1005],
20	Institute	NNP	ORGANIZATION	Institute	nn	21	SENT_12	[p1l935t977r1074b1006],
21	ofCanada	NNP	ORGANIZATION	ofCanada	prep_for	14	SENT_12	[p1l1087t974r1255b1005],
22	Clinical	JJ	ORGANIZATION	clinical	prep	14	SENT_12	[p1l1269t974r1390b1005],
23	Trials	NNPS	ORGANIZATION	Trials	nn	24	SENT_12	[p1l1404t974r1492b1005],
24	Group	NNP	ORGANIZATION	Group	dep	22	SENT_12	[p1l1506t977r1635b1015],
25	"	``	O	"	punct	14	SENT_12	[p1l1506t977r1635b1015],
26	'	''	O	'	_	0	SENT_12	[p1l1506t977r1635b1015],
27	~	FW	O	~	nn	28	SENT_12	[p1l1506t977r1635b1015],
28	‘	FW	O	‘	amod	6	SENT_12	[p1l1506t977r1635b1015],

1	ABSTRACT	NN	O	abstract	_	0	SENT_13	[p1l967t1116r1185b1139],

1	BACKG	NNP	O	BACKG	nsubj	5	SENT_14	[p1l93t1239r196b1259],
2	no	DT	O	no	det	4	SENT_14	[p1l204t1239r244b1259],
3	u	NN	O	u	nn	4	SENT_14	[p1l251t1239r268b1259],
4	N	NN	O	n	dep	1	SENT_14	[p1l277t1239r294b1259],
5	D	NN	O	d	_	0	SENT_14	[p1l303t1239r321b1259],
6	We	PRP	O	we	nsubj	7	SENT_14	[p1l90t1276r143b1304],
7	conducted	VBD	O	conduct	ccomp	5	SENT_14	[p1l158t1273r333b1304],
8	a	DT	O	a	dobj	7	SENT_14	[p1l348t1283r365b1304],
9	randomized	VBN	O	randomize	partmod	8	SENT_14	[p1l379t1273r593b1310],
10	,	,	O	,	_	0	SENT_14	[p1l379t1273r593b1310],
11	placebo	NN	O	placebo	nn	12	SENT_14	[p1l609t1273r939b1312],
12	—	NN	O	—	appos	8	SENT_14	[p1l609t1273r939b1312],
13	controlled	VBN	O	control	partmod	12	SENT_14	[p1l609t1273r939b1312],
14	,	,	O	,	_	0	SENT_14	[p1l609t1273r939b1312],
15	double-blind	JJ	O	double-blind	amod	16	SENT_14	[p1l956t1273r1175b1304],
16	trial	NN	O	trial	dobj	13	SENT_14	[p1l1190t1273r1257b1304],
17	to	TO	O	to	aux	18	SENT_14	[p1l1272t1279r1303b1304],
18	determine	VB	O	determine	infmod	16	SENT_14	[p1l1319t1273r1490b1304],
19	whether	IN	O	whether	complm	27	SENT_14	[p1l90t1323r229b1354],
20	the	DT	O	the	det	26	SENT_14	[p1l237t1323r288b1353],
21	epidermal	JJ	O	epidermal	amod	26	SENT_14	[p1l298t1323r466b1362],
22	growth	NN	O	growth	nn	26	SENT_14	[p1l475t1323r595b1362],
23	factor	NN	O	factor	nn	26	SENT_14	[p1l604t1323r702b1353],
24	receptor	NN	O	receptor	nn	26	SENT_14	[p1l710t1329r850b1362],
25	inhibitor	NN	O	inhibitor	nn	26	SENT_14	[p1l857t1323r1007b1354],
26	erlotinib	NN	O	erlotinib	nsubj	27	SENT_14	[p1l1015t1323r1157b1353],
27	prolongs	VBZ	O	prolong	ccomp	18	SENT_14	[p1l1167t1323r1317b1362],
28	survival	NN	O	survival	dobj	27	SENT_14	[p1l1328t1323r1451b1354],
29	in	IN	O	in	_	0	SENT_14	[p1l1459t1323r1491b1353],
30	non	JJ	O	non	amod	36	SENT_14	[p1l92t1373r337b1404],
31	—	JJ	O	—	amod	36	SENT_14	[p1l92t1373r337b1404],
32	small	JJ	O	small	amod	36	SENT_14	[p1l92t1373r337b1404],
33	—	NN	O	—	nn	36	SENT_14	[p1l92t1373r337b1404],
34	cell	NN	O	cell	nn	36	SENT_14	[p1l92t1373r337b1404],
35	lung	NN	O	lung	nn	36	SENT_14	[p1l346t1373r421b1412],
36	cancer	NN	O	cancer	prep_in	28	SENT_14	[p1l430t1383r536b1403],
37	after	IN	O	after	_	0	SENT_14	[p1l545t1373r620b1403],
38	the	DT	O	the	det	39	SENT_14	[p1l628t1373r679b1403],
39	failure	NN	O	failure	prep_after	27	SENT_14	[p1l688t1373r793b1404],
40	of	IN	O	of	_	0	SENT_14	[p1l803t1373r842b1403],
41	ﬁrst-line	NN	O	ﬁrst-line	nn	44	SENT_14	[p1l844t1373r984b1403],
42	or	CC	O	or	_	0	SENT_14	[p1l994t1383r1029b1404],
43	second-line	JJ	O	second-line	conj_or	41	SENT_14	[p1l1038t1373r1228b1403],
44	chemotherapy	NN	O	chemotherapy	prep_of	39	SENT_14	[p1l1237t1373r1478b1412],
45	.	.	O	.	_	0	SENT_14	[p1l1237t1373r1478b1412],

1	M	NN	O	m	dep	7	SENT_15	[p1l95t1479r115b1498],
2	ET	NNP	O	ET	nn	3	SENT_15	[p1l124t1479r157b1498],
3	H	NNP	O	H	dep	1	SENT_15	[p1l163t1479r181b1498],
4	o	NN	O	o	nn	5	SENT_15	[p1l189t1478r210b1498],
5	D	NN	O	d	dep	7	SENT_15	[p1l216t1479r234b1498],
6	5	CD	NUMBER	5	num	7	SENT_15	[p1l239t1478r254b1498],
7	Patients	NNS	O	patient	dep	30	SENT_15	[p1l91t1519r222b1549],
8	with	IN	O	with	_	0	SENT_15	[p1l235t1519r310b1550],
9	stage	NN	O	stage	nn	10	SENT_15	[p1l324t1525r410b1558],
10	IIIB	NN	O	iiib	prep_with	7	SENT_15	[p1l423t1521r484b1549],
11	or	CC	O	or	_	0	SENT_15	[p1l499t1528r534b1549],
12	IV	CD	NUMBER	iv	num	17	SENT_15	[p1l545t1521r582b1549],
13	non	JJ	O	non	amod	17	SENT_15	[p1l594t1518r845b1549],
14	—	JJ	O	—	amod	17	SENT_15	[p1l594t1518r845b1549],
15	small	JJ	O	small	amod	17	SENT_15	[p1l594t1518r845b1549],
16	—	NN	O	—	nn	17	SENT_15	[p1l594t1518r845b1549],
17	cell	NN	O	cell	prep_with	7	SENT_15	[p1l594t1518r845b1549],
18	lung	NN	O	lung	nn	19	SENT_15	[p1l857t1518r934b1558],
19	cancer	NN	O	cancer	nsubj	30	SENT_15	[p1l946t1529r1062b1556],
20	,	,	O	,	_	0	SENT_15	[p1l946t1529r1062b1556],
21	with	IN	O	with	_	0	SENT_15	[p1l1076t1519r1150b1549],
22	performance	NN	O	performance	nn	23	SENT_15	[p1l1163t1518r1378b1558],
23	status	NN	O	status	prep_with	19	SENT_15	[p1l1392t1525r1490b1549],
24	from	IN	O	from	_	0	SENT_15	[p1l92t1568r173b1599],
25	o	NN	O	o	prep_from	23	SENT_15	[p1l183t1571r201b1599],
26	to	TO	O	to	_	0	SENT_15	[p1l211t1575r242b1599],
27	3	CD	NUMBER	3	prep_to	25	SENT_15	[p1l252t1571r279b1606],
28	,	,	O	,	_	0	SENT_15	[p1l252t1571r279b1606],
29	were	VBD	O	be	cop	30	SENT_15	[p1l288t1579r366b1600],
30	eligible	JJ	O	eligible	_	0	SENT_15	[p1l375t1569r494b1608],
31	if	IN	O	if	mark	34	SENT_15	[p1l502t1568r531b1599],
32	they	PRP	O	they	nsubj	34	SENT_15	[p1l533t1569r601b1608],
33	had	VBD	O	have	aux	34	SENT_15	[p1l608t1569r668b1599],
34	received	VBN	O	receive	advcl	30	SENT_15	[p1l676t1569r809b1600],
35	one	CD	NUMBER	one	nn	40	SENT_15	[p1l817t1579r877b1599],
36	or	CC	O	or	_	0	SENT_15	[p1l885t1579r920b1599],
37	two	CD	NUMBER	two	conj_or	35	SENT_15	[p1l927t1575r986b1600],
38	prior	JJ	O	prior	amod	40	SENT_15	[p1l995t1569r1077b1608],
39	chemotherapy	NN	O	chemotherapy	nn	40	SENT_15	[p1l1084t1569r1320b1608],
40	regimens	NNS	O	regimen	dobj	34	SENT_15	[p1l1326t1569r1489b1608],
41	.	.	O	.	_	0	SENT_15	[p1l1326t1569r1489b1608],

1	The	DT	O	the	det	2	SENT_16	[p1l90t1618r153b1649],
2	patients	NNS	O	patient	nsubjpass	4	SENT_16	[p1l162t1619r292b1658],
3	were	VBD	O	be	auxpass	4	SENT_16	[p1l301t1629r379b1649],
4	stratified	VBN	O	stratify	_	0	SENT_16	[p1l389t1618r534b1649],
5	according	VBG	O	accord	_	0	SENT_16	[p1l543t1618r707b1658],
6	to	TO	O	to	prepc_according_to	4	SENT_16	[p1l715t1625r746b1649],
7	center	NN	O	center	pobj	4	SENT_16	[p1l756t1625r864b1656],
8	,	,	O	,	_	0	SENT_16	[p1l756t1625r864b1656],
9	performance	NN	O	performance	nn	10	SENT_16	[p1l875t1618r1086b1658],
10	status	NN	O	status	conj_and	7	SENT_16	[p1l1096t1625r1201b1656],
11	,	,	O	,	_	0	SENT_16	[p1l1096t1625r1201b1656],
12	response	NN	O	response	conj_and	7	SENT_16	[p1l1212t1628r1360b1658],
13	to	TO	O	to	_	0	SENT_16	[p1l1369t1625r1400b1649],
14	prior	JJ	O	prior	amod	15	SENT_16	[p1l1409t1619r1492b1658],
15	chemotherapy	NN	O	chemotherapy	prep_to	12	SENT_16	[p1l92t1669r332b1708],
16	,	,	O	,	_	0	SENT_16	[p1l92t1669r332b1708],
17	number	NN	O	number	conj_and	7	SENT_16	[p1l343t1669r474b1700],
18	of	IN	O	of	_	0	SENT_16	[p1l482t1668r521b1699],
19	prior	JJ	O	prior	amod	20	SENT_16	[p1l523t1669r605b1708],
20	regimens	NNS	O	regimen	prep_of	17	SENT_16	[p1l613t1669r775b1708],
21	,	,	O	,	_	0	SENT_16	[p1l613t1669r775b1708],
22	and	CC	O	and	_	0	SENT_16	[p1l787t1669r847b1699],
23	prior	RB	O	prior	advmod	25	SENT_16	[p1l856t1669r938b1708],
24	platinum-based	JJ	O	platinum-based	amod	25	SENT_16	[p1l946t1669r1205b1708],
25	therapy	NN	O	therapy	conj_and	7	SENT_16	[p1l1214t1669r1337b1708],
26	and	CC	O	and	_	0	SENT_16	[p1l1344t1669r1405b1699],
27	were	VBD	O	be	auxpass	29	SENT_16	[p1l1412t1679r1491b1700],
28	randomly	RB	O	randomly	advmod	29	SENT_16	[p1l92t1719r255b1758],
29	assigned	VBN	O	assign	conj_and	4	SENT_16	[p1l264t1719r413b1758],
30	in	IN	O	in	_	0	SENT_16	[p1l424t1719r456b1749],
31	a	DT	O	a	det	33	SENT_16	[p1l467t1729r485b1749],
32	2:1	CD	NUMBER	2:1	num	33	SENT_16	[p1l496t1721r547b1749],
33	ratio	NN	O	ratio	prep_in	29	SENT_16	[p1l559t1719r636b1749],
34	to	TO	O	to	aux	35	SENT_16	[p1l648t1725r680b1749],
35	receive	VB	O	receive	xcomp	29	SENT_16	[p1l692t1719r806b1750],
36	oral	JJ	O	oral	amod	37	SENT_16	[p1l818t1719r883b1749],
37	erlotinib	NN	O	erlotinib	dobj	35	SENT_16	[p1l895t1719r1049b1756],
38	,	,	O	,	_	0	SENT_16	[p1l895t1719r1049b1756],
39	at	IN	O	at	_	0	SENT_16	[p1l1062t1725r1094b1749],
40	a	DT	O	a	det	41	SENT_16	[p1l1103t1729r1121b1749],
41	dose	NN	O	dose	prep_at	29	SENT_16	[p1l1132t1719r1209b1749],
42	of	IN	O	of	_	0	SENT_16	[p1l1221t1718r1260b1749],
43	150	CD	NUMBER	150	num	44	SENT_16	[p1l1266t1721r1326b1749],
44	mg	NN	O	mg	prep_of	41	SENT_16	[p1l1337t1729r1393b1758],
45	daily	RB	SET	daily	advmod	44	SENT_16	[p1l1403t1719r1488b1758],
46	,	,	O	,	_	0	SENT_16	[p1l1403t1719r1488b1758],
47	or	CC	O	or	_	0	SENT_16	[p1l92t1779r127b1800],
48	placebo	NN	O	placebo	conj_or	44	SENT_16	[p1l136t1769r276b1808],
49	.	.	O	.	_	0	SENT_16	[p1l136t1769r276b1808],

1	R	NN	O	r	nn	3	SENT_17	[p1l94t1874r108b1893],
2	E	NN	O	e	nn	3	SENT_17	[p1l115t1874r128b1893],
3	S	NN	O	s	nsubj	18	SENT_17	[p1l133t1874r147b1893],
4	U	NNP	O	U	nn	8	SENT_17	[p1l154t1874r171b1893],
5	LTS	NNP	O	LTS	nn	8	SENT_17	[p1l179t1874r228b1893],
6	The	NNP	O	The	nn	8	SENT_17	[p1l90t1913r154b1944],
7	median	JJ	O	median	amod	8	SENT_17	[p1l166t1913r291b1944],
8	age	NN	O	age	dep	3	SENT_17	[p1l303t1923r359b1952],
9	of	IN	O	of	_	0	SENT_17	[p1l372t1913r412b1944],
10	the	DT	O	the	det	12	SENT_17	[p1l417t1913r468b1943],
11	731	CD	NUMBER	731	num	12	SENT_17	[p1l481t1915r541b1944],
12	patients	NNS	O	patient	prep_of	3	SENT_17	[p1l553t1913r686b1952],
13	who	WP	O	who	nsubj	14	SENT_17	[p1l697t1913r769b1944],
14	underwent	VBD	O	undergo	rcmod	12	SENT_17	[p1l782t1913r964b1944],
15	randomization	NN	O	randomization	dobj	14	SENT_17	[p1l974t1913r1223b1944],
16	was	VBD	O	be	cop	18	SENT_17	[p1l1233t1923r1297b1944],
17	61.4	CD	DURATION	61.4	num	18	SENT_17	[p1l1310t1915r1382b1944],
18	years	NNS	NUMBER	year	_	0	SENT_17	[p1l1393t1923r1489b1952],
19	;	:	O	;	_	0	SENT_17	[p1l1393t1923r1489b1952],
20	49	CD	PERCENT	49	num	21	SENT_17	[p1l91t1965r131b1994],
21	percent	NN	PERCENT	percent	nsubj	23	SENT_17	[p1l143t1969r270b2002],
22	had	VBD	O	have	aux	23	SENT_17	[p1l281t1963r342b1994],
23	received	VBN	O	receive	parataxis	18	SENT_17	[p1l355t1963r491b1994],
24	two	CD	NUMBER	two	num	27	SENT_17	[p1l504t1970r564b1994],
25	prior	JJ	O	prior	amod	27	SENT_17	[p1l577t1964r661b2002],
26	chemotherapy	NN	O	chemotherapy	nn	27	SENT_17	[p1l674t1963r914b2002],
27	regimens	NNS	O	regimen	dobj	23	SENT_17	[p1l925t1963r1091b2002],
28	,	,	O	,	_	0	SENT_17	[p1l925t1963r1091b2002],
29	and	CC	O	and	_	0	SENT_17	[p1l1106t1963r1167b1994],
30	93	CD	PERCENT	93	num	31	SENT_17	[p1l1181t1965r1219b1994],
31	percent	NN	PERCENT	percent	nsubj	33	SENT_17	[p1l1233t1970r1360b2002],
32	had	VBD	O	have	aux	33	SENT_17	[p1l1371t1963r1432b1994],
33	received	VBN	O	receive	parataxis	18	SENT_17	[p1l1445t1973r1490b1994, p1l92t2013r194b2044],
34	platinum-based	JJ	O	platinum-based	amod	35	SENT_17	[p1l208t2013r468b2052],
35	chemotherapy	NN	O	chemotherapy	dobj	33	SENT_17	[p1l481t2013r719b2052],
36	.	.	O	.	_	0	SENT_17	[p1l481t2013r719b2052],

1	The	DT	O	the	det	3	SENT_18	[p1l732t2013r794b2044],
2	response	NN	O	response	nn	3	SENT_18	[p1l807t2023r953b2052],
3	rate	NN	O	rate	nsubj	6	SENT_18	[p1l966t2020r1026b2044],
4	was	VBD	O	be	cop	6	SENT_18	[p1l1037t2023r1099b2044],
5	8.9	CD	PERCENT	8.9	num	6	SENT_18	[p1l1113t2016r1163b2044],
6	percent	NN	PERCENT	percent	_	0	SENT_18	[p1l1175t2020r1298b2052],
7	in	IN	O	in	_	0	SENT_18	[p1l1309t2014r1340b2043],
8	the	DT	O	the	det	9	SENT_18	[p1l1353t2013r1403b2044],
9	erlotinib	NN	O	erlotinib	prep_in	6	SENT_18	[p1l1416t2013r1490b2044, p1l92t2133r166b2164],

1	group	NN	O	group	nsubj	25	SENT_19	[p1l175t2143r272b2172],
2	and	CC	O	and	_	0	SENT_19	[p1l281t2133r341b2164],
3	less	JJR	O	less	mwe	4	SENT_19	[p1l350t2133r409b2164],
4	than	IN	O	than	quantmod	5	SENT_19	[p1l419t2133r492b2163],
5	1	CD	PERCENT	1	num	6	SENT_19	[p1l502t2135r519b2163],
6	percent	NN	PERCENT	percent	nsubj	25	SENT_19	[p1l528t2139r649b2172],
7	in	IN	O	in	_	0	SENT_19	[p1l655t2133r687b2163],
8	the	DT	O	the	det	10	SENT_19	[p1l695t2133r745b2164],
9	placebo	NN	O	placebo	nn	10	SENT_19	[p1l752t2133r877b2172],
10	group	NN	O	group	prep_in	6	SENT_19	[p1l885t2143r981b2172],
11	(	CD	NUMBER	(	num	12	SENT_19	[p1l992t2135r1158b2170],
12	P	NN	O	p	npadvmod	13	SENT_19	[p1l992t2135r1158b2170],
13	<	JJR	O	<	amod	6	SENT_19	[p1l992t2135r1158b2170],
14	0.001	CD	NUMBER	0.001	num	15	SENT_19	[p1l992t2135r1158b2170],
15	)	NN	O	)	dep	6	SENT_19	[p1l992t2135r1158b2170],
16	;	:	O	;	_	0	SENT_19	[p1l992t2135r1158b2170],
17	the	DT	O	the	det	19	SENT_19	[p1l1168t2133r1217b2163],
18	median	JJ	O	median	amod	19	SENT_19	[p1l1226t2133r1346b2164],
19	duration	NN	O	duration	dep	6	SENT_19	[p1l1355t2133r1491b2164],
20	of	IN	O	of	_	0	SENT_19	[p1l92t2183r131b2214],
21	the	DT	O	the	det	22	SENT_19	[p1l134t2183r183b2214],
22	response	NN	O	response	prep_of	19	SENT_19	[p1l193t2193r337b2222],
23	was	VBD	O	be	cop	25	SENT_19	[p1l346t2193r407b2214],
24	7.9	CD	DURATION	7.9	num	25	SENT_19	[p1l419t2185r468b2214],
25	months	NNS	NUMBER	month	_	0	SENT_19	[p1l478t2183r606b2214],
26	and	CC	O	and	_	0	SENT_19	[p1l619t2183r681b2214],
27	3.7	CD	DURATION	3.7	num	28	SENT_19	[p1l694t2185r745b2214],
28	months	NNS	NUMBER	month	conj_and	25	SENT_19	[p1l758t2183r898b2220],
29	,	,	O	,	_	0	SENT_19	[p1l758t2183r898b2220],
30	respectively	RB	O	respectively	advmod	25	SENT_19	[p1l912t2183r1115b2222],
31	.	.	O	.	_	0	SENT_19	[p1l912t2183r1115b2222],

1	Progression-free	JJ	O	progression-free	amod	2	SENT_20	[p1l1129t2183r1411b2222],
2	survival	NN	O	survival	nsubj	5	SENT_20	[p1l1425t2193r1490b2214, p1l90t2233r166b2264],
3	was	VBD	O	be	cop	5	SENT_20	[p1l175t2243r239b2264],
4	2.2	CD	DURATION	2.2	num	5	SENT_20	[p1l251t2236r303b2264],
5	months	NNS	NUMBER	month	_	0	SENT_20	[p1l314t2233r444b2264],
6	and	CC	O	and	_	0	SENT_20	[p1l455t2233r517b2264],
7	1.8	CD	DURATION	1.8	num	8	SENT_20	[p1l530t2236r580b2264],
8	months	NNS	NUMBER	month	conj_and	5	SENT_20	[p1l592t2233r732b2270],
9	,	,	O	,	_	0	SENT_20	[p1l592t2233r732b2270],
10	respectively	RB	O	respectively	dep	13	SENT_20	[p1l745t2233r943b2272],
11	(	CD	NUMBER	(	num	13	SENT_20	[p1l954t2233r1081b2269],
12	hazard	NN	O	hazard	nn	13	SENT_20	[p1l954t2233r1081b2269],
13	ratio	NN	O	ratio	dep	8	SENT_20	[p1l1092t2234r1180b2270],
14	,	,	O	,	_	0	SENT_20	[p1l1092t2234r1180b2270],
15	0.61	CD	NUMBER	0.61	appos	13	SENT_20	[p1l1193t2236r1276b2271],
16	,	,	O	,	_	0	SENT_20	[p1l1193t2236r1276b2271],
17	adjusted	VBN	O	adjust	partmod	8	SENT_20	[p1l1289t2233r1431b2272],
18	for	IN	O	for	_	0	SENT_20	[p1l1442t2233r1491b2264],
19	stratification	NN	O	stratification	nn	20	SENT_20	[p1l92t2353r308b2384],
20	categories	NNS	O	category	prep_for	17	SENT_20	[p1l334t2354r516b2393],
21	;	:	O	;	_	0	SENT_20	[p1l334t2354r516b2393],
22	P	NN	O	p	dep	23	SENT_20	[p1l542t2356r704b2389],
23	<	JJR	O	<	dep	8	SENT_20	[p1l542t2356r704b2389],
24	0.001	CD	NUMBER	0.001	num	25	SENT_20	[p1l542t2356r704b2389],
25	)	NN	O	)	dep	23	SENT_20	[p1l542t2356r704b2389],
26	.	.	O	.	_	0	SENT_20	[p1l542t2356r704b2389],

1	Overall	JJ	O	overall	amod	2	SENT_21	[p1l732t2353r852b2384],
2	survival	NN	O	survival	nsubj	5	SENT_21	[p1l877t2353r1005b2384],
3	was	VBD	O	be	cop	5	SENT_21	[p1l1029t2364r1093b2384],
4	6.7	CD	DURATION	6.7	num	5	SENT_21	[p1l1119t2356r1170b2384],
5	months	NNS	NUMBER	month	_	0	SENT_21	[p1l1196t2353r1325b2384],
6	and	CC	O	and	_	0	SENT_21	[p1l1351t2353r1413b2384],
7	4.7	CD	DURATION	4.7	num	8	SENT_21	[p1l1438t2356r1490b2384],
8	months	NNS	NUMBER	month	conj_and	5	SENT_21	[p1l92t2403r231b2441],
9	,	,	O	,	_	0	SENT_21	[p1l92t2403r231b2441],
10	respectively	RB	O	respectively	advmod	13	SENT_21	[p1l245t2403r443b2442],
11	(	CD	NUMBER	(	num	13	SENT_21	[p1l455t2403r582b2439],
12	hazard	NN	O	hazard	nn	13	SENT_21	[p1l455t2403r582b2439],
13	ratio	NN	O	ratio	appos	5	SENT_21	[p1l594t2404r681b2440],
14	,	,	O	,	_	0	SENT_21	[p1l594t2404r681b2440],
15	0.70	CD	NUMBER	0.70	appos	13	SENT_21	[p1l693t2406r772b2440],
16	;	:	O	;	_	0	SENT_21	[p1l693t2406r772b2440],
17	P	NN	O	p	dep	18	SENT_21	[p1l783t2406r942b2440],
18	<	JJR	O	<	dep	5	SENT_21	[p1l783t2406r942b2440],
19	0.001	CD	NUMBER	0.001	num	20	SENT_21	[p1l783t2406r942b2440],
20	)	NN	O	)	dep	18	SENT_21	[p1l783t2406r942b2440],
21	,	,	O	,	_	0	SENT_21	[p1l783t2406r942b2440],
22	in	IN	O	in	_	0	SENT_21	[p1l954t2404r986b2433],
23	favor	NN	O	favor	prep_in	5	SENT_21	[p1l997t2403r1079b2434],
24	of	IN	O	of	_	0	SENT_21	[p1l1089t2403r1128b2434],
25	erlotinib	NN	O	erlotinib	prep_of	23	SENT_21	[p1l1132t2403r1281b2434],
26	.	.	O	.	_	0	SENT_21	[p1l1132t2403r1281b2434],

1	Five	CD	PERCENT	five	num	2	SENT_22	[p1l1293t2404r1358b2434],
2	percent	NN	PERCENT	percent	nsubj	5	SENT_22	[p1l1368t2410r1493b2442],
3	of	IN	O	of	_	0	SENT_22	[p1l92t2453r131b2484],
4	patients	NNS	O	patient	prep_of	2	SENT_22	[p1l133t2454r263b2492],
5	discontinued	VBN	O	discontinue	_	0	SENT_22	[p1l274t2453r487b2484],
6	erlotinib	NN	O	erlotinib	dobj	5	SENT_22	[p1l497t2453r636b2484],
7	because	IN	O	because	_	0	SENT_22	[p1l646t2453r775b2484],
8	of	IN	O	of	prepc_because_of	5	SENT_22	[p1l785t2453r824b2484],
9	toxic	JJ	O	toxic	amod	10	SENT_22	[p1l827t2454r905b2484],
10	effects	NNS	O	effect	pobj	5	SENT_22	[p1l914t2453r1029b2484],
11	.	.	O	.	_	0	SENT_22	[p1l914t2453r1029b2484],

1	CONCLUSIONS	NNS	MISC	conclusion	nn	2	SENT_23	[p1l92t2564r331b2583],
2	Erlotinib	NN	MISC	erlotinib	nsubj	4	SENT_23	[p1l91t2604r236b2634],
3	can	MD	O	can	aux	4	SENT_23	[p1l249t2614r304b2634],
4	prolong	VB	O	prolong	_	0	SENT_23	[p1l316t2604r449b2643],
5	survival	NN	O	survival	dobj	4	SENT_23	[p1l460t2604r584b2635],
6	in	IN	O	in	_	0	SENT_23	[p1l595t2604r627b2634],
7	patients	NNS	O	patient	prep_in	4	SENT_23	[p1l639t2604r768b2643],
8	with	IN	O	with	_	0	SENT_23	[p1l780t2604r853b2635],
9	non	JJ	O	non	amod	15	SENT_23	[p1l865t2604r1110b2634],
10	—	JJ	O	—	amod	15	SENT_23	[p1l865t2604r1110b2634],
11	small	JJ	O	small	amod	15	SENT_23	[p1l865t2604r1110b2634],
12	—	NN	O	—	nn	15	SENT_23	[p1l865t2604r1110b2634],
13	cell	NN	O	cell	nn	15	SENT_23	[p1l865t2604r1110b2634],
14	lung	NN	O	lung	nn	15	SENT_23	[p1l1122t2604r1197b2643],
15	cancer	NN	O	cancer	prep_with	7	SENT_23	[p1l1208t2614r1315b2634],
16	after	IN	O	after	_	0	SENT_23	[p1l1326t2603r1401b2634],
17	ﬂrstline	NN	O	ﬂrstline	prep_after	4	SENT_23	[p1l1412t2603r1490b2634, p1l91t2653r152b2684],
18	or	CC	O	or	_	0	SENT_23	[p1l161t2663r196b2684],
19	second-line	JJ	O	second-line	amod	20	SENT_23	[p1l205t2653r395b2684],
20	chemotherapy	NN	O	chemotherapy	prep_after	4	SENT_23	[p1l405t2653r645b2692],
21	.	.	O	.	_	0	SENT_23	[p1l405t2653r645b2692],

1	N	NN	O	n	nn	3	SENT_24	[p1l431t2854r445b2869],
2	ENGLJ	NN	O	englj	nn	3	SENT_24	[p1l460t2853r544b2875],
3	MED	NN	O	med	_	0	SENT_24	[p1l559t2854r612b2869],
4	353	CD	NUMBER	353	dep	3	SENT_24	[p1l624t2853r688b2875],
5	;	:	O	;	_	0	SENT_24	[p1l624t2853r688b2875],
6	2	CD	NUMBER	2	num	8	SENT_24	[p1l624t2853r688b2875],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_24	[p1l723t2853r934b2875],
8	JULY14	NN	O	july14	dep	4	SENT_24	[p1l967t2853r1074b2875],
9	,	,	O	,	_	0	SENT_24	[p1l967t2853r1074b2875],
10	2005	CD	DATE	2005	appos	8	SENT_24	[p1l1087t2853r1151b2875],

1	The	DT	O	the	det	4	SENT_25	[p1l750t2950r801b2974],
2	New	NNP	O	New	nn	4	SENT_25	[p1l810t2951r872b2974],
3	England	NNP	O	England	nn	4	SENT_25	[p1l881t2950r992b2981],
4	Joumal	NNP	O	Joumal	_	0	SENT_25	[p1l1001t2950r1098b2974],
5	of	IN	O	of	_	0	SENT_25	[p1l1108t2950r1137b2974],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_25	[p1l1143t2950r1269b2974],

1	From	IN	O	from	dep	175	SENT_26	[p1l1532t1282r1594b1303],
2	the	DT	O	the	dep	175	SENT_26	[p1l1605t1279r1645b1303],
3	Departments	NNP	O	Departments	dep	175	SENT_26	[p1l1658t1282r1824b1311],
4	of	IN	O	of	dep	175	SENT_26	[p1l1835t1279r1863b1303],
5	Medical	NNP	O	Medical	dep	175	SENT_26	[p1l1871t1279r1968b1303],
6	Oncology	NNP	O	Oncology	dep	175	SENT_26	[p1l1980t1279r2065b1303, p1l1529t1325r1573b1348],
7	and	CC	O	and	dep	175	SENT_26	[p1l1580t1317r1624b1341],
8	Hematology	NNP	O	Hematology	dep	175	SENT_26	[p1l1636t1317r1787b1348],
9	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1797t1318r1884b1348],
10	F.A.S.	NNP	O	F.A.S.	dep	175	SENT_26	[p1l1797t1318r1884b1348],
11	)	NN	O	)	dep	175	SENT_26	[p1l1797t1318r1884b1348],
12	and	CC	O	and	dep	175	SENT_26	[p1l1895t1317r1939b1341],
13	Radiation	NNP	O	Radiation	dep	175	SENT_26	[p1l1950t1317r2065b1341],
14	Oncology	NNP	O	Oncology	dep	175	SENT_26	[p1l1530t1354r1649b1386],
15	(	NNP	O	(	dep	175	SENT_26	[p1l1659t1356r1734b1385],
16	A.B.	NNP	PERSON	A.B.	dep	175	SENT_26	[p1l1659t1356r1734b1385],
17	)	NNP	O	)	dep	175	SENT_26	[p1l1659t1356r1734b1385],
18	,	,	O	,	_	0	SENT_26	[p1l1659t1356r1734b1385],
19	the	DT	O	the	dep	175	SENT_26	[p1l1742t1354r1781b1378],
20	University	NNP	ORGANIZATION	University	dep	175	SENT_26	[p1l1791t1356r1914b1385],
21	Health	NNP	ORGANIZATION	Health	dep	175	SENT_26	[p1l1923t1354r2003b1378],
22	Network	NNP	ORGANIZATION	Network	dep	175	SENT_26	[p1l2015t1356r2066b1378, p1l1529t1392r1596b1420],
23	,	,	O	,	_	0	SENT_26	[p1l2015t1356r2066b1378, p1l1529t1392r1596b1420],
24	Princess	NNP	ORGANIZATION	Princess	dep	175	SENT_26	[p1l1619t1394r1724b1416],
25	Margaret	NNP	ORGANIZATION	Margaret	dep	175	SENT_26	[p1l1747t1394r1862b1423],
26	Hospital	NNP	ORGANIZATION	Hospital	dep	175	SENT_26	[p1l1883t1392r1989b1423],
27	Site	NN	ORGANIZATION	site	dep	175	SENT_26	[p1l2011t1394r2064b1420],
28	,	,	O	,	_	0	SENT_26	[p1l2011t1394r2064b1420],
29	and	CC	O	and	dep	175	SENT_26	[p1l1530t1429r1574b1453],
30	the	DT	O	the	dep	175	SENT_26	[p1l1585t1429r1624b1453],
31	University	NNP	O	University	dep	175	SENT_26	[p1l1636t1431r1758b1460],
32	ofToronto	NNP	O	ofToronto	dep	175	SENT_26	[p1l1768t1429r1896b1453],
33	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1910t1431r1994b1460],
34	F.A.S.	NNP	O	F.A.S.	dep	175	SENT_26	[p1l1910t1431r1994b1460],
35	,	,	O	,	_	0	SENT_26	[p1l1910t1431r1994b1460],
36	A.B.	NNP	PERSON	A.B.	dep	175	SENT_26	[p1l2005t1431r2063b1460],
37	)	CD	NUMBER	)	dep	175	SENT_26	[p1l2005t1431r2063b1460],
38	—	CD	NUMBER	—	dep	175	SENT_26	[p1l1528t1477r1560b1479],
39	both	DT	O	both	dep	175	SENT_26	[p1l1571t1462r1627b1486],
40	in	IN	O	in	dep	175	SENT_26	[p1l1641t1464r1661b1486],
41	Toronto	NNP	LOCATION	Toronto	dep	175	SENT_26	[p1l1673t1464r1781b1490],
42	;	:	O	;	_	0	SENT_26	[p1l1673t1464r1781b1490],
43	the	DT	O	the	dep	175	SENT_26	[p1l1793t1462r1833b1486],
44	Instituto	NNP	MISC	Instituto	dep	175	SENT_26	[p1l1847t1464r1955b1486],
45	de	NNP	MISC	de	dep	175	SENT_26	[p1l1967t1462r1996b1486],
46	Cancer	NNP	MISC	Cancer	dep	175	SENT_26	[p1l2009t1464r2065b1486, p1l1529t1508r1568b1524],
47	Arnaldo	NNP	PERSON	Arnaldo	dep	175	SENT_26	[p1l1576t1500r1677b1524],
48	Vieira	NNP	PERSON	Vieira	dep	175	SENT_26	[p1l1686t1502r1758b1524],
49	de	IN	PERSON	de	dep	175	SENT_26	[p1l1769t1500r1798b1524],
50	Carvalho	NNP	PERSON	Carvalho	dep	175	SENT_26	[p1l1809t1500r1926b1528],
51	,	,	O	,	_	0	SENT_26	[p1l1809t1500r1926b1528],
52	Sao	NNP	LOCATION	Sao	dep	175	SENT_26	[p1l1938t1502r1984b1524],
53	Paulo	NNP	LOCATION	Paulo	dep	175	SENT_26	[p1l1996t1500r2065b1524],
54	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1532t1539r1621b1569],
55	J.R.P.	NNP	O	J.R.P.	dep	175	SENT_26	[p1l1532t1539r1621b1569],
56	)	NN	O	)	dep	175	SENT_26	[p1l1532t1539r1621b1569],
57	;	:	O	;	_	0	SENT_26	[p1l1532t1539r1621b1569],
58	the	DT	O	the	dep	175	SENT_26	[p1l1631t1537r1670b1561],
59	Oncological	NNP	ORGANIZATION	Oncological	dep	175	SENT_26	[p1l1681t1537r1827b1569],
60	Institute	NNP	ORGANIZATION	Institute	dep	175	SENT_26	[p1l1840t1540r1940b1561],
61	Ion	NNP	ORGANIZATION	Ion	dep	175	SENT_26	[p1l1953t1540r1989b1561],
62	Chiricuta	NNP	ORGANIZATION	Chiricuta	dep	175	SENT_26	[p1l2001t1537r2066b1561, p1l1529t1580r1588b1603],
63	,	,	O	,	_	0	SENT_26	[p1l2001t1537r2066b1561, p1l1529t1580r1588b1603],
64	Cluj-Napoca	NNP	LOCATION	Cluj-Napoca	dep	175	SENT_26	[p1l1599t1575r1761b1606],
65	,	,	O	,	_	0	SENT_26	[p1l1599t1575r1761b1606],
66	Romania	NNP	LOCATION	Romania	dep	175	SENT_26	[p1l1773t1577r1883b1599],
67	(	NNP	O	(	dep	175	SENT_26	[p1l1893t1577r1964b1606],
68	T.C.	NNP	O	T.C.	dep	175	SENT_26	[p1l1893t1577r1964b1606],
69	)	NNP	O	)	dep	175	SENT_26	[p1l1893t1577r1964b1606],
70	;	:	O	;	_	0	SENT_26	[p1l1893t1577r1964b1606],
71	the	DT	O	the	dep	175	SENT_26	[p1l1974t1575r2013b1599],
72	Department	NNP	ORGANIZATION	Department	dep	175	SENT_26	[p1l2025t1577r2065b1599, p1l1531t1617r1646b1643],
73	of	IN	ORGANIZATION	of	dep	175	SENT_26	[p1l1659t1612r1687b1636],
74	Medical	NNP	ORGANIZATION	Medical	dep	175	SENT_26	[p1l1699t1612r1797b1636],
75	Oncology	NNP	ORGANIZATION	Oncology	dep	175	SENT_26	[p1l1813t1612r1939b1644],
76	,	,	O	,	_	0	SENT_26	[p1l1813t1612r1939b1644],
77	National	NNP	O	National	dep	175	SENT_26	[p1l1957t1612r2064b1636],
78	Cancer	NNP	O	Cancer	dep	175	SENT_26	[p1l1530t1652r1618b1674],
79	Centre	NNP	O	Centre	dep	175	SENT_26	[p1l1625t1652r1714b1678],
80	,	,	O	,	_	0	SENT_26	[p1l1625t1652r1714b1678],
81	Singapore	NNP	LOCATION	Singapore	dep	175	SENT_26	[p1l1724t1652r1852b1681],
82	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1863t1652r1965b1681],
83	E.H.T.	NNP	O	E.H.T.	dep	175	SENT_26	[p1l1863t1652r1965b1681],
84	)	NN	O	)	dep	175	SENT_26	[p1l1863t1652r1965b1681],
85	;	:	O	;	_	0	SENT_26	[p1l1863t1652r1965b1681],
86	the	DT	O	the	dep	175	SENT_26	[p1l1974t1650r2014b1674],
87	Department	NNP	ORGANIZATION	Department	dep	175	SENT_26	[p1l2024t1652r2065b1674, p1l1531t1692r1648b1719],
88	of	IN	ORGANIZATION	of	dep	175	SENT_26	[p1l1660t1687r1688b1711],
89	Oncology	NNP	ORGANIZATION	Oncology	dep	175	SENT_26	[p1l1696t1688r1822b1719],
90	,	,	O	,	_	0	SENT_26	[p1l1696t1688r1822b1719],
91	McGill	NNP	ORGANIZATION	McGill	dep	175	SENT_26	[p1l1838t1688r1918b1711],
92	University	NNP	ORGANIZATION	University	dep	175	SENT_26	[p1l1934t1690r2064b1719],
93	,	,	O	,	_	0	SENT_26	[p1l1934t1690r2064b1719],
94	Montreal	NNP	LOCATION	Montreal	dep	175	SENT_26	[p1l1531t1725r1645b1749],
95	(	NNP	O	(	dep	175	SENT_26	[p1l1661t1727r1740b1756],
96	V.H.	NNP	ORGANIZATION	V.H.	dep	175	SENT_26	[p1l1661t1727r1740b1756],
97	)	NNP	O	)	dep	175	SENT_26	[p1l1661t1727r1740b1756],
98	;	:	O	;	_	0	SENT_26	[p1l1661t1727r1740b1756],
99	the	DT	O	the	dep	175	SENT_26	[p1l1752t1725r1792b1749],
100	Faculty	NNP	MISC	Faculty	dep	175	SENT_26	[p1l1806t1725r1893b1756],
101	of	IN	MISC	of	dep	175	SENT_26	[p1l1904t1725r1932b1749],
102	Medicine	NNP	MISC	Medicine	dep	175	SENT_26	[p1l1941t1725r2064b1753],
103	,	,	O	,	_	0	SENT_26	[p1l1941t1725r2064b1753],
104	Chiangmai	NNP	ORGANIZATION	Chiangmai	dep	175	SENT_26	[p1l1530t1763r1662b1794],
105	University	NNP	ORGANIZATION	University	dep	175	SENT_26	[p1l1674t1765r1799b1794],
106	,	,	O	,	_	0	SENT_26	[p1l1674t1765r1799b1794],
107	Chiangmai	NNP	LOCATION	Chiangmai	dep	175	SENT_26	[p1l1809t1763r1949b1794],
108	,	,	O	,	_	0	SENT_26	[p1l1809t1763r1949b1794],
109	Thailand	NNP	LOCATION	Thailand	dep	175	SENT_26	[p1l1958t1763r2065b1787],
110	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1532t1802r1603b1831],
111	S.T.	NNP	LOCATION	S.T.	dep	175	SENT_26	[p1l1532t1802r1603b1831],
112	)	CD	NUMBER	)	dep	175	SENT_26	[p1l1532t1802r1603b1831],
113	;	:	O	;	_	0	SENT_26	[p1l1532t1802r1603b1831],
114	the	DT	O	the	dep	175	SENT_26	[p1l1612t1800r1652b1824],
115	Conﬁdence	NNP	ORGANIZATION	Conﬁdence	dep	175	SENT_26	[p1l1661t1800r1804b1824],
116	Medical	NNP	ORGANIZATION	Medical	dep	175	SENT_26	[p1l1814t1800r1912b1824],
117	Center	NNP	ORGANIZATION	Center	dep	175	SENT_26	[p1l1922t1802r2009b1828],
118	,	,	O	,	_	0	SENT_26	[p1l1922t1802r2009b1828],
119	San	NNP	LOCATION	San	dep	175	SENT_26	[p1l2019t1802r2064b1824],
120	Isidro	NNP	LOCATION	Isidro	dep	175	SENT_26	[p1l1531t1838r1609b1866],
121	,	,	O	,	_	0	SENT_26	[p1l1531t1838r1609b1866],
122	Argentina	NNP	LOCATION	Argentina	dep	175	SENT_26	[p1l1621t1839r1746b1869],
123	(	CD	NUMBER	(	dep	175	SENT_26	[p1l1760t1840r1842b1869],
124	D.C.	NNP	LOCATION	D.C.	dep	175	SENT_26	[p1l1760t1840r1842b1869],
125	)	CD	NUMBER	)	dep	175	SENT_26	[p1l1760t1840r1842b1869],
126	;	:	O	;	_	0	SENT_26	[p1l1760t1840r1842b1869],
127	Pramongkutklao	NNP	LOCATION	Pramongkutklao	dep	175	SENT_26	[p1l1857t1838r2065b1869],
128	Hospital	NNP	LOCATION	Hospital	dep	175	SENT_26	[p1l1531t1870r1641b1901],
129	,	,	O	,	_	0	SENT_26	[p1l1531t1870r1641b1901],
130	Bangkok	NNP	LOCATION	Bangkok	dep	175	SENT_26	[p1l1657t1870r1767b1901],
131	,	,	O	,	_	0	SENT_26	[p1l1657t1870r1767b1901],
132	Thailand	NNP	LOCATION	Thailand	dep	175	SENT_26	[p1l1780t1870r1886b1894],
133	(	NNP	O	(	dep	175	SENT_26	[p1l1903t1872r1984b1901],
134	S.M.	NNP	LOCATION	S.M.	dep	175	SENT_26	[p1l1903t1872r1984b1901],
135	)	NN	O	)	dep	175	SENT_26	[p1l1903t1872r1984b1901],
136	;	:	O	;	_	0	SENT_26	[p1l1903t1872r1984b1901],
137	Cross	NNP	ORGANIZATION	Cross	dep	175	SENT_26	[p1l1998t1872r2065b1894],
138	Cancer	NNP	ORGANIZATION	Cancer	dep	175	SENT_26	[p1l1530t1909r1618b1931],
139	Institute	NNP	ORGANIZATION	Institute	dep	175	SENT_26	[p1l1627t1909r1738b1935],
140	,	,	O	,	_	0	SENT_26	[p1l1627t1909r1738b1935],
141	Edmonton	NNP	LOCATION	Edmonton	dep	175	SENT_26	[p1l1749t1907r1889b1935],
142	,	,	O	,	_	0	SENT_26	[p1l1749t1907r1889b1935],
143	A	DT	O	a	dep	175	SENT_26	[p1l1898t1907r1962b1935],
144	|	JJ	O	|	dep	175	SENT_26	[p1l1898t1907r1962b1935],
145	ta.	NN	O	ta.	dep	175	SENT_26	[p1l1898t1907r1962b1935],
146	,	,	O	,	_	0	SENT_26	[p1l1898t1907r1962b1935],
147	Canada	NNP	LOCATION	Canada	dep	175	SENT_26	[p1l1971t1907r2065b1931],
148	(	NNP	O	(	dep	175	SENT_26	[p1l1532t1946r1617b1976],
149	M.S.	NNP	LOCATION	M.S.	dep	175	SENT_26	[p1l1532t1946r1617b1976],
150	)	NNP	O	)	dep	175	SENT_26	[p1l1532t1946r1617b1976],
151	;	:	O	;	_	0	SENT_26	[p1l1532t1946r1617b1976],
152	the	DT	O	the	dep	175	SENT_26	[p1l1630t1944r1670b1968],
153	Instituto	NNP	ORGANIZATION	Instituto	dep	175	SENT_26	[p1l1685t1947r1791b1968],
154	Nacional	NNP	ORGANIZATION	Nacional	dep	175	SENT_26	[p1l1806t1944r1917b1968],
155	de	NNP	ORGANIZATION	de	dep	175	SENT_26	[p1l1931t1944r1960b1968],
156	Cancer	NNP	ORGANIZATION	Cancer	dep	175	SENT_26	[p1l1973t1946r2064b1972],
157	,	,	O	,	_	0	SENT_26	[p1l1973t1946r2064b1972],
158	Praca	NNP	LOCATION	Praca	dep	175	SENT_26	[p1l1531t1984r1598b2013],
159	da	NNP	O	da	dep	175	SENT_26	[p1l1613t1982r1642b2006],
160	Cruz	NNP	PERSON	Cruz	dep	175	SENT_26	[p1l1657t1984r1714b2006],
161	Vermelha	NNP	PERSON	Vermelha	dep	175	SENT_26	[p1l1728t1982r1855b2010],
162	,	,	O	,	_	0	SENT_26	[p1l1728t1982r1855b2010],
163	Rio	NNP	LOCATION	Rio	dep	175	SENT_26	[p1l1872t1984r1911b2006],
164	de	IN	LOCATION	de	dep	175	SENT_26	[p1l1925t1982r1955b2006],
165	Janeiro	NNP	LOCATION	Janeiro	dep	175	SENT_26	[p1l1964t1984r2064b2013],
166	,	,	O	,	_	0	SENT_26	[p1l1964t1984r2064b2013],
167	Brazil	NNP	LOCATION	Brazil	dep	175	SENT_26	[p1l1531t2020r1600b2043],
168	(	NNP	O	(	dep	175	SENT_26	[p1l1618t2022r1705b2051],
169	R.M.	NNP	LOCATION	R.M.	dep	175	SENT_26	[p1l1618t2022r1705b2051],
170	)	NNP	O	)	dep	175	SENT_26	[p1l1618t2022r1705b2051],
171	;	:	O	;	_	0	SENT_26	[p1l1618t2022r1705b2051],
172	the	DT	O	the	dep	175	SENT_26	[p1l1719t2020r1759b2043],
173	Instituto	NNP	ORGANIZATION	Instituto	dep	175	SENT_26	[p1l1774t2022r1882b2044],
174	Medico	NNP	ORGANIZATION	Medico	dep	175	SENT_26	[p1l1897t2020r1991b2044],
175	Alexander	NNP	ORGANIZATION	Alexander	_	0	SENT_26	[p1l2004t2020r2065b2044, p1l1530t2127r1603b2151],

1	Fleming	NNP	PERSON	Fleming	nn	7	SENT_27	[p1l1616t2127r1725b2158],
2	,	,	O	,	_	0	SENT_27	[p1l1616t2127r1725b2158],
3	Buenos	NNP	PERSON	Buenos	appos	7	SENT_27	[p1l1741t2129r1834b2151],
4	Aires	NNP	PERSON	Aires	nn	7	SENT_27	[p1l1846t2128r1911b2151],
5	(	NNP	O	(	nn	7	SENT_27	[p1l1926t2129r2013b2158],
6	M.K.	NNP	LOCATION	M.K.	nn	7	SENT_27	[p1l1926t2129r2013b2158],
7	)	NNP	O	)	_	0	SENT_27	[p1l1926t2129r2013b2158],
8	;	:	O	;	_	0	SENT_27	[p1l1926t2129r2013b2158],
9	the	DT	O	the	det	11	SENT_27	[p1l2025t2127r2065b2151],
10	Oncology	NNP	ORGANIZATION	Oncology	nn	11	SENT_27	[p1l1530t2164r1653b2196],
11	Institute	NNP	ORGANIZATION	Institute	dep	7	SENT_27	[p1l1670t2167r1782b2192],
12	,	,	O	,	_	0	SENT_27	[p1l1670t2167r1782b2192],
13	Bucharest	NNP	LOCATION	Bucharest	appos	7	SENT_27	[p1l1801t2164r1934b2193],
14	,	,	O	,	_	0	SENT_27	[p1l1801t2164r1934b2193],
15	Romania	NNP	LOCATION	Romania	nn	18	SENT_27	[p1l1953t2167r2065b2188],
16	(	NNP	O	(	nn	18	SENT_27	[p1l1532t2204r1622b2233],
17	M.D.	NNP	O	M.D.	nn	18	SENT_27	[p1l1532t2204r1622b2233],
18	)	NNP	O	)	appos	7	SENT_27	[p1l1532t2204r1622b2233],
19	;	:	O	;	_	0	SENT_27	[p1l1532t2204r1622b2233],
20	Hotel	NNP	ORGANIZATION	Hotel	nn	24	SENT_27	[p1l1636t2202r1704b2226],
21	Dieu	NNP	ORGANIZATION	Dieu	nn	24	SENT_27	[p1l1718t2204r1774b2226],
22	Health	NNP	ORGANIZATION	Health	nn	24	SENT_27	[p1l1788t2202r1870b2226],
23	Sciences	NNPS	ORGANIZATION	Sciences	nn	24	SENT_27	[p1l1883t2204r1993b2226],
24	Hospital	NNP	ORGANIZATION	Hospital	dep	18	SENT_27	[p1l2006t2204r2065b2226, p1l1531t2240r1592b2271],
25	,	,	O	,	_	0	SENT_27	[p1l2006t2204r2065b2226, p1l1531t2240r1592b2271],
26	St.	NNP	LOCATION	St.	nn	34	SENT_27	[p1l1604t2242r1635b2264],
27	Catharines	NNP	LOCATION	Catharines	nn	34	SENT_27	[p1l1647t2240r1791b2268],
28	,	,	O	,	_	0	SENT_27	[p1l1647t2240r1791b2268],
29	Ont.	NNP	LOCATION	Ont.	appos	34	SENT_27	[p1l1804t2242r1867b2268],
30	,	,	O	,	_	0	SENT_27	[p1l1804t2242r1867b2268],
31	Canada	NNP	LOCATION	Canada	appos	34	SENT_27	[p1l1879t2240r1974b2264],
32	(	NNP	O	(	nn	34	SENT_27	[p1l1988t2242r2064b2271],
33	B.F.	NNP	LOCATION	B.F.	nn	34	SENT_27	[p1l1988t2242r2064b2271],
34	)	NNP	O	)	appos	7	SENT_27	[p1l1988t2242r2064b2271],
35	;	:	O	;	_	0	SENT_27	[p1l1988t2242r2064b2271],

1	the	DT	O	the	det	4	SENT_28	[p1l1529t2347r1569b2371],
2	National	NNP	ORGANIZATION	National	nn	4	SENT_28	[p1l1586t2347r1692b2371],
3	Cancer	NNP	ORGANIZATION	Cancer	nn	4	SENT_28	[p1l1709t2349r1796b2371],
4	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_28	[p1l1813t2349r1917b2371],
5	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1932t2347r1960b2371],
6	Canada	NNP	ORGANIZATION	Canada	prep_of	4	SENT_28	[p1l1971t2347r2065b2371],
7	Clinical	JJ	ORGANIZATION	clinical	amod	17	SENT_28	[p1l1530t2385r1621b2409],
8	Trials	NNPS	ORGANIZATION	Trials	nn	17	SENT_28	[p1l1630t2385r1697b2409],
9	Group	NNP	ORGANIZATION	Group	nn	17	SENT_28	[p1l1707t2387r1795b2416],
10	,	,	O	,	_	0	SENT_28	[p1l1707t2387r1795b2416],
11	Kingston	NNP	LOCATION	Kingston	appos	17	SENT_28	[p1l1807t2387r1925b2416],
12	,	,	O	,	_	0	SENT_28	[p1l1807t2387r1925b2416],
13	Ont.	NNP	LOCATION	Ont.	appos	17	SENT_28	[p1l1936t2387r1999b2413],
14	,	,	O	,	_	0	SENT_28	[p1l1936t2387r1999b2413],
15	Canada	NNP	LOCATION	Canada	appos	17	SENT_28	[p1l2009t2387r2065b2409, p1l1530t2422r1574b2446],
16	(	NNP	O	(	nn	17	SENT_28	[p1l1586t2424r1651b2453],
17	D.T.	NNP	LOCATION	D.T.	dep	6	SENT_28	[p1l1586t2424r1651b2453],
18	,	,	O	,	_	0	SENT_28	[p1l1586t2424r1651b2453],
19	D.J.	NNP	PERSON	D.J.	dep	6	SENT_28	[p1l1664t2424r1714b2453],
20	,	,	O	,	_	0	SENT_28	[p1l1664t2424r1714b2453],
21	L.S.	NNP	LOCATION	L.S.	nn	22	SENT_28	[p1l1726t2424r1788b2453],
22	)	NNP	O	)	dep	6	SENT_28	[p1l1726t2424r1788b2453],
23	;	:	O	;	_	0	SENT_28	[p1l1726t2424r1788b2453],
24	and	CC	O	and	_	0	SENT_28	[p1l1799t2422r1844b2446],
25	OSI	NNP	ORGANIZATION	OSI	nn	26	SENT_28	[p1l1855t2424r1901b2446],
26	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	6	SENT_28	[p1l1914t2422r2065b2446, p1l1529t2460r1602b2488],
27	,	,	O	,	_	0	SENT_28	[p1l1914t2422r2065b2446, p1l1529t2460r1602b2488],
28	Boulder	NNP	LOCATION	Boulder	dep	32	SENT_28	[p1l1614t2460r1716b2488],
29	,	,	O	,	_	0	SENT_28	[p1l1614t2460r1716b2488],
30	Colo.	NNP	LOCATION	Colo.	dep	28	SENT_28	[p1l1727t2460r1790b2484],
31	(	NNP	O	(	nn	32	SENT_28	[p1l1803t2462r1873b2491],
32	G.C.	NNP	LOCATION	G.C.	appos	4	SENT_28	[p1l1803t2462r1873b2491],
33	,	,	O	,	_	0	SENT_28	[p1l1803t2462r1873b2491],
34	P.S.	NNP	O	P.S.	nn	35	SENT_28	[p1l1886t2462r1950b2491],
35	)	NNP	O	)	appos	32	SENT_28	[p1l1886t2462r1950b2491],
36	.	.	O	.	_	0	SENT_28	[p1l1886t2462r1950b2491],

1	*	NN	O	*	_	0	SENT_29	[p1l1529t2535r1592b2559],
2	The	DT	O	the	det	3	SENT_29	[p1l1529t2535r1592b2559],
3	investigators	NNS	O	investigator	dep	1	SENT_29	[p1l1602t2537r1766b2566],
4	and	CC	O	and	_	0	SENT_29	[p1l1776t2535r1822b2559],
5	centers	NNS	O	center	dep	1	SENT_29	[p1l1832t2539r1924b2559],
6	participating	VBG	O	participate	partmod	1	SENT_29	[p1l1936t2537r2065b2566, p1l1547t2575r1585b2604],
7	in	IN	O	in	_	0	SENT_29	[p1l1600t2575r1620b2596],
8	this	DT	O	this	det	11	SENT_29	[p1l1635t2572r1681b2596],
9	National	NNP	ORGANIZATION	National	nn	11	SENT_29	[p1l1698t2572r1805b2596],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	11	SENT_29	[p1l1820t2574r1908b2596],
11	Institute	NNP	ORGANIZATION	Institute	prep_in	6	SENT_29	[p1l1923t2575r2028b2596],
12	of	IN	ORGANIZATION	of	_	0	SENT_29	[p1l2042t2572r2070b2596],
13	Canada	NNP	ORGANIZATION	Canada	nn	15	SENT_29	[p1l1546t2610r1637b2634],
14	Clinical	JJ	ORGANIZATION	clinical	amod	15	SENT_29	[p1l1647t2610r1734b2634],
15	Trials	NNPS	ORGANIZATION	Trials	prep_of	11	SENT_29	[p1l1743t2610r1807b2634],
16	Group	NNP	ORGANIZATION	Group	nn	17	SENT_29	[p1l1816t2612r1895b2641],
17	study	NN	O	study	nsubjpass	19	SENT_29	[p1l1904t2610r1970b2641],
18	are	VBP	O	be	auxpass	19	SENT_29	[p1l1978t2619r2014b2634],
19	listed	VBN	O	list	rcmod	15	SENT_29	[p1l2024t2610r2066b2634, p1l1546t2647r1574b2671],
20	in	IN	O	in	_	0	SENT_29	[p1l1584t2649r1604b2670],
21	the	DT	O	the	det	22	SENT_29	[p1l1613t2647r1652b2671],
22	Appendix	NNP	O	Appendix	prep_in	19	SENT_29	[p1l1659t2647r1782b2678],
23	.	.	O	.	_	0	SENT_29	[p1l1659t2647r1782b2678],

1	N	NN	MISC	n	nn	3	SENT_30	[p1l1531t2712r1549b2733],
2	Englj	NNP	MISC	Englj	nn	3	SENT_30	[p1l1563t2710r1630b2741],
3	Med	NNP	O	Med	_	0	SENT_30	[p1l1644t2710r1697b2734],
4	2005	CD	DATE	2005	num	3	SENT_30	[p1l1708t2711r1925b2738],
5	;	:	O	;	_	0	SENT_30	[p1l1708t2711r1925b2738],
6	353:123	CD	NUMBER	353:123	number	7	SENT_30	[p1l1708t2711r1925b2738],
7	-32	CD	NUMBER	-32	dep	3	SENT_30	[p1l1708t2711r1925b2738],
8	.	.	O	.	_	0	SENT_30	[p1l1708t2711r1925b2738],

1	Copyright	NN	O	copyright	_	0	SENT_31	[p1l1530t2752r1623b2777],
2	©	CD	NUMBER	©	num	6	SENT_31	[p1l1631t2754r1652b2775],
3	2005	CD	DATE	2005	num	6	SENT_31	[p1l1661t2753r1710b2771],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_31	[p1l1718t2752r1858b2771],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_31	[p1l1866t2752r1943b2771],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_31	[p1l1949t2753r2021b2777],
7	.	.	O	.	_	0	SENT_31	[p1l1949t2753r2021b2777],

1	The	DT	O	the	det	4	SENT_32	[p1l715t3138r752b3159],
2	NEW	NNP	O	NEW	nn	4	SENT_32	[p1l764t3140r845b3159],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_32	[p1l859t3140r1034b3159],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_32	[p1l1048t3140r1214b3166],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_32	[p1l1228t3138r1444b3165],

1	UNG	NNP	O	UNG	nn	2	SENT_33	[p1l332t3370r544b3427],
2	CANCER	NNP	O	CANCER	nsubj	6	SENT_33	[p1l565t3371r940b3427],
3	IS	VBZ	O	be	cop	6	SENT_33	[p1l960t3371r1038b3427],
4	THE	DT	O	the	det	6	SENT_33	[p1l1057t3371r1245b3426],
5	LEADING	VBG	O	lead	amod	6	SENT_33	[p1l1270t3370r1690b3427],
6	CAUSE	NN	O	cause	_	0	SENT_33	[p1l1711t3371r1996b3427],
7	OF	IN	O	of	prep	6	SENT_33	[p1l2019t3370r2135b3427],

1	cancer	NN	O	cancer	nn	2	SENT_34	[p1l332t3503r607b3556],
2	death	NN	O	death	_	0	SENT_34	[p1l649t3478r881b3556],
3	among	IN	O	among	_	0	SENT_34	[p1l925t3503r1225b3578],
4	men	NNS	O	man	prep_among	2	SENT_34	[p1l1266t3503r1452b3556],
5	and	CC	O	and	_	0	SENT_34	[p1l1495t3478r1652b3556],
6	women	NNS	O	woman	conj_and	4	SENT_34	[p1l1692t3503r2010b3557],
7	in	IN	O	in	_	0	SENT_34	[p1l2054t3479r2135b3555],
8	North	NNP	LOCATION	North	nn	9	SENT_34	[p1l329t3607r577b3685],
9	America	NNP	LOCATION	America	prep_in	2	SENT_34	[p1l591t3607r958b3685],
10	.	.	O	.	_	0	SENT_34	[p1l591t3607r958b3685],

1	1	CD	NUMBER	1	npadvmod	13	SENT_35	[p1l969t3601r1003b3645],
2	In	IN	O	in	_	0	SENT_35	[p1l1020t3614r1106b3684],
3	advanced	JJ	O	advanced	amod	5	SENT_35	[p1l1124t3606r1506b3686],
4	non	JJ	O	non	amod	5	SENT_35	[p1l1524t3606r2137b3685],
5	—	NN	O	—	prep_in	13	SENT_35	[p1l1524t3606r2137b3685],
6	small	JJ	O	small	amod	10	SENT_35	[p1l1524t3606r2137b3685],
7	—	NN	O	—	nn	10	SENT_35	[p1l1524t3606r2137b3685],
8	cell	NN	O	cell	nn	10	SENT_35	[p1l1524t3606r2137b3685],
9	lung	NN	O	lung	nn	10	SENT_35	[p2l11t32r201b132],
10	cancer	NN	O	cancer	dep	5	SENT_35	[p2l231t57r517b127],
11	,	,	O	,	_	0	SENT_35	[p2l231t57r517b127],
12	chemotherapy	NN	O	chemotherapy	nsubj	13	SENT_35	[p2l556t31r1154b132],
13	offers	VBZ	O	offer	_	0	SENT_35	[p2l1182t31r1418b110],
14	symptomatic	JJ	O	symptomatic	amod	15	SENT_35	[p2l1454t32r1993b132],
15	relief	NN	O	relief	dobj	13	SENT_35	[p2l2025t58r2134b110, p2l11t158r157b236],
16	and	CC	O	and	_	0	SENT_35	[p2l164t158r318b236],
17	modest	JJ	O	modest	amod	18	SENT_35	[p2l343t159r656b236],
18	improvement	NN	O	improvement	conj_and	15	SENT_35	[p2l676t159r1242b258],
19	in	IN	O	in	_	0	SENT_35	[p2l1262t159r1342b235],
20	survivalz	NN	O	survivalz	prep_in	15	SENT_35	[p2l1369t154r1744b253],
21	;	:	O	;	_	0	SENT_35	[p2l1369t154r1744b253],
22	responses	NNS	O	response	nsubj	24	SENT_35	[p2l1774t184r2134b258, p2l12t313r95b365],
23	are	VBP	O	be	cop	24	SENT_35	[p2l123t313r252b365],
24	brief	JJ	O	brief	parataxis	13	SENT_35	[p2l280t286r505b382],
25	,	,	O	,	_	0	SENT_35	[p2l280t286r505b382],
26	with	IN	O	with	_	0	SENT_35	[p2l533t287r727b366],
27	a	DT	O	a	det	29	SENT_35	[p2l752t313r797b365],
28	median	JJ	O	median	amod	29	SENT_35	[p2l822t287r1146b365],
29	time	NN	O	time	prep_with	24	SENT_35	[p2l1173t287r1364b365],
30	to	TO	O	to	_	0	SENT_35	[p2l1391t303r1472b365],
31	progression	NN	O	progression	prep_to	29	SENT_35	[p2l1498t287r2023b387],
32	of	IN	O	of	_	0	SENT_35	[p2l2050t286r2152b365],
33	three	CD	NUMBER	three	number	35	SENT_35	[p2l12t414r229b493],
34	to	TO	O	to	dep	35	SENT_35	[p2l267t431r348b493],
35	ﬁve	CD	NUMBER	ﬁve	num	36	SENT_35	[p2l386t414r535b494],
36	months	NNS	NUMBER	month	prep_of	31	SENT_35	[p2l573t415r929b493],
37	.	.	O	.	_	0	SENT_35	[p2l573t415r929b493],

1	Second	JJ	ORDINAL	second	amod	4	SENT_36	[p2l974t414r1481b493],
2	—	NN	O	—	nn	4	SENT_36	[p2l974t414r1481b493],
3	line	NN	O	line	nn	4	SENT_36	[p2l974t414r1481b493],
4	chemotherapy	NN	O	chemotherapy	nsubj	8	SENT_36	[p2l1520t414r2138b515],
5	with	IN	O	with	_	0	SENT_36	[p2l7t543r196b622],
6	docetaxel	NN	O	docetaxel	prep_with	4	SENT_36	[p2l219t542r616b621],
7	can	MD	O	can	aux	8	SENT_36	[p2l639t568r782b621],
8	prolong	VB	O	prolong	_	0	SENT_36	[p2l803t542r1145b643],
9	survival	NN	O	survival	dobj	8	SENT_36	[p2l1165t543r1483b622],
10	after	IN	O	after	_	0	SENT_36	[p2l1504t542r1697b621],
11	platinumbased	JJ	O	platinumbased	amod	12	SENT_36	[p2l1715t542r2134b643, p2l12t670r258b747],
12	therapy	NN	O	therapy	prep_after	8	SENT_36	[p2l296t670r619b769],
13	for	IN	O	for	_	0	SENT_36	[p2l652t669r777b747],
14	non	JJ	O	non	amod	20	SENT_36	[p2l811t669r1457b747],
15	—	JJ	O	—	amod	20	SENT_36	[p2l811t669r1457b747],
16	small	JJ	O	small	amod	20	SENT_36	[p2l811t669r1457b747],
17	—	NN	O	—	nn	20	SENT_36	[p2l811t669r1457b747],
18	cell	NN	O	cell	nn	20	SENT_36	[p2l811t669r1457b747],
19	lung	NN	O	lung	nn	20	SENT_36	[p2l1493t670r1689b769],
20	cancer	NN	O	cancer	prep_for	12	SENT_36	[p2l1725t665r2134b747],
21	.	.	O	.	_	0	SENT_36	[p2l1725t665r2134b747],

1	-	:	O	-	_	0	SENT_37	[p2l1725t665r2134b747],
2	°	NN	O	°	_	0	SENT_37	[p2l1725t665r2134b747],
3	”	CD	NUMBER	”	num	4	SENT_37	[p2l1725t665r2134b747],
4	4	CD	NUMBER	4	nsubj	8	SENT_37	[p2l1725t665r2134b747],
5	However	RB	O	however	advmod	8	SENT_37	[p2l11t805r414b893],
6	,	,	O	,	_	0	SENT_37	[p2l11t805r414b893],
7	there	EX	O	there	expl	8	SENT_37	[p2l458t798r677b876],
8	is	VBZ	O	be	rcmod	2	SENT_37	[p2l715t798r781b876],
9	at	IN	O	at	_	0	SENT_37	[p2l821t814r902b876],
10	present	JJ	DATE	present	amod	13	SENT_37	[p2l934t814r1262b898],
11	no	DT	O	no	det	13	SENT_37	[p2l1295t823r1403b876],
12	deﬁned	JJ	O	deﬁned	amod	13	SENT_37	[p2l1444t797r1768b876],
13	role	NN	O	role	prep_at	8	SENT_37	[p2l1806t797r1972b876],
14	for	IN	O	for	_	0	SENT_37	[p2l2010t797r2137b876],
15	third	JJ	ORDINAL	third	amod	18	SENT_37	[p2l12t925r421b1004],
16	—	NN	O	—	nn	18	SENT_37	[p2l12t925r421b1004],
17	line	NN	O	line	nn	18	SENT_37	[p2l12t925r421b1004],
18	chemotherapy	NN	O	chemotherapy	prep_for	13	SENT_37	[p2l464t926r1095b1026],
19	.	.	O	.	_	0	SENT_37	[p2l464t926r1095b1026],

1	The	DT	O	the	det	2	SENT_38	[p2l1138t925r1301b1004],
2	futility	NN	O	futility	nsubjpass	10	SENT_38	[p2l1343t925r1626b1026],
3	of	IN	O	of	_	0	SENT_38	[p2l1664t925r1765b1004],
4	offering	VBG	O	offer	prepc_of	2	SENT_38	[p2l1789t925r2138b1026],
5	third	JJ	ORDINAL	third	amod	8	SENT_38	[p2l12t1053r401b1132],
6	—	NN	O	—	nn	8	SENT_38	[p2l12t1053r401b1132],
7	line	NN	O	line	nn	8	SENT_38	[p2l12t1053r401b1132],
8	chemotherapy	NN	O	chemotherapy	dobj	4	SENT_38	[p2l424t1053r1021b1154],
9	was	VBD	O	be	auxpass	10	SENT_38	[p2l1035t1080r1194b1133],
10	demonstrated	VBN	O	demonstrate	_	0	SENT_38	[p2l1218t1053r1795b1132],
11	by	IN	O	by	_	0	SENT_38	[p2l1818t1053r1914b1154],
12	Massarelli	NNP	PERSON	Massarelli	agent	10	SENT_38	[p2l1929t1061r2134b1132, p2l13t1180r271b1258],
13	et	FW	O	et	nn	15	SENT_38	[p2l295t1197r372b1258],
14	al.	FW	O	al.	nn	15	SENT_38	[p2l391t1176r561b1275],
15	,5	NN	O	,5	dobj	10	SENT_38	[p2l391t1176r561b1275],
16	who	WP	O	who	nsubj	17	SENT_38	[p2l583t1181r769b1259],
17	reported	VBD	O	report	rcmod	15	SENT_38	[p2l795t1181r1161b1280],
18	a	DT	O	a	det	20	SENT_38	[p2l1184t1207r1228b1258],
19	response	NN	O	response	nn	20	SENT_38	[p2l1250t1206r1637b1280],
20	rate	NN	O	rate	dobj	17	SENT_38	[p2l1662t1196r1821b1258],
21	of	IN	O	of	_	0	SENT_38	[p2l1846t1180r1947b1258],
22	only	RB	O	only	quantmod	23	SENT_38	[p2l1954t1181r2139b1280],
23	2	CD	PERCENT	2	num	24	SENT_38	[p2l11t1314r59b1386],
24	percent	NN	PERCENT	percent	prep_of	20	SENT_38	[p2l93t1325r420b1409],
25	and	CC	O	and	_	0	SENT_38	[p2l450t1309r608b1387],
26	a	DT	O	a	det	28	SENT_38	[p2l643t1335r687b1387],
27	median	JJ	O	median	amod	28	SENT_38	[p2l720t1309r1042b1387],
28	survival	NN	O	survival	conj_and	20	SENT_38	[p2l1079t1309r1404b1388],
29	of	IN	O	of	_	0	SENT_38	[p2l1440t1308r1542b1387],
30	four	CD	DURATION	four	num	31	SENT_38	[p2l1559t1308r1740b1388],
31	months	NNS	NUMBER	month	prep_of	28	SENT_38	[p2l1772t1308r2129b1387],
32	.	.	O	.	_	0	SENT_38	[p2l1772t1308r2129b1387],

1	Shepherd	NNP	O	Shepherd	nsubj	5	SENT_39	[p2l13t1436r420b1536],
2	et	FW	O	et	nn	3	SENT_39	[p2l444t1452r520b1514],
3	al.	FW	O	al.	dep	1	SENT_39	[p2l538t1429r678b1514],
4	6	CD	NUMBER	6	dep	1	SENT_39	[p2l538t1429r678b1514],
5	showed	VBD	O	show	_	0	SENT_39	[p2l703t1436r1026b1515],
6	that	IN	O	that	complm	24	SENT_39	[p2l1050t1436r1217b1514],
7	among	IN	O	among	_	0	SENT_39	[p2l1235t1461r1534b1536],
8	patients	NNS	O	patient	prep_among	24	SENT_39	[p2l1553t1437r1888b1536],
9	treated	VBN	O	treat	partmod	8	SENT_39	[p2l1913t1452r2134b1514, p2l12t1565r108b1643],
10	with	IN	O	with	_	0	SENT_39	[p2l138t1565r327b1644],
11	docetaxel	NN	O	docetaxel	prep_with	9	SENT_39	[p2l364t1565r761b1643],
12	after	IN	O	after	_	0	SENT_39	[p2l795t1564r989b1643],
13	the	DT	O	the	det	14	SENT_39	[p2l1022t1565r1151b1643],
14	failure	NN	O	failure	prep_after	9	SENT_39	[p2l1186t1564r1455b1644],
15	of	IN	O	of	_	0	SENT_39	[p2l1492t1564r1592b1643],
16	two	CD	NUMBER	two	num	20	SENT_39	[p2l1609t1581r1761b1644],
17	or	CC	O	or	_	0	SENT_39	[p2l1799t1590r1888b1643],
18	more	JJR	O	more	num	20	SENT_39	[p2l1918t1590r2135b1643],
19	chemotherapy	NN	O	chemotherapy	nn	20	SENT_39	[p2l12t1693r609b1793],
20	regimens	NNS	O	regimen	prep_of	14	SENT_39	[p2l645t1693r1057b1793],
21	,	,	O	,	_	0	SENT_39	[p2l645t1693r1057b1793],
22	survival	NN	O	survival	nsubj	24	SENT_39	[p2l1105t1693r1417b1772],
23	was	VBD	O	be	cop	24	SENT_39	[p2l1453t1719r1613b1772],
24	identical	JJ	O	identical	ccomp	5	SENT_39	[p2l1655t1693r2013b1771],
25	to	TO	O	to	_	0	SENT_39	[p2l2056t1709r2134b1771],
26	that	DT	O	that	prep_to	24	SENT_39	[p2l12t1821r179b1899],
27	among	IN	O	among	_	0	SENT_39	[p2l198t1846r497b1921],
28	patients	NNS	O	patient	prep_among	26	SENT_39	[p2l518t1821r852b1921],
29	treated	VBN	O	treat	partmod	28	SENT_39	[p2l880t1820r1168b1899],
30	with	IN	O	with	_	0	SENT_39	[p2l1189t1821r1378b1900],
31	supportive	JJ	O	supportive	amod	32	SENT_39	[p2l1405t1821r1848b1921],
32	care	NN	O	care	prep_with	29	SENT_39	[p2l1873t1847r2067b1899],
33	.	.	O	.	_	0	SENT_39	[p2l1873t1847r2067b1899],

1	The	DT	O	the	det	5	SENT_40	[p2l137t1948r298b2027],
2	epidermal	JJ	O	epidermal	amod	5	SENT_40	[p2l340t1949r764b2049],
3	growth	NN	O	growth	nn	5	SENT_40	[p2l804t1949r1107b2049],
4	factor	NN	O	factor	nn	5	SENT_40	[p2l1147t1948r1394b2027],
5	receptor	NN	O	receptor	nsubj	11	SENT_40	[p2l1431t1965r1782b2049],
6	(	CD	NUMBER	(	num	9	SENT_40	[p2l1824t1954r2130b2040],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_40	[p2l1824t1954r2130b2040],
8	)	NN	O	)	nn	9	SENT_40	[p2l1824t1954r2130b2040],
9	family	NN	O	family	dep	5	SENT_40	[p2l11t2076r277b2177],
10	is	VBZ	O	be	cop	11	SENT_40	[p2l293t2077r358b2155],
11	part	NN	O	part	_	0	SENT_40	[p2l381t2093r554b2177],
12	of	IN	O	of	_	0	SENT_40	[p2l571t2076r672b2155],
13	a	DT	O	a	det	18	SENT_40	[p2l675t2103r719b2155],
14	complex	JJ	O	complex	amod	18	SENT_40	[p2l740t2077r1101b2177],
15	signal	NN	O	signal	nn	18	SENT_40	[p2l1121t2076r1950b2177],
16	—	NN	O	—	nn	18	SENT_40	[p2l1121t2076r1950b2177],
17	transduction	NN	O	transduction	nn	18	SENT_40	[p2l1121t2076r1950b2177],
18	network	NN	O	network	prep_of	11	SENT_40	[p2l1971t2093r2134b2155, p2l7t2205r229b2284],
19	that	WDT	O	that	nsubj	21	SENT_40	[p2l257t2205r424b2283],
20	is	VBZ	O	be	cop	21	SENT_40	[p2l451t2205r515b2283],
21	central	JJ	O	central	rcmod	18	SENT_40	[p2l551t2204r838b2283],
22	to	TO	O	to	_	0	SENT_40	[p2l870t2221r949b2283],
23	several	JJ	O	several	amod	26	SENT_40	[p2l984t2205r1269b2284],
24	critical	JJ	O	critical	amod	26	SENT_40	[p2l1301t2205r1585b2283],
25	cellular	JJ	O	cellular	amod	26	SENT_40	[p2l1618t2205r1929b2284],
26	processes	NNS	O	process	prep_to	21	SENT_40	[p2l1957t2230r2134b2305, p2l12t2359r297b2411],
27	.	.	O	.	_	0	SENT_40	[p2l1957t2230r2134b2305, p2l12t2359r297b2411],

1	Since	IN	O	since	mark	5	SENT_41	[p2l342t2333r563b2411],
2	EGFR	NN	ORGANIZATION	egfr	nsubjpass	5	SENT_41	[p2l600t2338r859b2416],
3	is	VBZ	O	be	auxpass	5	SENT_41	[p2l885t2333r950b2411],
4	often	RB	O	often	advmod	5	SENT_41	[p2l991t2332r1207b2411],
5	found	VBN	O	find	advcl	20	SENT_41	[p2l1245t2332r1496b2412],
6	in	IN	O	in	_	0	SENT_41	[p2l1532t2333r1613b2410],
7	non	JJ	O	non	amod	12	SENT_41	[p2l1650t2332r2134b2411, p2l12t2459r155b2537],
8	—	NN	O	—	nn	12	SENT_41	[p2l1650t2332r2134b2411, p2l12t2459r155b2537],
9	smallcell	NN	O	smallcell	nn	12	SENT_41	[p2l1650t2332r2134b2411, p2l12t2459r155b2537],
10	lung	NN	O	lung	nn	12	SENT_41	[p2l191t2459r388b2559],
11	cancer	NN	O	cancer	nn	12	SENT_41	[p2l422t2485r703b2537],
12	cells	NNS	O	cell	prep_in	5	SENT_41	[p2l738t2455r1062b2554],
13	,7	CD	NUMBER	,7	number	14	SENT_41	[p2l738t2455r1062b2554],
14	’	CD	NUMBER	’	dep	12	SENT_41	[p2l738t2455r1062b2554],
15	8	CD	NUMBER	8	dep	14	SENT_41	[p2l738t2455r1062b2554],
16	it	PRP	O	it	nsubj	20	SENT_41	[p2l1099t2460r1160b2537],
17	has	VBZ	O	have	aux	20	SENT_41	[p2l1192t2460r1334b2537],
18	been	VBN	O	be	cop	20	SENT_41	[p2l1374t2460r1577b2537],
19	the	DT	O	the	det	20	SENT_41	[p2l1614t2460r1746b2537],
20	focus	NN	O	focus	_	0	SENT_41	[p2l1783t2459r2011b2538],
21	of	IN	O	of	_	0	SENT_41	[p2l2051t2459r2152b2537],
22	efforts	NNS	O	effort	prep_of	20	SENT_41	[p2l12t2587r289b2666],
23	to	TO	O	to	aux	24	SENT_41	[p2l320t2604r399b2666],
24	develop	VB	O	develop	infmod	22	SENT_41	[p2l427t2587r748b2688],
25	new	JJ	O	new	amod	26	SENT_41	[p2l776t2613r951b2667],
26	agents	NNS	O	agent	dobj	24	SENT_41	[p2l973t2604r1245b2688],
27	that	WDT	O	that	nsubj	28	SENT_41	[p2l1274t2588r1441b2666],
28	target	VBP	O	target	rcmod	26	SENT_41	[p2l1462t2604r1711b2688],
29	the	DT	O	the	det	31	SENT_41	[p2l1733t2587r1862b2666],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_41	[p2l1886t2593r2146b2671],
31	pathway	NN	O	pathway	dobj	28	SENT_41	[p2l10t2716r377b2816],
32	.	.	O	.	_	0	SENT_41	[p2l10t2716r377b2816],

1	Erlotinib	NNP	O	Erlotinib	dep	113	SENT_42	[p2l412t2716r784b2794],
2	(	NNP	O	(	dep	113	SENT_42	[p2l820t2721r1186b2811],
3	Tarceva	NNP	O	Tarceva	dep	113	SENT_42	[p2l820t2721r1186b2811],
4	,	,	O	,	_	0	SENT_42	[p2l820t2721r1186b2811],
5	OSI	NNP	ORGANIZATION	OSI	dep	113	SENT_42	[p2l1223t2721r1378b2794],
6	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	113	SENT_42	[p2l1406t2715r2130b2807],
7	)	NN	O	)	dep	113	SENT_42	[p2l1406t2715r2130b2807],
8	and	CC	O	and	dep	113	SENT_42	[p2l11t2843r166b2922],
9	geﬁtinib	NN	O	geﬁtinib	dep	113	SENT_42	[p2l198t2843r562b2944],
10	(	CD	NUMBER	(	dep	113	SENT_42	[p2l601t2851r907b2939],
11	Iressa	NNP	O	Iressa	dep	113	SENT_42	[p2l601t2851r907b2939],
12	,	,	O	,	_	0	SENT_42	[p2l601t2851r907b2939],
13	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	dep	113	SENT_42	[p2l943t2851r1504b2935],
14	)	CD	NUMBER	)	dep	113	SENT_42	[p2l943t2851r1504b2935],
15	inhibit	VBP	O	inhibit	dep	113	SENT_42	[p2l1543t2844r1835b2922],
16	the	DT	O	the	dep	113	SENT_42	[p2l1864t2844r1995b2922],
17	ty	NN	O	ty	dep	113	SENT_42	[p2l2029t2860r2133b2944],
18	—	NN	O	—	dep	113	SENT_42	[p2l2029t2860r2133b2944],
19	rosine	NN	O	rosine	dep	113	SENT_42	[p2l11t2972r273b3050],
20	kinase	NN	O	kinase	dep	113	SENT_42	[p2l302t2972r569b3051],
21	activity	NN	O	activity	dep	113	SENT_42	[p2l598t2972r890b3072],
22	of	IN	O	of	dep	113	SENT_42	[p2l915t2971r1015b3050],
23	EGFR	NN	ORGANIZATION	egfr	dep	113	SENT_42	[p2l1023t2977r1281b3055],
24	and	CC	O	and	dep	113	SENT_42	[p2l1298t2972r1453b3050],
25	have	VBP	O	have	dep	113	SENT_42	[p2l1481t2972r1667b3051],
26	been	VBN	O	be	dep	113	SENT_42	[p2l1698t2972r1895b3050],
27	studied	VBN	O	study	dep	113	SENT_42	[p2l1925t2971r2134b3051, p2l11t3100r135b3178],
28	eXtensively	RB	O	extensively	dep	113	SENT_42	[p2l155t3094r793b3200],
29	.9	CD	NUMBER	.9	dep	113	SENT_42	[p2l155t3094r793b3200],
30	'12	CD	NUMBER	'12	dep	113	SENT_42	[p2l155t3094r793b3200],
31	In	IN	O	in	dep	113	SENT_42	[p2l814t3107r902b3177],
32	randomized	JJ	O	randomized	dep	113	SENT_42	[p2l925t3100r1446b3178],
33	phase	NN	O	phase	dep	113	SENT_42	[p2l1467t3100r1718b3200],
34	2	CD	NUMBER	2	dep	113	SENT_42	[p2l1741t3106r1788b3177],
35	trials	NNS	O	trial	dep	113	SENT_42	[p2l1813t3100r2025b3178],
36	of	IN	O	of	dep	113	SENT_42	[p2l2051t3099r2152b3178],
37	geﬁtinib	NN	O	geﬁtinib	dep	113	SENT_42	[p2l11t3227r362b3328],
38	(	CD	NUMBER	(	dep	113	SENT_42	[p2l393t3234r666b3319],
39	Iressa	NNP	O	Iressa	dep	113	SENT_42	[p2l393t3234r666b3319],
40	Dose	NNP	O	Dose	dep	113	SENT_42	[p2l688t3234r899b3306],
41	Evaluation	NN	O	evaluation	dep	113	SENT_42	[p2l923t3228r1363b3307],
42	in	IN	O	in	dep	113	SENT_42	[p2l1387t3228r1468b3305],
43	Advanced	NNP	O	Advanced	dep	113	SENT_42	[p2l1490t3227r1898b3307],
44	Lung	NN	O	lung	dep	113	SENT_42	[p2l1921t3235r2139b3328],
45	Cancer	NN	O	cancer	dep	113	SENT_42	[p2l11t3361r313b3433],
46	[	CD	NUMBER	[	dep	113	SENT_42	[p2l346t3362r684b3445],
47	IDEAL	JJ	O	ideal	dep	113	SENT_42	[p2l346t3362r684b3445],
48	]	NN	O	]	dep	113	SENT_42	[p2l346t3362r684b3445],
49	1	CD	NUMBER	1	dep	113	SENT_42	[p2l725t3361r769b3432],
50	and	CC	O	and	dep	113	SENT_42	[p2l797t3355r955b3433],
51	2	CD	NUMBER	2	dep	113	SENT_42	[p2l983t3349r1286b3450],
52	)	CD	NUMBER	)	dep	113	SENT_42	[p2l983t3349r1286b3450],
53	,1	CD	NUMBER	,1	dep	113	SENT_42	[p2l983t3349r1286b3450],
54	°	CD	NUMBER	°	dep	113	SENT_42	[p2l983t3349r1286b3450],
55	’“	IN	O	’“	dep	113	SENT_42	[p2l983t3349r1286b3450],
56	the	DT	O	the	dep	113	SENT_42	[p2l1315t3355r1445b3433],
57	tumors	NNS	O	tumor	dep	113	SENT_42	[p2l1474t3371r1780b3434],
58	of	IN	O	of	dep	113	SENT_42	[p2l1811t3354r1912b3433],
59	10	CD	NUMBER	10	dep	113	SENT_42	[p2l1925t3361r2023b3433],
60	to	TO	O	to	dep	113	SENT_42	[p2l2052t3371r2132b3433],
61	20	CD	PERCENT	20	dep	113	SENT_42	[p2l11t3489r113b3562],
62	percent	NN	PERCENT	percent	dep	113	SENT_42	[p2l144t3500r471b3584],
63	of	IN	O	of	dep	113	SENT_42	[p2l499t3483r601b3562],
64	patients	NNS	O	patient	dep	113	SENT_42	[p2l613t3484r955b3584],
65	who	WP	O	who	dep	113	SENT_42	[p2l985t3484r1170b3563],
66	were	VBD	O	be	dep	113	SENT_42	[p2l1199t3510r1404b3563],
67	previously	RB	DATE	previously	dep	113	SENT_42	[p2l1435t3483r1879b3584],
68	treated	VBN	O	treat	dep	113	SENT_42	[p2l1907t3500r2133b3562, p2l12t3612r109b3690],
69	with	IN	O	with	dep	113	SENT_42	[p2l125t3612r318b3691],
70	platinum	NN	O	platinum	dep	113	SENT_42	[p2l340t3611r1021b3712],
71	—	NN	O	—	dep	113	SENT_42	[p2l340t3611r1021b3712],
72	based	VBN	O	base	dep	113	SENT_42	[p2l340t3611r1021b3712],
73	regimens	NNS	O	regimen	dep	113	SENT_42	[p2l1044t3612r1444b3712],
74	responded	VBD	O	respond	dep	113	SENT_42	[p2l1469t3611r1948b3712],
75	,	,	O	,	_	0	SENT_42	[p2l1469t3611r1948b3712],
76	and	CC	O	and	dep	113	SENT_42	[p2l1976t3611r2134b3690],
77	in	IN	O	in	dep	113	SENT_42	[p3l11t21r94b98],
78	a	DT	O	a	dep	113	SENT_42	[p3l133t47r177b99],
79	phase	NN	O	phase	dep	113	SENT_42	[p3l216t21r468b121],
80	2	CD	NUMBER	2	dep	113	SENT_42	[p3l509t26r555b98],
81	trial	NN	O	trial	dep	113	SENT_42	[p3l598t21r771b99],
82	of	IN	O	of	dep	113	SENT_42	[p3l812t20r914b99],
83	erlotinib	NN	O	erlotinib	dep	113	SENT_42	[p3l936t21r1307b99],
84	among	IN	O	among	dep	113	SENT_42	[p3l1348t46r1654b121],
85	previously	RB	DATE	previously	dep	113	SENT_42	[p3l1690t21r2139b121],
86	treated	VBN	O	treat	dep	113	SENT_42	[p3l12t148r307b227],
87	patients	NNS	O	patient	dep	113	SENT_42	[p3l337t149r674b249],
88	with	IN	O	with	dep	113	SENT_42	[p3l698t149r884b228],
89	non	JJ	O	non	dep	113	SENT_42	[p3l910t149r1526b227],
90	—	JJ	O	—	dep	113	SENT_42	[p3l910t149r1526b227],
91	small	JJ	O	small	dep	113	SENT_42	[p3l910t149r1526b227],
92	—	NN	O	—	dep	113	SENT_42	[p3l910t149r1526b227],
93	cell	NN	O	cell	dep	113	SENT_42	[p3l910t149r1526b227],
94	lung	NN	O	lung	dep	113	SENT_42	[p3l1551t149r1741b249],
95	cancer	NN	O	cancer	dep	113	SENT_42	[p3l1765t174r2034b227],
96	in	IN	O	in	dep	113	SENT_42	[p3l2056t149r2137b226],
97	which	WDT	O	which	dep	113	SENT_42	[p3l7t277r262b356],
98	10	CD	PERCENT	10	dep	113	SENT_42	[p3l304t282r402b355],
99	percent	NN	PERCENT	percent	dep	113	SENT_42	[p3l440t293r767b377],
100	or	CC	O	or	dep	113	SENT_42	[p3l801t302r892b355],
101	more	JJR	O	more	dep	113	SENT_42	[p3l927t302r1150b355],
102	of	IN	O	of	dep	113	SENT_42	[p3l1190t276r1292b355],
103	the	DT	O	the	dep	113	SENT_42	[p3l1312t276r1443b355],
104	cells	NNS	O	cell	dep	113	SENT_42	[p3l1482t277r1669b355],
105	expressed	VBD	O	express	dep	113	SENT_42	[p3l1711t276r2134b377],
106	EGFR	NN	ORGANIZATION	egfr	dep	113	SENT_42	[p3l10t410r278b500],
107	,	,	O	,	_	0	SENT_42	[p3l10t410r278b500],
108	the	DT	O	the	dep	113	SENT_42	[p3l313t405r440b483],
109	response	NN	O	response	dep	113	SENT_42	[p3l469t430r842b505],
110	rate	NN	O	rate	dep	113	SENT_42	[p3l870t421r1024b483],
111	Was	VBD	O	be	dep	113	SENT_42	[p3l1048t431r1207b484],
112	12.3	CD	PERCENT	12.3	dep	113	SENT_42	[p3l1241t410r1414b483],
113	percent	NN	PERCENT	percent	_	0	SENT_42	[p3l1445t399r1862b505],
114	.	.	O	.	_	0	SENT_42	[p3l1445t399r1862b505],

1	”	NN	O	”	_	0	SENT_43	[p3l1445t399r1862b505],
2	These	DT	O	these	det	4	SENT_43	[p3l1888t405r2135b483],
3	promising	JJ	O	promising	amod	4	SENT_43	[p3l10t533r452b633],
4	rates	NNS	O	rate	nsubj	7	SENT_43	[p3l472t549r669b611],
5	are	VBP	O	be	cop	7	SENT_43	[p3l693t559r817b611],
6	perhaps	RB	O	perhaps	advmod	7	SENT_43	[p3l840t532r1174b633],
7	higher	JJR	O	higher	rcmod	1	SENT_43	[p3l1200t533r1475b633],
8	than	IN	O	than	_	0	SENT_43	[p3l1496t533r1682b611],
9	those	DT	O	those	det	10	SENT_43	[p3l1706t532r1930b611],
10	possible	JJ	O	possible	prep_than	7	SENT_43	[p3l1953t558r2134b633, p3l13t660r209b738],
11	With	IN	O	with	dep	1	SENT_43	[p3l238t660r430b739],
12	other	JJ	O	other	amod	13	SENT_43	[p3l464t660r692b738],
13	forms	NNS	O	form	pobj	11	SENT_43	[p3l722t659r975b738],
14	of	IN	O	of	_	0	SENT_43	[p3l1010t659r1112b738],
15	chemotherapy	NN	O	chemotherapy	prep_of	13	SENT_43	[p3l1128t653r1874b760],
16	,	,	O	,	_	0	SENT_43	[p3l1128t653r1874b760],
17	-	:	O	-	_	0	SENT_43	[p3l1128t653r1874b760],
18	'	''	O	'	_	0	SENT_43	[p3l1128t653r1874b760],
19	°	CD	NUMBER	°	nsubj	25	SENT_43	[p3l1128t653r1874b760],
20	"	``	O	"	punct	19	SENT_43	[p3l1128t653r1874b760],
21	6	CD	NUMBER	6	dep	19	SENT_43	[p3l1128t653r1874b760],
22	but	CC	O	but	prep	19	SENT_43	[p3l1908t660r2050b739],
23	it	PRP	O	it	dep	22	SENT_43	[p3l2078t661r2139b738],
24	is	VBZ	O	be	cop	25	SENT_43	[p3l11t789r77b867],
25	unknown	JJ	O	unknown	ccomp	1	SENT_43	[p3l99t789r497b868],
26	Whether	IN	O	whether	complm	33	SENT_43	[p3l513t789r859b868],
27	treatment	NN	O	treatment	nsubj	33	SENT_43	[p3l876t805r1284b867],
28	with	IN	O	with	_	0	SENT_43	[p3l1294t789r1481b868],
29	an	DT	O	a	det	32	SENT_43	[p3l1501t814r1600b867],
30	EGFRinhib	NN	O	egfrinhib	nn	32	SENT_43	[p3l1619t788r2134b872],
31	—	NN	O	—	nn	32	SENT_43	[p3l1619t788r2134b872],
32	itor	NN	O	itor	prep_with	27	SENT_43	[p3l11t917r158b995],
33	prolongs	VBZ	O	prolong	ccomp	25	SENT_43	[p3l175t917r554b1017],
34	survival	NN	O	survival	dobj	33	SENT_43	[p3l581t917r921b996],
35	.	.	O	.	_	0	SENT_43	[p3l581t917r921b996],

1	For	IN	O	for	_	0	SENT_44	[p3l947t924r1092b995],
2	this	DT	O	this	det	3	SENT_44	[p3l1111t917r1263b995],
3	reason	NN	O	reason	prep_for	19	SENT_44	[p3l1288t942r1592b1012],
4	,	,	O	,	_	0	SENT_44	[p3l1288t942r1592b1012],
5	the	DT	O	the	det	8	SENT_44	[p3l1620t916r1749b995],
6	National	NNP	ORGANIZATION	National	nn	8	SENT_44	[p3l1769t917r2135b996],
7	Cancer	NNP	ORGANIZATION	Cancer	nn	8	SENT_44	[p3l11t1050r307b1123],
8	Institute	NNP	ORGANIZATION	Institute	nsubj	19	SENT_44	[p3l345t1045r697b1124],
9	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l741t1044r841b1123],
10	Canada	NNP	ORGANIZATION	Canada	nn	12	SENT_44	[p3l865t1044r1181b1123],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_44	[p3l1222t1044r1543b1123],
12	Trials	NNPS	ORGANIZATION	Trials	prep_of	8	SENT_44	[p3l1581t1045r1817b1123],
13	Group	NNP	ORGANIZATION	Group	nn	17	SENT_44	[p3l1862t1050r2134b1145],
14	(	CD	NUMBER	(	num	17	SENT_44	[p3l16t1179r118b1264],
15	N	NNP	O	N	nn	17	SENT_44	[p3l16t1179r118b1264],
16	CIC	NNP	ORGANIZATION	CIC	nn	17	SENT_44	[p3l122t1178r278b1251],
17	CTG	NNP	ORGANIZATION	CTG	dep	12	SENT_44	[p3l309t1178r533b1264],
18	)	NN	O	)	dep	17	SENT_44	[p3l309t1178r533b1264],
19	conducted	VBD	O	conduct	_	0	SENT_44	[p3l568t1172r1008b1252],
20	a	DT	O	a	det	23	SENT_44	[p3l1036t1199r1080b1251],
21	trial	NN	O	trial	nn	23	SENT_44	[p3l1108t1173r1274b1251],
22	(	NN	O	(	nn	23	SENT_44	[p3l1307t1178r1623b1264],
23	BR	NN	O	br	dobj	19	SENT_44	[p3l1307t1178r1623b1264],
24	.21	CD	NUMBER	.21	num	25	SENT_44	[p3l1307t1178r1623b1264],
25	)	NN	O	)	nsubj	27	SENT_44	[p3l1307t1178r1623b1264],
26	to	TO	O	to	aux	27	SENT_44	[p3l1658t1189r1737b1251],
27	compare	VB	O	compare	infmod	23	SENT_44	[p3l1768t1198r2135b1273],
28	erlotinib	NN	O	erlotinib	dobj	27	SENT_44	[p3l12t1300r370b1379],
29	with	IN	O	with	_	0	SENT_44	[p3l397t1301r586b1380],
30	placebo	NN	O	placebo	prep_with	27	SENT_44	[p3l614t1300r941b1401],
31	after	IN	O	after	_	0	SENT_44	[p3l972t1300r1165b1379],
32	the	DT	O	the	det	33	SENT_44	[p3l1192t1301r1322b1379],
33	failure	NN	O	failure	prep_after	27	SENT_44	[p3l1352t1300r1621b1380],
34	of	IN	O	of	_	0	SENT_44	[p3l1651t1300r1752b1379],
35	standard	JJ	O	standard	amod	36	SENT_44	[p3l1765t1300r2135b1379],
36	chemotherapy	NN	O	chemotherapy	prep_of	33	SENT_44	[p3l12t1429r619b1529],
37	for	IN	O	for	_	0	SENT_44	[p3l639t1428r762b1507],
38	non	JJ	O	non	amod	44	SENT_44	[p3l784t1428r1416b1507],
39	—	JJ	O	—	amod	44	SENT_44	[p3l784t1428r1416b1507],
40	small	JJ	O	small	amod	44	SENT_44	[p3l784t1428r1416b1507],
41	—	NN	O	—	nn	44	SENT_44	[p3l784t1428r1416b1507],
42	cell	NN	O	cell	nn	44	SENT_44	[p3l784t1428r1416b1507],
43	lung	NN	O	lung	nn	44	SENT_44	[p3l1439t1429r1633b1529],
44	cancer	NN	O	cancer	prep_for	36	SENT_44	[p3l1655t1454r1946b1507],
45	.	.	O	.	_	0	SENT_44	[p3l1655t1454r1946b1507],

1	The	DT	O	the	det	2	SENT_45	[p3l1974t1429r2134b1507],
2	inclusion	NN	O	inclusion	nsubjpass	10	SENT_45	[p3l11t1557r403b1636],
3	of	IN	O	of	_	0	SENT_45	[p3l430t1556r531b1635],
4	a	DT	O	a	det	6	SENT_45	[p3l538t1583r583b1635],
5	control	NN	O	control	nn	6	SENT_45	[p3l609t1557r911b1635],
6	group	NN	O	group	prep_of	2	SENT_45	[p3l938t1582r1189b1657],
7	receiving	VBG	O	receive	partmod	6	SENT_45	[p3l1217t1557r1599b1657],
8	placebo	NN	O	placebo	dobj	7	SENT_45	[p3l1622t1556r1948b1657],
9	was	VBD	O	be	auxpass	10	SENT_45	[p3l1972t1583r2133b1636],
10	considered	VBN	O	consider	_	0	SENT_45	[p3l12t1684r468b1763],
11	ethical	JJ	O	ethical	acomp	10	SENT_45	[p3l489t1685r761b1763],
12	in	IN	O	in	_	0	SENT_45	[p3l781t1685r861b1762],
13	view	NN	O	view	prep_in	11	SENT_45	[p3l877t1685r1067b1764],
14	of	IN	O	of	_	0	SENT_45	[p3l1085t1684r1185b1763],
15	the	DT	O	the	det	16	SENT_45	[p3l1187t1685r1314b1763],
16	lack	NN	O	lack	prep_of	13	SENT_45	[p3l1334t1684r1506b1764],
17	of	IN	O	of	_	0	SENT_45	[p3l1522t1684r1622b1763],
18	beneﬁt	NN	O	beneﬁt	prep_of	16	SENT_45	[p3l1625t1684r1916b1763],
19	from	IN	O	from	_	0	SENT_45	[p3l1931t1684r2136b1763],
20	further	JJ	O	further	amod	21	SENT_45	[p3l11t1812r306b1892],
21	chemotherapy	NN	O	chemotherapy	prep_from	18	SENT_45	[p3l336t1813r942b1913],
22	after	IN	O	after	_	0	SENT_45	[p3l968t1812r1161b1891],
23	the	DT	O	the	det	24	SENT_45	[p3l1190t1812r1319b1891],
24	failure	NN	O	failure	prep_after	21	SENT_45	[p3l1350t1812r1618b1892],
25	of	IN	O	of	_	0	SENT_45	[p3l1650t1812r1751b1891],
26	standard	JJ	O	standard	amod	29	SENT_45	[p3l1765t1812r2135b1891],
27	treatment	NN	O	treatment	nn	29	SENT_45	[p3l12t1934r553b2019],
28	.5	CD	NUMBER	.5	num	29	SENT_45	[p3l12t1934r553b2019],
29	’	NN	O	’	prep_of	24	SENT_45	[p3l12t1934r553b2019],
30	6	CD	NUMBER	6	tmod	11	SENT_45	[p3l12t1934r553b2019],

1	METHODS	NNS	O	method	_	0	SENT_46	[p3l790t2277r1340b2336],

1	STU	NNP	O	STU	nn	4	SENT_47	[p3l11t2454r156b2503],
2	M	NN	O	m	nn	4	SENT_47	[p3l177t2454r277b2503],
3	D	NN	O	d	nn	4	SENT_47	[p3l319t2454r366b2503],
4	ES	NN	O	e	_	0	SENT_47	[p3l383t2454r467b2503],
5	I	PRP	O	I	dep	6	SENT_47	[p3l485t2454r497b2503],
6	c	NN	O	c	dep	4	SENT_47	[p3l517t2454r564b2503],
7	;	:	O	;	_	0	SENT_47	[p3l517t2454r564b2503],
8	N	NN	O	n	dep	6	SENT_47	[p3l586t2454r630b2503],

1	This	DT	O	this	det	2	SENT_48	[p3l7t2554r192b2633],
2	international	JJ	O	international	nsubjpass	48	SENT_48	[p3l229t2555r799b2650],
3	,	,	O	,	_	0	SENT_48	[p3l229t2555r799b2650],
4	phase	NN	O	phase	appos	2	SENT_48	[p3l839t2554r1086b2655],
5	3	CD	NUMBER	3	num	4	SENT_48	[p3l1123t2560r1193b2650],
6	,	,	O	,	_	0	SENT_48	[p3l1123t2560r1193b2650],
7	randomized	VBN	O	randomize	partmod	2	SENT_48	[p3l1235t2554r1770b2650],
8	,	,	O	,	_	0	SENT_48	[p3l1235t2554r1770b2650],
9	doubleblind	NN	O	doubleblind	nn	14	SENT_48	[p3l1812t2554r2134b2634, p3l11t2683r253b2778],
10	,	,	O	,	_	0	SENT_48	[p3l1812t2554r2134b2634, p3l11t2683r253b2778],
11	placebo	NN	O	placebo	dep	14	SENT_48	[p3l282t2682r1081b2783],
12	—	NN	O	—	nn	14	SENT_48	[p3l282t2682r1081b2783],
13	controlled	VBN	O	control	amod	14	SENT_48	[p3l282t2682r1081b2783],
14	trial	NN	O	trial	dobj	7	SENT_48	[p3l1106t2682r1273b2761],
15	of	IN	O	of	_	0	SENT_48	[p3l1299t2682r1398b2761],
16	erlotinib	NN	O	erlotinib	prep_of	14	SENT_48	[p3l1406t2682r1764b2761],
17	after	IN	O	after	mark	38	SENT_48	[p3l1790t2682r1983b2761],
18	the	DT	O	the	det	19	SENT_48	[p3l2006t2682r2135b2761],
19	failure	NN	O	failure	nsubjpass	38	SENT_48	[p3l10t2810r282b2890],
20	of	IN	O	of	_	0	SENT_48	[p3l322t2810r423b2889],
21	ﬁrst	NN	O	ﬁrst	nn	23	SENT_48	[p3l443t2810r814b2889],
22	—	CD	NUMBER	—	num	23	SENT_48	[p3l443t2810r814b2889],
23	line	NN	O	line	prep_of	19	SENT_48	[p3l443t2810r814b2889],
24	or	CC	O	or	_	0	SENT_48	[p3l854t2836r944b2889],
25	second	JJ	ORDINAL	second	amod	28	SENT_48	[p3l981t2810r1480b2889],
26	—	NN	O	—	nn	28	SENT_48	[p3l981t2810r1480b2889],
27	line	NN	O	line	nn	28	SENT_48	[p3l981t2810r1480b2889],
28	chemotherapy	NN	O	chemotherapy	nsubjpass	38	SENT_48	[p3l1519t2811r2139b2911],
29	for	IN	O	for	_	0	SENT_48	[p3l10t2938r134b3017],
30	non	JJ	O	non	amod	36	SENT_48	[p3l154t2938r779b3017],
31	—	JJ	O	—	amod	36	SENT_48	[p3l154t2938r779b3017],
32	small	JJ	O	small	amod	36	SENT_48	[p3l154t2938r779b3017],
33	—	NN	O	—	nn	36	SENT_48	[p3l154t2938r779b3017],
34	cell	NN	O	cell	nn	36	SENT_48	[p3l154t2938r779b3017],
35	lung	NN	O	lung	nn	36	SENT_48	[p3l802t2939r994b3039],
36	cancer	NN	O	cancer	prep_for	28	SENT_48	[p3l1015t2964r1288b3017],
37	was	VBD	O	be	auxpass	38	SENT_48	[p3l1304t2965r1464b3018],
38	designed	VBN	O	design	dep	14	SENT_48	[p3l1491t2938r1867b3039],
39	by	IN	O	by	_	0	SENT_48	[p3l1891t2938r1988b3039],
40	the	DT	O	the	det	45	SENT_48	[p3l2007t2939r2135b3017],
41	N	NN	O	n	nn	45	SENT_48	[p3l8t3074r83b3145],
42	CIC	NNP	ORGANIZATION	CIC	nn	45	SENT_48	[p3l86t3072r244b3145],
43	CT	NNP	O	CT	nn	45	SENT_48	[p3l276t3072r400b3145],
44	G.	NNP	O	G.	nn	45	SENT_48	[p3l402t3072r498b3145],
45	Patients	NNPS	O	Patients	agent	38	SENT_48	[p3l531t3067r872b3145],
46	were	VBD	O	be	auxpass	48	SENT_48	[p3l899t3093r1103b3146],
47	randomly	RB	O	randomly	advmod	48	SENT_48	[p3l1133t3067r1549b3167],
48	assigned	VBN	O	assign	_	0	SENT_48	[p3l1573t3067r1952b3167],
49	in	IN	O	in	_	0	SENT_48	[p3l1980t3067r2063b3144],
50	a	DT	O	a	det	52	SENT_48	[p3l2091t3093r2135b3145],
51	2:1	CD	NUMBER	2:1	num	52	SENT_48	[p3l10t3200r138b3273],
52	ratio	NN	O	ratio	prep_in	48	SENT_48	[p3l162t3195r351b3273],
53	to	TO	O	to	aux	54	SENT_48	[p3l376t3211r454b3273],
54	receive	VB	O	receive	xcomp	48	SENT_48	[p3l478t3195r759b3274],
55	oral	JJ	O	oral	amod	56	SENT_48	[p3l784t3194r943b3273],
56	erlotinib	NN	O	erlotinib	dobj	54	SENT_48	[p3l966t3194r1317b3273],
57	at	IN	O	at	_	0	SENT_48	[p3l1341t3211r1420b3273],
58	a	DT	O	a	det	59	SENT_48	[p3l1438t3221r1482b3273],
59	dose	NN	O	dose	prep_at	54	SENT_48	[p3l1505t3195r1695b3273],
60	of	IN	O	of	_	0	SENT_48	[p3l1720t3194r1819b3273],
61	150	CD	NUMBER	150	num	62	SENT_48	[p3l1828t3200r1976b3273],
62	mg	NN	O	mg	prep_of	59	SENT_48	[p3l2000t3221r2139b3295],
63	daily	JJ	SET	daily	amod	62	SENT_48	[p3l11t3323r217b3423],
64	or	CC	O	or	_	0	SENT_48	[p3l247t3348r338b3401],
65	placebo	NN	O	placebo	prep_of	59	SENT_48	[p3l366t3322r729b3423],
66	.	.	O	.	_	0	SENT_48	[p3l366t3322r729b3423],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_49	[p3l767t3323r1444b3406],
2	was	VBD	O	be	auxpass	3	SENT_49	[p3l1473t3349r1637b3402],
3	performed	VBN	O	perform	_	0	SENT_49	[p3l1671t3322r2134b3423],
4	centrally	RB	O	centrally	amod	11	SENT_49	[p3l11t3450r381b3551],
5	by	IN	O	by	_	0	SENT_49	[p3l411t3451r508b3551],
6	Applied	NNP	ORGANIZATION	Applied	nn	10	SENT_49	[p3l534t3450r872b3551],
7	Logic	NNP	ORGANIZATION	Logic	nn	10	SENT_49	[p3l904t3451r1140b3551],
8	Associates	NNPS	ORGANIZATION	Associates	nn	10	SENT_49	[p3l1170t3451r1622b3529],
9	(	NNP	O	(	nn	10	SENT_49	[p3l1662t3458r2129b3546],
10	Houston	NNP	LOCATION	Houston	prep_by	4	SENT_49	[p3l1662t3458r2129b3546],
11	)	NN	O	)	dobj	3	SENT_49	[p3l1662t3458r2129b3546],
12	,	,	O	,	_	0	SENT_49	[p3l1662t3458r2129b3546],
13	with	IN	O	with	_	0	SENT_49	[p3l6t3579r195b3658],
14	the	DT	O	the	det	15	SENT_49	[p3l240t3579r369b3657],
15	use	NN	O	use	prep_with	3	SENT_49	[p3l415t3605r553b3658],
16	of	IN	O	of	_	0	SENT_49	[p3l599t3578r700b3657],
17	the	DT	O	the	det	19	SENT_49	[p3l727t3579r855b3657],
18	minimization	NN	O	minimization	nn	19	SENT_49	[p3l901t3580r1477b3657],
19	method	NN	O	method	prep_of	15	SENT_49	[p3l1522t3573r1957b3657],
20	.	.	O	.	_	0	SENT_49	[p3l1522t3573r1957b3657],

1	”	NN	O	”	nn	2	SENT_50	[p3l1522t3573r1957b3657],
2	Patients	NNS	O	patient	_	0	SENT_50	[p3l2002t3586r2133b3657, p3l11t3707r240b3785],

1	Were	VBD	O	be	cop	2	SENT_51	[p3l275t3733r477b3786],
2	stratiﬁed	JJ	O	stratiﬁed	_	0	SENT_51	[p3l516t3706r890b3785],
3	according	VBG	O	accord	_	0	SENT_51	[p3l926t3706r1348b3807],
4	to	TO	O	to	prepc_according_to	2	SENT_51	[p3l1383t3723r1462b3785],
5	center	NN	O	center	pobj	2	SENT_51	[p3l1500t3723r1777b3802],
6	,	,	O	,	_	0	SENT_51	[p3l1500t3723r1777b3802],
7	Eastern	NNP	MISC	Eastern	appos	5	SENT_51	[p3l1819t3714r2135b3785],

1	Cooperative	NNP	O	Cooperative	nn	5	SENT_52	[p4l10t21r513b121],
2	Oncology	NNP	O	Oncology	nn	5	SENT_52	[p4l551t20r961b121],
3	Group	NNP	O	Group	nn	5	SENT_52	[p4l994t26r1267b121],
4	performance	NN	O	performance	nn	5	SENT_52	[p4l1304t20r1847b121],
5	status	NN	O	status	nsubj	28	SENT_52	[p4l1887t37r2133b100],
6	(	CD	NUMBER	(	num	7	SENT_52	[p4l15t154r92b240],
7	o	NN	O	o	dep	5	SENT_52	[p4l15t154r92b240],
8	or	CC	O	or	_	0	SENT_52	[p4l137t174r226b227],
9	1	CD	NUMBER	1	conj_or	5	SENT_52	[p4l270t154r314b226],
10	vs.	CC	O	vs.	prep	9	SENT_52	[p4l353t175r463b228],
11	2	CD	NUMBER	2	dep	10	SENT_52	[p4l511t154r558b226],
12	or	CC	O	or	_	0	SENT_52	[p4l603t174r693b227],
13	3	CD	NUMBER	3	dep	10	SENT_52	[p4l734t154r805b244],
14	,	,	O	,	_	0	SENT_52	[p4l734t154r805b244],
15	with	IN	O	with	_	0	SENT_52	[p4l849t148r1038b228],
16	higher	JJR	O	higher	amod	17	SENT_52	[p4l1082t149r1360b249],
17	scores	NNS	O	score	prep_with	28	SENT_52	[p4l1402t174r1663b227],
18	indicating	VBG	O	indicate	partmod	17	SENT_52	[p4l1708t149r2138b249],
19	greater	JJR	O	greater	amod	21	SENT_52	[p4l10t293r307b377],
20	impairment	NN	O	impairment	nn	21	SENT_52	[p4l334t277r893b377],
21	)	NN	O	)	dobj	18	SENT_52	[p4l334t277r893b377],
22	,	,	O	,	_	0	SENT_52	[p4l334t277r893b377],
23	best	JJS	O	best	amod	24	SENT_52	[p4l929t277r1104b355],
24	response	NN	O	response	nsubj	28	SENT_52	[p4l1128t302r1508b377],
25	to	TO	O	to	_	0	SENT_52	[p4l1539t293r1617b355],
26	prior	JJ	O	prior	amod	27	SENT_52	[p4l1647t277r1860b377],
27	therapy	NN	O	therapy	prep_to	24	SENT_52	[p4l1887t277r2134b355, p4l9t431r108b505],
28	(	VBD	O	(	_	0	SENT_52	[p4l139t405r557b505],
29	complete	JJ	O	complete	amod	32	SENT_52	[p4l139t405r557b505],
30	or	CC	O	or	_	0	SENT_52	[p4l588t430r677b483],
31	partial	JJ	O	partial	amod	32	SENT_52	[p4l703t404r974b505],
32	response	NN	O	response	nsubj	45	SENT_52	[p4l1003t430r1382b505],
33	vs.	CC	O	vs.	prep	32	SENT_52	[p4l1408t431r1517b484],
34	stable	JJ	O	stable	amod	35	SENT_52	[p4l1554t404r1801b483],
35	disease	NN	O	disease	dep	33	SENT_52	[p4l1832t404r2135b483],
36	vs.	CC	O	vs.	prep	35	SENT_52	[p4l6t559r115b612],
37	progressive	JJ	O	progressive	amod	39	SENT_52	[p4l143t533r628b633],
38	disease	NN	O	disease	nn	39	SENT_52	[p4l653t532r1015b628],
39	)	NN	O	)	dep	36	SENT_52	[p4l653t532r1015b628],
40	,	,	O	,	_	0	SENT_52	[p4l653t532r1015b628],
41	number	NN	O	number	appos	39	SENT_52	[p4l1044t533r1380b612],
42	of	IN	O	of	_	0	SENT_52	[p4l1402t532r1503b611],
43	prior	JJ	O	prior	amod	44	SENT_52	[p4l1507t533r1719b633],
44	regimens	NNS	O	regimen	prep_of	41	SENT_52	[p4l1740t533r2133b633],
45	received	VBD	O	receive	ccomp	28	SENT_52	[p4l10t660r352b740],
46	(	CD	NUMBER	(	number	47	SENT_52	[p4l384t667r567b752],
47	one	CD	NUMBER	one	dobj	45	SENT_52	[p4l384t667r567b752],
48	vs.	IN	O	vs.	_	0	SENT_52	[p4l590t687r700b740],
49	two	CD	NUMBER	two	number	50	SENT_52	[p4l734t667r945b756],
50	)	CD	NUMBER	)	prep_vs.	47	SENT_52	[p4l734t667r945b756],
51	,	,	O	,	_	0	SENT_52	[p4l734t667r945b756],
52	and	CC	O	and	_	0	SENT_52	[p4l979t660r1134b739],
53	exposure	NN	O	exposure	prep_vs.	47	SENT_52	[p4l1163t686r1542b761],
54	to	TO	O	to	_	0	SENT_52	[p4l1571t677r1650b739],
55	prior	JJ	O	prior	amod	57	SENT_52	[p4l1678t661r1890b761],
56	platinum	NN	O	platinum	nn	57	SENT_52	[p4l1914t661r2134b761, p4l10t814r205b868],
57	therapy	NN	O	therapy	prep_to	53	SENT_52	[p4l230t789r548b889],
58	(	CD	NUMBER	(	tmod	28	SENT_52	[p4l573t796r728b889],
59	yes	UH	O	yes	dobj	28	SENT_52	[p4l573t796r728b889],
60	vs.	CC	O	vs.	prep	28	SENT_52	[p4l750t815r859b868],
61	no	DT	O	no	det	62	SENT_52	[p4l890t796r1055b880],
62	)	NN	O	)	dep	60	SENT_52	[p4l890t796r1055b880],
63	.	.	O	.	_	0	SENT_52	[p4l890t796r1055b880],

1	The	DT	O	the	det	4	SENT_53	[p4l136t916r299b995],
2	primary	JJ	O	primary	amod	4	SENT_53	[p4l350t917r694b1017],
3	end	NN	O	end	nn	4	SENT_53	[p4l741t916r897b995],
4	point	NN	O	point	nsubj	7	SENT_53	[p4l948t917r1180b1017],
5	was	VBD	O	be	cop	7	SENT_53	[p4l1223t943r1386b996],
6	overall	JJ	O	overall	amod	7	SENT_53	[p4l1441t916r1726b996],
7	survival	NN	O	survival	_	0	SENT_53	[p4l1779t916r2128b996],
8	.	.	O	.	_	0	SENT_53	[p4l1779t916r2128b996],

1	Secondary	JJ	O	secondary	amod	3	SENT_54	[p4l12t1044r456b1145],
2	end	NN	O	end	nn	3	SENT_54	[p4l493t1045r649b1123],
3	points	NNS	O	point	nsubj	4	SENT_54	[p4l687t1045r958b1145],
4	included	VBD	O	include	ccomp	13	SENT_54	[p4l1000t1044r1373b1124],
5	progression	NN	O	progression	npadvmod	7	SENT_54	[p4l1412t1044r2134b1145],
6	—	CD	NUMBER	—	num	5	SENT_54	[p4l1412t1044r2134b1145],
7	free	JJ	O	free	amod	8	SENT_54	[p4l1412t1044r2134b1145],
8	survival	NN	O	survival	dobj	4	SENT_54	[p4l12t1173r361b1268],
9	,	,	O	,	_	0	SENT_54	[p4l12t1173r361b1268],
10	overall	JJ	O	overall	amod	12	SENT_54	[p4l397t1173r681b1252],
11	response	NN	O	response	nn	12	SENT_54	[p4l709t1198r1096b1273],
12	rate	NN	O	rate	nsubj	13	SENT_54	[p4l1125t1189r1285b1251],
13	(	VBD	O	(	_	0	SENT_54	[p4l1319t1172r1745b1273],
14	complete	JJ	O	complete	amod	17	SENT_54	[p4l1319t1172r1745b1273],
15	and	CC	O	and	_	0	SENT_54	[p4l1774t1173r1932b1251],
16	partial	JJ	O	partial	conj_and	14	SENT_54	[p4l1959t1199r2133b1273, p4l11t1301r201b1396],
17	)	NN	O	)	dobj	13	SENT_54	[p4l1959t1199r2133b1273, p4l11t1301r201b1396],
18	,	,	O	,	_	0	SENT_54	[p4l1959t1199r2133b1273, p4l11t1301r201b1396],
19	duration	NN	O	duration	conj_and	17	SENT_54	[p4l231t1301r599b1380],
20	of	IN	O	of	_	0	SENT_54	[p4l624t1300r725b1379],
21	response	NN	O	response	prep_of	19	SENT_54	[p4l731t1326r1142b1401],
22	,	,	O	,	_	0	SENT_54	[p4l731t1326r1142b1401],
23	toxic	JJ	O	toxic	amod	24	SENT_54	[p4l1172t1301r1377b1379],
24	effects	NNS	O	effect	appos	21	SENT_54	[p4l1401t1300r1704b1396],
25	,	,	O	,	_	0	SENT_54	[p4l1401t1300r1704b1396],
26	and	CC	O	and	_	0	SENT_54	[p4l1733t1301r1891b1379],
27	quality	NN	O	quality	dobj	13	SENT_54	[p4l1916t1300r2133b1401, p4l10t1429r112b1529],
28	of	IN	O	of	_	0	SENT_54	[p4l134t1428r235b1507],
29	life	NN	O	life	prep_of	27	SENT_54	[p4l242t1428r396b1507],
30	.	.	O	.	_	0	SENT_54	[p4l242t1428r396b1507],

1	Responses	NNS	O	response	nsubjpass	3	SENT_55	[p4l426t1435r877b1529],
2	were	VBD	O	be	auxpass	3	SENT_55	[p4l901t1455r1103b1508],
3	assessed	VBN	O	assess	_	0	SENT_55	[p4l1128t1428r1493b1507],
4	with	IN	O	with	_	0	SENT_55	[p4l1514t1429r1704b1508],
5	the	DT	O	the	det	6	SENT_55	[p4l1731t1429r1860b1507],
6	use	NN	O	use	prep_with	3	SENT_55	[p4l1886t1455r2025b1508],
7	of	IN	O	of	_	0	SENT_55	[p4l2053t1428r2153b1507],
8	the	DT	O	the	det	9	SENT_55	[p4l11t1557r139b1635],
9	Response	NN	O	response	prep_of	6	SENT_55	[p4l168t1563r584b1657],
10	Evaluation	NN	O	evaluation	nn	11	SENT_55	[p4l614t1557r1068b1636],
11	Criteria	NNS	O	criterion	nsubj	15	SENT_55	[p4l1098t1557r1422b1635],
12	in	IN	O	in	_	0	SENT_55	[p4l1449t1557r1531b1634],
13	Solid	JJ	MISC	solid	amod	14	SENT_55	[p4l1563t1556r1779b1635],
14	Tumors	NNS	MISC	tumor	prep_in	11	SENT_55	[p4l1805t1562r2130b1636],
15	(	VBP	O	(	rcmod	9	SENT_55	[p4l15t1678r509b1779],
16	RECIST	NN	O	recist	dobj	15	SENT_55	[p4l15t1678r509b1779],
17	)	CD	NUMBER	)	num	18	SENT_55	[p4l15t1678r509b1779],
18	,14	CD	NUMBER	,14	nsubjpass	23	SENT_55	[p4l15t1678r509b1779],
19	and	CC	O	and	_	0	SENT_55	[p4l535t1684r687b1762],
20	toxic	JJ	O	toxic	amod	21	SENT_55	[p4l714t1684r911b1762],
21	effects	NNS	O	effect	conj_and	18	SENT_55	[p4l937t1683r1200b1762],
22	were	VBD	O	be	auxpass	23	SENT_55	[p4l1224t1710r1422b1764],
23	assessed	VBN	O	assess	rcmod	16	SENT_55	[p4l1448t1684r1804b1762],
24	according	VBG	O	accord	_	0	SENT_55	[p4l1829t1684r2135b1762, p4l10t1813r146b1913],
25	to	TO	O	to	prepc_according_to	23	SENT_55	[p4l164t1829r244b1891],
26	the	DT	O	the	det	29	SENT_55	[p4l269t1812r400b1891],
27	Common	JJ	O	common	amod	29	SENT_55	[p4l424t1818r831b1891],
28	Toxicity	NN	O	toxicity	nn	29	SENT_55	[p4l851t1813r1191b1913],
29	Criteria	NNS	O	criterion	pobj	23	SENT_55	[p4l1209t1813r1533b1891],
30	of	IN	O	of	_	0	SENT_55	[p4l1555t1812r1657b1891],
31	the	DT	O	the	det	39	SENT_55	[p4l1663t1812r1793b1891],
32	N	NN	O	n	nn	39	SENT_55	[p4l1815t1820r1890b1892],
33	ation	NN	O	ation	nn	39	SENT_55	[p4l1892t1813r2134b1891],
34	—	CD	NUMBER	—	num	39	SENT_55	[p4l1892t1813r2134b1891],
35	al	NNP	O	al	nn	39	SENT_55	[p4l10t1941r80b2019],
36	Cancer	NNP	O	Cancer	nn	39	SENT_55	[p4l109t1946r400b2019],
37	Institute	NNP	O	Institute	nn	39	SENT_55	[p4l425t1941r770b2020],
38	(	NN	O	(	nn	39	SENT_55	[p4l805t1941r1133b2032],
39	version	NN	O	version	prep_of	29	SENT_55	[p4l805t1941r1133b2032],
40	2.0	CD	NUMBER	2.0	num	41	SENT_55	[p4l1162t1946r1347b2032],
41	)	NN	O	)	dep	39	SENT_55	[p4l1162t1946r1347b2032],
42	.	.	O	.	_	0	SENT_55	[p4l1162t1946r1347b2032],

1	The	DT	O	the	det	3	SENT_56	[p4l1379t1940r1538b2019],
2	European	NNP	ORGANIZATION	European	nn	3	SENT_56	[p4l1566t1948r1967b2041],
3	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_56	[p4l1997t1946r2134b2019, p4l10t2069r447b2169],
4	for	IN	ORGANIZATION	for	_	0	SENT_56	[p4l487t2068r609b2147],
5	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_56	[p4l645t2068r1020b2152],
6	and	CC	ORGANIZATION	and	_	0	SENT_56	[p4l1061t2069r1214b2147],
7	Treatment	NN	ORGANIZATION	treatment	conj_and	3	SENT_56	[p4l1251t2074r1685b2147],
8	of	IN	ORGANIZATION	of	_	0	SENT_56	[p4l1721t2068r1820b2147],
9	Cancer	NN	ORGANIZATION	cancer	prep_of	7	SENT_56	[p4l1842t2074r2136b2147],
10	(	CD	NUMBER	(	num	9	SENT_56	[p4l15t2202r397b2288],
11	EORTC	NN	O	eortc	nn	14	SENT_56	[p4l15t2202r397b2288],
12	)	CD	NUMBER	)	num	14	SENT_56	[p4l15t2202r397b2288],
13	quality	NN	O	quality	nn	14	SENT_56	[p4l427t2196r1014b2297],
14	—	NN	O	—	dep	3	SENT_56	[p4l427t2196r1014b2297],
15	of	IN	O	of	_	0	SENT_56	[p4l427t2196r1014b2297],
16	—	CD	NUMBER	—	num	18	SENT_56	[p4l427t2196r1014b2297],
17	life	NN	O	life	nn	18	SENT_56	[p4l427t2196r1014b2297],
18	questionnaire	NN	O	questionnaire	prep_of	14	SENT_56	[p4l1038t2197r1632b2297],
19	(	CD	NUMBER	(	num	20	SENT_56	[p4l1661t2202r2130b2295],
20	QLQ	NN	O	qlq	dep	14	SENT_56	[p4l1661t2202r2130b2295],
21	.	.	O	.	_	0	SENT_56	[p4l1661t2202r2130b2295],

1	—	NN	O	—	_	0	SENT_57	[p4l1661t2202r2130b2295],
2	.	.	O	.	_	0	SENT_57	[p4l1661t2202r2130b2295],

1	C30	NN	O	c30	nn	2	SENT_58	[p4l1661t2202r2130b2295],
2	)	NN	O	)	_	0	SENT_58	[p4l1661t2202r2130b2295],
3	and	CC	O	and	_	0	SENT_58	[p4l10t2324r165b2403],
4	the	DT	O	the	det	6	SENT_58	[p4l211t2325r340b2403],
5	quality	NN	O	quality	nn	6	SENT_58	[p4l388t2324r960b2425],
6	—	NN	O	—	conj_and	2	SENT_58	[p4l388t2324r960b2425],
7	of	IN	O	of	_	0	SENT_58	[p4l388t2324r960b2425],
8	—	CD	NUMBER	—	num	10	SENT_58	[p4l388t2324r960b2425],
9	life	NN	O	life	nn	10	SENT_58	[p4l388t2324r960b2425],
10	questionnaire	NN	O	questionnaire	prep_of	6	SENT_58	[p4l1007t2325r1587b2425],
11	for	IN	O	for	_	0	SENT_58	[p4l1633t2324r1757b2403],
12	patients	NNS	O	patient	prep_for	10	SENT_58	[p4l1798t2325r2133b2425],
13	with	IN	O	with	_	0	SENT_58	[p4l6t2453r198b2532],
14	lung	NN	O	lung	prep_with	12	SENT_58	[p4l225t2452r423b2553],
15	cancer	NN	O	cancer	dep	2	SENT_58	[p4l448t2478r729b2531],
16	(	CD	NUMBER	(	num	17	SENT_58	[p4l759t2458r1140b2551],
17	QLQ	NN	O	qlq	dep	15	SENT_58	[p4l759t2458r1140b2551],
18	.	.	O	.	_	0	SENT_58	[p4l759t2458r1140b2551],

1	—	NN	O	—	_	0	SENT_59	[p4l759t2458r1140b2551],
2	.	.	O	.	_	0	SENT_59	[p4l759t2458r1140b2551],

1	LC	NN	O	lc	nsubjpass	5	SENT_60	[p4l759t2458r1140b2551],
2	13	CD	NUMBER	13	num	3	SENT_60	[p4l1153t2458r1281b2544],
3	)	NN	O	)	dep	1	SENT_60	[p4l1153t2458r1281b2544],
4	were	VBD	O	be	auxpass	5	SENT_60	[p4l1310t2479r1516b2532],
5	used	VBN	O	use	_	0	SENT_60	[p4l1544t2452r1743b2532],
6	to	TO	O	to	aux	7	SENT_60	[p4l1771t2469r1851b2531],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_60	[p4l1881t2453r2132b2532, p4l10t2597r131b2659],
8	patients	NNS	O	patient	nsubj	10	SENT_60	[p4l158t2581r519b2681],
9	’	CD	NUMBER	’	num	10	SENT_60	[p4l158t2581r519b2681],
10	quality	NN	O	quality	xcomp	7	SENT_60	[p4l549t2581r835b2681],
11	of	IN	O	of	_	0	SENT_60	[p4l856t2580r957b2659],
12	life	NN	O	life	prep_of	10	SENT_60	[p4l962t2580r1116b2659],
13	.	.	O	.	_	0	SENT_60	[p4l962t2580r1116b2659],

1	The	DT	O	the	det	2	SENT_61	[p4l136t2708r299b2787],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_61	[p4l322t2709r686b2809],
3	was	VBD	O	be	auxpass	4	SENT_61	[p4l705t2735r868b2788],
4	approved	VBN	O	approve	_	0	SENT_61	[p4l892t2709r1291b2809],
5	by	IN	O	by	_	0	SENT_61	[p4l1314t2708r1412b2809],
6	the	DT	O	the	det	7	SENT_61	[p4l1432t2709r1562b2787],
7	ethics	NNS	O	ethic	agent	4	SENT_61	[p4l1587t2709r1836b2787],
8	review	VBP	O	review	rcmod	7	SENT_61	[p4l1860t2709r2138b2788],
9	boards	NNS	O	board	dobj	8	SENT_61	[p4l11t2836r302b2915],
10	at	IN	O	at	_	0	SENT_61	[p4l336t2853r415b2915],
11	all	DT	O	all	det	13	SENT_61	[p4l441t2836r540b2915],
12	participating	VBG	O	participate	amod	13	SENT_61	[p4l570t2837r1116b2937],
13	institutions	NNS	O	institution	prep_at	9	SENT_61	[p4l1143t2837r1650b2932],
14	,	,	O	,	_	0	SENT_61	[p4l1143t2837r1650b2932],
15	and	CC	O	and	_	0	SENT_61	[p4l1687t2837r1842b2915],
16	all	DT	O	all	det	17	SENT_61	[p4l1873t2836r1971b2915],
17	patients	NNS	O	patient	nsubj	18	SENT_61	[p4l2001t2863r2134b2937, p4l11t2965r240b3043],
18	provided	VBD	O	provide	conj_and	4	SENT_61	[p4l268t2964r639b3065],
19	written	VBN	O	write	amod	21	SENT_61	[p4l661t2965r965b3044],
20	informed	VBN	O	inform	amod	21	SENT_61	[p4l990t2964r1385b3043],
21	consent	NN	O	consent	dobj	18	SENT_61	[p4l1412t2981r1765b3043],
22	.	.	O	.	_	0	SENT_61	[p4l1412t2981r1765b3043],

1	Support	NN	O	support	nsubjpass	3	SENT_62	[p4l1800t2970r2140b3065],
2	was	VBD	O	be	auxpass	3	SENT_62	[p4l6t3119r170b3172],
3	provided	VBN	O	provide	_	0	SENT_62	[p4l202t3092r584b3193],
4	by	IN	O	by	_	0	SENT_62	[p4l616t3093r714b3193],
5	the	DT	O	the	det	7	SENT_62	[p4l741t3092r873b3171],
6	N	NN	O	n	nn	7	SENT_62	[p4l902t3100r977b3171],
7	CIC	NN	ORGANIZATION	cic	agent	3	SENT_62	[p4l982t3098r1140b3171],
8	and	CC	O	and	_	0	SENT_62	[p4l1173t3093r1332b3171],
9	OSI	NNP	ORGANIZATION	OSI	nn	10	SENT_62	[p4l1363t3098r1521b3171],
10	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	agent	3	SENT_62	[p4l1550t3093r2131b3172, p4l11t3221r197b3299],
11	.	.	O	.	_	0	SENT_62	[p4l1550t3093r2131b3172, p4l11t3221r197b3299],

1	Data	NNS	O	datum	nsubjpass	3	SENT_63	[p4l242t3227r440b3299],
2	were	VBD	O	be	auxpass	3	SENT_63	[p4l470t3247r669b3300],
3	collected	VBN	O	collect	_	0	SENT_63	[p4l706t3221r1095b3316],
4	,	,	O	,	_	0	SENT_63	[p4l706t3221r1095b3316],
5	managed	VBD	O	manage	dep	3	SENT_63	[p4l1137t3220r1544b3321],
6	,	,	O	,	_	0	SENT_63	[p4l1137t3220r1544b3321],
7	and	CC	O	and	_	0	SENT_63	[p4l1585t3220r1739b3299],
8	analyzed	VBN	O	analyze	dep	3	SENT_63	[p4l1775t3220r2135b3321],
9	by	IN	O	by	_	0	SENT_63	[p4l11t3349r107b3449],
10	the	DT	O	the	det	11	SENT_63	[p4l124t3348r251b3427],
11	N	NN	O	n	prep_by	8	SENT_63	[p4l270t3356r346b3428],
12	CIC	NNP	ORGANIZATION	CIC	nn	13	SENT_63	[p4l350t3354r508b3427],
13	CTG	NNP	ORGANIZATION	CTG	nsubj	5	SENT_63	[p4l535t3354r757b3444],
14	,	,	O	,	_	0	SENT_63	[p4l535t3354r757b3444],
15	and	CC	O	and	_	0	SENT_63	[p4l787t3349r944b3427],
16	the	DT	O	the	det	17	SENT_63	[p4l970t3349r1100b3427],
17	manuscript	NN	O	manuscript	nsubjpass	19	SENT_63	[p4l1126t3349r1623b3449],
18	was	VBD	O	be	auxpass	19	SENT_63	[p4l1638t3375r1801b3428],
19	written	VBN	O	write	conj_and	3	SENT_63	[p4l1824t3349r2134b3428],
20	by	IN	O	by	_	0	SENT_63	[p4l11t3477r109b3577],
21	members	NNS	O	member	agent	19	SENT_63	[p4l140t3477r541b3555],
22	of	IN	O	of	_	0	SENT_63	[p4l578t3476r678b3555],
23	the	DT	O	the	det	25	SENT_63	[p4l694t3476r823b3555],
24	NCIC	NNP	ORGANIZATION	NCIC	nn	25	SENT_63	[p4l855t3482r1089b3555],
25	CTG	NNP	ORGANIZATION	CTG	prep_of	21	SENT_63	[p4l1124t3482r1343b3555],
26	.	.	O	.	_	0	SENT_63	[p4l1124t3482r1343b3555],

1	OSI	NNP	ORGANIZATION	OSI	nn	2	SENT_64	[p4l1383t3482r1538b3555],
2	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nsubj	8	SENT_64	[p4l1569t3477r2134b3556, p4l11t3604r166b3683],
3	reviewed	VBD	O	review	_	0	SENT_64	[p4l214t3604r583b3684],
4	the	DT	O	the	det	6	SENT_64	[p4l629t3605r758b3683],
5	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_64	[p4l803t3604r992b3683],
6	manuscript	NN	O	manuscript	dobj	3	SENT_64	[p4l1037t3605r1525b3705],
7	and	CC	O	and	_	0	SENT_64	[p4l1564t3604r1720b3683],
8	provided	VBN	O	provide	conj_and	3	SENT_64	[p4l1763t3604r2135b3705],
9	comments	NNS	O	comment	dobj	8	SENT_64	[p5l11t37r452b99],
10	on	IN	O	on	_	0	SENT_64	[p5l481t46r586b99],
11	it	PRP	O	it	prep_on	8	SENT_64	[p5l611t21r687b99],
12	.	.	O	.	_	0	SENT_64	[p5l611t21r687b99],

1	Conﬁdentiality	NN	O	conﬁdentiality	nsubjpass	3	SENT_65	[p5l719t20r1339b121],
2	was	VBD	O	be	auxpass	3	SENT_65	[p5l1356t47r1516b100],
3	maintained	VBN	O	maintain	_	0	SENT_65	[p5l1543t20r2018b99],
4	by	IN	O	by	_	0	SENT_65	[p5l2044t21r2140b121],
5	both	CC	O	both	preconj	9	SENT_65	[p5l11t149r201b227],
6	the	DT	O	the	det	9	SENT_65	[p5l232t149r359b227],
7	N	NN	O	n	nn	9	SENT_65	[p5l387t156r462b228],
8	CIC	NNP	ORGANIZATION	CIC	nn	9	SENT_65	[p5l464t154r618b227],
9	CTG	NNP	ORGANIZATION	CTG	agent	3	SENT_65	[p5l650t154r843b227],
10	and	CC	O	and	_	0	SENT_65	[p5l874t148r1028b227],
11	OSI	NNP	ORGANIZATION	OSI	nn	12	SENT_65	[p5l1057t154r1211b227],
12	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	conj_and	9	SENT_65	[p5l1238t149r1944b228],
13	.	.	O	.	_	0	SENT_65	[p5l1238t149r1944b228],

1	The	DT	O	the	det	3	SENT_66	[p5l1976t149r2135b227],
2	study	NN	O	study	nn	3	SENT_66	[p5l12t276r234b377],
3	chair	NN	O	chair	nsubj	16	SENT_66	[p5l251t277r476b372],
4	,	,	O	,	_	0	SENT_66	[p5l251t277r476b372],
5	Dr.	NNP	O	Dr.	nn	6	SENT_66	[p5l501t283r624b355],
6	Shepherd	NNP	PERSON	Shepherd	nsubj	16	SENT_66	[p5l654t276r1072b377],
7	,	,	O	,	_	0	SENT_66	[p5l654t276r1072b377],
8	and	CC	O	and	_	0	SENT_66	[p5l1097t276r1252b355],
9	the	DT	O	the	det	11	SENT_66	[p5l1273t277r1401b355],
10	physician	NN	O	physician	nn	11	SENT_66	[p5l1421t277r1815b377],
11	coordinator	NN	O	coordinator	conj_and	3	SENT_66	[p5l1838t277r2134b355, p5l10t421r248b500],
12	,	,	O	,	_	0	SENT_66	[p5l1838t277r2134b355, p5l10t421r248b500],
13	Dr.	NNP	O	Dr.	nn	14	SENT_66	[p5l275t411r401b483],
14	Seymour	NNP	PERSON	Seymour	appos	3	SENT_66	[p5l435t410r830b505],
15	,	,	O	,	_	0	SENT_66	[p5l435t410r830b505],
16	reviewed	VBN	O	review	_	0	SENT_66	[p5l862t405r1240b484],
17	all	PDT	O	all	predet	19	SENT_66	[p5l1265t405r1366b483],
18	the	DT	O	the	det	19	SENT_66	[p5l1393t405r1525b483],
19	data	NNS	O	datum	dobj	16	SENT_66	[p5l1553t405r1735b483],
20	and	CC	O	and	_	0	SENT_66	[p5l1759t404r1917b483],
21	confirmed	VBD	O	confirm	conj_and	16	SENT_66	[p5l1945t430r2133b483, p5l10t532r298b611],
22	their	PRP$	O	they	poss	23	SENT_66	[p5l325t533r527b611],
23	completeness	NN	O	completeness	dobj	21	SENT_66	[p5l552t533r1130b633],
24	and	CC	O	and	_	0	SENT_66	[p5l1157t532r1313b611],
25	accuracy	NN	O	accuracy	conj_and	23	SENT_66	[p5l1337t559r1712b633],
26	.	.	O	.	_	0	SENT_66	[p5l1337t559r1712b633],

1	124	CD	NUMBER	124	num	3	SENT_67	[p5l149t708r205b729],
2	N	NN	O	n	nn	3	SENT_67	[p5l918t710r932b725],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_67	[p5l947t709r1031b731],
4	MED	VBD	O	med	_	0	SENT_67	[p5l1046t710r1099b725],
5	35	CD	NUMBER	35	number	6	SENT_67	[p5l1111t709r1136b731],
6	:2	CD	NUMBER	:2	dobj	4	SENT_67	[p5l1155t709r1175b729],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_67	[p5l1210t709r1421b731],
8	JULY	NNP	DATE	JULY	dep	6	SENT_67	[p5l1455t710r1515b731],
9	14	CD	DATE	14	num	8	SENT_67	[p5l1527t709r1562b731],
10	,	,	DATE	,	_	0	SENT_67	[p5l1527t709r1562b731],
11	2005	CD	DATE	2005	num	8	SENT_67	[p5l1575t709r1638b731],

1	The	DT	O	the	det	4	SENT_68	[p5l935t742r986b766],
2	New	NNP	O	New	nn	4	SENT_68	[p5l995t743r1057b766],
3	Englan	NNP	O	Englan	nn	4	SENT_68	[p5l1066t742r1160b773],
4	oumal	NN	O	oumal	_	0	SENT_68	[p5l1200t742r1283b766],
5	of	IN	O	of	_	0	SENT_68	[p5l1293t742r1322b766],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_68	[p5l1329t742r1454b766],

1	ERLOTINIB	NNP	O	ERLOTINIB	nsubj	4	SENT_69	[p5l480t930r667b949],
2	IN	IN	O	in	prep	1	SENT_69	[p5l682t930r720b949],
3	PREVIOUSLY	RB	DATE	previously	pcomp	2	SENT_69	[p5l736t930r941b949],
4	TREATED	VBN	O	treat	_	0	SENT_69	[p5l952t930r1103b949],
5	NON	NN	O	non	dobj	4	SENT_69	[p5l1118t930r1422b949],
6	.	.	O	.	_	0	SENT_69	[p5l1118t930r1422b949],

1	—	NN	O	—	_	0	SENT_70	[p5l1118t930r1422b949],
2	.	.	O	.	_	0	SENT_70	[p5l1118t930r1422b949],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_71	[p5l1118t930r1422b949],
2	LUNG	NN	O	lung	_	0	SENT_71	[p5l1436t930r1530b949],
3	CANCER	NNP	O	CANCER	dep	2	SENT_71	[p5l1544t930r1680b949],

1	ELIGIBILITY	NN	O	eligibility	nn	3	SENT_72	[p5l17t1144r503b1193],
2	CRITERIA	NNS	O	criterion	nn	3	SENT_72	[p5l541t1144r918b1193],
3	Patients	NNS	O	patient	nsubj	26	SENT_72	[p5l10t1243r343b1321],
4	18	CD	DURATION	18	num	5	SENT_72	[p5l387t1248r483b1321],
5	years	NNS	NUMBER	year	npadvmod	3	SENT_72	[p5l519t1269r733b1343],
6	of	IN	O	of	_	0	SENT_72	[p5l775t1242r875b1321],
7	age	NN	O	age	prep_of	3	SENT_72	[p5l895t1269r1038b1343],
8	or	CC	O	or	_	0	SENT_72	[p5l1078t1268r1167b1321],
9	older	JJR	O	older	prep_of	3	SENT_72	[p5l1204t1242r1422b1321],
10	with	IN	O	with	_	0	SENT_72	[p5l1454t1242r1643b1322],
11	an	DT	O	a	det	17	SENT_72	[p5l1681t1268r1782b1321],
12	Eastern	NNP	ORGANIZATION	Eastern	nn	17	SENT_72	[p5l1819t1250r2136b1321],
13	Cooperative	NNP	ORGANIZATION	Cooperative	nn	17	SENT_72	[p5l12t1371r510b1471],
14	Oncology	NNP	ORGANIZATION	Oncology	nn	17	SENT_72	[p5l530t1371r936b1471],
15	Group	NNP	ORGANIZATION	Group	nn	17	SENT_72	[p5l952t1376r1222b1471],
16	(	CD	NUMBER	(	num	17	SENT_72	[p5l1249t1376r1573b1462],
17	ECOG	NNP	O	ECOG	prep_with	9	SENT_72	[p5l1249t1376r1573b1462],
18	)	CD	NUMBER	)	num	20	SENT_72	[p5l1249t1376r1573b1462],
19	performance	NN	O	performance	nn	20	SENT_72	[p5l1597t1370r2135b1471],
20	status	NN	O	status	dep	17	SENT_72	[p5l13t1515r257b1578],
21	between	IN	O	between	_	0	SENT_72	[p5l282t1499r630b1578],
22	o	NN	O	o	prep_between	20	SENT_72	[p5l652t1504r699b1577],
23	and	CC	O	and	_	0	SENT_72	[p5l720t1498r875b1577],
24	3	CD	NUMBER	3	prep_between	20	SENT_72	[p5l897t1504r941b1577],
25	were	VBD	O	be	cop	26	SENT_72	[p5l961t1525r1162b1578],
26	eligible	JJ	O	eligible	_	0	SENT_72	[p5l1184t1498r1490b1599],
27	in	IN	O	in	_	0	SENT_72	[p5l1511t1499r1592b1576],
28	the	DT	O	the	det	29	SENT_72	[p5l1614t1499r1742b1577],
29	presence	NN	O	presence	prep_in	26	SENT_72	[p5l1762t1524r2135b1599],
30	of	IN	O	of	_	0	SENT_72	[p5l12t1626r112b1705],
31	documented	VBN	O	document	amod	33	SENT_72	[p5l115t1627r630b1706],
32	pathological	JJ	O	pathological	amod	33	SENT_72	[p5l650t1626r1164b1727],
33	evidence	NN	O	evidence	prep_of	29	SENT_72	[p5l1185t1627r1536b1706],
34	of	IN	O	of	_	0	SENT_72	[p5l1558t1626r1657b1705],
35	non	JJ	O	non	amod	41	SENT_72	[p5l1659t1626r2134b1705],
36	—	JJ	O	—	amod	41	SENT_72	[p5l1659t1626r2134b1705],
37	small	JJ	O	small	amod	41	SENT_72	[p5l1659t1626r2134b1705],
38	—	NN	O	—	nn	41	SENT_72	[p5l1659t1626r2134b1705],
39	cell	NN	O	cell	nn	41	SENT_72	[p5l12t1754r154b1833],
40	lung	NN	O	lung	nn	41	SENT_72	[p5l182t1755r376b1855],
41	cancer	NN	O	cancer	prep_of	33	SENT_72	[p5l403t1780r694b1833],
42	.	.	O	.	_	0	SENT_72	[p5l403t1780r694b1833],

1	The	DT	O	the	det	2	SENT_73	[p5l725t1755r887b1833],
2	patients	NNS	O	patient	nsubj	3	SENT_73	[p5l915t1755r1250b1855],
3	had	VBD	O	have	_	0	SENT_73	[p5l1282t1754r1437b1833],
4	to	TO	O	to	aux	6	SENT_73	[p5l1467t1771r1546b1833],
5	have	VB	O	have	aux	6	SENT_73	[p5l1577t1754r1764b1834],
6	received	VBN	O	receive	xcomp	3	SENT_73	[p5l1794t1755r2135b1834],
7	one	CD	NUMBER	one	nn	10	SENT_73	[p5l12t1908r167b1961],
8	or	CC	O	or	_	0	SENT_73	[p5l199t1908r288b1961],
9	two	CD	NUMBER	two	nn	10	SENT_73	[p5l317t1899r471b1962],
10	regimens	NNS	O	regimen	dobj	6	SENT_73	[p5l503t1883r904b1983],
11	of	IN	O	of	_	0	SENT_73	[p5l937t1882r1039b1961],
12	combination	NN	O	combination	nn	13	SENT_73	[p5l1052t1883r1603b1961],
13	chemotherapy	NN	O	chemotherapy	prep_of	10	SENT_73	[p5l1634t1882r2133b1961, p5l11t2037r159b2111],
14	and	CC	O	and	_	0	SENT_73	[p5l185t2011r342b2089],
15	not	RB	O	not	xcomp	3	SENT_73	[p5l372t2027r518b2089],
16	be	VB	O	be	cop	17	SENT_73	[p5l543t2011r639b2089],
17	eligible	JJ	O	eligible	dep	6	SENT_73	[p5l671t2010r986b2111],
18	for	IN	O	for	_	0	SENT_73	[p5l1016t2010r1141b2089],
19	further	JJ	O	further	amod	20	SENT_73	[p5l1168t2010r1470b2090],
20	chemotherapy	NN	O	chemotherapy	prep_for	17	SENT_73	[p5l1498t2010r2129b2111],
21	.	.	O	.	_	0	SENT_73	[p5l1498t2010r2129b2111],

1	Patients	NNS	O	patient	nsubj	10	SENT_74	[p5l10t2139r349b2217],
2	70	CD	DURATION	70	num	3	SENT_74	[p5l381t2144r481b2217],
3	years	NNS	NUMBER	year	npadvmod	1	SENT_74	[p5l505t2165r719b2239],
4	of	IN	O	of	_	0	SENT_74	[p5l748t2138r848b2217],
5	age	NN	O	age	prep_of	1	SENT_74	[p5l856t2165r999b2239],
6	or	CC	O	or	_	0	SENT_74	[p5l1026t2164r1115b2217],
7	older	JJR	O	older	conj_or	5	SENT_74	[p5l1139t2138r1358b2217],
8	may	MD	O	may	aux	10	SENT_74	[p5l1381t2165r1558b2239],
9	have	VB	O	have	aux	10	SENT_74	[p5l1579t2139r1768b2218],
10	received	VBN	O	receive	_	0	SENT_74	[p5l1794t2139r2135b2218],
11	therapy	NN	O	therapy	dobj	10	SENT_74	[p5l12t2267r329b2367],
12	with	IN	O	with	_	0	SENT_74	[p5l344t2267r533b2346],
13	one	CD	NUMBER	one	nn	17	SENT_74	[p5l557t2292r710b2345],
14	or	CC	O	or	_	0	SENT_74	[p5l734t2292r823b2345],
15	two	CD	NUMBER	two	nn	17	SENT_74	[p5l844t2283r996b2346],
16	single	JJ	O	single	amod	17	SENT_74	[p5l1023t2267r1273b2367],
17	agents	NNS	O	agent	prep_with	10	SENT_74	[p5l1296t2283r1595b2367],
18	.	.	O	.	_	0	SENT_74	[p5l1296t2283r1595b2367],

1	Patients	NNS	O	patient	nsubj	2	SENT_75	[p5l1623t2267r1955b2345],
2	had	VBD	O	have	_	0	SENT_75	[p5l1980t2267r2136b2345],
3	to	TO	O	to	aux	5	SENT_75	[p5l12t2411r91b2473],
4	have	VB	O	have	aux	5	SENT_75	[p5l121t2394r309b2474],
5	recovered	VBN	O	recover	xcomp	2	SENT_75	[p5l338t2394r744b2474],
6	from	IN	O	from	_	0	SENT_75	[p5l773t2394r980b2473],
7	any	DT	O	any	det	9	SENT_75	[p5l1008t2420r1155b2495],
8	toxic	JJ	O	toxic	amod	9	SENT_75	[p5l1181t2395r1381b2473],
9	effects	NNS	O	effect	prep_from	5	SENT_75	[p5l1410t2394r1680b2473],
10	of	IN	O	of	_	0	SENT_75	[p5l1712t2394r1813b2473],
11	therapy	NN	O	therapy	prep_of	9	SENT_75	[p5l1823t2395r2140b2495],
12	and	CC	O	and	_	0	SENT_75	[p5l11t2523r167b2601],
13	were	VBD	O	be	auxpass	15	SENT_75	[p5l184t2549r386b2602],
14	randomly	RB	O	randomly	advmod	15	SENT_75	[p5l408t2522r817b2623],
15	assigned	VBN	O	assign	conj_and	2	SENT_75	[p5l834t2522r1204b2623],
16	to	TO	O	to	_	0	SENT_75	[p5l1227t2539r1306b2601],
17	the	DT	O	the	det	19	SENT_75	[p5l1330t2523r1459b2601],
18	study	NN	O	study	nn	19	SENT_75	[p5l1483t2522r1708b2623],
19	treatment	NN	O	treatment	prep_to	15	SENT_75	[p5l1726t2539r2141b2601],
20	at	IN	DURATION	at	quantmod	22	SENT_75	[p5l11t2667r90b2729],
21	least	JJS	DURATION	least	mwe	20	SENT_75	[p5l118t2651r315b2729],
22	21	CD	DURATION	21	num	23	SENT_75	[p5l344t2656r444b2728],
23	days	NNS	NUMBER	day	npadvmod	15	SENT_75	[p5l480t2650r661b2751],
24	after	IN	O	after	_	0	SENT_75	[p5l697t2650r890b2729],
25	chemotherapy	NN	O	chemotherapy	prep_after	15	SENT_75	[p5l922t2650r1529b2751],
26	(	CD	NUMBER	(	num	25	SENT_75	[p5l1563t2656r1694b2742],
27	14	CD	DURATION	14	num	28	SENT_75	[p5l1563t2656r1694b2742],
28	days	NNS	NUMBER	day	npadvmod	15	SENT_75	[p5l1729t2650r1910b2751],
29	after	IN	O	after	_	0	SENT_75	[p5l1945t2650r2138b2729],
30	treatment	NN	O	treatment	prep_after	15	SENT_75	[p5l12t2795r426b2857],
31	with	IN	O	with	_	0	SENT_75	[p5l439t2779r629b2858],
32	vinca	NN	O	vinca	nn	33	SENT_75	[p5l647t2779r868b2858],
33	alkaloids	NNS	O	alkaloid	prep_with	30	SENT_75	[p5l889t2778r1266b2858],
34	or	CC	O	or	_	0	SENT_75	[p5l1292t2804r1381b2857],
35	gemcitabine	NN	O	gemcitabine	nn	36	SENT_75	[p5l1400t2779r1952b2879],
36	)	NN	O	)	conj_or	33	SENT_75	[p5l1400t2779r1952b2879],
37	and	CC	O	and	_	0	SENT_75	[p5l1980t2779r2136b2857],
38	7	CD	DURATION	7	num	39	SENT_75	[p5l13t2914r59b2985],
39	days	NNS	NUMBER	day	npadvmod	15	SENT_75	[p5l89t2906r273b3007],
40	after	IN	O	after	_	0	SENT_75	[p5l304t2906r501b2985],
41	radiation	NN	O	radiation	conj_and	30	SENT_75	[p5l528t2906r942b2985],
42	.	.	O	.	_	0	SENT_75	[p5l528t2906r942b2985],

1	Adequate	JJ	O	adequate	amod	5	SENT_76	[p5l973t2907r1379b3007],
2	hematologic	JJ	O	hematologic	amod	5	SENT_76	[p5l1409t2907r1948b3007],
3	and	CC	O	and	_	0	SENT_76	[p5l1977t2906r2134b2985],
4	biochemical	JJ	O	biochemical	amod	5	SENT_76	[p5l12t3034r532b3113],
5	values	NNS	O	value	nsubjpass	7	SENT_76	[p5l552t3034r812b3114],
6	were	VBD	O	be	auxpass	7	SENT_76	[p5l835t3061r1036b3114],
7	required	VBN	O	require	_	0	SENT_76	[p5l1062t3035r1440b3135],
8	.	.	O	.	_	0	SENT_76	[p5l1062t3035r1440b3135],

1	Patients	NNS	O	patient	nsubj	12	SENT_77	[p5l139t3163r472b3241],
2	with	IN	O	with	_	0	SENT_77	[p5l494t3163r683b3242],
3	prior	JJ	O	prior	amod	5	SENT_77	[p5l707t3163r920b3263],
4	breast	NN	O	breast	nn	5	SENT_77	[p5l942t3162r1202b3241],
5	cancer	NN	O	cancer	prep_with	1	SENT_77	[p5l1223t3188r1515b3258],
6	,	,	O	,	_	0	SENT_77	[p5l1223t3188r1515b3258],
7	melanoma	NN	O	melanoma	conj_or	5	SENT_77	[p5l1545t3162r2018b3258],
8	,	,	O	,	_	0	SENT_77	[p5l1545t3162r2018b3258],
9	or	CC	O	or	_	0	SENT_77	[p5l2050t3188r2138b3241],
10	hypernephroma	NN	O	hypernephroma	conj_or	5	SENT_77	[p5l12t3291r691b3391],
11	were	VBD	O	be	cop	12	SENT_77	[p5l707t3317r909b3370],
12	ineligible	JJ	O	ineligible	_	0	SENT_77	[p5l930t3290r1347b3391],
13	,	,	O	,	_	0	SENT_77	[p5l930t3290r1347b3391],
14	as	IN	O	as	mark	21	SENT_77	[p5l1374t3317r1458b3369],
15	were	VBD	O	be	cop	16	SENT_77	[p5l1477t3317r1679b3370],
16	those	DT	O	those	csubj	21	SENT_77	[p5l1702t3290r1929b3369],
17	with	IN	O	with	_	0	SENT_77	[p5l1947t3290r2136b3370],
18	other	JJ	O	other	amod	20	SENT_77	[p5l12t3419r241b3497],
19	malignant	JJ	O	malignant	amod	20	SENT_77	[p5l279t3419r725b3519],
20	diseases	NNS	O	disease	prep_with	16	SENT_77	[p5l762t3418r1114b3497],
21	(	VBP	O	(	advcl	12	SENT_77	[p5l1163t3426r1470b3519],
22	except	IN	O	except	mark	28	SENT_77	[p5l1163t3426r1470b3519],
23	basal	JJ	O	basal	amod	27	SENT_77	[p5l1507t3419r1913b3497],
24	—	NN	O	—	nn	27	SENT_77	[p5l1507t3419r1913b3497],
25	cell	NN	O	cell	nn	27	SENT_77	[p5l1507t3419r1913b3497],
26	skin	NN	O	skin	nn	27	SENT_77	[p5l1956t3419r2134b3498],
27	cancers	NNS	O	cancer	nsubj	28	SENT_77	[p5l12t3554r357b3638],
28	)	VBP	O	)	advcl	21	SENT_77	[p5l12t3554r357b3638],
29	within	IN	O	within	_	0	SENT_77	[p5l387t3547r661b3626],
30	the	DT	O	the	det	33	SENT_77	[p5l692t3546r820b3625],
31	preceding	VBG	O	precede	amod	33	SENT_77	[p5l848t3546r1274b3647],
32	ﬁve	NN	O	ﬁve	nn	33	SENT_77	[p5l1299t3546r1444b3626],
33	years	NNS	DURATION	year	prep_within	28	SENT_77	[p5l1468t3573r1708b3647],
34	.	.	O	.	_	0	SENT_77	[p5l1468t3573r1708b3647],

1	Other	JJ	O	other	amod	3	SENT_78	[p5l1743t3547r1987b3625],
2	exclusion	NN	O	exclusion	nn	3	SENT_78	[p5l2014t3573r2134b3625, p5l12t3675r318b3754],
3	criteria	NNS	O	criterion	nsubj	7	SENT_78	[p5l346t3675r653b3753],
4	were	VBD	O	be	cop	7	SENT_78	[p5l678t3701r884b3754],
5	symptomatic	JJ	O	symptomatic	amod	7	SENT_78	[p5l917t3675r1480b3775],
6	brain	NN	O	brain	nn	7	SENT_78	[p5l1511t3675r1734b3753],
7	metastases	NNS	O	metastase	_	0	SENT_78	[p5l1765t3691r2134b3753, p6l13t47r163b116],
8	,	,	O	,	_	0	SENT_78	[p5l1765t3691r2134b3753, p6l13t47r163b116],

1	clinically	RB	O	clinically	advmod	2	SENT_79	[p6l191t20r567b121],
2	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_79	[p6l586t20r1037b121],
3	cardiac	JJ	O	cardiac	amod	7	SENT_79	[p6l1055t21r1354b99],
4	disease	NN	O	disease	dep	7	SENT_79	[p6l1377t20r1676b99],
5	Within	IN	O	within	_	0	SENT_79	[p6l1694t21r1964b100],
6	one	CD	DURATION	one	prep_within	4	SENT_79	[p6l1986t46r2136b99],
7	year	NN	NUMBER	year	_	0	SENT_79	[p6l7t175r195b249],
8	,	,	O	,	_	0	SENT_79	[p6l7t175r195b249],
9	Ventricular	JJ	O	ventricular	amod	10	SENT_79	[p6l222t148r671b228],
10	arrhythmias	NNS	O	arrhythmia	conj_and	7	SENT_79	[p6l693t149r1194b249],
11	requiring	VBG	O	require	partmod	10	SENT_79	[p6l1222t149r1612b249],
12	medication	NN	O	medication	dobj	11	SENT_79	[p6l1635t149r2130b244],
13	,	,	O	,	_	0	SENT_79	[p6l1635t149r2130b244],
14	and	CC	O	and	_	0	SENT_79	[p6l11t277r166b355],
15	clinically	RB	O	clinically	advmod	16	SENT_79	[p6l189t276r559b377],
16	signiﬁcant	JJ	O	signiﬁcant	dep	17	SENT_79	[p6l578t276r1024b377],
17	ophthalmologic	JJ	O	ophthalmologic	conj_and	7	SENT_79	[p6l1041t276r1712b377],
18	or	CC	O	or	_	0	SENT_79	[p6l1734t302r1823b355],
19	gastrointestinal	JJ	O	gastrointestinal	amod	20	SENT_79	[p6l1842t293r2135b377, p6l11t406r400b484],
20	abnormalities	NNS	O	abnormality	conj_and	7	SENT_79	[p6l422t406r1032b484],
21	.	.	O	.	_	0	SENT_79	[p6l422t406r1032b484],

1	sru	NN	O	sru	nn	2	SENT_80	[p6l12t678r158b727],
2	DY	NN	O	dy	nsubj	3	SENT_80	[p6l178t678r278b727],
3	pnoceounes	VBZ	O	pnoceoune	_	0	SENT_80	[p6l321t678r867b727],
4	Within	IN	O	within	_	0	SENT_80	[p6l8t778r303b857],
5	seven	CD	DURATION	seven	num	6	SENT_80	[p6l332t804r561b858],
6	days	NNS	NUMBER	day	prep_within	16	SENT_80	[p6l589t778r769b879],
7	before	IN	O	before	_	0	SENT_80	[p6l799t778r1066b857],
8	randomization	NN	O	randomization	prep_before	6	SENT_80	[p6l1093t779r1744b874],
9	,	,	O	,	_	0	SENT_80	[p6l1093t779r1744b874],
10	a	DT	O	a	det	11	SENT_80	[p6l1776t805r1821b857],
11	history	NN	O	history	nsubjpass	16	SENT_80	[p6l1846t779r2140b879],
12	and	CC	O	and	_	0	SENT_80	[p6l11t907r166b985],
13	physical	JJ	O	physical	amod	14	SENT_80	[p6l185t907r526b1007],
14	examination	NN	O	examination	nsubjpass	16	SENT_80	[p6l547t907r1067b985],
15	were	VBD	O	be	auxpass	16	SENT_80	[p6l1084t933r1284b986],
16	obtained	VBN	O	obtain	dep	3	SENT_80	[p6l1307t906r1675b985],
17	and	CC	O	and	_	0	SENT_80	[p6l1695t906r1850b985],
18	hematologic	JJ	O	hematologic	amod	21	SENT_80	[p6l1871t907r2134b985, p6l12t1035r297b1135],
19	and	CC	O	and	_	0	SENT_80	[p6l323t1035r476b1113],
20	biochemical	JJ	O	biochemical	conj_and	18	SENT_80	[p6l503t1035r1011b1113],
21	testing	NN	O	testing	nsubjpass	36	SENT_80	[p6l1036t1035r1340b1135],
22	,	,	O	,	_	0	SENT_80	[p6l1036t1035r1340b1135],
23	chest	NN	O	chest	nn	24	SENT_80	[p6l1373t1034r1591b1113],
24	radiography	NN	O	radiography	appos	21	SENT_80	[p6l1613t1035r2131b1135],
25	,	,	O	,	_	0	SENT_80	[p6l1613t1035r2131b1135],
26	and	CC	O	and	_	0	SENT_80	[p6l11t1163r169b1241],
27	assessments	NNS	O	assessment	nsubjpass	36	SENT_80	[p6l193t1179r729b1241],
28	of	IN	O	of	_	0	SENT_80	[p6l757t1162r858b1241],
29	toxic	JJ	O	toxic	amod	30	SENT_80	[p6l865t1163r1070b1241],
30	effects	NNS	O	effect	prep_of	27	SENT_80	[p6l1095t1162r1372b1241],
31	and	CC	O	and	_	0	SENT_80	[p6l1397t1162r1555b1241],
32	quality	NN	O	quality	nsubjpass	36	SENT_80	[p6l1581t1162r1873b1263],
33	of	IN	O	of	_	0	SENT_80	[p6l1894t1162r1995b1241],
34	life	NN	O	life	prep_of	32	SENT_80	[p6l2001t1162r2134b1241],
35	Were	VBD	O	be	auxpass	36	SENT_80	[p6l7t1317r214b1370],
36	obtained	VBN	O	obtain	conj_and	16	SENT_80	[p6l248t1290r656b1369],
37	.	.	O	.	_	0	SENT_80	[p6l248t1290r656b1369],

1	Computed	VBN	O	compute	csubjpass	10	SENT_81	[p6l694t1290r1150b1391],
2	tomographic	JJ	O	tomographic	amod	3	SENT_81	[p6l1183t1291r1747b1391],
3	scans	NNS	O	scan	dobj	1	SENT_81	[p6l1781t1316r2015b1369],
4	of	IN	O	of	_	0	SENT_81	[p6l2051t1290r2152b1369],
5	the	DT	O	the	det	6	SENT_81	[p6l12t1418r143b1497],
6	chest	NN	O	chest	prep_of	3	SENT_81	[p6l180t1419r407b1497],
7	and	CC	O	and	_	0	SENT_81	[p6l436t1418r594b1497],
8	abdomen	NN	O	abdomen	prep_of	3	SENT_81	[p6l629t1419r1034b1497],
9	were	VBD	O	be	auxpass	10	SENT_81	[p6l1065t1445r1270b1498],
10	obtained	VBN	O	obtain	_	0	SENT_81	[p6l1307t1419r1686b1497],
11	Within	IN	O	within	dep	10	SENT_81	[p6l1717t1419r1996b1498],
12	28	CD	DURATION	28	num	13	SENT_81	[p6l2032t1424r2133b1497],
13	days	NNS	NUMBER	day	pobj	11	SENT_81	[p6l12t1547r190b1647],
14	before	IN	O	before	_	0	SENT_81	[p6l219t1546r481b1625],
15	randomization	NN	O	randomization	prep_before	10	SENT_81	[p6l506t1546r1146b1625],
16	.	.	O	.	_	0	SENT_81	[p6l506t1546r1146b1625],

1	For	IN	O	for	_	0	SENT_82	[p6l1176t1554r1319b1625],
2	a	DT	O	a	det	3	SENT_82	[p6l1340t1573r1385b1625],
3	patient	NN	O	patient	prep_for	17	SENT_82	[p6l1407t1547r1701b1647],
4	to	TO	O	to	aux	6	SENT_82	[p6l1721t1563r1799b1625],
5	be	VB	O	be	auxpass	6	SENT_82	[p6l1827t1547r1921b1625],
6	evaluated	VBN	O	evaluate	infmod	3	SENT_82	[p6l1948t1547r2135b1626, p6l12t1674r241b1754],
7	for	IN	O	for	_	0	SENT_82	[p6l261t1674r384b1753],
8	a	DT	O	a	det	9	SENT_82	[p6l402t1701r446b1753],
9	response	NN	O	response	prep_for	6	SENT_82	[p6l466t1700r868b1775],
10	,	,	O	,	_	0	SENT_82	[p6l466t1700r868b1775],
11	at	IN	O	at	quantmod	13	SENT_82	[p6l894t1691r973b1753],
12	least	JJS	O	least	mwe	11	SENT_82	[p6l988t1674r1185b1753],
13	one	CD	NUMBER	one	num	15	SENT_82	[p6l1202t1700r1354b1753],
14	measurable	JJ	O	measurable	amod	15	SENT_82	[p6l1375t1675r1862b1754],
15	lesion	NN	O	lesion	nsubjpass	17	SENT_82	[p6l1882t1674r2136b1753],
16	Was	VBD	O	be	auxpass	17	SENT_82	[p6l7t1829r167b1882],
17	required	VBN	O	require	_	0	SENT_82	[p6l192t1802r564b1903],
18	,	,	O	,	_	0	SENT_82	[p6l192t1802r564b1903],
19	but	CC	O	but	_	0	SENT_82	[p6l594t1802r733b1882],
20	measurable	JJ	O	measurable	amod	21	SENT_82	[p6l751t1802r1230b1882],
21	disease	NN	O	disease	nsubj	24	SENT_82	[p6l1255t1802r1553b1881],
22	was	VBD	O	be	cop	24	SENT_82	[p6l1573t1829r1732b1882],
23	not	RB	O	not	neg	24	SENT_82	[p6l1757t1819r1899b1881],
24	mandatory	JJ	O	mandatory	conj_but	17	SENT_82	[p6l1917t1828r2135b1881, p6l12t1931r283b2031],
25	for	IN	O	for	_	0	SENT_82	[p6l316t1930r441b2009],
26	eligibility	NN	O	eligibility	prep_for	24	SENT_82	[p6l476t1931r895b2031],
27	.	.	O	.	_	0	SENT_82	[p6l476t1931r895b2031],

1	Only	RB	O	only	advmod	2	SENT_83	[p6l938t1930r1143b2031],
2	patients	NNS	O	patient	nsubjpass	7	SENT_83	[p6l1175t1931r1517b2031],
3	with	IN	O	with	_	0	SENT_83	[p6l1552t1930r1745b2010],
4	measurable	JJ	O	measurable	amod	5	SENT_83	[p6l1783t1957r2133b2010, p6l11t2058r185b2137],
5	disease	NN	O	disease	prep_with	2	SENT_83	[p6l216t2058r524b2137],
6	Were	VBD	O	be	auxpass	7	SENT_83	[p6l547t2085r749b2138],
7	included	VBN	O	include	_	0	SENT_83	[p6l776t2058r1141b2138],
8	in	IN	O	in	_	0	SENT_83	[p6l1168t2059r1248b2136],
9	the	DT	O	the	det	10	SENT_83	[p6l1276t2059r1405b2137],
10	analyses	NNS	O	analysis	prep_in	7	SENT_83	[p6l1432t2058r1781b2159],
11	of	IN	O	of	_	0	SENT_83	[p6l1810t2058r1911b2137],
12	complete	JJ	O	complete	amod	15	SENT_83	[p6l1920t2084r2134b2137, p6l10t2187r214b2287],
13	or	CC	O	or	_	0	SENT_83	[p6l239t2212r328b2265],
14	partial	JJ	O	partial	amod	15	SENT_83	[p6l350t2186r621b2287],
15	response	NN	O	response	prep_of	10	SENT_83	[p6l645t2212r1048b2287],
16	.	.	O	.	_	0	SENT_83	[p6l645t2212r1048b2287],

1	Administration	NN	O	administration	nsubj	6	SENT_84	[p6l137t2314r785b2393],
2	of	IN	O	of	_	0	SENT_84	[p6l820t2314r920b2393],
3	the	DT	O	the	det	5	SENT_84	[p6l936t2315r1065b2393],
4	study	NN	O	study	nn	5	SENT_84	[p6l1100t2315r1325b2415],
5	medication	NN	O	medication	prep_of	1	SENT_84	[p6l1355t2315r1829b2393],
6	was	VBD	O	be	_	0	SENT_84	[p6l1858t2341r2019b2394],
7	to	TO	O	to	aux	8	SENT_84	[p6l2055t2331r2134b2393],
8	start	VB	O	start	xcomp	6	SENT_84	[p6l13t2459r210b2521],
9	Within	IN	O	within	dep	8	SENT_84	[p6l248t2443r531b2522],
10	two	CD	DURATION	two	num	11	SENT_84	[p6l579t2459r735b2522],
11	days	NNS	NUMBER	day	pobj	9	SENT_84	[p6l785t2442r971b2543],
12	after	IN	O	after	_	0	SENT_84	[p6l1020t2442r1220b2521],
13	randomization	NN	O	randomization	prep_after	11	SENT_84	[p6l1265t2442r1937b2521],
14	.	.	O	.	_	0	SENT_84	[p6l1265t2442r1937b2521],

1	For	IN	O	for	_	0	SENT_85	[p6l1989t2450r2137b2521],
2	grade	NN	O	grade	nn	4	SENT_85	[p6l11t2571r251b2671],
3	2	CD	NUMBER	2	num	4	SENT_85	[p6l285t2576r332b2648],
4	diarrhea	NN	O	diarrhea	prep_for	8	SENT_85	[p6l369t2570r751b2666],
5	,	,	O	,	_	0	SENT_85	[p6l369t2570r751b2666],
6	loperamide	NN	O	loperamide	nsubjpass	8	SENT_85	[p6l790t2570r1281b2671],
7	Was	VBD	O	be	auxpass	8	SENT_85	[p6l1311t2597r1475b2650],
8	recommended	VBN	O	recommend	_	0	SENT_85	[p6l1511t2570r2134b2649],
9	Without	IN	O	without	_	0	SENT_85	[p6l7t2699r352b2778],
10	reduction	NN	O	reduction	prep_without	8	SENT_85	[p6l392t2698r811b2778],
11	of	IN	O	of	_	0	SENT_85	[p6l857t2698r959b2777],
12	the	DT	O	the	det	13	SENT_85	[p6l987t2699r1119b2777],
13	dose	NN	O	dose	prep_of	10	SENT_85	[p6l1166t2698r1364b2777],
14	of	IN	O	of	_	0	SENT_85	[p6l1411t2698r1514b2777],
15	erlotinib	NN	O	erlotinib	prep_of	13	SENT_85	[p6l1542t2699r1939b2777],
16	.	.	O	.	_	0	SENT_85	[p6l1542t2699r1939b2777],

1	For	IN	O	for	_	0	SENT_86	[p6l1989t2706r2137b2777],
2	grade	NN	O	grade	nn	4	SENT_86	[p6l11t2827r251b2927],
3	3	CD	NUMBER	3	num	4	SENT_86	[p6l293t2832r336b2905],
4	diarrhea	NN	O	diarrhea	prep_for	10	SENT_86	[p6l381t2827r763b2922],
5	,	,	O	,	_	0	SENT_86	[p6l381t2827r763b2922],
6	the	DT	O	the	det	8	SENT_86	[p6l810t2827r941b2905],
7	study	NN	O	study	nn	8	SENT_86	[p6l983t2827r1213b2927],
8	treatment	NN	O	treatment	nsubjpass	10	SENT_86	[p6l1250t2843r1673b2905],
9	was	VBD	O	be	auxpass	10	SENT_86	[p6l1704t2853r1867b2906],
10	withheld	VBN	O	withhold	_	0	SENT_86	[p6l1906t2827r2133b2906, p6l12t2954r197b3033],
11	until	IN	O	until	mark	15	SENT_86	[p6l222t2954r421b3034],
12	the	DT	O	the	det	13	SENT_86	[p6l446t2955r577b3033],
13	diarrhea	NN	O	diarrhea	nsubj	18	SENT_86	[p6l600t2954r945b3033],
14	Was	VBD	O	be	cop	15	SENT_86	[p6l960t2981r1120b3034],
15	grade	NN	O	grade	advcl	10	SENT_86	[p6l1143t2955r1374b3055],
16	1	CD	NUMBER	1	num	15	SENT_86	[p6l1400t2960r1444b3032],
17	or	CC	O	or	_	0	SENT_86	[p6l1467t2980r1555b3033],
18	less	JJR	O	less	conj_or	15	SENT_86	[p6l1573t2955r1750b3050],
19	,	,	O	,	_	0	SENT_86	[p6l1573t2955r1750b3050],
20	and	CC	O	and	cc	10	SENT_86	[p6l1776t2955r1930b3033],
21	then	RB	O	then	advmod	10	SENT_86	[p6l1952t2955r2137b3033],
22	erlotinib	NN	O	erlotinib	nsubjpass	31	SENT_86	[p6l12t3082r375b3161],
23	at	IN	O	at	_	0	SENT_86	[p6l400t3099r480b3161],
24	a	DT	O	a	det	25	SENT_86	[p6l498t3109r542b3161],
25	dose	NN	O	dose	prep_at	22	SENT_86	[p6l565t3082r762b3161],
26	of	IN	O	of	_	0	SENT_86	[p6l787t3082r888b3161],
27	100	CD	NUMBER	100	num	29	SENT_86	[p6l897t3088r1049b3161],
28	mg	NN	O	mg	nn	29	SENT_86	[p6l1073t3109r1214b3183],
29	daily	NN	SET	daily	prep_of	25	SENT_86	[p6l1235t3083r1439b3183],
30	was	VBD	O	be	auxpass	31	SENT_86	[p6l1454t3109r1617b3162],
31	started	VBN	O	start	ccomp	10	SENT_86	[p6l1645t3083r1963b3161],
32	.	.	O	.	_	0	SENT_86	[p6l1645t3083r1963b3161],

1	For	IN	O	for	_	0	SENT_87	[p6l1991t3090r2138b3161],
2	grade	NN	O	grade	prep_for	12	SENT_87	[p6l11t3211r250b3311],
3	1	CD	NUMBER	1	num	2	SENT_87	[p6l285t3216r329b3288],
4	or	CC	O	or	_	0	SENT_87	[p6l362t3236r451b3289],
5	2	CD	NUMBER	2	num	6	SENT_87	[p6l478t3216r525b3288],
6	rash	NN	O	rash	conj_or	2	SENT_87	[p6l556t3211r760b3306],
7	,	,	O	,	_	0	SENT_87	[p6l556t3211r760b3306],
8	treatment	NN	O	treatment	nn	9	SENT_87	[p6l796t3227r1210b3289],
9	modification	NN	O	modification	nsubjpass	12	SENT_87	[p6l1235t3210r1779b3289],
10	was	VBD	O	be	auxpass	12	SENT_87	[p6l1805t3237r1965b3290],
11	not	RB	O	not	neg	12	SENT_87	[p6l1997t3227r2141b3289],
12	recommended	VBN	O	recommend	_	0	SENT_87	[p6l12t3338r664b3417],
13	.	.	O	.	_	0	SENT_87	[p6l12t3338r664b3417],

1	For	IN	O	for	_	0	SENT_88	[p6l706t3346r854b3417],
2	grade	NN	O	grade	nn	4	SENT_88	[p6l889t3338r1131b3439],
3	3	CD	NUMBER	3	num	4	SENT_88	[p6l1170t3344r1214b3417],
4	rash	NN	O	rash	prep_for	13	SENT_88	[p6l1257t3339r1467b3434],
5	,	,	O	,	_	0	SENT_88	[p6l1257t3339r1467b3434],
6	treatment	NN	O	treatment	nsubj	8	SENT_88	[p6l1512t3355r1939b3417],
7	was	VBD	O	be	cop	8	SENT_88	[p6l1968t3365r2133b3418],
8	Withheld	NNP	O	Withheld	dep	13	SENT_88	[p6l7t3467r399b3562],
9	,	,	O	,	_	0	SENT_88	[p6l7t3467r399b3562],
10	the	DT	O	the	det	11	SENT_88	[p6l427t3467r554b3545],
11	rash	NN	O	rash	nsubjpass	13	SENT_88	[p6l576t3467r754b3545],
12	was	VBD	O	be	auxpass	13	SENT_88	[p6l771t3493r931b3546],
13	treated	VBN	O	treat	_	0	SENT_88	[p6l955t3466r1238b3545],
14	symptomatically	RB	O	symptomatically	advmod	13	SENT_88	[p6l1261t3467r1956b3567],
15	,	,	O	,	_	0	SENT_88	[p6l1261t3467r1956b3567],
16	and	CC	O	and	_	0	SENT_88	[p6l1983t3466r2137b3545],
17	erlotinib	NN	O	erlotinib	nsubjpass	26	SENT_88	[p6l12t3595r374b3673],
18	at	IN	O	at	_	0	SENT_88	[p6l411t3611r491b3673],
19	a	DT	O	a	det	20	SENT_88	[p6l522t3621r566b3673],
20	dose	NN	O	dose	prep_at	17	SENT_88	[p6l601t3594r798b3673],
21	of	IN	O	of	_	0	SENT_88	[p6l835t3594r937b3673],
22	100	CD	NUMBER	100	num	24	SENT_88	[p6l957t3600r1110b3673],
23	mg	NN	O	mg	nn	24	SENT_88	[p6l1147t3621r1288b3695],
24	daily	NN	SET	daily	prep_of	20	SENT_88	[p6l1321t3594r1525b3695],
25	was	VBD	O	be	auxpass	26	SENT_88	[p6l1552t3621r1715b3674],
26	restarted	VBN	O	restart	conj_and	13	SENT_88	[p6l1753t3595r2135b3673],

1	When	WRB	O	when	advmod	5	SENT_89	[p7l7t21r244b100],
2	the	DT	O	the	det	3	SENT_89	[p7l271t21r402b99],
3	rash	NN	O	rash	nsubj	5	SENT_89	[p7l427t21r607b99],
4	was	VBD	O	be	cop	5	SENT_89	[p7l628t47r789b100],
5	grade	NN	O	grade	_	0	SENT_89	[p7l816t21r1051b121],
6	1	CD	NUMBER	1	num	5	SENT_89	[p7l1080t26r1124b98],
7	or	CC	O	or	_	0	SENT_89	[p7l1150t46r1239b99],
8	less	JJR	O	less	conj_or	5	SENT_89	[p7l1260t21r1440b99],
9	.	.	O	.	_	0	SENT_89	[p7l1260t21r1440b99],

1	History	NN	O	history	nn	2	SENT_90	[p7l139t149r460b249],
2	taking	NN	O	taking	nsubjpass	13	SENT_90	[p7l489t149r788b249],
3	,	,	O	,	_	0	SENT_90	[p7l489t149r788b249],
4	physical	JJ	O	physical	amod	5	SENT_90	[p7l825t149r1177b249],
5	examination	NN	O	examination	appos	2	SENT_90	[p7l1210t149r1770b244],
6	,	,	O	,	_	0	SENT_90	[p7l1210t149r1770b244],
7	and	CC	O	and	_	0	SENT_90	[p7l1808t148r1966b227],
8	hematologic	JJ	O	hematologic	amod	11	SENT_90	[p7l1999t149r2133b227, p7l11t277r431b377],
9	and	CC	O	and	_	0	SENT_90	[p7l455t276r609b355],
10	biochemical	JJ	O	biochemical	amod	11	SENT_90	[p7l635t276r1143b355],
11	testing	NN	O	testing	nsubjpass	13	SENT_90	[p7l1168t277r1452b377],
12	were	VBD	O	be	auxpass	13	SENT_90	[p7l1470t303r1669b356],
13	performed	VBN	O	perform	_	0	SENT_90	[p7l1694t276r2136b377],
14	every	DT	SET	every	quantmod	15	SENT_90	[p7l11t431r225b505],
15	four	CD	SET	four	num	16	SENT_90	[p7l248t404r427b484],
16	Weeks	NNS	SET	week	dobj	13	SENT_90	[p7l447t405r731b500],
17	,	,	O	,	_	0	SENT_90	[p7l447t405r731b500],
18	and	CC	O	and	_	0	SENT_90	[p7l764t404r920b483],
19	radiologic	JJ	O	radiologic	amod	20	SENT_90	[p7l948t405r1375b505],
20	investigations	NNS	O	investigation	dobj	13	SENT_90	[p7l1402t405r1987b505],
21	every	DT	SET	every	det	23	SENT_90	[p7l2018t431r2134b484, p7l11t559r135b633],
22	eight	CD	SET	eight	num	23	SENT_90	[p7l157t533r369b633],
23	Weeks	NNS	SET	week	dep	20	SENT_90	[p7l384t532r665b612],
24	.	.	O	.	_	0	SENT_90	[p7l384t532r665b612],

1	Patients	NNS	O	patient	nsubj	14	SENT_91	[p7l694t533r1045b611],
2	’	CD	NUMBER	’	num	3	SENT_91	[p7l694t533r1045b611],
3	quality	NN	O	quality	nsubjpass	7	SENT_91	[p7l1075t533r1356b633],
4	of	IN	O	of	_	0	SENT_91	[p7l1376t532r1476b611],
5	life	NN	O	life	prep_of	3	SENT_91	[p7l1481t532r1609b611],
6	was	VBD	O	be	auxpass	7	SENT_91	[p7l1630t559r1789b612],
7	evaluated	VBN	O	evaluate	rcmod	1	SENT_91	[p7l1817t533r2135b612, p7l11t661r107b739],
8	every	DT	SET	every	det	10	SENT_91	[p7l131t687r343b761],
9	four	CD	SET	four	num	10	SENT_91	[p7l363t660r541b740],
10	Weeks	NNS	SET	week	dobj	7	SENT_91	[p7l558t661r818b740],
11	in	IN	O	in	_	0	SENT_91	[p7l845t661r926b738],
12	countries	NNS	O	country	prep_in	10	SENT_91	[p7l952t661r1342b740],
13	with	IN	O	with	prep	7	SENT_91	[p7l1365t661r1554b740],
14	validated	VBN	O	validate	_	0	SENT_91	[p7l1575t660r1955b740],
15	versions	NNS	O	version	dobj	14	SENT_91	[p7l1975t687r2134b740, p7l12t789r231b867],
16	of	IN	O	of	_	0	SENT_91	[p7l259t788r358b867],
17	the	DT	O	the	det	18	SENT_91	[p7l366t789r495b867],
18	questionnaires	NNS	O	questionnaire	prep_of	15	SENT_91	[p7l521t789r1169b889],
19	.	.	O	.	_	0	SENT_91	[p7l521t789r1169b889],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_92	[p7l16t1073r219b1122],
2	EXPRESSION	NN	O	expression	nsubjpass	14	SENT_92	[p7l263t1073r773b1122],
3	Separate	JJ	O	separate	amod	2	SENT_92	[p7l13t1179r369b1274],
4	Written	VBN	O	write	partmod	2	SENT_92	[p7l395t1174r699b1253],
5	consent	NN	O	consent	dobj	4	SENT_92	[p7l730t1190r1064b1252],
6	for	IN	O	for	_	0	SENT_92	[p7l1090t1173r1213b1252],
7	optional	JJ	O	optional	amod	9	SENT_92	[p7l1241t1174r1592b1274],
8	tissue	NN	O	tissue	nn	9	SENT_92	[p7l1623t1174r1864b1253],
9	banking	NN	O	banking	prep_for	4	SENT_92	[p7l1895t1173r2134b1253, p7l10t1302r148b1402],
10	and	CC	O	and	_	0	SENT_92	[p7l169t1302r325b1380],
11	correlative	JJ	O	correlative	amod	12	SENT_92	[p7l349t1302r787b1381],
12	studies	NNS	O	study	prep_for	4	SENT_92	[p7l812t1301r1106b1381],
13	was	VBD	O	be	auxpass	14	SENT_92	[p7l1128t1328r1289b1381],
14	obtained	VBN	O	obtain	_	0	SENT_92	[p7l1316t1302r1712b1380],
15	.	.	O	.	_	0	SENT_92	[p7l1316t1302r1712b1380],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_93	[p7l1740t1307r1999b1385],
2	expression	NN	O	expression	nsubjpass	4	SENT_93	[p7l2013t1328r2134b1380, p7l9t1430r372b1530],
3	was	VBD	O	be	auxpass	4	SENT_93	[p7l394t1456r555b1509],
4	determined	VBN	O	determine	_	0	SENT_93	[p7l584t1429r1068b1508],
5	with	IN	O	with	_	0	SENT_93	[p7l1090t1430r1279b1509],
6	the	DT	O	the	det	7	SENT_93	[p7l1306t1429r1435b1508],
7	use	NN	O	use	prep_with	4	SENT_93	[p7l1461t1456r1601b1509],
8	of	IN	O	of	_	0	SENT_93	[p7l1628t1429r1729b1508],
9	immunohistochemistry	NN	O	immunohistochemistry	prep_of	7	SENT_93	[p7l1736t1430r2134b1509, p7l11t1558r664b1658],
10	in	IN	O	in	_	0	SENT_93	[p7l699t1558r782b1635],
11	a	DT	O	a	det	13	SENT_93	[p7l821t1584r866b1636],
12	central	JJ	O	central	amod	13	SENT_93	[p7l906t1557r1202b1636],
13	laboratory	NN	O	laboratory	prep_in	4	SENT_93	[p7l1241t1557r1691b1658],
14	that	WDT	O	that	nsubj	15	SENT_93	[p7l1727t1558r1899b1636],
15	used	VBD	O	use	rcmod	13	SENT_93	[p7l1934t1557r2134b1637],
16	Dako	NNP	PERSON	Dako	nn	17	SENT_93	[p7l9t1686r237b1765],
17	kits	NNS	O	kit	nsubj	19	SENT_93	[p7l259t1685r405b1765],
18	(	CD	NUMBER	(	num	19	SENT_93	[p7l434t1686r1229b1786],
19	Dal	NN	O	dal	xcomp	15	SENT_93	[p7l434t1686r1229b1786],
20	<	JJR	O	<	amod	22	SENT_93	[p7l434t1686r1229b1786],
21	oCytomation	NN	O	ocytomation	nn	22	SENT_93	[p7l434t1686r1229b1786],
22	)	NN	O	)	dep	19	SENT_93	[p7l434t1686r1229b1786],
23	.	.	O	.	_	0	SENT_93	[p7l434t1686r1229b1786],

1	Positivity	NN	O	positivity	nsubjpass	3	SENT_94	[p7l1254t1686r1631b1786],
2	was	VBD	O	be	auxpass	3	SENT_94	[p7l1643t1712r1802b1765],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_94	[p7l1826t1685r2136b1764],
4	as	IN	O	as	_	0	SENT_94	[p7l10t1840r94b1892],
5	more	JJR	O	more	mwe	6	SENT_94	[p7l121t1839r341b1892],
6	than	IN	O	than	quantmod	7	SENT_94	[p7l370t1813r557b1892],
7	10	CD	PERCENT	10	num	8	SENT_94	[p7l588t1819r685b1892],
8	percent	NN	PERCENT	percent	prep_as	3	SENT_94	[p7l712t1830r1033b1914],
9	of	IN	O	of	_	0	SENT_94	[p7l1056t1813r1156b1892],
10	cells	NNS	O	cell	prep_of	8	SENT_94	[p7l1166t1813r1348b1892],
11	staining	VBG	O	stain	partmod	10	SENT_94	[p7l1379t1814r1726b1914],
12	at	IN	O	at	_	0	SENT_94	[p7l1749t1830r1828b1892],
13	any	DT	O	any	det	14	SENT_94	[p7l1850t1839r1997b1914],
14	intensity	NN	O	intensity	prep_at	11	SENT_94	[p7l2020t1814r2134b1891, p7l11t1942r290b2042],
15	for	IN	O	for	_	0	SENT_94	[p7l310t1941r433b2020],
16	EGFR	NN	ORGANIZATION	egfr	prep_for	14	SENT_94	[p7l455t1947r726b2025],
17	.	.	O	.	_	0	SENT_94	[p7l455t1947r726b2025],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_95	[p7l11t2226r526b2275],
2	ANALYSIS	NN	O	analysis	nsubj	18	SENT_95	[p7l561t2226r962b2275],
3	The	DT	O	the	det	4	SENT_95	[p7l7t2327r171b2405],
4	trial	NN	O	trial	nsubjpass	6	SENT_95	[p7l205t2327r375b2405],
5	was	VBD	O	be	auxpass	6	SENT_95	[p7l404t2353r567b2406],
6	designed	VBN	O	design	rcmod	2	SENT_95	[p7l603t2326r991b2427],
7	to	TO	O	to	aux	8	SENT_95	[p7l1024t2343r1104b2405],
8	detect	VB	O	detect	xcomp	6	SENT_95	[p7l1140t2327r1418b2422],
9	,	,	O	,	_	0	SENT_95	[p7l1140t2327r1418b2422],
10	with	IN	O	with	_	0	SENT_95	[p7l1453t2327r1645b2406],
11	90	CD	PERCENT	90	num	13	SENT_95	[p7l1678t2332r1779b2405],
12	percent	NN	PERCENT	percent	nn	13	SENT_95	[p7l1812t2343r2139b2427],
13	power	NN	O	power	prep_with	8	SENT_95	[p7l9t2480r280b2555],
14	and	CC	O	and	_	0	SENT_95	[p7l309t2455r464b2533],
15	a	DT	O	a	det	16	SENT_95	[p7l496t2481r540b2533],
16	tWo	NN	NUMBER	two	conj_and	13	SENT_95	[p7l571t2454r987b2534],
17	—	CD	NUMBER	—	dobj	8	SENT_95	[p7l571t2454r987b2534],
18	sided	VBD	O	side	_	0	SENT_95	[p7l571t2454r987b2534],
19	type	NN	O	type	nn	21	SENT_95	[p7l1020t2471r1190b2555],
20	I	CD	NUMBER	i	num	21	SENT_95	[p7l1221t2462r1251b2532],
21	error	NN	O	error	dobj	18	SENT_95	[p7l1283t2480r1494b2533],
22	of	IN	O	of	_	0	SENT_95	[p7l1523t2454r1624b2533],
23	5	CD	PERCENT	5	num	24	SENT_95	[p7l1639t2462r1682b2533],
24	percent	NN	PERCENT	percent	prep_of	21	SENT_95	[p7l1717t2471r2055b2555],
25	,	,	O	,	_	0	SENT_95	[p7l1717t2471r2055b2555],
26	a	DT	O	a	det	29	SENT_95	[p7l2092t2481r2137b2533],
27	33	CD	PERCENT	33	num	29	SENT_95	[p7l11t2588r108b2661],
28	percent	NN	PERCENT	percent	nn	29	SENT_95	[p7l147t2599r467b2683],
29	improvement	NN	O	improvement	appos	24	SENT_95	[p7l498t2583r1072b2683],
30	in	IN	O	in	_	0	SENT_95	[p7l1103t2583r1184b2660],
31	median	JJ	O	median	amod	32	SENT_95	[p7l1220t2582r1536b2661],
32	survival	NN	O	survival	prep_in	29	SENT_95	[p7l1575t2583r1892b2662],
33	from	IN	O	from	_	0	SENT_95	[p7l1928t2582r2135b2661],
34	four	CD	DURATION	four	num	35	SENT_95	[p7l11t2710r188b2790],
35	months	NNS	NUMBER	month	prep_from	18	SENT_95	[p7l207t2711r531b2789],
36	as	IN	O	as	_	0	SENT_95	[p7l554t2737r638b2789],
37	estimated	VBN	O	estimate	prep_as	35	SENT_95	[p7l662t2710r1072b2789],
38	in	IN	O	in	_	0	SENT_95	[p7l1092t2711r1173b2788],
39	the	DT	O	the	det	41	SENT_95	[p7l1195t2711r1324b2789],
40	placebo	NN	O	placebo	nn	41	SENT_95	[p7l1344t2711r1671b2811],
41	group	NN	O	group	prep_in	37	SENT_95	[p7l1693t2736r1969b2811],
42	.	.	O	.	_	0	SENT_95	[p7l1693t2736r1969b2811],

1	For	IN	O	for	_	0	SENT_96	[p7l1994t2718r2138b2789],
2	the	DT	O	the	det	4	SENT_96	[p7l11t2839r142b2917],
3	ﬁnal	JJ	O	ﬁnal	amod	4	SENT_96	[p7l181t2838r375b2917],
4	analysis	NN	O	analysis	prep_for	22	SENT_96	[p7l412t2838r777b2939],
5	,	,	O	,	_	0	SENT_96	[p7l412t2838r777b2939],
6	582	CD	NUMBER	582	num	7	SENT_96	[p7l824t2844r976b2917],
7	deaths	NNS	O	death	nsubj	22	SENT_96	[p7l1017t2838r1295b2917],
8	were	VBD	O	be	auxpass	9	SENT_96	[p7l1332t2865r1537b2918],
9	required	VBN	O	require	rcmod	7	SENT_96	[p7l1576t2838r1939b2939],
10	and	CC	O	and	_	0	SENT_96	[p7l1976t2838r2134b2917],
11	Were	VBD	O	be	auxpass	12	SENT_96	[p7l6t2993r211b3046],
12	projected	VBN	O	project	rcmod	7	SENT_96	[p7l245t2967r637b3067],
13	to	TO	O	to	aux	14	SENT_96	[p7l669t2983r748b3045],
14	occur	VB	O	occur	xcomp	12	SENT_96	[p7l783t2992r1017b3046],
15	with	IN	O	with	_	0	SENT_96	[p7l1042t2967r1231b3046],
16	a	DT	O	a	det	18	SENT_96	[p7l1263t2993r1308b3045],
17	sample	NN	O	sample	nn	18	SENT_96	[p7l1340t2966r1641b3067],
18	size	NN	O	size	prep_with	14	SENT_96	[p7l1675t2967r1833b3045],
19	of	IN	O	of	_	0	SENT_96	[p7l1867t2966r1967b3045],
20	700	CD	NUMBER	700	num	21	SENT_96	[p7l1982t2972r2134b3045],
21	patients	NNS	O	patient	prep_of	18	SENT_96	[p7l9t3095r352b3195],
22	enrolled	VBD	O	enrol	_	0	SENT_96	[p7l382t3094r736b3173],
23	over	IN	O	over	_	0	SENT_96	[p7l765t3120r946b3174],
24	a	DT	O	a	det	25	SENT_96	[p7l970t3121r1014b3173],
25	period	NN	O	period	prep_over	22	SENT_96	[p7l1039t3094r1318b3195],
26	of	IN	O	of	_	0	SENT_96	[p7l1346t3094r1447b3173],
27	14	CD	DURATION	14	num	28	SENT_96	[p7l1460t3100r1559b3173],
28	months	NNS	NUMBER	month	prep_of	25	SENT_96	[p7l1587t3095r1917b3173],
29	with	IN	O	with	_	0	SENT_96	[p7l1942t3095r2134b3174],
30	6	CD	DURATION	6	num	31	SENT_96	[p7l11t3228r58b3301],
31	months	NNS	NUMBER	month	prep_with	22	SENT_96	[p7l96t3223r427b3301],
32	of	IN	O	of	_	0	SENT_96	[p7l467t3222r569b3301],
33	follow	VBP	O	follow	prepc_of	31	SENT_96	[p7l588t3222r1032b3323],
34	—	RB	O	—	advmod	33	SENT_96	[p7l588t3222r1032b3323],
35	up	RB	O	up	advmod	33	SENT_96	[p7l588t3222r1032b3323],
36	.	.	O	.	_	0	SENT_96	[p7l588t3222r1032b3323],

1	The	DT	O	the	det	3	SENT_97	[p7l1072t3223r1236b3301],
2	required	VBN	O	require	amod	3	SENT_97	[p7l1274t3222r1637b3323],
3	number	NN	O	number	nsubj	7	SENT_97	[p7l1674t3223r2016b3302],
4	of	IN	O	of	_	0	SENT_97	[p7l2051t3222r2153b3301],
5	deaths	NNS	O	death	prep_of	3	SENT_97	[p7l11t3351r287b3429],
6	had	VBD	O	have	aux	7	SENT_97	[p7l313t3350r468b3429],
7	occurred	VBN	O	occur	_	0	SENT_97	[p7l491t3351r861b3430],
8	byJanuary	JJ	O	byjanuary	acomp	7	SENT_97	[p7l884t3351r1316b3451],
9	2004	CD	DATE	2004	tmod	8	SENT_97	[p7l1333t3356r1565b3446],
10	,	,	O	,	_	0	SENT_97	[p7l1333t3356r1565b3446],
11	and	CC	O	and	_	0	SENT_97	[p7l1592t3350r1748b3429],
12	the	DT	O	the	det	13	SENT_97	[p7l1771t3351r1900b3429],
13	database	NN	O	database	nsubjpass	15	SENT_97	[p7l1923t3350r2134b3429, p7l11t3478r197b3557],
14	Was	VBD	O	be	auxpass	15	SENT_97	[p7l219t3505r379b3558],
15	locked	VBN	O	lock	conj_and	7	SENT_97	[p7l406t3478r684b3558],
16	as	IN	O	as	_	0	SENT_97	[p7l708t3505r792b3557],
17	of	IN	O	of	prepc_as_of	15	SENT_97	[p7l820t3478r921b3557],
18	April	NNP	DATE	April	pobj	15	SENT_97	[p7l923t3479r1136b3579],
19	23	CD	DATE	23	num	18	SENT_97	[p7l1161t3484r1286b3574],
20	,	,	DATE	,	_	0	SENT_97	[p7l1161t3484r1286b3574],
21	2004	CD	DATE	2004	num	18	SENT_97	[p7l1316t3484r1547b3557],
22	.	.	O	.	_	0	SENT_97	[p7l1316t3484r1547b3557],

1	There	EX	O	there	expl	2	SENT_98	[p7l1574t3479r1819b3557],
2	Was	VBD	O	be	_	0	SENT_98	[p7l1840t3505r2001b3558],
3	no	DT	O	no	det	5	SENT_98	[p7l2028t3504r2134b3557],
4	interim	JJ	O	interim	amod	5	SENT_98	[p7l10t3607r321b3685],
5	analysis	NN	O	analysis	nsubj	2	SENT_98	[p7l354t3607r711b3707],
6	.	.	O	.	_	0	SENT_98	[p7l354t3607r711b3707],

1	Tumor	NN	O	tumor	nn	2	SENT_99	[p7l748t3612r1039b3686],
2	responses	NNS	O	response	nsubjpass	4	SENT_99	[p7l1070t3632r1491b3707],
3	Were	VBD	O	be	auxpass	4	SENT_99	[p7l1523t3633r1725b3686],
4	validated	VBN	O	validate	_	0	SENT_99	[p7l1755t3606r2135b3686],
5	centrally	RB	O	centrally	dep	4	SENT_99	[p8l11t20r373b121],
6	for	IN	O	for	_	0	SENT_99	[p8l393t20r516b99],
7	the	DT	O	the	det	8	SENT_99	[p8l539t21r668b99],
8	ﬁrst	NN	O	ﬁrst	prep_for	5	SENT_99	[p8l693t20r866b99],
9	333	CD	NUMBER	333	num	10	SENT_99	[p8l887t26r1037b99],
10	patients	NNS	O	patient	dep	5	SENT_99	[p8l1064t21r1398b121],
11	in	IN	O	in	_	0	SENT_99	[p8l1425t21r1507b98],
12	the	DT	O	the	det	13	SENT_99	[p8l1532t21r1661b99],
13	trial	NN	O	trial	prep_in	10	SENT_99	[p8l1687t21r1876b99],
14	.	.	O	.	_	0	SENT_99	[p8l1687t21r1876b99],

1	The	DT	O	the	det	7	SENT_100	[p8l136t148r296b227],
2	stratiﬁed	JJ	O	stratiﬁed	amod	7	SENT_100	[p8l321t148r690b227],
3	lo	NN	O	lo	nn	7	SENT_100	[p8l712t149r788b227],
4	g	NN	O	g	nn	7	SENT_100	[p8l794t148r1075b249],
5	—	CD	NUMBER	—	num	7	SENT_100	[p8l794t148r1075b249],
6	rank	NN	O	rank	nn	7	SENT_100	[p8l794t148r1075b249],
7	test	NN	O	test	nsubjpass	32	SENT_100	[p8l1094t165r1261b244],
8	,	,	O	,	_	0	SENT_100	[p8l1094t165r1261b244],
9	accounting	VBG	O	account	partmod	7	SENT_100	[p8l1289t149r1758b249],
10	for	IN	O	for	_	0	SENT_100	[p8l1777t148r1899b227],
11	stratiﬁcation	NN	O	stratiﬁcation	nn	12	SENT_100	[p8l1921t165r2135b227, p8l10t276r356b355],
12	factors	NNS	O	factor	prep_for	9	SENT_100	[p8l396t276r680b355],
13	at	IN	O	at	_	0	SENT_100	[p8l721t293r800b355],
14	randomization	NN	O	randomization	prep_at	12	SENT_100	[p8l834t276r1462b355],
15	(	CD	NUMBER	(	num	14	SENT_100	[p8l1507t284r1808b377],
16	except	IN	O	except	_	0	SENT_100	[p8l1507t284r1808b377],
17	center	NN	O	center	nn	18	SENT_100	[p8l1843t284r2130b368],
18	)	NN	O	)	prep_except	9	SENT_100	[p8l1843t284r2130b368],
19	and	CC	O	and	_	0	SENT_100	[p8l10t404r166b483],
20	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_100	[p8l189t410r448b488],
21	protein	NN	O	protein	conj_and	18	SENT_100	[p8l460t405r767b505],
22	expression	NN	O	expression	npadvmod	24	SENT_100	[p8l792t405r1246b505],
23	(	CD	NUMBER	(	num	22	SENT_100	[p8l1274t405r1628b505],
24	positive	JJ	O	positive	amod	18	SENT_100	[p8l1274t405r1628b505],
25	vs.	CC	O	vs.	prep	18	SENT_100	[p8l1648t431r1758b484],
26	negative	JJ	O	negative	dep	25	SENT_100	[p8l1788t405r2135b505],
27	vs.	CC	O	vs.	prep	26	SENT_100	[p8l6t559r117b612],
28	unknown	JJ	O	unknown	amod	29	SENT_100	[p8l150t533r621b628],
29	)	NN	O	)	dep	27	SENT_100	[p8l150t533r621b628],
30	,	,	O	,	_	0	SENT_100	[p8l150t533r621b628],
31	was	VBD	O	be	auxpass	32	SENT_100	[p8l650t559r813b612],
32	used	VBN	O	use	_	0	SENT_100	[p8l843t532r1041b612],
33	to	TO	O	to	aux	34	SENT_100	[p8l1069t549r1149b611],
34	compare	VB	O	compare	xcomp	32	SENT_100	[p8l1179t558r1553b633],
35	progressionfree	JJ	O	progressionfree	amod	36	SENT_100	[p8l1580t533r2133b633, p8l11t660r171b739],
36	survival	NN	O	survival	dobj	34	SENT_100	[p8l196t661r513b740],
37	and	CC	O	and	_	0	SENT_100	[p8l535t660r690b739],
38	overall	JJ	O	overall	amod	39	SENT_100	[p8l713t661r991b740],
39	survival	NN	O	survival	dobj	34	SENT_100	[p8l1014t661r1332b740],
40	between	IN	O	between	_	0	SENT_100	[p8l1354t661r1704b740],
41	treatment	NN	O	treatment	nn	42	SENT_100	[p8l1726t677r2140b739],
42	groups	NNS	O	group	prep_between	36	SENT_100	[p8l10t814r335b889],
43	.	.	O	.	_	0	SENT_100	[p8l10t814r335b889],

1	Exploratory	JJ	O	exploratory	amod	5	SENT_101	[p8l372t789r877b889],
2	forward	RB	O	forward	advmod	5	SENT_101	[p8l906t788r1246b868],
3	stepwise	JJ	O	stepwise	amod	5	SENT_101	[p8l1281t789r1648b889],
4	regression	NN	O	regression	nn	5	SENT_101	[p8l1682t789r2134b889],
5	analyses	NNS	O	analysis	nsubjpass	14	SENT_101	[p8l10t917r365b1017],
6	with	IN	O	with	_	0	SENT_101	[p8l397t917r587b996],
7	the	DT	O	the	det	8	SENT_101	[p8l621t916r750b995],
8	use	NN	O	use	prep_with	5	SENT_101	[p8l784t943r924b996],
9	of	IN	O	of	_	0	SENT_101	[p8l958t916r1059b995],
10	the	DT	O	the	det	12	SENT_101	[p8l1075t916r1205b995],
11	Cox	NN	ORGANIZATION	cox	nn	12	SENT_101	[p8l1239t922r1404b995],
12	model	NN	O	model	prep_of	8	SENT_101	[p8l1435t916r1701b995],
13	were	VBD	O	be	auxpass	14	SENT_101	[p8l1731t943r1932b996],
14	performed	VBN	O	perform	_	0	SENT_101	[p8l1965t943r2134b1017, p8l11t1044r322b1123],
15	to	TO	O	to	aux	16	SENT_101	[p8l353t1061r433b1123],
16	adjust	VB	O	adjust	ccomp	14	SENT_101	[p8l464t1045r726b1145],
17	for	IN	O	for	_	0	SENT_101	[p8l750t1044r876b1123],
18	treatment	NN	O	treatment	nn	19	SENT_101	[p8l903t1061r1326b1123],
19	effect	NN	O	effect	prep_for	16	SENT_101	[p8l1351t1044r1591b1123],
20	and	CC	O	and	_	0	SENT_101	[p8l1615t1045r1773b1123],
21	to	TO	O	to	aux	22	SENT_101	[p8l1803t1061r1882b1123],
22	identify	VB	O	identify	ccomp	14	SENT_101	[p8l1913t1044r2133b1123, p8l11t1172r148b1273],
23	prognostic	JJ	O	prognostic	amod	24	SENT_101	[p8l169t1173r629b1273],
24	factors	NNS	O	factor	dobj	22	SENT_101	[p8l652t1172r934b1251],
25	for	IN	O	for	_	0	SENT_101	[p8l959t1172r1081b1251],
26	progression	NN	O	progression	nn	29	SENT_101	[p8l1100t1172r1797b1273],
27	—	CD	NUMBER	—	num	29	SENT_101	[p8l1100t1172r1797b1273],
28	free	JJ	O	free	amod	29	SENT_101	[p8l1100t1172r1797b1273],
29	survival	NN	O	survival	prep_for	22	SENT_101	[p8l1822t1173r2136b1252],
30	and	CC	O	and	_	0	SENT_101	[p8l10t1301r168b1379],
31	overall	JJ	O	overall	amod	32	SENT_101	[p8l201t1301r485b1380],
32	survival	NN	O	survival	prep_for	22	SENT_101	[p8l517t1301r867b1380],
33	.	.	O	.	_	0	SENT_101	[p8l517t1301r867b1380],

1	Candidate	NN	O	candidate	nn	2	SENT_102	[p8l904t1301r1340b1379],
2	covariates	NNS	O	covariate	nsubj	3	SENT_102	[p8l1372t1301r1796b1380],
3	included	VBD	O	include	_	0	SENT_102	[p8l1829t1300r2133b1380, p8l11t1428r108b1507],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_103	[p8l132t1434r395b1512],
2	expression	NN	O	expression	_	0	SENT_103	[p8l411t1429r899b1529],
3	,	,	O	,	_	0	SENT_103	[p8l411t1429r899b1529],
4	stratification	NN	O	stratification	nn	5	SENT_103	[p8l932t1428r1482b1507],
5	factors	NNS	O	factor	nsubj	6	SENT_103	[p8l1508t1428r1799b1507],
6	(	VBP	O	(	dep	2	SENT_103	[p8l1832t1435r2139b1529],
7	except	IN	O	except	_	0	SENT_103	[p8l1832t1435r2139b1529],
8	center	NN	O	center	nn	9	SENT_103	[p8l11t1564r334b1652],
9	)	NN	O	)	prep_except	6	SENT_103	[p8l11t1564r334b1652],
10	,	,	O	,	_	0	SENT_103	[p8l11t1564r334b1652],
11	sex	NN	O	sex	appos	2	SENT_103	[p8l367t1583r524b1652],
12	,	,	O	,	_	0	SENT_103	[p8l367t1583r524b1652],
13	age	NN	O	age	appos	2	SENT_103	[p8l554t1583r699b1657],
14	(	CD	NUMBER	(	number	15	SENT_103	[p8l730t1562r862b1648],
15	60	CD	DURATION	60	num	16	SENT_103	[p8l730t1562r862b1648],
16	years	NNS	NUMBER	year	tmod	13	SENT_103	[p8l884t1583r1102b1657],
17	or	CC	O	or	_	0	SENT_103	[p8l1131t1582r1221b1635],
18	less	JJR	O	less	conj_or	13	SENT_103	[p8l1242t1557r1400b1635],
19	vs.	CC	O	vs.	prep	18	SENT_103	[p8l1424t1583r1535b1636],
20	more	JJR	DURATION	more	mwe	21	SENT_103	[p8l1566t1582r1789b1635],
21	than	IN	DURATION	than	quantmod	22	SENT_103	[p8l1815t1557r2006b1635],
22	60	CD	DURATION	60	num	23	SENT_103	[p8l2033t1562r2134b1635],
23	years	NNS	NUMBER	year	dep	19	SENT_103	[p8l6t1691r275b1785],
24	)	RB	O	)	advmod	23	SENT_103	[p8l6t1691r275b1785],
25	,	,	O	,	_	0	SENT_103	[p8l6t1691r275b1785],
26	race	NN	O	race	nn	29	SENT_103	[p8l305t1711r473b1763],
27	or	CC	O	or	_	0	SENT_103	[p8l499t1710r587b1763],
28	ethnic	JJ	O	ethnic	conj_or	26	SENT_103	[p8l609t1685r864b1763],
29	group	NN	O	group	appos	2	SENT_103	[p8l888t1710r1135b1785],
30	(	CD	NUMBER	(	npadvmod	31	SENT_103	[p8l1166t1685r1427b1776],
31	Asian	JJ	MISC	asian	amod	29	SENT_103	[p8l1166t1685r1427b1776],
32	vs.	CC	O	vs.	prep	29	SENT_103	[p8l1447t1711r1554b1764],
33	others	NNS	O	other	dep	32	SENT_103	[p8l1585t1685r1902b1780],
34	)	RB	O	)	advmod	33	SENT_103	[p8l1585t1685r1902b1780],
35	,	,	O	,	_	0	SENT_103	[p8l1585t1685r1902b1780],
36	prior	JJ	O	prior	amod	38	SENT_103	[p8l1930t1685r2139b1785],
37	radiotherapy	NN	O	radiotherapy	nn	38	SENT_103	[p8l11t1813r540b1913],
38	(	NN	O	(	appos	2	SENT_103	[p8l566t1819r718b1913],
39	yes	RB	O	yes	advmod	38	SENT_103	[p8l566t1819r718b1913],
40	vs.	IN	O	vs.	_	0	SENT_103	[p8l741t1839r849b1892],
41	no	DT	O	no	det	42	SENT_103	[p8l879t1820r1041b1908],
42	)	NN	O	)	prep_vs.	38	SENT_103	[p8l879t1820r1041b1908],
43	,	,	O	,	_	0	SENT_103	[p8l879t1820r1041b1908],
44	histologic	JJ	O	histologic	amod	45	SENT_103	[p8l1072t1813r1484b1913],
45	subtype	NN	O	subtype	appos	2	SENT_103	[p8l1510t1812r1828b1913],
46	of	IN	O	of	_	0	SENT_103	[p8l1854t1812r1953b1891],
47	cancer	NN	O	cancer	nn	49	SENT_103	[p8l1961t1838r2135b1891, p8l11t1967r135b2019],
48	(	CD	NUMBER	(	num	49	SENT_103	[p8l161t1941r896b2032],
49	adenocarcinoma	NN	O	adenocarcinoma	prep_of	45	SENT_103	[p8l161t1941r896b2032],
50	vs.	CC	O	vs.	prep	49	SENT_103	[p8l914t1967r1024b2020],
51	others	NNS	O	other	dep	50	SENT_103	[p8l1054t1941r1376b2036],
52	)	RB	O	)	advmod	51	SENT_103	[p8l1054t1941r1376b2036],
53	,	,	O	,	_	0	SENT_103	[p8l1054t1941r1376b2036],
54	and	CC	O	and	_	0	SENT_103	[p8l1406t1940r1561b2019],
55	smoking	NN	O	smoking	nn	56	SENT_103	[p8l1586t1940r1961b2041],
56	status	NN	O	status	prep_of	45	SENT_103	[p8l1984t1957r2135b2019, p8l11t2086r131b2149],
57	(	CD	NUMBER	(	num	58	SENT_103	[p8l159t2070r504b2161],
58	smoker	NN	O	smoker	dep	56	SENT_103	[p8l159t2070r504b2161],
59	vs.	FW	O	vs.	nn	63	SENT_103	[p8l517t2096r624b2149],
60	nonsmoker	FW	O	nonsmoker	nn	63	SENT_103	[p8l651t2070r1134b2149],
61	vs.	FW	O	vs.	nn	63	SENT_103	[p8l1148t2096r1255b2149],
62	unknown	JJ	O	unknown	amod	63	SENT_103	[p8l1281t2070r1735b2161],
63	)	NN	O	)	dep	56	SENT_103	[p8l1281t2070r1735b2161],
64	.	.	O	.	_	0	SENT_103	[p8l1281t2070r1735b2161],

1	Race	NN	O	race	nsubj	2	SENT_104	[p8l1761t2076r1958b2153],
2	was	VBD	O	be	_	0	SENT_104	[p8l1975t2096r2134b2149],
3	self	NN	O	self	nn	4	SENT_104	[p8l12t2197r544b2298],
4	—	NN	O	—	nsubj	5	SENT_104	[p8l12t2197r544b2298],
5	reported	VBD	O	report	ccomp	2	SENT_104	[p8l12t2197r544b2298],
6	or	CC	O	or	_	0	SENT_104	[p8l565t2223r654b2276],
7	determined	VBN	O	determine	conj_or	5	SENT_104	[p8l672t2197r1156b2276],
8	by	IN	O	by	_	0	SENT_104	[p8l1178t2198r1275b2298],
9	study	NN	O	study	nn	10	SENT_104	[p8l1294t2197r1520b2298],
10	personnel	NNS	O	personnel	prep_by	7	SENT_104	[p8l1536t2198r1959b2298],
11	and	CC	O	and	_	0	SENT_104	[p8l1980t2197r2135b2276],
12	was	VBD	O	be	auxpass	14	SENT_104	[p8l6t2352r165b2405],
13	not	RB	O	not	neg	14	SENT_104	[p8l189t2342r331b2404],
14	based	VBN	O	base	conj_and	2	SENT_104	[p8l348t2325r586b2404],
15	on	IN	O	on	_	0	SENT_104	[p8l607t2351r713b2404],
16	country	NN	O	country	prep_on	14	SENT_104	[p8l735t2342r1052b2426],
17	of	IN	O	of	_	0	SENT_104	[p8l1069t2325r1169b2404],
18	domicile	NN	O	domicile	prep_of	16	SENT_104	[p8l1172t2325r1555b2404],
19	.	.	O	.	_	0	SENT_104	[p8l1172t2325r1555b2404],

1	Fisher	NNP	PERSON	Fisher	poss	4	SENT_105	[p8l1580t2325r1904b2404],
2	’s	POS	O	’s	_	0	SENT_105	[p8l1580t2325r1904b2404],
3	exact	JJ	O	exact	amod	4	SENT_105	[p8l1929t2342r2141b2404],
4	test	NN	O	test	nsubjpass	6	SENT_105	[p8l11t2471r163b2533],
5	was	VBD	O	be	auxpass	6	SENT_105	[p8l184t2481r344b2534],
6	used	VBN	O	use	_	0	SENT_105	[p8l376t2455r572b2534],
7	to	TO	O	to	aux	8	SENT_105	[p8l602t2471r681b2533],
8	compare	VB	O	compare	xcomp	6	SENT_105	[p8l715t2480r1089b2555],
9	response	NN	O	response	nn	10	SENT_105	[p8l1121t2480r1508b2555],
10	rates	NNS	O	rate	dobj	8	SENT_105	[p8l1540t2471r1743b2533],
11	between	IN	O	between	_	0	SENT_105	[p8l1778t2455r2134b2534],
12	levels	NNS	O	level	prep_between	10	SENT_105	[p8l10t2583r243b2662],
13	of	IN	O	of	_	0	SENT_105	[p8l278t2582r379b2661],
14	potential	JJ	O	potential	amod	15	SENT_105	[p8l392t2583r777b2683],
15	predictors	NNS	O	predictor	prep_of	12	SENT_105	[p8l807t2583r1236b2683],
16	and	CC	O	and	_	0	SENT_105	[p8l1268t2582r1424b2661],
17	rates	NNS	O	rate	prep_of	12	SENT_105	[p8l1453t2599r1651b2661],
18	of	IN	O	of	_	0	SENT_105	[p8l1684t2582r1784b2661],
19	toxic	JJ	O	toxic	amod	20	SENT_105	[p8l1797t2583r1997b2661],
20	effects	NNS	O	effect	prep_of	15	SENT_105	[p8l2028t2582r2134b2661, p8l11t2710r202b2789],
21	between	IN	O	between	_	0	SENT_105	[p8l239t2711r589b2790],
22	treatments	NNS	O	treatment	prep_between	20	SENT_105	[p8l624t2727r1110b2789],
23	.	.	O	.	_	0	SENT_105	[p8l624t2727r1110b2789],

1	Times	NNP	O	Times	_	0	SENT_106	[p8l1149t2711r1414b2789],
2	to	TO	O	to	_	0	SENT_106	[p8l1454t2727r1534b2789],
3	deterioration	NN	O	deterioration	prep_to	1	SENT_106	[p8l1573t2710r2134b2789],

1	(	NN	O	(	_	0	SENT_107	[p8l15t2845r90b2930],
2	a	DT	O	a	det	4	SENT_107	[p8l15t2845r90b2930],
3	10-point	JJ	O	10-point	amod	4	SENT_107	[p8l126t2839r499b2939],
4	increase	NN	O	increase	dep	1	SENT_107	[p8l527t2839r881b2917],
5	from	IN	O	from	_	0	SENT_107	[p8l915t2838r1126b2917],
6	the	DT	O	the	det	9	SENT_107	[p8l1162t2839r1293b2917],
7	baseline	NN	O	baseline	nn	9	SENT_107	[p8l1328t2839r1681b2917],
8	score	NN	NUMBER	score	nn	9	SENT_107	[p8l1718t2846r1972b2930],
9	)	NN	O	)	prep_from	4	SENT_107	[p8l1718t2846r1972b2930],
10	for	IN	O	for	prep	9	SENT_107	[p8l2012t2838r2138b2917],

1	N	NN	O	n	nn	3	SENT_108	[p8l527t3016r540b3031],
2	ENGLJ	NN	O	englj	nn	3	SENT_108	[p8l556t3015r640b3037],
3	MED	NN	O	med	_	0	SENT_108	[p8l655t3016r707b3031],
4	353	CD	NUMBER	353	dep	3	SENT_108	[p8l720t3015r784b3037],
5	;	:	O	;	_	0	SENT_108	[p8l720t3015r784b3037],
6	2	CD	NUMBER	2	num	7	SENT_108	[p8l720t3015r784b3037],
7	www	NN	O	www	dep	3	SENT_108	[p8l818t3016r893b3031],
8	.	.	O	.	_	0	SENT_108	[p8l818t3016r893b3031],

1	EJM	NN	O	ejm	_	0	SENT_109	[p8l921t3015r994b3037],
2	.	.	O	.	_	0	SENT_109	[p8l921t3015r994b3037],

1	O	NN	O	o	_	0	SENT_110	[p8l921t3015r994b3037],
2	C.	FW	O	c.	nn	3	SENT_110	[p8l1015t3015r1030b3031],
3	ULY	FW	O	uly	amod	1	SENT_110	[p8l1079t3016r1123b3031],
4	14	CD	NUMBER	14	dep	1	SENT_110	[p8l1136t3015r1170b3037],
5	,	,	O	,	_	0	SENT_110	[p8l1136t3015r1170b3037],
6	2005	CD	DATE	2005	num	7	SENT_110	[p8l1183t3015r1246b3037],
7	125	CD	NUMBER	125	appos	4	SENT_110	[p8l1960t3014r2015b3036],

1	The	DT	O	the	det	5	SENT_111	[p8l702t3048r753b3072],
2	New	NNP	O	New	nn	5	SENT_111	[p8l762t3049r824b3072],
3	England	NNP	O	England	nn	5	SENT_111	[p8l833t3048r944b3079],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_111	[p8l953t3049r1041b3072],
5	o	NN	O	o	_	0	SENT_111	[p8l1060t3056r1075b3072],
6	Medicine	NN	O	medicine	dep	5	SENT_111	[p8l1095t3048r1220b3072],

1	The	DT	O	the	det	4	SENT_112	[p8l715t3236r752b3257],
2	NEW	NNP	O	NEW	nn	4	SENT_112	[p8l764t3238r845b3257],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_112	[p8l859t3238r1034b3257],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_112	[p8l1048t3238r1214b3264],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_112	[p8l1228t3236r1444b3263],

1	Table	NNP	O	Table	_	0	SENT_113	[p9l61t142r197b190],
2	1	CD	NUMBER	1	dep	1	SENT_113	[p9l218t147r259b190],
3	.	.	O	.	_	0	SENT_113	[p9l218t147r259b190],

1	Baseline	NN	O	baseline	nn	2	SENT_114	[p9l281t142r499b191],
2	Characteristics	NNS	O	characteristic	_	0	SENT_114	[p9l516t142r907b191],
3	of	IN	O	of	_	0	SENT_114	[p9l925t141r985b191],
4	the	DT	O	the	det	5	SENT_114	[p9l990t142r1075b191],
5	Patients	NNS	O	patient	prep_of	2	SENT_114	[p9l1095t143r1353b191],
6	.	.	O	.	_	0	SENT_114	[p9l1095t143r1353b191],

1	*	NN	O	*	_	0	SENT_115	[p9l1095t143r1353b191],

1	Erlotinib	NNP	O	Erlotinib	nn	3	SENT_116	[p9l1379t281r1596b329],
2	Placebo	NNP	O	Placebo	nn	3	SENT_116	[p9l1821t281r2021b329],
3	Characteristic	NNP	O	Characteristic	_	0	SENT_116	[p9l62t353r426b401],
4	(	CD	NUMBER	(	num	5	SENT_116	[p9l1375t357r1433b417],
5	N	NN	O	n	dep	3	SENT_116	[p9l1375t357r1433b417],
6	=	JJ	O	=	amod	17	SENT_116	[p9l1445t356r1596b417],
7	488	CD	NUMBER	488	number	8	SENT_116	[p9l1445t356r1596b417],
8	)	CD	NUMBER	)	num	10	SENT_116	[p9l1445t356r1596b417],
9	(	NN	O	(	nn	10	SENT_116	[p9l1808t357r1866b417],
10	N	NN	O	n	npadvmod	13	SENT_116	[p9l1808t357r1866b417],
11	=	JJ	O	=	quantmod	12	SENT_116	[p9l1879t357r2030b417],
12	243	CD	NUMBER	243	num	10	SENT_116	[p9l1879t357r2030b417],
13	)	JJ	O	)	amod	17	SENT_116	[p9l1879t357r2030b417],
14	Age	NN	O	age	nn	17	SENT_116	[p9l61t485r160b545],
15	(	CD	NUMBER	(	num	17	SENT_116	[p9l185t486r263b545],
16	yr	NN	DURATION	yr	nn	17	SENT_116	[p9l185t486r263b545],
17	)	NN	O	)	dep	5	SENT_116	[p9l185t486r263b545],

1	Median	JJ	O	median	amod	2	SENT_117	[p9l164t588r355b637],
2	62	CD	NUMBER	62	dep	7	SENT_117	[p9l1433t592r1490b637],
3	59	CD	NUMBER	59	num	4	SENT_117	[p9l1866t593r1924b637],
4	Range	NNP	O	Range	dep	2	SENT_117	[p9l164t699r321b759],
5	34-87	CD	NUMBER	34-87	num	4	SENT_117	[p9l1408t698r1564b744],
6	32-89	CD	NUMBER	32-89	dep	7	SENT_117	[p9l1842t698r1996b744],
7	<	JJR	O	<	dep	18	SENT_117	[p9l159t805r256b850],
8	60	CD	PERCENT	60	number	9	SENT_117	[p9l159t805r256b850],
9	(	CD	PERCENT	(	num	10	SENT_117	[p9l280t804r348b865],
10	%	NN	PERCENT	%	dep	7	SENT_117	[p9l280t804r348b865],
11	of	IN	O	of	_	0	SENT_117	[p9l367t801r424b850],
12	patients	NNS	O	patient	prep_of	10	SENT_117	[p9l437t806r662b865],
13	)	IN	O	)	_	0	SENT_117	[p9l437t806r662b865],
14	42.6	CD	PERCENT	42.6	num	15	SENT_117	[p9l1431t806r1540b850],
15	51.0	CD	PERCENT	51.0	prep_)	12	SENT_117	[p9l1866t805r1974b850],
16	260	CD	PERCENT	260	number	17	SENT_117	[p9l159t911r256b957],
17	(	CD	PERCENT	(	num	18	SENT_117	[p9l280t911r348b972],
18	%	NN	PERCENT	%	_	0	SENT_117	[p9l280t911r348b972],
19	of	IN	O	of	_	0	SENT_117	[p9l367t908r424b957],
20	patients	NNS	O	patient	prep_of	18	SENT_117	[p9l437t912r662b971],
21	)	IN	O	)	dep	18	SENT_117	[p9l437t912r662b971],
22	57.4	CD	NUMBER	57.4	num	23	SENT_117	[p9l1432t913r1539b957],
23	49.0	CD	NUMBER	49.0	pobj	21	SENT_117	[p9l1864t911r1974b957],

1	Sex	NN	O	sex	_	0	SENT_118	[p9l64t1019r151b1063],
2	(	CD	PERCENT	(	num	3	SENT_118	[p9l174t1017r242b1078],
3	%	NN	PERCENT	%	dep	1	SENT_118	[p9l174t1017r242b1078],
4	of	IN	O	of	_	0	SENT_118	[p9l261t1014r318b1063],
5	patients	NNS	O	patient	prep_of	3	SENT_118	[p9l331t1019r556b1078],
6	)	IN	O	)	amod	5	SENT_118	[p9l331t1019r556b1078],

1	Male	JJ	O	male	_	0	SENT_119	[p9l164t1121r288b1169],
2	64.5	CD	NUMBER	64.5	number	3	SENT_119	[p9l1433t1126r1536b1170],
3	65.8	CD	NUMBER	65.8	dep	1	SENT_119	[p9l1866t1125r1972b1170],
4	Female	JJ	O	female	dep	1	SENT_119	[p9l164t1228r346b1276],
5	35.5	CD	NUMBER	35.5	number	6	SENT_119	[p9l1432t1232r1536b1276],
6	34.2	CD	NUMBER	34.2	dep	4	SENT_119	[p9l1866t1232r1972b1276],

1	Race	NN	O	race	nn	4	SENT_120	[p9l67t1339r185b1383],
2	or	CC	O	or	_	0	SENT_120	[p9l205t1352r258b1383],
3	ethnic	JJ	O	ethnic	nn	4	SENT_120	[p9l276t1335r436b1383],
4	group	NN	O	group	_	0	SENT_120	[p9l455t1352r607b1398],
5	(	CD	PERCENT	(	num	6	SENT_120	[p9l633t1337r701b1398],
6	%	NN	PERCENT	%	dep	4	SENT_120	[p9l633t1337r701b1398],
7	of	IN	O	of	_	0	SENT_120	[p9l720t1334r777b1383],
8	patients	NNS	O	patient	prep_of	6	SENT_120	[p9l790t1339r1056b1398],
9	)	NN	O	)	dep	8	SENT_120	[p9l790t1339r1056b1398],
10	'	''	O	'	_	0	SENT_120	[p9l790t1339r1056b1398],
11	i	FW	O	i	dep	9	SENT_120	[p9l790t1339r1056b1398],
12	'	''	O	'	_	0	SENT_120	[p9l790t1339r1056b1398],

1	Asian	JJ	MISC	asian	amod	2	SENT_121	[p9l158t1444r301b1489],
2	12.9	CD	NUMBER	12.9	_	0	SENT_121	[p9l1435t1445r1539b1489],
3	12.2	CD	NUMBER	12.2	dep	2	SENT_121	[p9l1869t1446r1972b1489],
4	Other	JJ	O	other	amod	6	SENT_121	[p9l160t1548r312b1596],
5	87.1	CD	NUMBER	87.1	number	6	SENT_121	[p9l1432t1551r1537b1596],
6	87.8	CD	NUMBER	87.8	dep	3	SENT_121	[p9l1865t1551r1972b1596],

1	Performance	NNP	O	Performance	nn	2	SENT_122	[p9l67t1654r399b1703],
2	status	NN	O	status	_	0	SENT_122	[p9l419t1664r575b1703],
3	(	CD	PERCENT	(	num	4	SENT_122	[p9l601t1657r669b1718],
4	%	NN	PERCENT	%	dep	2	SENT_122	[p9l601t1657r669b1718],
5	of	IN	O	of	_	0	SENT_122	[p9l688t1654r746b1703],
6	patients	NNS	O	patient	prep_of	4	SENT_122	[p9l758t1658r1025b1718],
7	)	CD	NUMBER	)	num	6	SENT_122	[p9l758t1658r1025b1718],
8	:	:	O	:	_	0	SENT_122	[p9l758t1658r1025b1718],
9	§	CD	NUMBER	§	dep	6	SENT_122	[p9l758t1658r1025b1718],
10	:	:	O	:	_	0	SENT_122	[p9l758t1658r1025b1718],

1	o	NN	O	o	dep	14	SENT_123	[p9l159t1764r188b1809],
2	13.1	CD	NUMBER	13.1	num	1	SENT_123	[p9l1436t1765r1537b1809],
3	14.0	CD	NUMBER	14.0	number	4	SENT_123	[p9l1869t1764r1974b1809],
4	1	CD	NUMBER	1	num	6	SENT_123	[p9l164t1872r184b1915],
5	52.5	CD	NUMBER	52.5	number	6	SENT_123	[p9l1440t1872r1544b1916],
6	54.3	CD	NUMBER	54.3	dep	1	SENT_123	[p9l1866t1871r1969b1916],
7	2	CD	NUMBER	2	number	8	SENT_123	[p9l160t1978r186b2022],
8	25.8	CD	NUMBER	25.8	num	10	SENT_123	[p9l1432t1977r1539b2023],
9	23.0	CD	NUMBER	23.0	number	10	SENT_123	[p9l1865t1977r1974b2023],
10	3	CD	NUMBER	3	dep	6	SENT_123	[p9l161t2085r184b2129],
11	8.6	CD	NUMBER	8.6	dep	14	SENT_123	[p9l1464t2084r1539b2129],
12	8.6	CD	NUMBER	8.6	num	14	SENT_123	[p9l1898t2084r1973b2129],
13	Weight	NNP	O	Weight	nn	14	SENT_123	[p9l61t2187r244b2251],
14	loss	NN	O	loss	dep	19	SENT_123	[p9l265t2187r364b2236],
15	>	JJR	O	>	dep	14	SENT_123	[p9l384t2190r534b2238],
16	10	CD	PERCENT	10	number	17	SENT_123	[p9l384t2190r534b2238],
17	%	NN	PERCENT	%	amod	15	SENT_123	[p9l384t2190r534b2238],
18	(	CD	PERCENT	(	num	19	SENT_123	[p9l559t2190r627b2251],
19	%	NN	PERCENT	%	dep	26	SENT_123	[p9l559t2190r627b2251],
20	of	IN	O	of	_	0	SENT_123	[p9l646t2187r704b2236],
21	patients	NNS	O	patient	prep_of	19	SENT_123	[p9l716t2191r942b2251],
22	)	IN	O	)	_	0	SENT_123	[p9l716t2191r942b2251],
23	11.0	CD	NUMBER	11.0	num	24	SENT_123	[p9l1436t2190r1540b2236],
24	12.0	CD	NUMBER	12.0	prep_)	21	SENT_123	[p9l1869t2190r1974b2236],
25	Pathological	JJ	O	pathological	amod	26	SENT_123	[p9l67t2294r383b2358],
26	subtype	NN	O	subtype	dep	28	SENT_123	[p9l407t2294r609b2357],
27	(	CD	PERCENT	(	num	28	SENT_123	[p9l634t2296r702b2357],
28	%	NN	PERCENT	%	_	0	SENT_123	[p9l634t2296r702b2357],
29	of	IN	O	of	_	0	SENT_123	[p9l721t2293r779b2342],
30	patients	NNS	O	patient	prep_of	28	SENT_123	[p9l791t2298r1017b2357],
31	)	IN	O	)	dep	28	SENT_123	[p9l791t2298r1017b2357],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_124	[p9l158t2400r605b2449],
2	50.4	CD	NUMBER	50.4	num	1	SENT_124	[p9l1432t2404r1539b2449],
3	49.0	CD	NUMBER	49.0	num	5	SENT_124	[p9l1864t2404r1974b2449],
4	Squamous-cell	JJ	O	squamous-cell	amod	5	SENT_124	[p9l161t2507r544b2570],
5	carcinoma	NN	O	carcinoma	dep	1	SENT_124	[p9l567t2512r840b2555],
6	29.5	CD	NUMBER	29.5	number	7	SENT_124	[p9l1432t2511r1536b2555],
7	32.1	CD	NUMBER	32.1	num	8	SENT_124	[p9l1866t2511r1970b2555],
8	Other	JJ	O	other	dep	5	SENT_124	[p9l160t2614r312b2662],
9	20.1	CD	NUMBER	20.1	number	10	SENT_124	[p9l1432t2617r1537b2662],
10	18.9	CD	NUMBER	18.9	num	8	SENT_124	[p9l1869t2617r1972b2662],

1	Prior	RB	O	prior	_	0	SENT_125	[p9l67t2725r190b2768],
2	chemotherapy	NN	O	chemotherapy	pobj	1	SENT_125	[p9l207t2720r583b2784],
3	(	CD	PERCENT	(	num	4	SENT_125	[p9l607t2723r675b2784],
4	%	NN	PERCENT	%	dep	2	SENT_125	[p9l607t2723r675b2784],
5	of	IN	O	of	_	0	SENT_125	[p9l694t2720r752b2768],
6	patients	NNS	O	patient	prep_of	1	SENT_125	[p9l764t2724r990b2784],
7	)	IN	O	)	prep	1	SENT_125	[p9l764t2724r990b2784],

1	One	CD	NUMBER	one	num	2	SENT_126	[p9l160t2831r269b2875],
2	regimen	NN	O	regimen	_	0	SENT_126	[p9l291t2831r501b2891],
3	50.6	CD	NUMBER	50.6	number	4	SENT_126	[p9l1432t2830r1539b2875],
4	50.2	CD	NUMBER	50.2	dep	2	SENT_126	[p9l1866t2830r1972b2875],
5	Two	CD	NUMBER	two	dep	4	SENT_126	[p9l157t2938r261b2982],
6	or	CC	O	or	_	0	SENT_126	[p9l281t2950r335b2982],
7	more	JJR	O	more	amod	8	SENT_126	[p9l355t2950r488b2982],
8	regimens	NNS	O	regimen	dep	2	SENT_126	[p9l510t2938r750b2997],
9	49.4	CD	NUMBER	49.4	number	10	SENT_126	[p9l1431t2938r1539b2982],
10	49.8	CD	NUMBER	49.8	num	12	SENT_126	[p9l1864t2936r1972b2982],
11	Platinum-based	JJ	O	platinum-based	amod	12	SENT_126	[p9l164t3040r569b3088],
12	therapy	NN	O	therapy	dep	8	SENT_126	[p9l590t3040r786b3103],
13	92.0	CD	NUMBER	92.0	num	14	SENT_126	[p9l1432t3043r1540b3088],
14	91.8	CD	NUMBER	91.8	dep	2	SENT_126	[p9l1866t3043r1972b3089],

1	Response	NN	O	response	_	0	SENT_127	[p9l67t3151r318b3209],
2	to	TO	O	to	_	0	SENT_127	[p9l336t3156r387b3195],
3	prior	JJ	O	prior	amod	4	SENT_127	[p9l409t3151r532b3209],
4	chemotherapy	NN	O	chemotherapy	prep_to	1	SENT_127	[p9l550t3147r926b3210],

1	(	CD	PERCENT	(	num	2	SENT_128	[p9l262t3221r329b3282],
2	%	NN	PERCENT	%	_	0	SENT_128	[p9l262t3221r329b3282],
3	of	IN	O	of	dep	2	SENT_128	[p9l349t3218r406b3267],
4	patients	NNS	O	patient	pobj	3	SENT_128	[p9l419t3223r644b3282],
5	)	IN	O	)	dep	2	SENT_128	[p9l419t3223r644b3282],

1	Complete	JJ	O	complete	amod	4	SENT_129	[p9l160t3326r411b3388],
2	or	CC	O	or	_	0	SENT_129	[p9l431t3342r484b3374],
3	partial	JJ	O	partial	amod	4	SENT_129	[p9l504t3326r663b3388],
4	response	NN	O	response	_	0	SENT_129	[p9l688t3342r924b3388],
5	38.1	CD	NUMBER	38.1	number	6	SENT_129	[p9l1432t3328r1537b3374],
6	37.9	CD	NUMBER	37.9	num	8	SENT_129	[p9l1866t3329r1972b3374],
7	Stable	JJ	O	stable	amod	8	SENT_129	[p9l160t3432r319b3480],
8	disease	NN	O	disease	dep	4	SENT_129	[p9l338t3432r533b3480],
9	34.0	CD	NUMBER	34.0	number	10	SENT_129	[p9l1432t3435r1541b3480],
10	34.2	CD	NUMBER	34.2	num	12	SENT_129	[p9l1866t3436r1972b3480],
11	Progressive	JJ	O	progressive	amod	12	SENT_129	[p9l164t3543r463b3602],
12	disease	NN	O	disease	dep	8	SENT_129	[p9l483t3539r677b3587],
13	27.9	CD	NUMBER	27.9	number	14	SENT_129	[p9l1432t3543r1539b3587],
14	28.0	CD	NUMBER	28.0	num	12	SENT_129	[p9l1865t3542r1974b3587],

1	Smoking	NN	O	smoking	nn	2	SENT_130	[p9l64t3645r295b3709],
2	status	NN	O	status	_	0	SENT_130	[p9l315t3654r470b3694],
3	(	CD	PERCENT	(	num	4	SENT_130	[p9l497t3647r565b3708],
4	%	NN	PERCENT	%	dep	2	SENT_130	[p9l497t3647r565b3708],
5	of	IN	O	of	_	0	SENT_130	[p9l584t3645r641b3694],
6	patients	NNS	O	patient	prep_of	4	SENT_130	[p9l654t3649r879b3708],
7	)	IN	O	)	amod	6	SENT_130	[p9l654t3649r879b3708],

1	Current	JJ	DATE	current	amod	2	SENT_131	[p9l160t3755r358b3800],
2	smoker	NN	O	smoker	_	0	SENT_131	[p9l378t3752r572b3800],
3	or	CC	O	or	_	0	SENT_131	[p9l590t3769r643b3800],
4	ever	RB	O	ever	advmod	5	SENT_131	[p9l661t3769r768b3800],
5	smoked	VBN	O	smoke	conj_or	2	SENT_131	[p9l787t3752r990b3800],
6	73.4	CD	NUMBER	73.4	num	7	SENT_131	[p9l1434t3756r1539b3800],
7	77.0	CD	NUMBER	77.0	dobj	5	SENT_131	[p9l1868t3755r1974b3800],

1	Never	RB	O	never	neg	2	SENT_132	[p10l164t35r316b79],
2	smoked	VBN	O	smoke	_	0	SENT_132	[p10l335t30r538b79],
3	21.3	CD	NUMBER	21.3	num	4	SENT_132	[p10l1432t34r1536b79],
4	17.3	CD	NUMBER	17.3	dobj	2	SENT_132	[p10l1869t34r1969b79],

1	Unknown	JJ	O	unknown	_	0	SENT_133	[p10l163t137r409b186],
2	5.3	CD	NUMBER	5.3	number	3	SENT_133	[p10l1465t141r1536b185],
3	5.8	CD	NUMBER	5.8	dep	1	SENT_133	[p10l1898t140r1972b186],

1	EG	NN	O	eg	nn	4	SENT_134	[p10l67t247r135b292],
2	FR	NN	O	fr	nn	4	SENT_134	[p10l148t248r210b291],
3	protein	NN	O	protein	nn	4	SENT_134	[p10l232t248r414b306],
4	expression	NN	O	expression	_	0	SENT_134	[p10l436t248r713b306],
5	(	CD	PERCENT	(	num	6	SENT_134	[p10l741t246r809b307],
6	%	NN	PERCENT	%	dep	4	SENT_134	[p10l741t246r809b307],
7	of	IN	O	of	_	0	SENT_134	[p10l829t243r886b292],
8	patients	NNS	O	patient	prep_of	6	SENT_134	[p10l899t243r1154b307],
9	)	IN	O	)	_	0	SENT_134	[p10l899t243r1154b307],
10	§	CD	NUMBER	§	prep_)	8	SENT_134	[p10l899t243r1154b307],

1	Positive	JJ	O	positive	_	0	SENT_135	[p10l164t355r364b399],
2	24.0	CD	NUMBER	24.0	number	3	SENT_135	[p10l1432t353r1541b399],
3	27.6	CD	NUMBER	27.6	dep	1	SENT_135	[p10l1865t354r1973b399],

1	Negative	JJ	O	negative	_	0	SENT_136	[p10l164t461r392b520],
2	19.1	CD	NUMBER	19.1	number	3	SENT_136	[p10l1436t461r1537b505],
3	19.8	CD	NUMBER	19.8	dep	1	SENT_136	[p10l1869t460r1972b505],
4	Unknown	JJ	O	unknown	dep	1	SENT_136	[p10l163t563r409b612],
5	56.9	CD	NUMBER	56.9	number	6	SENT_136	[p10l1432t567r1539b612],
6	52.6	CD	NUMBER	52.6	dep	4	SENT_136	[p10l1866t567r1973b611],

1	*	NN	O	*	_	0	SENT_137	[p10l10t745r39b773],
2	‘	CD	NUMBER	‘	num	1	SENT_137	[p10l10t745r39b773],
3	Because	IN	O	because	_	0	SENT_137	[p10l64t745r276b789],
4	of	IN	O	of	_	0	SENT_137	[p10l295t740r352b789],
5	rounding	VBG	O	round	prep_because_of	1	SENT_137	[p10l365t741r615b805],
6	,	,	O	,	_	0	SENT_137	[p10l365t741r615b805],
7	not	RB	O	not	neg	9	SENT_137	[p10l640t750r722b789],
8	all	DT	O	all	det	9	SENT_137	[p10l742t741r795b789],
9	percentages	NNS	O	percentage	dep	10	SENT_137	[p10l820t750r1133b805],
10	sum	NN	O	sum	ccomp	1	SENT_137	[p10l1155t758r1264b789],
11	to	TO	O	to	_	0	SENT_137	[p10l1285t750r1336b789],
12	100	CD	NUMBER	100	prep_to	10	SENT_137	[p10l1359t744r1462b789],
13	.	.	O	.	_	0	SENT_137	[p10l1359t744r1462b789],

1	1	CD	NUMBER	1	dep	8	SENT_138	[p10l12t817r42b876],
2	'	''	O	'	_	0	SENT_138	[p10l12t817r42b876],
3	Race	NN	O	race	nn	6	SENT_138	[p10l64t817r182b861],
4	or	CC	O	or	_	0	SENT_138	[p10l200t830r254b861],
5	ethnic	JJ	O	ethnic	conj_or	3	SENT_138	[p10l270t813r431b861],
6	group	NN	O	group	nsubjpass	17	SENT_138	[p10l449t830r601b877],
7	was	VBD	O	be	auxpass	8	SENT_138	[p10l619t830r717b862],
8	self-reported	JJ	O	self-reported	_	0	SENT_138	[p10l738t812r1067b876],
9	or	CC	O	or	_	0	SENT_138	[p10l1088t830r1142b861],
10	determined	VBN	O	determine	conj_or	8	SENT_138	[p10l1158t813r1457b861],
11	by	IN	O	by	_	0	SENT_138	[p10l1481t813r1536b876],
12	study	NN	O	study	nn	13	SENT_138	[p10l1554t813r1694b876],
13	personnel	NNS	O	personnel	agent	8	SENT_138	[p10l1714t813r1968b876],
14	and	CC	O	and	_	0	SENT_138	[p10l1991t813r2083b861],
15	was	VBD	O	be	auxpass	17	SENT_138	[p10l57t903r155b934],
16	not	RB	O	not	neg	17	SENT_138	[p10l179t895r262b934],
17	based	VBN	O	base	conj_and	8	SENT_138	[p10l283t886r431b934],
18	on	IN	O	on	_	0	SENT_138	[p10l453t903r515b934],
19	country	NN	O	country	nn	20	SENT_138	[p10l537t895r734b949],
20	ofdomicile	NN	O	ofdomicile	prep_on	17	SENT_138	[p10l752t885r1058b934],
21	.	.	O	.	_	0	SENT_138	[p10l752t885r1058b934],

1	ii	LS	O	ii	_	0	SENT_139	[p10l12t962r42b1021],
2	:	:	O	:	_	0	SENT_139	[p10l12t962r42b1021],
3	A	DT	O	a	det	5	SENT_139	[p10l57t961r94b1006],
4	higher	JJR	O	higher	amod	5	SENT_139	[p10l115t958r279b1022],
5	score	NN	NUMBER	score	nsubj	6	SENT_139	[p10l298t975r435b1006],
6	indicates	VBZ	O	indicate	dep	1	SENT_139	[p10l457t958r687b1006],
7	greater	JJR	O	greater	amod	8	SENT_139	[p10l709t967r892b1022],
8	impairment	NN	O	impairment	dobj	6	SENT_139	[p10l912t963r1232b1021],
9	.	.	O	.	_	0	SENT_139	[p10l912t963r1232b1021],

1	§	NN	O	§	nsubjpass	12	SENT_140	[p10l11t1030r31b1094],
2	Epidermal	JJ	O	epidermal	amod	10	SENT_140	[p10l64t1031r324b1094],
3	growth	NN	O	growth	nn	10	SENT_140	[p10l347t1031r524b1094],
4	factor	NN	O	factor	nn	10	SENT_140	[p10l545t1030r697b1079],
5	receptor	NN	O	receptor	nn	10	SENT_140	[p10l717t1040r933b1094],
6	(	NN	O	(	nn	10	SENT_140	[p10l956t1035r1046b1094],
7	EG	NN	O	eg	nn	10	SENT_140	[p10l956t1035r1046b1094],
8	FR	NN	O	fr	nn	10	SENT_140	[p10l1058t1035r1138b1094],
9	)	NN	O	)	nn	10	SENT_140	[p10l1058t1035r1138b1094],
10	expression	NN	O	expression	dep	1	SENT_140	[p10l1163t1035r1440b1094],
11	was	VBD	O	be	auxpass	12	SENT_140	[p10l1461t1048r1559b1079],
12	assessed	VBN	O	assess	_	0	SENT_140	[p10l1581t1031r1813b1079],
13	by	IN	O	by	_	0	SENT_140	[p10l1838t1031r1892b1094],
14	immunohistochemistry	NN	O	immunohistochemistry	agent	12	SENT_140	[p10l1912t1035r2082b1079, p10l62t1103r525b1166],
15	.	.	O	.	_	0	SENT_140	[p10l1912t1035r2082b1079, p10l62t1103r525b1166],

1	cough	NN	O	cough	nsubjpass	25	SENT_141	[p10l11t1421r300b1521],
2	,	,	O	,	_	0	SENT_141	[p10l11t1421r300b1521],
3	dyspnea	NN	O	dyspnea	conj_and	1	SENT_141	[p10l326t1421r686b1521],
4	,	,	O	,	_	0	SENT_141	[p10l326t1421r686b1521],
5	and	CC	O	and	_	0	SENT_141	[p10l710t1421r867b1499],
6	pain	NN	O	pain	conj_and	1	SENT_141	[p10l888t1421r1076b1521],
7	were	VBD	O	be	auxpass	8	SENT_141	[p10l1095t1447r1299b1500],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_141	[p10l1322t1420r1735b1499],
9	prospectively	RB	O	prospectively	advmod	8	SENT_141	[p10l1757t1446r2132b1521, p10l11t1549r233b1649],
10	as	IN	O	as	_	0	SENT_141	[p10l256t1575r340b1627],
11	the	DT	O	the	det	14	SENT_141	[p10l371t1549r502b1627],
12	primary	JJ	O	primary	amod	14	SENT_141	[p10l528t1549r871b1649],
13	end	NN	O	end	nn	14	SENT_141	[p10l894t1549r1050b1627],
14	points	NNS	O	point	prep_as	8	SENT_141	[p10l1075t1549r1345b1649],
15	for	IN	O	for	_	0	SENT_141	[p10l1375t1548r1500b1627],
16	the	DT	O	the	det	17	SENT_141	[p10l1525t1549r1656b1627],
17	analysis	NN	O	analysis	prep_for	14	SENT_141	[p10l1683t1549r2021b1649],
18	of	IN	O	of	_	0	SENT_141	[p10l2051t1548r2152b1627],
19	quality	NN	O	quality	prep_of	17	SENT_141	[p10l11t1677r303b1777],
20	of	IN	O	of	_	0	SENT_141	[p10l328t1676r430b1755],
21	life	NN	O	life	nn	22	SENT_141	[p10l439t1671r654b1755],
22	”	NN	O	”	prep_of	19	SENT_141	[p10l439t1671r654b1755],
23	and	CC	O	and	_	0	SENT_141	[p10l686t1677r838b1755],
24	were	VBD	O	be	auxpass	25	SENT_141	[p10l863t1703r1068b1756],
25	analyzed	VBN	O	analyze	conj_and	8	SENT_141	[p10l1097t1677r1472b1777],
26	with	IN	O	with	_	0	SENT_141	[p10l1496t1677r1689b1756],
27	the	DT	O	the	det	28	SENT_141	[p10l1718t1677r1850b1755],
28	use	NN	O	use	prep_with	25	SENT_141	[p10l1879t1703r2020b1756],
29	of	IN	O	of	_	0	SENT_141	[p10l2051t1676r2152b1755],
30	the	DT	O	the	det	33	SENT_141	[p10l11t1805r142b1883],
31	log	NN	O	log	nn	33	SENT_141	[p10l185t1804r560b1905],
32	—	CD	NUMBER	—	num	33	SENT_141	[p10l185t1804r560b1905],
33	ranl	NN	O	ranl	prep_of	28	SENT_141	[p10l185t1804r560b1905],
34	<	JJR	O	<	amod	35	SENT_141	[p10l185t1804r560b1905],
35	test	NN	O	test	dobj	8	SENT_141	[p10l599t1821r774b1900],
36	,	,	O	,	_	0	SENT_141	[p10l599t1821r774b1900],
37	with	IN	O	with	_	0	SENT_141	[p10l819t1805r1011b1884],
38	adjustment	NN	O	adjustment	prep_with	35	SENT_141	[p10l1054t1805r1542b1905],
39	according	VBG	O	accord	_	0	SENT_141	[p10l1580t1805r2011b1905],
40	to	TO	O	to	prepc_according_to	8	SENT_141	[p10l2052t1821r2133b1883],
41	the	DT	O	the	det	44	SENT_141	[p10l11t1932r142b2010],
42	Hochberg	NNP	PERSON	Hochberg	nn	44	SENT_141	[p10l190t1932r624b2032],
43	method	NN	O	method	nn	44	SENT_141	[p10l670t1925r1085b2010],
44	“	NN	O	“	pobj	8	SENT_141	[p10l670t1925r1085b2010],
45	for	IN	O	for	_	0	SENT_141	[p10l1134t1931r1259b2010],
46	the	DT	O	the	det	47	SENT_141	[p10l1305t1932r1437b2010],
47	comparison	NN	O	comparison	prep_for	44	SENT_141	[p10l1486t1933r2001b2032],
48	of	IN	O	of	_	0	SENT_141	[p10l2051t1931r2152b2010],
49	multiple	JJ	O	multiple	amod	51	SENT_141	[p10l10t2061r371b2161],
50	end	NN	O	end	nn	51	SENT_141	[p10l400t2060r555b2139],
51	points	NNS	O	point	prep_of	47	SENT_141	[p10l581t2061r877b2161],
52	.	.	O	.	_	0	SENT_141	[p10l581t2061r877b2161],

1	All	DT	O	all	det	3	SENT_142	[p10l905t2060r1024b2138],
2	P	NN	O	p	nn	3	SENT_142	[p10l1048t2067r1100b2138],
3	Values	NNS	O	value	nsubj	6	SENT_142	[p10l1118t2061r1378b2140],
4	were	VBD	O	be	cop	6	SENT_142	[p10l1401t2087r1602b2140],
5	tvvo	JJ	O	tvvo	amod	6	SENT_142	[p10l1628t2061r2068b2140],
6	—	NN	O	—	_	0	SENT_142	[p10l1628t2061r2068b2140],
7	sided	VBD	O	side	rcmod	6	SENT_142	[p10l1628t2061r2068b2140],
8	.	.	O	.	_	0	SENT_142	[p10l1628t2061r2068b2140],

1	RESULTS	NNS	O	result	_	0	SENT_143	[p10l828t2369r1306b2428],

1	PATIENT	NN	O	patient	nn	2	SENT_144	[p10l16t2597r360b2646],
2	CHARACTERISTICS	NNS	O	characteristic	nsubjpass	14	SENT_144	[p10l397t2597r1156b2646],
3	Between	IN	O	between	_	0	SENT_144	[p10l9t2704r366b2777],
4	August	NNP	DATE	August	prep_between	14	SENT_144	[p10l402t2705r708b2798],
5	2001	CD	DATE	2001	num	4	SENT_144	[p10l742t2703r949b2776],
6	and	CC	O	and	_	0	SENT_144	[p10l988t2698r1144b2776],
7	January	NNP	DATE	January	conj_and	4	SENT_144	[p10l1172t2705r1499b2798],
8	2003	CD	DATE	2003	num	7	SENT_144	[p10l1533t2703r1764b2793],
9	,	,	O	,	_	0	SENT_144	[p10l1533t2703r1764b2793],
10	731	CD	NUMBER	731	num	7	SENT_144	[p10l1810t2703r1962b2776],
11	patients	NNS	O	patient	nsubjpass	14	SENT_144	[p10l2001t2724r2133b2798, p10l11t2826r240b2904],
12	were	VBD	O	be	auxpass	14	SENT_144	[p10l262t2852r464b2905],
13	randomly	RB	O	randomly	advmod	14	SENT_144	[p10l488t2826r898b2926],
14	assigned	VBN	O	assign	_	0	SENT_144	[p10l917t2826r1287b2926],
15	to	TO	O	to	aux	16	SENT_144	[p10l1312t2842r1391b2904],
16	erlotinib	VB	O	erlotinib	xcomp	14	SENT_144	[p10l1417t2826r1775b2904],
17	(	NN	O	(	nn	19	SENT_144	[p10l1806t2831r2019b2917],
18	488	CD	NUMBER	488	num	19	SENT_144	[p10l1806t2831r2019b2917],
19	)	NN	O	)	dobj	16	SENT_144	[p10l1806t2831r2019b2917],
20	or	CC	O	or	_	0	SENT_144	[p10l2048t2851r2138b2904],
21	placebo	NN	O	placebo	nn	22	SENT_144	[p10l9t2953r335b3054],
22	(	NN	O	(	conj_or	19	SENT_144	[p10l364t2959r606b3045],
23	243	CD	NUMBER	243	num	24	SENT_144	[p10l364t2959r606b3045],
24	)	NN	O	)	dep	22	SENT_144	[p10l364t2959r606b3045],
25	.	.	O	.	_	0	SENT_144	[p10l364t2959r606b3045],

1	TWenty	CD	NUMBER	twenty	number	2	SENT_145	[p10l630t2959r1124b3054],
2	—	CD	NUMBER	—	num	4	SENT_145	[p10l630t2959r1124b3054],
3	tWo	NN	NUMBER	two	nn	4	SENT_145	[p10l630t2959r1124b3054],
4	patients	NNS	O	patient	nsubj	5	SENT_145	[p10l1146t2954r1481b3054],
5	(	VBP	O	(	_	0	SENT_145	[p10l1509t2959r1639b3045],
6	12	CD	NUMBER	12	nsubj	17	SENT_145	[p10l1509t2959r1639b3045],
7	assigned	VBN	O	assign	partmod	6	SENT_145	[p10l1661t2953r2032b3054],
8	to	TO	O	to	_	0	SENT_145	[p10l2055t2970r2134b3032],
9	erlotinib	NN	O	erlotinib	prep_to	7	SENT_145	[p10l11t3082r377b3160],
10	and	CC	O	and	_	0	SENT_145	[p10l401t3082r558b3160],
11	10	CD	NUMBER	10	prep_to	7	SENT_145	[p10l585t3087r683b3160],
12	assigned	VBN	O	assign	partmod	11	SENT_145	[p10l706t3082r1085b3182],
13	to	TO	O	to	_	0	SENT_145	[p10l1108t3098r1188b3160],
14	placebo	NN	O	placebo	nn	15	SENT_145	[p10l1211t3082r1575b3182],
15	)	NN	O	)	prep_to	12	SENT_145	[p10l1211t3082r1575b3182],
16	were	VBD	O	be	cop	17	SENT_145	[p10l1599t3108r1805b3161],
17	ineligible	JJ	O	ineligible	ccomp	5	SENT_145	[p10l1827t3082r2133b3182, p10l11t3209r135b3288],
18	for	IN	O	for	_	0	SENT_145	[p10l171t3209r295b3288],
19	the	DT	O	the	det	21	SENT_145	[p10l328t3210r458b3288],
20	following	VBG	O	follow	amod	21	SENT_145	[p10l493t3209r903b3310],
21	reasons	NNS	O	reason	prep_for	17	SENT_145	[p10l935t3235r1284b3288],
22	:	:	O	:	_	0	SENT_145	[p10l935t3235r1284b3288],
23	three	CD	NUMBER	three	num	26	SENT_145	[p10l1324t3210r1536b3288],
24	prior	JJ	O	prior	amod	26	SENT_145	[p10l1571t3210r1783b3310],
25	chemotherapy	NN	O	chemotherapy	nn	26	SENT_145	[p10l1816t3210r2134b3288, p10l11t3338r328b3438],
26	regimens	NNS	O	regimen	nsubj	27	SENT_145	[p10l359t3338r752b3438],
27	(	VBP	O	(	parataxis	5	SENT_145	[p10l795t3343r933b3433],
28	9	CD	NUMBER	9	num	29	SENT_145	[p10l795t3343r933b3433],
29	)	NN	O	)	dobj	27	SENT_145	[p10l795t3343r933b3433],
30	;	:	O	;	_	0	SENT_145	[p10l795t3343r933b3433],
31	single	JJ	O	single	amod	34	SENT_145	[p10l975t3338r1500b3438],
32	—	JJ	O	—	amod	34	SENT_145	[p10l975t3338r1500b3438],
33	agent	NN	O	agent	nn	34	SENT_145	[p10l975t3338r1500b3438],
34	chemotherapy	NN	O	chemotherapy	dep	29	SENT_145	[p10l1532t3337r2139b3438],
35	for	IN	O	for	dep	45	SENT_145	[p10l10t3465r133b3544],
36	patients	NNS	O	patient	pobj	35	SENT_145	[p10l151t3466r480b3566],
37	less	JJR	DURATION	less	mwe	38	SENT_145	[p10l504t3466r656b3544],
38	than	IN	DURATION	than	quantmod	39	SENT_145	[p10l682t3466r867b3544],
39	70	CD	DURATION	70	num	40	SENT_145	[p10l891t3471r989b3544],
40	years	NNS	NUMBER	year	npadvmod	36	SENT_145	[p10l1009t3492r1219b3566],
41	of	IN	O	of	_	0	SENT_145	[p10l1246t3465r1345b3544],
42	age	NN	O	age	nn	43	SENT_145	[p10l1349t3492r1490b3566],
43	(	NN	O	(	prep_of	36	SENT_145	[p10l1518t3471r1653b3561],
44	2	CD	NUMBER	2	num	45	SENT_145	[p10l1518t3471r1653b3561],
45	)	NN	O	)	dep	27	SENT_145	[p10l1518t3471r1653b3561],
46	;	:	O	;	_	0	SENT_145	[p10l1518t3471r1653b3561],
47	inadequate	JJ	O	inadequate	amod	48	SENT_145	[p10l1679t3466r2135b3566],
48	time	NN	O	time	dep	45	SENT_145	[p10l11t3593r197b3670],
49	since	IN	O	since	_	0	SENT_145	[p10l239t3593r456b3670],
50	the	DT	O	the	det	55	SENT_145	[p10l497t3593r628b3670],
51	last	JJ	O	last	amod	55	SENT_145	[p10l668t3593r823b3670],
52	treatment	NN	O	treatment	nn	55	SENT_145	[p10l859t3609r1281b3670],
53	(	NN	O	(	nn	55	SENT_145	[p10l1322t3599r1462b3687],
54	5	CD	NUMBER	5	num	55	SENT_145	[p10l1322t3599r1462b3687],
55	)	NN	O	)	prep_since	48	SENT_145	[p10l1322t3599r1462b3687],
56	;	:	O	;	_	0	SENT_145	[p10l1322t3599r1462b3687],
57	abnormal	JJ	O	abnormal	amod	58	SENT_145	[p10l1506t3593r1924b3671],
58	biochemistry	NN	O	biochemistry	dep	45	SENT_145	[p10l1964t3593r2133b3671, p11l11t24r436b124],

1	results	NNS	O	result	nsubj	2	SENT_146	[p11l463t24r740b103],
2	(	VBP	O	(	_	0	SENT_146	[p11l779t29r917b119],
3	4	CD	NUMBER	4	number	4	SENT_146	[p11l779t29r917b119],
4	)	CD	NUMBER	)	dobj	2	SENT_146	[p11l779t29r917b119],
5	;	:	O	;	_	0	SENT_146	[p11l779t29r917b119],
6	and	CC	O	and	_	0	SENT_146	[p11l952t24r1108b102],
7	symptomatic	JJ	O	symptomatic	amod	9	SENT_146	[p11l1141t24r1689b124],
8	brain	NN	O	brain	nn	9	SENT_146	[p11l1721t24r1940b102],
9	metastases	NNS	O	metastase	nsubj	10	SENT_146	[p11l1972t50r2134b102, p11l11t168r348b230],
10	(	VBP	O	(	conj_and	2	SENT_146	[p11l384t157r522b243],
11	2	CD	NUMBER	2	number	12	SENT_146	[p11l384t157r522b243],
12	)	CD	NUMBER	)	dobj	10	SENT_146	[p11l384t157r522b243],
13	.	.	O	.	_	0	SENT_146	[p11l384t157r522b243],

1	All	DT	O	all	det	3	SENT_147	[p11l554t152r675b229],
2	731	CD	NUMBER	731	num	3	SENT_147	[p11l705t157r859b230],
3	patients	NNS	O	patient	nsubjpass	5	SENT_147	[p11l887t152r1229b252],
4	were	VBD	O	be	auxpass	5	SENT_147	[p11l1256t178r1461b231],
5	included	VBN	O	include	_	0	SENT_147	[p11l1490t152r1863b231],
6	in	IN	O	in	_	0	SENT_147	[p11l1891t152r1973b229],
7	the	DT	O	the	det	9	SENT_147	[p11l2002t152r2134b230],
8	efficacy	NN	O	efficacy	nn	9	SENT_147	[p11l11t279r338b380],
9	analyses	NNS	O	analysis	prep_in	5	SENT_147	[p11l358t280r733b380],
10	,	,	O	,	_	0	SENT_147	[p11l358t280r733b380],
11	and	CC	O	and	_	0	SENT_147	[p11l763t280r920b358],
12	727	CD	NUMBER	727	num	14	SENT_147	[p11l946t285r1098b358],
13	treated	JJ	O	treated	amod	14	SENT_147	[p11l1125t279r1414b358],
14	patients	NNS	O	patient	nsubjpass	27	SENT_147	[p11l1438t280r1773b380],
15	(	IN	O	(	_	0	SENT_147	[p11l1806t285r1985b371],
16	485	CD	NUMBER	485	prep_(	14	SENT_147	[p11l1806t285r1985b371],
17	assigned	VBN	O	assign	partmod	14	SENT_147	[p11l2015t306r2133b358, p11l12t408r290b508],
18	to	TO	O	to	_	0	SENT_147	[p11l331t424r410b486],
19	erlotinib	NN	O	erlotinib	prep_to	17	SENT_147	[p11l452t408r810b486],
20	and	CC	O	and	_	0	SENT_147	[p11l851t408r1007b486],
21	242	CD	NUMBER	242	conj_and	19	SENT_147	[p11l1047t413r1201b486],
22	assigned	VBN	O	assign	partmod	21	SENT_147	[p11l1242t408r1612b508],
23	to	TO	O	to	_	0	SENT_147	[p11l1653t424r1731b486],
24	placebo	NN	O	placebo	nn	25	SENT_147	[p11l1772t408r2130b508],
25	)	NN	O	)	prep_to	22	SENT_147	[p11l1772t408r2130b508],
26	were	VBD	O	be	auxpass	27	SENT_147	[p11l6t562r207b615],
27	included	VBN	O	include	conj_and	5	SENT_147	[p11l232t536r598b615],
28	in	IN	O	in	_	0	SENT_147	[p11l622t536r703b613],
29	the	DT	O	the	det	31	SENT_147	[p11l728t536r858b614],
30	safety	NN	O	safety	nn	31	SENT_147	[p11l885t535r1126b636],
31	analyses	NNS	O	analysis	prep_in	27	SENT_147	[p11l1146t535r1521b636],
32	.	.	O	.	_	0	SENT_147	[p11l1146t535r1521b636],

1	Eight	CD	NUMBER	eight	num	2	SENT_148	[p11l1550t536r1779b636],
2	patients	NNS	O	patient	nsubjpass	27	SENT_148	[p11l1798t536r2133b636],
3	assigned	VBN	O	assign	partmod	2	SENT_148	[p11l10t664r380b764],
4	to	TO	O	to	aux	5	SENT_148	[p11l406t680r485b742],
5	erlotinib	VB	O	erlotinib	xcomp	3	SENT_148	[p11l512t664r870b742],
6	(	CD	PERCENT	(	number	7	SENT_148	[p11l901t669r1060b755],
7	1.6	CD	PERCENT	1.6	num	9	SENT_148	[p11l901t669r1060b755],
8	percent	NN	PERCENT	percent	nn	9	SENT_148	[p11l1084t671r1429b764],
9	)	NN	O	)	dobj	5	SENT_148	[p11l1084t671r1429b764],
10	and	CC	O	and	_	0	SENT_148	[p11l1459t663r1614b742],
11	18	CD	NUMBER	18	conj_and	9	SENT_148	[p11l1642t669r1738b742],
12	assigned	VBN	O	assign	partmod	11	SENT_148	[p11l1764t664r2135b764],
13	to	TO	O	to	_	0	SENT_148	[p11l11t808r90b869],
14	placebo	NN	O	placebo	nn	15	SENT_148	[p11l126t792r453b891],
15	(	NN	O	(	prep_to	12	SENT_148	[p11l495t797r655b882],
16	7.4	CD	PERCENT	7.4	num	15	SENT_148	[p11l495t797r655b882],
17	percent	NN	PERCENT	percent	nsubj	19	SENT_148	[p11l690t798r1034b891],
18	)	CD	NUMBER	)	num	17	SENT_148	[p11l690t798r1034b891],
19	received	VBD	O	receive	parataxis	27	SENT_148	[p11l1075t792r1424b870],
20	other	JJ	O	other	amod	22	SENT_148	[p11l1464t792r1691b869],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_148	[p11l1726t797r1988b874],
22	inhibitors	NNS	O	inhibitor	dobj	19	SENT_148	[p11l2016t792r2132b868, p11l10t920r346b998],
23	after	IN	O	after	_	0	SENT_148	[p11l372t919r570b998],
24	study	NN	O	study	nn	25	SENT_148	[p11l594t920r824b1020],
25	medication	NN	O	medication	prep_after	19	SENT_148	[p11l845t920r1329b998],
26	was	VBD	O	be	auxpass	27	SENT_148	[p11l1350t946r1513b999],
27	discontinued	VBN	O	discontinue	_	0	SENT_148	[p11l1541t919r2129b999],
28	.	.	O	.	_	0	SENT_148	[p11l1541t919r2129b999],

1	The	DT	O	the	det	2	SENT_149	[p11l7t1047r170b1126],
2	groups	NNS	O	group	nsubjpass	4	SENT_149	[p11l210t1073r509b1148],
3	were	VBD	O	be	auxpass	4	SENT_149	[p11l546t1074r751b1127],
4	balanced	VBN	O	balance	_	0	SENT_149	[p11l791t1047r1174b1126],
5	with	IN	O	with	_	0	SENT_149	[p11l1209t1048r1402b1127],
6	respect	NN	O	respect	prep_with	4	SENT_149	[p11l1441t1064r1753b1148],
7	to	TO	O	to	_	0	SENT_149	[p11l1788t1064r1867b1126],
8	baseline	NN	O	baseline	nn	9	SENT_149	[p11l1909t1048r2132b1126, p11l9t1176r167b1254],
9	characteristics	NNS	O	characteristic	prep_to	4	SENT_149	[p11l198t1176r818b1254],
10	and	CC	O	and	_	0	SENT_149	[p11l849t1176r1007b1254],
11	important	JJ	O	important	amod	13	SENT_149	[p11l1036t1176r1472b1276],
12	prognostic	JJ	O	prognostic	amod	13	SENT_149	[p11l1493t1176r1952b1276],
13	variables	NNS	O	variable	nsubj	14	SENT_149	[p11l1974t1202r2134b1255, p11l10t1304r251b1383],
14	(	VBP	O	(	conj_and	4	SENT_149	[p11l283t1305r536b1396],
15	Table	NNP	O	Table	nsubj	17	SENT_149	[p11l283t1305r536b1396],
16	1	CD	NUMBER	1	num	17	SENT_149	[p11l566t1310r668b1396],
17	)	CD	NUMBER	)	xcomp	14	SENT_149	[p11l566t1310r668b1396],
18	.	.	O	.	_	0	SENT_149	[p11l566t1310r668b1396],

1	RESPONSE	NN	O	response	tmod	17	SENT_150	[p11l15t1589r444b1638],
2	AN	DT	O	a	det	4	SENT_150	[p11l482t1589r588b1638],
3	D	NN	O	d	nn	4	SENT_150	[p11l612t1589r659b1638],
4	SURVIVAL	NN	O	survival	dep	1	SENT_150	[p11l699t1589r1100b1639],
5	In	IN	O	in	_	0	SENT_150	[p11l9t1696r96b1766],
6	patients	NNS	O	patient	prep_in	17	SENT_150	[p11l129t1689r471b1789],
7	with	IN	O	with	_	0	SENT_150	[p11l503t1689r695b1768],
8	at	IN	O	at	quantmod	10	SENT_150	[p11l728t1705r809b1767],
9	least	JJS	O	least	mwe	8	SENT_150	[p11l837t1689r1038b1767],
10	one	CD	NUMBER	one	num	12	SENT_150	[p11l1068t1714r1222b1767],
11	target	NN	O	target	nn	12	SENT_150	[p11l1256t1705r1512b1789],
12	lesion	NN	O	lesion	prep_with	6	SENT_150	[p11l1540t1689r1823b1784],
13	,	,	O	,	_	0	SENT_150	[p11l1540t1689r1823b1784],
14	the	DT	O	the	det	15	SENT_150	[p11l1863t1689r1994b1767],
15	lesions	NNS	O	lesion	nsubjpass	17	SENT_150	[p11l2028t1689r2133b1767, p11l12t1817r234b1895],
16	Were	VBD	O	be	auxpass	17	SENT_150	[p11l275t1843r480b1896],
17	evaluated	VBN	O	evaluate	_	0	SENT_150	[p11l525t1817r926b1896],
18	according	VBG	O	accord	_	0	SENT_150	[p11l968t1817r1400b1917],
19	to	TO	O	to	prepc_according_to	17	SENT_150	[p11l1440t1833r1520b1895],
20	RECIST	NNP	O	RECIST	pobj	17	SENT_150	[p11l1563t1822r1902b1900],
21	(	CD	NUMBER	(	number	22	SENT_150	[p11l1946t1822r2133b1908],
22	427	CD	NUMBER	427	num	23	SENT_150	[p11l1946t1822r2133b1908],
23	patients	NNS	O	patient	dep	20	SENT_150	[p11l9t1945r351b2045],
24	assigned	VBN	O	assign	partmod	20	SENT_150	[p11l378t1945r757b2045],
25	to	TO	O	to	_	0	SENT_150	[p11l783t1961r863b2023],
26	erlotinib	NN	O	erlotinib	prep_to	24	SENT_150	[p11l890t1945r1257b2023],
27	and	CC	O	and	_	0	SENT_150	[p11l1283t1944r1441b2023],
28	211	CD	NUMBER	211	conj_and	20	SENT_150	[p11l1467t1950r1623b2022],
29	assigned	VBN	O	assign	partmod	28	SENT_150	[p11l1648t1945r2027b2045],
30	to	TO	O	to	_	0	SENT_150	[p11l2052t1961r2133b2023],
31	placebo	NN	O	placebo	nn	32	SENT_150	[p11l9t2072r404b2173],
32	)	NN	O	)	prep_to	29	SENT_150	[p11l9t2072r404b2173],
33	.	.	O	.	_	0	SENT_150	[p11l9t2072r404b2173],

1	In	IN	O	in	_	0	SENT_151	[p11l434t2080r522b2150],
2	the	DT	O	the	det	4	SENT_151	[p11l549t2073r680b2151],
3	erlotinib	JJ	O	erlotinib	amod	4	SENT_151	[p11l708t2073r1075b2151],
4	group	NN	O	group	prep_in	8	SENT_151	[p11l1102t2098r1383b2173],
5	,	,	O	,	_	0	SENT_151	[p11l1102t2098r1383b2173],
6	the	DT	O	the	det	7	SENT_151	[p11l1416t2073r1547b2151],
7	rates	NNS	O	rate	nsubj	8	SENT_151	[p11l1574t2089r1776b2151],
8	ofcom	VBP	O	ofcom	_	0	SENT_151	[p11l1805t2072r2133b2151],
9	—	JJ	O	—	amod	11	SENT_151	[p11l1805t2072r2133b2151],
10	plete	NN	O	plete	nn	11	SENT_151	[p11l9t2201r216b2301],
11	response	NN	O	response	nsubj	17	SENT_151	[p11l246t2226r632b2301],
12	and	CC	O	and	_	0	SENT_151	[p11l661t2200r819b2279],
13	partial	JJ	O	partial	amod	14	SENT_151	[p11l847t2201r1125b2301],
14	response	NN	O	response	conj_and	11	SENT_151	[p11l1154t2226r1540b2301],
15	Were	VBD	O	be	cop	17	SENT_151	[p11l1566t2227r1770b2280],
16	0.7	CD	PERCENT	0.7	num	17	SENT_151	[p11l1801t2206r1931b2279],
17	percent	NN	PERCENT	percent	ccomp	8	SENT_151	[p11l1961t2227r2133b2301, p11l11t2345r193b2407],
18	and	CC	O	and	_	0	SENT_151	[p11l224t2328r383b2407],
19	8.2	CD	PERCENT	8.2	num	20	SENT_151	[p11l420t2334r550b2407],
20	percent	NN	PERCENT	percent	ccomp	8	SENT_151	[p11l587t2345r934b2429],
21	,	,	O	,	_	0	SENT_151	[p11l587t2345r934b2429],
22	respectively	RB	O	respectively	dep	25	SENT_151	[p11l976t2328r1479b2429],
23	(	CD	NUMBER	(	num	25	SENT_151	[p11l1517t2328r1868b2420],
24	median	JJ	O	median	amod	25	SENT_151	[p11l1517t2328r1868b2420],
25	duration	NN	O	duration	dep	17	SENT_151	[p11l1906t2329r2132b2408, p11l11t2457r204b2552],
26	,	,	O	,	_	0	SENT_151	[p11l1906t2329r2132b2408, p11l11t2457r204b2552],
27	7.9	CD	DURATION	7.9	num	28	SENT_151	[p11l235t2462r365b2535],
28	months	NNS	NUMBER	month	tmod	25	SENT_151	[p11l391t2456r784b2552],
29	)	RB	O	)	advmod	17	SENT_151	[p11l391t2456r784b2552],
30	;	:	O	;	_	0	SENT_151	[p11l391t2456r784b2552],
31	in	IN	O	in	_	0	SENT_151	[p11l811t2457r893b2534],
32	the	DT	O	the	det	34	SENT_151	[p11l916t2457r1045b2535],
33	placebo	NN	O	placebo	nn	34	SENT_151	[p11l1066t2456r1393b2557],
34	group	NN	O	group	prep_in	45	SENT_151	[p11l1416t2482r1693b2557],
35	,	,	O	,	_	0	SENT_151	[p11l1416t2482r1693b2557],
36	the	DT	O	the	det	37	SENT_151	[p11l1721t2457r1850b2535],
37	rate	NN	O	rate	nsubj	45	SENT_151	[p11l1873t2473r2029b2535],
38	of	IN	O	of	_	0	SENT_151	[p11l2053t2456r2153b2535],
39	partial	JJ	O	partial	amod	40	SENT_151	[p11l9t2585r280b2685],
40	response	NN	O	response	prep_of	37	SENT_151	[p11l303t2610r682b2685],
41	was	VBD	O	be	cop	45	SENT_151	[p11l701t2611r863b2664],
42	less	JJR	O	less	mwe	43	SENT_151	[p11l887t2584r1041b2663],
43	than	IN	O	than	quantmod	44	SENT_151	[p11l1068t2584r1255b2663],
44	1	CD	PERCENT	1	num	45	SENT_151	[p11l1282t2590r1326b2662],
45	percent	NN	PERCENT	percent	parataxis	8	SENT_151	[p11l1349t2601r1669b2685],
46	(	CD	NUMBER	(	num	47	SENT_151	[p11l1693t2590r2130b2680],
47	P	NN	O	p	npadvmod	48	SENT_151	[p11l1693t2590r2130b2680],
48	<	JJR	O	<	amod	45	SENT_151	[p11l1693t2590r2130b2680],
49	0.001	CD	NUMBER	0.001	num	50	SENT_151	[p11l1693t2590r2130b2680],
50	)	NN	O	)	dep	45	SENT_151	[p11l1693t2590r2130b2680],
51	,	,	O	,	_	0	SENT_151	[p11l1693t2590r2130b2680],
52	but	CC	O	but	_	0	SENT_151	[p11l11t2713r152b2792],
53	these	DT	O	these	det	54	SENT_151	[p11l180t2713r399b2791],
54	responses	NNS	O	response	nsubjpass	58	SENT_151	[p11l433t2738r854b2813],
55	were	VBD	O	be	auxpass	58	SENT_151	[p11l884t2739r1086b2792],
56	not	RB	O	not	neg	58	SENT_151	[p11l1119t2729r1263b2791],
57	externally	RB	O	externally	advmod	58	SENT_151	[p11l1292t2712r1702b2813],
58	validated	VBN	O	validate	parataxis	8	SENT_151	[p11l1726t2712r2129b2792],
59	.	.	O	.	_	0	SENT_151	[p11l1726t2712r2129b2792],

1	In	IN	O	in	_	0	SENT_152	[p11l9t2848r96b2918],
2	an	DT	O	a	det	3	SENT_152	[p11l122t2866r222b2919],
3	intention	NN	O	intention	prep_in	42	SENT_152	[p11l248t2841r988b2919],
4	—	CD	NUMBER	—	number	6	SENT_152	[p11l248t2841r988b2919],
5	to	TO	O	to	dep	6	SENT_152	[p11l248t2841r988b2919],
6	—	CD	NUMBER	—	num	8	SENT_152	[p11l248t2841r988b2919],
7	treat	NN	O	treat	nn	8	SENT_152	[p11l248t2841r988b2919],
8	analysis	NN	O	analysis	nsubj	13	SENT_152	[p11l1008t2840r1339b2941],
9	of	IN	O	of	_	0	SENT_152	[p11l1368t2840r1469b2919],
10	all	DT	O	all	det	11	SENT_152	[p11l1477t2840r1575b2919],
11	patients	NNS	O	patient	prep_of	8	SENT_152	[p11l1600t2841r1935b2941],
12	randomly	RB	O	randomly	advmod	13	SENT_152	[p11l1963t2866r2134b2919, p11l11t2969r281b3069],
13	assigned	VBN	O	assign	rcmod	3	SENT_152	[p11l307t2968r685b3069],
14	to	TO	O	to	_	0	SENT_152	[p11l717t2985r797b3047],
15	treatment	NN	O	treatment	prep_to	13	SENT_152	[p11l830t2985r1272b3064],
16	,	,	O	,	_	0	SENT_152	[p11l830t2985r1272b3064],
17	the	DT	O	the	det	20	SENT_152	[p11l1309t2969r1441b3047],
18	disease	NN	O	disease	nn	20	SENT_152	[p11l1473t2969r2134b3047],
19	—	NN	O	—	nn	20	SENT_152	[p11l1473t2969r2134b3047],
20	control	NN	O	control	nsubj	42	SENT_152	[p11l1473t2969r2134b3047],
21	rate	NN	O	rate	dep	20	SENT_152	[p11l10t3113r170b3175],
22	(	CD	NUMBER	(	num	21	SENT_152	[p11l206t3097r387b3192],
23	i.e.	FW	O	i.e.	dep	20	SENT_152	[p11l206t3097r387b3192],
24	,	,	O	,	_	0	SENT_152	[p11l206t3097r387b3192],
25	the	DT	O	the	det	26	SENT_152	[p11l420t3097r549b3175],
26	rate	NN	O	rate	appos	23	SENT_152	[p11l578t3113r734b3175],
27	of	IN	O	of	_	0	SENT_152	[p11l763t3096r864b3175],
28	complete	JJ	O	complete	amod	31	SENT_152	[p11l874t3097r1262b3197],
29	or	CC	O	or	_	0	SENT_152	[p11l1291t3122r1380b3175],
30	partial	JJ	O	partial	conj_or	28	SENT_152	[p11l1404t3097r1675b3197],
31	responses	NNS	O	response	prep_of	26	SENT_152	[p11l1703t3122r2131b3197],
32	and	CC	O	and	_	0	SENT_152	[p11l10t3225r169b3303],
33	stable	JJ	O	stable	amod	35	SENT_152	[p11l202t3224r457b3303],
34	disease	NN	O	disease	nn	35	SENT_152	[p11l490t3224r833b3316],
35	)	NN	O	)	prep_of	26	SENT_152	[p11l490t3224r833b3316],
36	in	IN	O	in	_	0	SENT_152	[p11l870t3225r953b3302],
37	the	DT	O	the	det	39	SENT_152	[p11l986t3224r1118b3303],
38	erlotinib	JJ	O	erlotinib	amod	39	SENT_152	[p11l1151t3225r1522b3303],
39	group	NN	O	group	prep_in	35	SENT_152	[p11l1555t3250r1813b3325],
40	was	VBD	O	be	cop	42	SENT_152	[p11l1842t3251r2003b3304],
41	45	CD	PERCENT	45	num	42	SENT_152	[p11l2032t3230r2131b3303],
42	percent	NN	PERCENT	percent	_	0	SENT_152	[p11l9t3369r349b3453],
43	;	:	O	;	_	0	SENT_152	[p11l9t3369r349b3453],
44	38	CD	PERCENT	38	num	45	SENT_152	[p11l380t3358r478b3431],
45	percent	NN	PERCENT	percent	nsubj	49	SENT_152	[p11l504t3369r825b3453],
46	of	IN	O	of	_	0	SENT_152	[p11l846t3352r947b3431],
47	the	DT	O	the	det	48	SENT_152	[p11l954t3353r1083b3431],
48	patients	NNS	O	patient	prep_of	45	SENT_152	[p11l1108t3353r1442b3453],
49	had	VBD	O	have	dep	42	SENT_152	[p11l1470t3353r1625b3431],
50	progressive	JJ	O	progressive	amod	51	SENT_152	[p11l1650t3353r2135b3453],
51	disease	NN	O	disease	dobj	49	SENT_152	[p11l11t3481r338b3576],
52	,	,	O	,	_	0	SENT_152	[p11l11t3481r338b3576],
53	and	CC	O	and	_	0	SENT_152	[p11l370t3480r526b3559],
54	among	IN	O	among	_	0	SENT_152	[p11l552t3506r851b3581],
55	the	DT	O	the	prep_among	62	SENT_152	[p11l875t3480r1005b3559],
56	remaining	VBG	O	remain	amod	55	SENT_152	[p11l1032t3481r1473b3581],
57	17	CD	PERCENT	17	num	59	SENT_152	[p11l1500t3486r1596b3559],
58	percent	NN	PERCENT	percent	nn	59	SENT_152	[p11l1622t3497r1939b3581],
59	progression	NN	O	progression	nsubjpass	62	SENT_152	[p11l1958t3506r2134b3581, p11l10t3609r364b3709],
60	Was	VBD	O	be	auxpass	62	SENT_152	[p11l384t3635r543b3688],
61	not	RB	O	not	neg	62	SENT_152	[p11l571t3625r712b3687],
62	conﬁrmed	VBN	O	conﬁrmed	dep	42	SENT_152	[p11l733t3608r1187b3687],
63	.	.	O	.	_	0	SENT_152	[p11l733t3608r1187b3687],

1	The	DT	O	the	det	2	SENT_153	[p11l1214t3608r1374b3687],
2	likelihood	NN	O	likelihood	_	0	SENT_153	[p11l1398t3609r1819b3688],
3	of	IN	O	of	_	0	SENT_153	[p11l1844t3608r1945b3687],
4	a	DT	O	a	det	5	SENT_153	[p11l1953t3635r1997b3687],
5	response	NN	O	response	prep_of	2	SENT_153	[p11l2022t3635r2134b3687, p12l12t46r306b121],

1	to	TO	O	to	prep	40	SENT_154	[p12l340t37r419b99],
2	erlotinib	VB	O	erlotinib	dep	1	SENT_154	[p12l454t21r812b99],
3	(	CD	NUMBER	(	num	4	SENT_154	[p12l851t20r1105b112],
4	Table	NNP	O	Table	dobj	2	SENT_154	[p12l851t20r1105b112],
5	2	CD	NUMBER	2	num	4	SENT_154	[p12l1138t26r1215b112],
6	)	CD	NUMBER	)	nsubjpass	20	SENT_154	[p12l1138t26r1215b112],
7	among	IN	O	among	_	0	SENT_154	[p12l1253t46r1553b121],
8	patients	NNS	O	patient	prep_among	6	SENT_154	[p12l1581t21r1916b121],
9	with	IN	O	with	_	0	SENT_154	[p12l1946t21r2134b100],
10	non	JJ	O	non	amod	16	SENT_154	[p12l10t149r656b227],
11	—	JJ	O	—	amod	16	SENT_154	[p12l10t149r656b227],
12	small	JJ	O	small	amod	16	SENT_154	[p12l10t149r656b227],
13	—	NN	O	—	nn	16	SENT_154	[p12l10t149r656b227],
14	cell	NN	O	cell	nn	16	SENT_154	[p12l10t149r656b227],
15	lung	NN	O	lung	nn	16	SENT_154	[p12l690t149r887b249],
16	cancer	NN	O	cancer	prep_with	8	SENT_154	[p12l919t174r1200b227],
17	was	VBD	O	be	auxpass	20	SENT_154	[p12l1228t175r1391b228],
18	not	RB	O	not	neg	20	SENT_154	[p12l1428t165r1573b227],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_154	[p12l1604t148r2139b249],
20	altered	VBN	O	alter	rcmod	4	SENT_154	[p12l10t277r303b355],
21	by	IN	O	by	_	0	SENT_154	[p12l342t277r440b377],
22	performance	NN	O	performance	nn	23	SENT_154	[p12l473t276r1027b377],
23	status	NN	O	status	agent	20	SENT_154	[p12l1068t293r1345b372],
24	,	,	O	,	_	0	SENT_154	[p12l1068t293r1345b372],
25	prior	RB	O	prior	advmod	26	SENT_154	[p12l1388t277r1605b377],
26	treatments	NNS	O	treatment	conj_or	23	SENT_154	[p12l1641t293r2128b372],
27	,	,	O	,	_	0	SENT_154	[p12l1641t293r2128b372],
28	prior	JJ	O	prior	amod	29	SENT_154	[p12l9t405r226b505],
29	response	NN	O	response	conj_or	23	SENT_154	[p12l260t430r671b505],
30	,	,	O	,	_	0	SENT_154	[p12l260t430r671b505],
31	or	CC	O	or	_	0	SENT_154	[p12l714t430r805b483],
32	age	NN	O	age	conj_or	23	SENT_154	[p12l838t431r1007b505],
33	,	,	O	,	_	0	SENT_154	[p12l838t431r1007b505],
34	but	CC	O	but	_	0	SENT_154	[p12l1051t405r1194b484],
35	it	PRP	O	it	nsubj	37	SENT_154	[p12l1225t405r1286b483],
36	was	VBD	O	be	cop	37	SENT_154	[p12l1314t431r1477b484],
37	higher	JJR	O	higher	conj_but	20	SENT_154	[p12l1516t404r1800b505],
38	among	IN	O	among	_	0	SENT_154	[p12l1833t430r2137b505],
39	Women	NNS	O	woman	prep_among	37	SENT_154	[p12l6t558r324b612],
40	(	VBP	O	(	_	0	SENT_154	[p12l352t538r804b627],
41	P	NN	O	p	nsubj	42	SENT_154	[p12l352t538r804b627],
42	=	JJ	O	=	xcomp	40	SENT_154	[p12l352t538r804b627],
43	0.006	CD	NUMBER	0.006	num	44	SENT_154	[p12l352t538r804b627],
44	)	NN	O	)	nsubj	40	SENT_154	[p12l352t538r804b627],
45	,	,	O	,	_	0	SENT_154	[p12l352t538r804b627],
46	nonsmokers	NNS	O	nonsmoker	appos	44	SENT_154	[p12l833t533r1361b612],
47	(	VBP	O	(	rcmod	46	SENT_154	[p12l1391t538r1828b627],
48	P	NN	O	p	dobj	47	SENT_154	[p12l1391t538r1828b627],
49	<	JJR	O	<	amod	48	SENT_154	[p12l1391t538r1828b627],
50	0.001	CD	NUMBER	0.001	num	51	SENT_154	[p12l1391t538r1828b627],
51	)	NN	O	)	tmod	47	SENT_154	[p12l1391t538r1828b627],
52	,	,	O	,	_	0	SENT_154	[p12l1391t538r1828b627],
53	Asians	NNPS	MISC	Asians	appos	51	SENT_154	[p12l1852t533r2133b610],

1	126	CD	NUMBER	126	num	3	SENT_155	[p12l149t702r205b724],
2	N	NN	O	n	nn	3	SENT_155	[p12l918t705r932b720],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_155	[p12l947t704r1031b726],
4	MED	VBD	O	med	_	0	SENT_155	[p12l1046t705r1099b720],
5	35	CD	NUMBER	35	number	6	SENT_155	[p12l1111t704r1136b726],
6	:2	CD	NUMBER	:2	num	8	SENT_155	[p12l1155t704r1175b724],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_155	[p12l1210t704r1421b726],
8	JULY14	NN	O	july14	dobj	4	SENT_155	[p12l1455t704r1562b726],
9	,	,	O	,	_	0	SENT_155	[p12l1455t704r1562b726],
10	2005	CD	DATE	2005	appos	8	SENT_155	[p12l1575t704r1638b726],

1	The	DT	O	the	det	4	SENT_156	[p12l935t737r986b761],
2	New	NNP	O	New	nn	4	SENT_156	[p12l995t738r1057b761],
3	Englan	NNP	O	Englan	nn	4	SENT_156	[p12l1066t737r1160b768],
4	oumal	NN	O	oumal	_	0	SENT_156	[p12l1200t737r1283b761],
5	of	IN	O	of	_	0	SENT_156	[p12l1293t737r1322b761],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_156	[p12l1329t737r1454b761],

1	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	NNP	O	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	_	0	SENT_157	[p12l480t925r1633b944],
2	ER	NN	O	er	dep	1	SENT_157	[p12l1638t925r1680b944],

1	(	NN	O	(	nn	2	SENT_158	[p12l16t1145r409b1235],
2	P	NN	O	p	nsubj	3	SENT_158	[p12l16t1145r409b1235],
3	=	JJ	O	=	_	0	SENT_158	[p12l16t1145r409b1235],
4	0.02	CD	NUMBER	0.02	num	5	SENT_158	[p12l16t1145r409b1235],
5	)	NN	O	)	dobj	3	SENT_158	[p12l16t1145r409b1235],
6	,	,	O	,	_	0	SENT_158	[p12l16t1145r409b1235],
7	patients	NNS	O	patient	dobj	3	SENT_158	[p12l434t1140r764b1240],
8	with	IN	O	with	_	0	SENT_158	[p12l782t1140r969b1219],
9	adenocarcinoma	NN	O	adenocarcinoma	prep_with	7	SENT_158	[p12l989t1140r1688b1218],
10	(	CD	NUMBER	(	num	11	SENT_158	[p12l1711t1145r2142b1235],
11	P	NN	O	p	npadvmod	12	SENT_158	[p12l1711t1145r2142b1235],
12	<	JJR	O	<	amod	9	SENT_158	[p12l1711t1145r2142b1235],
13	0.001	CD	NUMBER	0.001	num	14	SENT_158	[p12l1711t1145r2142b1235],
14	)	NN	O	)	dep	7	SENT_158	[p12l1711t1145r2142b1235],
15	,	,	O	,	_	0	SENT_158	[p12l1711t1145r2142b1235],
16	and	CC	O	and	_	0	SENT_158	[p12l11t1268r168b1346],
17	patients	NNS	O	patient	dobj	3	SENT_158	[p12l190t1268r526b1368],
18	in	IN	O	in	_	0	SENT_158	[p12l551t1268r632b1345],
19	whom	WP	O	whom	rel	28	SENT_158	[p12l652t1267r925b1347],
20	10	CD	PERCENT	10	num	21	SENT_158	[p12l952t1273r1050b1346],
21	percent	NN	PERCENT	percent	nsubj	28	SENT_158	[p12l1073t1284r1395b1368],
22	or	CC	O	or	_	0	SENT_158	[p12l1415t1293r1504b1346],
23	more	JJR	O	more	conj_or	21	SENT_158	[p12l1525t1293r1746b1346],
24	of	IN	O	of	_	0	SENT_158	[p12l1770t1267r1872b1346],
25	the	DT	O	the	det	27	SENT_158	[p12l1877t1268r2007b1346],
26	tumor	NN	O	tumor	nn	27	SENT_158	[p12l2031t1284r2145b1347, p12l12t1421r190b1474],
27	cells	NNS	O	cell	prep_of	23	SENT_158	[p12l230t1395r413b1474],
28	expressed	VBD	O	express	rcmod	17	SENT_158	[p12l458t1395r876b1496],
29	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_158	[p12l916t1401r1177b1479],
30	(	CD	NUMBER	(	num	31	SENT_158	[p12l1213t1401r1615b1487],
31	P	NN	O	p	dobj	28	SENT_158	[p12l1213t1401r1615b1487],
32	=	JJ	O	=	advmod	28	SENT_158	[p12l1213t1401r1615b1487],
33	0.10	CD	NUMBER	0.10	num	34	SENT_158	[p12l1213t1401r1615b1487],
34	)	NN	O	)	dep	32	SENT_158	[p12l1213t1401r1615b1487],
35	.	.	O	.	_	0	SENT_158	[p12l1213t1401r1615b1487],

1	In	IN	O	in	_	0	SENT_159	[p12l1661t1403r1749b1473],
2	multiple	JJ	O	multiple	amod	6	SENT_159	[p12l1791t1396r2147b1496],
3	logistic	JJ	O	logistic	amod	6	SENT_159	[p12l11t1524r805b1624],
4	—	NN	O	—	nn	6	SENT_159	[p12l11t1524r805b1624],
5	regression	NN	O	regression	nn	6	SENT_159	[p12l11t1524r805b1624],
6	analyses	NNS	O	analysis	prep_in	36	SENT_159	[p12l833t1524r1209b1624],
7	,	,	O	,	_	0	SENT_159	[p12l833t1524r1209b1624],
8	never	RB	O	never	neg	10	SENT_159	[p12l1244t1549r1472b1603],
9	having	VBG	O	have	aux	10	SENT_159	[p12l1498t1524r1785b1624],
10	smoked	VBN	O	smoke	dep	6	SENT_159	[p12l1812t1523r2147b1603],
11	(	CD	NUMBER	(	num	12	SENT_159	[p12l16t1657r465b1747],
12	P	NN	O	p	npadvmod	13	SENT_159	[p12l16t1657r465b1747],
13	<	JJR	O	<	acomp	10	SENT_159	[p12l16t1657r465b1747],
14	0.001	CD	NUMBER	0.001	num	15	SENT_159	[p12l16t1657r465b1747],
15	)	NN	O	)	dep	13	SENT_159	[p12l16t1657r465b1747],
16	,	,	O	,	_	0	SENT_159	[p12l16t1657r465b1747],
17	the	DT	O	the	det	18	SENT_159	[p12l511t1651r643b1730],
18	presence	NN	O	presence	appos	15	SENT_159	[p12l682t1677r1065b1752],
19	of	IN	O	of	_	0	SENT_159	[p12l1106t1651r1208b1730],
20	adenocarcinoma	NN	O	adenocarcinoma	nn	22	SENT_159	[p12l1229t1652r1953b1730],
21	(	CD	NUMBER	(	num	22	SENT_159	[p12l1996t1658r2147b1743],
22	P	NN	O	p	prep_of	18	SENT_159	[p12l1996t1658r2147b1743],
23	:	:	O	:	_	0	SENT_159	[p12l1996t1658r2147b1743],
24	0.01	CD	NUMBER	0.01	num	25	SENT_159	[p12l12t1785r260b1875],
25	)	NN	O	)	dep	18	SENT_159	[p12l12t1785r260b1875],
26	,	,	O	,	_	0	SENT_159	[p12l12t1785r260b1875],
27	and	CC	O	and	_	0	SENT_159	[p12l291t1779r447b1858],
28	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_159	[p12l470t1785r731b1863],
29	expression	NN	O	expression	dep	18	SENT_159	[p12l745t1780r1200b1880],
30	(	CD	NUMBER	(	num	31	SENT_159	[p12l1230t1785r1602b1871],
31	P	NN	O	p	dep	29	SENT_159	[p12l1230t1785r1602b1871],
32	=	JJ	O	=	amod	34	SENT_159	[p12l1230t1785r1602b1871],
33	0.03	CD	NUMBER	0.03	num	34	SENT_159	[p12l1230t1785r1602b1871],
34	)	NN	O	)	nsubjpass	36	SENT_159	[p12l1230t1785r1602b1871],
35	were	VBD	O	be	auxpass	36	SENT_159	[p12l1628t1806r1830b1859],
36	associated	VBN	O	associate	_	0	SENT_159	[p12l1854t1780r2145b1858, p12l11t1908r187b1986],
37	With	IN	O	with	_	0	SENT_159	[p12l208t1908r398b1987],
38	responsiveness	NN	O	responsiveness	prep_with	36	SENT_159	[p12l423t1908r1064b2008],
39	to	TO	O	to	_	0	SENT_159	[p12l1092t1924r1172b1986],
40	erlotinib	NN	O	erlotinib	prep_to	36	SENT_159	[p12l1199t1908r1584b1986],
41	.	.	O	.	_	0	SENT_159	[p12l1199t1908r1584b1986],

1	At	IN	O	at	_	0	SENT_160	[p12l138t2043r238b2114],
2	the	DT	O	the	det	3	SENT_160	[p12l257t2036r386b2114],
3	time	NN	O	time	prep_at	10	SENT_160	[p12l410t2036r598b2114],
4	of	IN	O	of	_	0	SENT_160	[p12l623t2035r724b2114],
5	analysis	NN	O	analysis	prep_of	3	SENT_160	[p12l729t2036r1086b2136],
6	,	,	O	,	_	0	SENT_160	[p12l729t2036r1086b2136],
7	587	CD	NUMBER	587	num	8	SENT_160	[p12l1118t2041r1270b2114],
8	deaths	NNS	O	death	nsubj	10	SENT_160	[p12l1296t2036r1569b2114],
9	had	VBD	O	have	aux	10	SENT_160	[p12l1595t2036r1751b2114],
10	occurred	VBN	O	occur	_	0	SENT_160	[p12l1776t2035r2147b2115],
11	(	NN	O	(	dobj	10	SENT_160	[p12l16t2169r201b2255],
12	378	CD	NUMBER	378	num	11	SENT_160	[p12l16t2169r201b2255],
13	in	IN	O	in	_	0	SENT_160	[p12l229t2164r312b2241],
14	the	DT	O	the	det	16	SENT_160	[p12l338t2164r470b2242],
15	erlotinib	JJ	O	erlotinib	amod	16	SENT_160	[p12l497t2163r866b2242],
16	group	NN	O	group	prep_in	11	SENT_160	[p12l893t2189r1150b2264],
17	and	CC	O	and	_	0	SENT_160	[p12l1176t2163r1335b2242],
18	209	CD	NUMBER	209	dobj	10	SENT_160	[p12l1361t2169r1517b2242],
19	in	IN	O	in	_	0	SENT_160	[p12l1543t2164r1626b2241],
20	the	DT	O	the	det	22	SENT_160	[p12l1652t2164r1785b2242],
21	placebo	NN	O	placebo	nn	22	SENT_160	[p12l1809t2164r2144b2264],
22	group	NN	O	group	prep_in	18	SENT_160	[p12l11t2298r330b2392],
23	)	CD	NUMBER	)	dep	18	SENT_160	[p12l11t2298r330b2392],
24	.	.	O	.	_	0	SENT_160	[p12l11t2298r330b2392],

1	Figure	NNP	O	Figure	nsubj	3	SENT_161	[p12l369t2292r645b2392],
2	1	CD	NUMBER	1	num	1	SENT_161	[p12l684t2297r728b2369],
3	shows	VBZ	O	show	_	0	SENT_161	[p12l765t2291r1034b2371],
4	Kaplan	NNP	PERSON	Kaplan	dobj	3	SENT_161	[p12l1071t2292r1685b2392],
5	.	.	O	.	_	0	SENT_161	[p12l1071t2292r1685b2392],

1	—	NN	O	—	_	0	SENT_162	[p12l1071t2292r1685b2392],
2	.	.	O	.	_	0	SENT_162	[p12l1071t2292r1685b2392],

1	Meier	NNP	PERSON	Meier	_	0	SENT_163	[p12l1071t2292r1685b2392],
2	curves	NNS	O	curve	dep	1	SENT_163	[p12l1717t2318r1986b2371],
3	for	IN	O	for	_	0	SENT_163	[p12l2023t2291r2149b2370],
4	overall	JJ	O	overall	amod	5	SENT_163	[p12l12t2419r299b2499],
5	survival	NN	O	survival	prep_for	2	SENT_163	[p12l322t2420r649b2499],
6	and	CC	O	and	_	0	SENT_163	[p12l671t2420r829b2498],
7	progression	NN	O	progression	conj_and	5	SENT_163	[p12l851t2419r1576b2520],
8	—	CD	NUMBER	—	num	10	SENT_163	[p12l851t2419r1576b2520],
9	free	JJ	O	free	amod	10	SENT_163	[p12l851t2419r1576b2520],
10	survival	NN	O	survival	dep	2	SENT_163	[p12l1600t2420r1952b2499],
11	.	.	O	.	_	0	SENT_163	[p12l1600t2420r1952b2499],

1	Median	JJ	O	median	amod	3	SENT_164	[p12l1978t2427r2144b2498, p12l12t2547r199b2626],
2	overall	JJ	O	overall	amod	3	SENT_164	[p12l224t2548r510b2627],
3	survival	NN	O	survival	nsubj	10	SENT_164	[p12l535t2547r863b2627],
4	in	IN	O	in	_	0	SENT_164	[p12l886t2548r968b2625],
5	the	DT	O	the	det	7	SENT_164	[p12l993t2548r1125b2626],
6	erlotinib	JJ	O	erlotinib	amod	7	SENT_164	[p12l1150t2548r1519b2626],
7	group	NN	O	group	prep_in	3	SENT_164	[p12l1545t2573r1801b2648],
8	was	VBD	O	be	cop	10	SENT_164	[p12l1822t2574r1986b2627],
9	6.7	CD	DURATION	6.7	num	10	SENT_164	[p12l2013t2553r2145b2626],
10	months	NNS	NUMBER	month	_	0	SENT_164	[p12l12t2676r373b2771],
11	,	,	O	,	_	0	SENT_164	[p12l12t2676r373b2771],
12	and	CC	O	and	_	0	SENT_164	[p12l433t2676r593b2754],
13	in	IN	O	in	_	0	SENT_164	[p12l647t2676r731b2753],
14	the	DT	O	the	det	16	SENT_164	[p12l786t2676r919b2754],
15	placebo	NN	O	placebo	nn	16	SENT_164	[p12l973t2675r1311b2776],
16	group	NN	O	group	prep_in	20	SENT_164	[p12l1367t2701r1626b2776],
17	it	PRP	O	it	nsubj	20	SENT_164	[p12l1681t2676r1743b2754],
18	was	VBD	O	be	cop	20	SENT_164	[p12l1789t2702r1954b2755],
19	4.7	CD	DURATION	4.7	num	20	SENT_164	[p12l2010t2682r2144b2754],
20	months	NNS	NUMBER	month	conj_and	10	SENT_164	[p12l12t2804r343b2882],
21	(	RB	O	(	advmod	20	SENT_164	[p12l389t2804r783b2904],
22	adjusted	VBN	O	adjust	amod	24	SENT_164	[p12l389t2804r783b2904],
23	hazard	NN	O	hazard	nn	24	SENT_164	[p12l822t2803r1116b2882],
24	ratio	NN	O	ratio	attr	20	SENT_164	[p12l1156t2804r1379b2899],
25	,	,	O	,	_	0	SENT_164	[p12l1156t2804r1379b2899],
26	0.70	CD	NUMBER	0.70	appos	24	SENT_164	[p12l1424t2809r1637b2899],
27	;	:	O	;	_	0	SENT_164	[p12l1424t2809r1637b2899],
28	95	CD	PERCENT	95	num	31	SENT_164	[p12l1681t2809r1781b2882],
29	percent	NN	PERCENT	percent	nn	31	SENT_164	[p12l1822t2820r2151b2904],
30	conﬁdence	NN	O	conﬁdence	nn	31	SENT_164	[p12l12t2931r486b3010],
31	interval	NN	O	interval	dep	24	SENT_164	[p12l511t2932r858b3027],
32	,	,	O	,	_	0	SENT_164	[p12l511t2932r858b3027],
33	0.58	CD	NUMBER	0.58	number	35	SENT_164	[p12l890t2937r1074b3010],
34	to	TO	O	to	dep	35	SENT_164	[p12l1102t2948r1183b3010],
35	0.85	CD	NUMBER	0.85	appos	31	SENT_164	[p12l1209t2937r1423b3027],
36	;	:	O	;	_	0	SENT_164	[p12l1209t2937r1423b3027],
37	P	NN	O	p	dep	38	SENT_164	[p12l1451t2937r1870b3023],
38	<	JJR	O	<	dep	24	SENT_164	[p12l1451t2937r1870b3023],
39	0.001	CD	NUMBER	0.001	num	40	SENT_164	[p12l1451t2937r1870b3023],
40	)	NN	O	)	dep	24	SENT_164	[p12l1451t2937r1870b3023],
41	.	.	O	.	_	0	SENT_164	[p12l1451t2937r1870b3023],

1	In	IN	O	in	_	0	SENT_165	[p12l1900t2939r1988b3009],
2	the	DT	O	the	det	5	SENT_165	[p12l2014t2932r2145b3010],
3	Cox	NN	O	cox	nn	5	SENT_165	[p12l12t3066r180b3139],
4	regression	NN	O	regression	nn	5	SENT_165	[p12l204t3061r659b3161],
5	analysis	NN	O	analysis	prep_in	8	SENT_165	[p12l686t3061r1052b3161],
6	,	,	O	,	_	0	SENT_165	[p12l686t3061r1052b3161],
7	erlotinib	NN	O	erlotinib	nsubj	8	SENT_165	[p12l1087t3060r1456b3139],
8	remained	VBD	O	remain	_	0	SENT_165	[p12l1485t3060r1895b3139],
9	associated	VBN	O	associate	dep	8	SENT_165	[p12l1922t3086r2144b3139, p12l12t3189r258b3267],
10	with	IN	O	with	_	0	SENT_165	[p12l284t3189r472b3268],
11	longer	JJR	O	longer	amod	12	SENT_165	[p12l502t3188r775b3289],
12	survival	NN	O	survival	prep_with	9	SENT_165	[p12l805t3189r1118b3268],
13	(	CD	NUMBER	(	num	14	SENT_165	[p12l1153t3194r1599b3284],
14	P	NN	O	p	npadvmod	15	SENT_165	[p12l1153t3194r1599b3284],
15	=	JJ	O	=	amod	12	SENT_165	[p12l1153t3194r1599b3284],
16	0.002	CD	NUMBER	0.002	num	17	SENT_165	[p12l1153t3194r1599b3284],
17	)	NN	O	)	dobj	9	SENT_165	[p12l1153t3194r1599b3284],
18	,	,	O	,	_	0	SENT_165	[p12l1153t3194r1599b3284],
19	as	IN	O	as	dep	20	SENT_165	[p12l1634t3215r1719b3267],
20	did	VBD	O	do	dep	17	SENT_165	[p12l1752t3188r1884b3267],
21	Asian	JJ	MISC	asian	amod	24	SENT_165	[p12l1911t3189r2148b3267],
22	origin	NN	O	origin	nn	24	SENT_165	[p12l12t3317r273b3417],
23	(	CD	NUMBER	(	num	24	SENT_165	[p12l325t3322r737b3412],
24	P	NN	O	p	nsubj	25	SENT_165	[p12l325t3322r737b3412],
25	=	JJ	O	=	xcomp	20	SENT_165	[p12l325t3322r737b3412],
26	0.01	CD	NUMBER	0.01	num	27	SENT_165	[p12l325t3322r737b3412],
27	)	NN	O	)	nsubj	20	SENT_165	[p12l325t3322r737b3412],
28	,	,	O	,	_	0	SENT_165	[p12l325t3322r737b3412],
29	adenocarcinoma	NN	O	adenocarcinoma	appos	27	SENT_165	[p12l790t3316r1513b3395],
30	on	IN	O	on	_	0	SENT_165	[p12l1560t3342r1668b3395],
31	histologic	JJ	O	histologic	amod	34	SENT_165	[p12l1715t3316r2147b3417],
32	examination	NN	O	examination	nn	34	SENT_165	[p12l12t3445r547b3523],
33	(	CD	NUMBER	(	num	34	SENT_165	[p12l579t3450r1033b3540],
34	P	NN	O	p	prep_on	29	SENT_165	[p12l579t3450r1033b3540],
35	=	JJ	O	=	amod	37	SENT_165	[p12l579t3450r1033b3540],
36	0.004	CD	NUMBER	0.004	tmod	35	SENT_165	[p12l579t3450r1033b3540],
37	)	NN	O	)	dep	29	SENT_165	[p12l579t3450r1033b3540],
38	,	,	O	,	_	0	SENT_165	[p12l579t3450r1033b3540],
39	and	CC	O	and	_	0	SENT_165	[p12l1065t3444r1221b3523],
40	never	RB	O	never	neg	42	SENT_165	[p12l1248t3470r1476b3524],
41	having	VBG	O	have	aux	42	SENT_165	[p12l1500t3444r1787b3545],
42	smoked	VBN	O	smoke	dep	8	SENT_165	[p12l1812t3444r2147b3524],
43	(	CD	NUMBER	(	num	44	SENT_165	[p12l16t3578r420b3664],
44	P	NN	O	p	dobj	42	SENT_165	[p12l16t3578r420b3664],
45	=	JJ	O	=	amod	44	SENT_165	[p12l16t3578r420b3664],
46	0.048	CD	NUMBER	0.048	tmod	45	SENT_165	[p12l16t3578r420b3664],
47	vs.	CC	O	vs.	_	0	SENT_165	[p12l461t3599r573b3652],
48	current	JJ	DATE	current	conj_vs.	44	SENT_165	[p12l623t3589r940b3652],
49	or	CC	O	or	_	0	SENT_165	[p12l979t3598r1070b3651],
50	past	JJ	DATE	past	amod	52	SENT_165	[p12l1110t3589r1293b3673],
51	smoking	NN	O	smoking	nn	52	SENT_165	[p12l1334t3573r1774b3673],
52	)	NN	O	)	conj_vs.	44	SENT_165	[p12l1334t3573r1774b3673],
53	.	.	O	.	_	0	SENT_165	[p12l1334t3573r1774b3673],

1	Table	NNP	O	Table	nsubj	3	SENT_166	[p12l1820t3573r2053b3651],
2	3	CD	NUMBER	3	num	1	SENT_166	[p12l2098t3578r2143b3651],
3	shows	VBZ	O	show	_	0	SENT_166	[p12l13t3701r277b3780],
4	the	DT	O	the	det	7	SENT_166	[p12l299t3701r426b3779],
5	exploratory	JJ	O	exploratory	amod	7	SENT_166	[p12l447t3701r921b3801],
6	subgroup	NN	O	subgroup	nn	7	SENT_166	[p12l938t3700r1336b3801],
7	analyses	NNS	O	analysis	dobj	3	SENT_166	[p12l1357t3701r1725b3801],
8	.	.	O	.	_	0	SENT_166	[p12l1357t3701r1725b3801],

1	Although	IN	O	although	mark	7	SENT_167	[p12l1747t3700r2145b3801],
2	the	DT	O	the	det	4	SENT_167	[p13l12t20r144b99],
3	sample	NN	O	sample	nn	4	SENT_167	[p13l172t21r478b121],
4	sizes	NNS	O	size	nsubj	7	SENT_167	[p13l503t21r704b99],
5	may	MD	O	may	aux	7	SENT_167	[p13l730t47r907b121],
6	be	VB	O	be	cop	7	SENT_167	[p13l928t20r1024b99],
7	inadequate	JJ	O	inadequate	advcl	20	SENT_167	[p13l1047t20r1513b121],
8	to	TO	O	to	aux	9	SENT_167	[p13l1538t37r1617b99],
9	detect	VB	O	detect	xcomp	7	SENT_167	[p13l1643t20r1899b99],
10	small	JJ	O	small	amod	13	SENT_167	[p13l1919t20r2148b99],
11	or	CC	O	or	_	0	SENT_167	[p13l12t174r102b227],
12	moderate	JJ	O	moderate	conj_or	10	SENT_167	[p13l139t149r541b227],
13	differences	NNS	O	difference	dobj	9	SENT_167	[p13l583t148r1073b244],
14	,	,	O	,	_	0	SENT_167	[p13l583t148r1073b244],
15	a	DT	O	a	det	16	SENT_167	[p13l1118t175r1163b227],
16	beneﬁt	NN	O	beneﬁt	nsubj	20	SENT_167	[p13l1202t148r1501b227],
17	from	IN	O	from	_	0	SENT_167	[p13l1536t148r1744b227],
18	erlotinib	NN	O	erlotinib	prep_from	16	SENT_167	[p13l1786t149r2145b227],
19	was	VBD	O	be	cop	20	SENT_167	[p13l7t304r169b357],
20	apparent	JJ	O	apparent	_	0	SENT_167	[p13l199t294r579b378],
21	in	IN	O	in	_	0	SENT_167	[p13l602t278r683b355],
22	most	JJS	O	most	prep_in	20	SENT_167	[p13l711t294r929b356],
23	of	IN	O	of	_	0	SENT_167	[p13l952t277r1053b356],
24	the	DT	O	the	det	25	SENT_167	[p13l1063t278r1192b356],
25	subgroups	NNS	O	subgroup	prep_of	22	SENT_167	[p13l1222t278r1696b378],
26	.	.	O	.	_	0	SENT_167	[p13l1222t278r1696b378],

1	The	DT	O	the	det	2	SENT_168	[p13l1726t278r1888b356],
2	interaction	NN	O	interaction	nsubj	13	SENT_168	[p13l1916t278r2145b356, p13l11t406r272b484],
3	between	IN	O	between	_	0	SENT_168	[p13l305t406r657b485],
4	treatment	NN	O	treatment	prep_between	2	SENT_168	[p13l690t422r1107b484],
5	and	CC	O	and	_	0	SENT_168	[p13l1134t406r1291b484],
6	the	DT	O	the	det	7	SENT_168	[p13l1324t405r1454b484],
7	covariate	JJ	O	covariate	nsubj	13	SENT_168	[p13l1488t406r1863b485],
8	deﬁning	VBG	O	deﬁning	partmod	7	SENT_168	[p13l1897t405r2145b484, p13l11t534r150b634],
9	the	DT	O	the	det	10	SENT_168	[p13l181t534r311b612],
10	subgroup	NN	O	subgroup	dobj	8	SENT_168	[p13l345t534r750b634],
11	was	VBD	O	be	cop	13	SENT_168	[p13l781t560r942b613],
12	statistically	RB	O	statistically	advmod	13	SENT_168	[p13l979t534r1457b634],
13	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_168	[p13l1487t533r1940b634],
14	only	RB	O	only	advmod	13	SENT_168	[p13l1969t533r2152b634],
15	for	IN	O	for	_	0	SENT_168	[p13l12t661r135b740],
16	smoking	NN	O	smoking	nn	17	SENT_168	[p13l158t662r535b762],
17	status	NN	O	status	prep_for	13	SENT_168	[p13l557t678r829b741],
18	.	.	O	.	_	0	SENT_168	[p13l557t678r829b741],

1	At	IN	O	at	_	0	SENT_169	[p13l855t669r955b740],
2	the	DT	O	the	det	3	SENT_169	[p13l974t662r1104b740],
3	time	NN	O	time	prep_at	10	SENT_169	[p13l1129t662r1317b740],
4	of	IN	O	of	_	0	SENT_169	[p13l1341t661r1443b740],
5	analysis	NN	O	analysis	prep_of	3	SENT_169	[p13l1447t661r1805b762],
6	,	,	O	,	_	0	SENT_169	[p13l1447t661r1805b762],
7	682	CD	NUMBER	682	num	8	SENT_169	[p13l1835t667r1989b740],
8	patients	NNS	O	patient	nsubj	10	SENT_169	[p13l2013t688r2145b762, p13l12t790r243b868],
9	had	VBD	O	have	aux	10	SENT_169	[p13l282t790r438b868],
10	had	VBN	O	have	_	0	SENT_169	[p13l474t790r630b868],
11	progression	NN	O	progression	dobj	10	SENT_169	[p13l664t790r1176b890],
12	of	IN	O	of	_	0	SENT_169	[p13l1213t789r1313b868],
13	disease	NN	O	disease	nn	14	SENT_169	[p13l1332t789r1637b868],
14	(	NN	O	(	prep_of	11	SENT_169	[p13l1678t795r1862b881],
15	450	CD	NUMBER	450	num	14	SENT_169	[p13l1678t795r1862b881],
16	in	IN	O	in	_	0	SENT_169	[p13l1899t790r1980b867],
17	the	DT	O	the	det	19	SENT_169	[p13l2017t790r2147b868],
18	erlotinib	JJ	O	erlotinib	amod	19	SENT_169	[p13l12t918r373b996],
19	group	NN	O	group	prep_in	11	SENT_169	[p13l397t943r649b1018],
20	and	CC	O	and	_	0	SENT_169	[p13l674t918r830b996],
21	232	CD	NUMBER	232	conj_and	11	SENT_169	[p13l854t923r1007b996],
22	in	IN	O	in	_	0	SENT_169	[p13l1031t918r1113b995],
23	the	DT	O	the	det	25	SENT_169	[p13l1137t918r1267b996],
24	placebo	NN	O	placebo	nn	25	SENT_169	[p13l1289t918r1618b1018],
25	group	NN	O	group	prep_in	21	SENT_169	[p13l1642t925r1954b1018],
26	)	CD	NUMBER	)	dep	21	SENT_169	[p13l1642t925r1954b1018],
27	.	.	O	.	_	0	SENT_169	[p13l1642t925r1954b1018],

1	Median	JJ	O	median	amod	2	SENT_170	[p13l1980t925r2145b996, p13l12t1045r195b1124],
2	progression	NN	O	progression	_	0	SENT_170	[p13l231t1045r940b1146],
3	—	CD	NUMBER	—	num	5	SENT_170	[p13l231t1045r940b1146],
4	free	JJ	O	free	amod	5	SENT_170	[p13l231t1045r940b1146],
5	survival	NN	O	survival	nsubj	8	SENT_170	[p13l979t1046r1299b1125],
6	was	VBD	O	be	cop	8	SENT_170	[p13l1331t1072r1493b1125],
7	2.2	CD	DURATION	2.2	num	8	SENT_170	[p13l1532t1051r1662b1124],
8	months	NNS	NUMBER	month	rcmod	2	SENT_170	[p13l1700t1046r2026b1124],
9	in	IN	O	in	_	0	SENT_170	[p13l2066t1046r2147b1123],
10	the	DT	O	the	det	12	SENT_170	[p13l12t1174r142b1252],
11	erlotinib	JJ	O	erlotinib	amod	12	SENT_170	[p13l173t1174r532b1252],
12	group	NN	O	group	prep_in	8	SENT_170	[p13l563t1199r815b1274],
13	and	CC	O	and	_	0	SENT_170	[p13l846t1174r1002b1252],
14	1.8	CD	DURATION	1.8	num	15	SENT_170	[p13l1034t1179r1160b1252],
15	months	NNS	NUMBER	month	conj_and	12	SENT_170	[p13l1191t1174r1517b1252],
16	in	IN	O	in	_	0	SENT_170	[p13l1547t1174r1629b1251],
17	the	DT	O	the	det	19	SENT_170	[p13l1659t1174r1789b1252],
18	placebo	NN	O	placebo	nn	19	SENT_170	[p13l1817t1174r2145b1274],
19	group	NN	O	group	prep_in	15	SENT_170	[p13l11t1327r264b1402],
20	(	RB	O	(	advmod	21	SENT_170	[p13l293t1301r677b1402],
21	adjusted	VBN	O	adjust	amod	15	SENT_170	[p13l293t1301r677b1402],
22	hazard	NN	O	hazard	nn	23	SENT_170	[p13l701t1301r989b1380],
23	ratio	NN	O	ratio	dep	2	SENT_170	[p13l1012t1302r1230b1397],
24	,	,	O	,	_	0	SENT_170	[p13l1012t1302r1230b1397],
25	0.61	CD	NUMBER	0.61	appos	23	SENT_170	[p13l1259t1307r1468b1397],
26	;	:	O	;	_	0	SENT_170	[p13l1259t1307r1468b1397],
27	95	CD	PERCENT	95	num	30	SENT_170	[p13l1496t1307r1593b1380],
28	percent	NN	PERCENT	percent	nn	30	SENT_170	[p13l1619t1318r1941b1402],
29	conﬁdence	NN	O	conﬁdence	nn	30	SENT_170	[p13l1960t1327r2145b1380, p13l12t1429r318b1508],
30	interval	NN	O	interval	dep	2	SENT_170	[p13l345t1430r683b1525],
31	,	,	O	,	_	0	SENT_170	[p13l345t1430r683b1525],
32	0.51	CD	NUMBER	0.51	num	34	SENT_170	[p13l716t1435r899b1508],
33	to	TO	O	to	dep	34	SENT_170	[p13l926t1446r1006b1508],
34	0.74	CD	NUMBER	0.74	appos	30	SENT_170	[p13l1034t1435r1243b1525],
35	;	:	O	;	_	0	SENT_170	[p13l1034t1435r1243b1525],
36	P	NN	O	p	dep	37	SENT_170	[p13l1272t1435r1683b1521],
37	<	JJR	O	<	dep	2	SENT_170	[p13l1272t1435r1683b1521],
38	0.001	CD	NUMBER	0.001	num	39	SENT_170	[p13l1272t1435r1683b1521],
39	)	NN	O	)	dep	37	SENT_170	[p13l1272t1435r1683b1521],
40	.	.	O	.	_	0	SENT_170	[p13l1272t1435r1683b1521],

1	In	IN	O	in	_	0	SENT_171	[p13l1713t1437r1801b1507],
2	the	DT	O	the	det	4	SENT_171	[p13l1828t1430r1957b1508],
3	Cox	NN	ORGANIZATION	cox	nn	4	SENT_171	[p13l1984t1435r2150b1508],
4	model	NN	O	model	prep_in	32	SENT_171	[p13l12t1559r303b1654],
5	,	,	O	,	_	0	SENT_171	[p13l12t1559r303b1654],
6	treatment	NN	O	treatment	appos	4	SENT_171	[p13l330t1575r746b1637],
7	with	IN	O	with	_	0	SENT_171	[p13l758t1559r948b1639],
8	erlotinib	NN	O	erlotinib	prep_with	6	SENT_171	[p13l969t1559r1330b1637],
9	(	CD	NUMBER	(	num	10	SENT_171	[p13l1357t1564r1767b1650],
10	P	NN	O	p	npadvmod	11	SENT_171	[p13l1357t1564r1767b1650],
11	<	JJR	O	<	amod	8	SENT_171	[p13l1357t1564r1767b1650],
12	0.001	CD	NUMBER	0.001	num	13	SENT_171	[p13l1357t1564r1767b1650],
13	)	NN	O	)	dep	6	SENT_171	[p13l1357t1564r1767b1650],
14	and	CC	O	and	_	0	SENT_171	[p13l1793t1559r1950b1637],
15	never	RB	O	never	neg	17	SENT_171	[p13l1970t1584r2145b1638, p13l12t1714r94b1766],
16	having	VBG	O	have	aux	17	SENT_171	[p13l113t1688r400b1788],
17	smoked	VBN	O	smoke	dep	6	SENT_171	[p13l421t1688r756b1767],
18	(	CD	NUMBER	(	num	19	SENT_171	[p13l784t1693r1111b1779],
19	P	NN	O	p	npadvmod	20	SENT_171	[p13l784t1693r1111b1779],
20	<	JJR	O	<	acomp	17	SENT_171	[p13l784t1693r1111b1779],
21	0.01	CD	NUMBER	0.01	nsubjpass	32	SENT_171	[p13l784t1693r1111b1779],
22	for	IN	O	for	_	0	SENT_171	[p13l1134t1687r1257b1766],
23	the	DT	O	the	det	24	SENT_171	[p13l1278t1688r1408b1766],
24	comparison	NN	O	comparison	prep_for	21	SENT_171	[p13l1431t1688r1938b1788],
25	with	IN	O	with	_	0	SENT_171	[p13l1957t1687r2147b1767],
26	current	JJ	DATE	current	prep_with	24	SENT_171	[p13l12t1832r317b1895],
27	or	CC	O	or	_	0	SENT_171	[p13l334t1841r422b1894],
28	past	JJ	DATE	past	amod	30	SENT_171	[p13l439t1832r616b1916],
29	smoking	NN	O	smoking	nn	30	SENT_171	[p13l633t1816r1030b1916],
30	)	NN	O	)	conj_or	26	SENT_171	[p13l633t1816r1030b1916],
31	were	VBD	O	be	auxpass	32	SENT_171	[p13l1051t1842r1251b1895],
32	associated	VBN	O	associate	_	0	SENT_171	[p13l1271t1815r1703b1894],
33	with	IN	O	with	_	0	SENT_171	[p13l1718t1816r1906b1895],
34	longer	JJR	O	longer	amod	35	SENT_171	[p13l1926t1816r2147b1916, p13l12t1970r93b2022],
35	progression	NN	O	progression	prep_with	32	SENT_171	[p13l112t1943r820b2044],
36	—	CD	NUMBER	—	num	38	SENT_171	[p13l112t1943r820b2044],
37	free	JJ	O	free	amod	38	SENT_171	[p13l112t1943r820b2044],
38	survival	NN	O	survival	dep	35	SENT_171	[p13l847t1944r1190b2023],
39	.	.	O	.	_	0	SENT_171	[p13l847t1944r1190b2023],

1	TOXIC	JJ	O	toxic	amod	2	SENT_172	[p13l9t2229r261b2278],
2	EFFECTS	NNS	O	effect	nsubj	10	SENT_172	[p13l304t2229r642b2278],
3	Four	CD	NUMBER	four	num	4	SENT_172	[p13l10t2337r211b2409],
4	patients	NNS	O	patient	dep	2	SENT_172	[p13l246t2330r583b2430],
5	who	WP	O	who	nsubj	6	SENT_172	[p13l620t2330r805b2409],
6	underwent	VBD	O	undergo	rcmod	2	SENT_172	[p13l846t2330r1307b2409],
7	randomization	NN	O	randomization	dobj	6	SENT_172	[p13l1341t2329r1973b2408],
8	did	VBD	O	do	aux	10	SENT_172	[p13l2013t2329r2147b2408],
9	not	RB	O	not	neg	10	SENT_172	[p13l12t2474r155b2536],
10	receive	VB	O	receive	_	0	SENT_172	[p13l170t2458r454b2537],
11	treatment	NN	O	treatment	dobj	10	SENT_172	[p13l475t2474r906b2536],
12	.	.	O	.	_	0	SENT_172	[p13l475t2474r906b2536],

1	Table	NNP	O	Table	nn	3	SENT_173	[p13l929t2458r1155b2536],
2	4	CD	NUMBER	4	num	3	SENT_173	[p13l1174t2463r1225b2536],
3	shows	NNS	O	show	_	0	SENT_173	[p13l1246t2458r1509b2537],
4	that	WDT	O	that	dobj	18	SENT_173	[p13l1532t2458r1698b2536],
5	19	CD	PERCENT	19	num	6	SENT_173	[p13l1717t2463r1813b2536],
6	percent	NN	PERCENT	percent	nsubj	18	SENT_173	[p13l1834t2474r2153b2558],
7	of	IN	O	of	_	0	SENT_173	[p13l12t2585r114b2664],
8	the	DT	O	the	det	10	SENT_173	[p13l120t2586r250b2664],
9	erlotinib	JJ	O	erlotinib	amod	10	SENT_173	[p13l275t2586r635b2664],
10	group	NN	O	group	prep_of	6	SENT_173	[p13l661t2611r913b2686],
11	required	VBN	O	require	partmod	10	SENT_173	[p13l939t2585r1296b2686],
12	dose	NN	O	dose	nn	13	SENT_173	[p13l1322t2586r1515b2664],
13	reductions	NNS	O	reduction	dobj	11	SENT_173	[p13l1541t2585r1989b2665],
14	because	IN	O	because	_	0	SENT_173	[p13l2017t2586r2145b2664, p13l12t2740r248b2793],
15	of	IN	O	of	prepc_because_of	11	SENT_173	[p13l289t2713r391b2792],
16	drug	NN	O	drug	nn	17	SENT_173	[p13l413t2714r950b2814],
17	—	NN	O	—	pobj	11	SENT_173	[p13l413t2714r950b2814],
18	related	JJ	O	related	rcmod	3	SENT_173	[p13l413t2714r950b2814],
19	toxic	JJ	O	toxic	amod	20	SENT_173	[p13l990t2714r1196b2792],
20	effects	NNS	O	effect	dobj	18	SENT_173	[p13l1236t2713r1540b2809],
21	,	,	O	,	_	0	SENT_173	[p13l1236t2713r1540b2809],
22	as	IN	O	as	amod	20	SENT_173	[p13l1585t2740r1671b2792],
23	compared	VBN	O	compare	prep	22	SENT_173	[p13l1713t2714r2146b2814],
24	with	IN	O	with	pcomp	23	SENT_173	[p13l7t2842r195b2921],
25	2	CD	PERCENT	2	num	26	SENT_173	[p13l218t2847r265b2919],
26	percent	NN	PERCENT	percent	pobj	24	SENT_173	[p13l288t2858r605b2942],
27	of	IN	O	of	_	0	SENT_173	[p13l624t2841r724b2920],
28	the	DT	O	the	det	30	SENT_173	[p13l729t2842r858b2920],
29	placebo	NN	O	placebo	nn	30	SENT_173	[p13l879t2841r1203b2942],
30	group	NN	O	group	prep_of	26	SENT_173	[p13l1227t2867r1500b2942],
31	,	,	O	,	_	0	SENT_173	[p13l1227t2867r1500b2942],
32	most	JJS	O	most	appos	30	SENT_173	[p13l1529t2858r1744b2920],
33	frequently	RB	O	frequently	advmod	18	SENT_173	[p13l1762t2841r2147b2942, p13l11t2970r81b3070],
34	because	IN	O	because	mwe	18	SENT_173	[p13l101t2970r434b3049],
35	of	IN	O	of	_	0	SENT_173	[p13l461t2969r561b3048],
36	rash	NN	O	rash	nn	37	SENT_173	[p13l568t2970r749b3048],
37	(	NN	O	(	prep_of	18	SENT_173	[p13l779t2975r910b3061],
38	12	CD	PERCENT	12	num	40	SENT_173	[p13l779t2975r910b3061],
39	percent	NN	PERCENT	percent	nn	40	SENT_173	[p13l934t2976r1280b3070],
40	)	NN	O	)	dep	37	SENT_173	[p13l934t2976r1280b3070],
41	and	CC	O	and	_	0	SENT_173	[p13l1310t2970r1467b3048],
42	diarrhea	NN	O	diarrhea	prep_of	18	SENT_173	[p13l1493t2970r1846b3048],
43	(	CD	PERCENT	(	number	44	SENT_173	[p13l1874t2977r1948b3061],
44	5	CD	PERCENT	5	num	46	SENT_173	[p13l1874t2977r1948b3061],
45	percent	NN	PERCENT	percent	nn	46	SENT_173	[p13l1975t2996r2145b3070, p13l12t3105r244b3193],
46	)	NN	O	)	dep	42	SENT_173	[p13l1975t2996r2145b3070, p13l12t3105r244b3193],
47	;	:	O	;	_	0	SENT_173	[p13l1975t2996r2145b3070, p13l12t3105r244b3193],
48	26	CD	NUMBER	26	num	49	SENT_173	[p13l270t3103r370b3176],
49	patients	NNS	O	patient	dep	3	SENT_173	[p13l391t3098r724b3198],
50	(	IN	O	(	_	0	SENT_173	[p13l752t3104r827b3189],
51	5	CD	PERCENT	5	num	52	SENT_173	[p13l752t3104r827b3189],
52	percent	NN	PERCENT	percent	prep_(	49	SENT_173	[p13l850t3105r1192b3198],
53	)	CD	NUMBER	)	num	55	SENT_173	[p13l850t3105r1192b3198],
54	discontinued	VBN	O	discontinue	amod	55	SENT_173	[p13l1220t3097r1768b3177],
55	erlotinib	NN	O	erlotinib	dep	3	SENT_173	[p13l1790t3098r2146b3176],
56	because	IN	O	because	_	0	SENT_173	[p13l12t3226r346b3305],
57	of	IN	O	of	_	0	SENT_173	[p13l376t3225r478b3304],
58	drug	NN	O	drug	nn	62	SENT_173	[p13l489t3225r1013b3326],
59	—	NN	O	—	nn	62	SENT_173	[p13l489t3225r1013b3326],
60	related	JJ	O	related	amod	62	SENT_173	[p13l489t3225r1013b3326],
61	toxic	JJ	O	toxic	amod	62	SENT_173	[p13l1043t3226r1244b3304],
62	effects	NNS	O	effect	prep_because_of	55	SENT_173	[p13l1274t3225r1571b3321],
63	,	,	O	,	_	0	SENT_173	[p13l1274t3225r1571b3321],
64	as	IN	O	as	mark	62	SENT_173	[p13l1606t3252r1690b3304],
65	compared	VBN	O	compare	_	0	SENT_173	[p13l1722t3225r2147b3326],
66	with	IN	O	with	_	0	SENT_173	[p13l7t3354r198b3433],
67	4	CD	NUMBER	4	num	68	SENT_173	[p13l217t3359r267b3432],
68	patients	NNS	O	patient	prep_compared_with	62	SENT_173	[p13l287t3354r623b3454],
69	(	IN	O	(	_	0	SENT_173	[p13l651t3359r728b3445],
70	2	CD	PERCENT	2	num	71	SENT_173	[p13l651t3359r728b3445],
71	percent	NN	PERCENT	percent	prep_(	68	SENT_173	[p13l750t3361r1095b3454],
72	)	CD	NUMBER	)	dobj	62	SENT_173	[p13l750t3361r1095b3454],
73	receiving	VBG	O	receive	partmod	72	SENT_173	[p13l1122t3354r1507b3454],
74	placebo	NN	O	placebo	dobj	73	SENT_173	[p13l1524t3354r1877b3454],
75	.	.	O	.	_	0	SENT_173	[p13l1524t3354r1877b3454],

1	There	EX	O	there	expl	2	SENT_174	[p13l1900t3354r2146b3432],
2	was	VBD	O	be	_	0	SENT_174	[p13l7t3508r169b3561],
3	a	DT	O	a	det	5	SENT_174	[p13l202t3508r247b3560],
4	higher	JJR	O	higher	amod	5	SENT_174	[p13l276t3481r556b3582],
5	incidence	NN	O	incidence	nsubj	2	SENT_174	[p13l584t3481r989b3560],
6	of	IN	O	of	_	0	SENT_174	[p13l1021t3481r1122b3560],
7	infection	NN	O	infection	prep_of	5	SENT_174	[p13l1134t3481r1512b3560],
8	among	IN	O	among	_	0	SENT_174	[p13l1542t3507r1843b3582],
9	the	DT	O	the	det	11	SENT_174	[p13l1872t3482r2001b3560],
10	erlotinib	NN	O	erlotinib	nn	11	SENT_174	[p13l2034t3508r2145b3560, p13l11t3610r292b3688],
11	patients	NNS	O	patient	prep_among	7	SENT_174	[p13l322t3610r692b3710],
12	,	,	O	,	_	0	SENT_174	[p13l322t3610r692b3710],
13	which	WDT	O	which	nsubj	15	SENT_174	[p13l724t3610r990b3689],
14	may	MD	O	may	aux	15	SENT_174	[p13l1021t3636r1201b3710],
15	reﬂect	VB	O	reﬂect	rcmod	11	SENT_174	[p13l1227t3609r1502b3688],
16	longer	RBR	O	longer	advmod	15	SENT_174	[p13l1526t3610r1810b3710],
17	follow	VB	O	follow	ccomp	15	SENT_174	[p13l1838t3609r2144b3689],
18	—	CD	NUMBER	—	dobj	17	SENT_174	[p13l1838t3609r2144b3689],

1	up	RB	O	up	quantmod	2	SENT_175	[p14l12t47r118b121],
2	(	CD	NUMBER	(	num	3	SENT_175	[p14l164t26r613b112],
3	P	NN	O	p	_	0	SENT_175	[p14l164t26r613b112],
4	<	JJR	O	<	dep	3	SENT_175	[p14l164t26r613b112],
5	0.001	CD	NUMBER	0.001	num	6	SENT_175	[p14l164t26r613b112],
6	)	NN	O	)	dep	4	SENT_175	[p14l164t26r613b112],
7	.	.	O	.	_	0	SENT_175	[p14l164t26r613b112],

1	There	EX	O	there	expl	2	SENT_176	[p14l654t21r904b99],
2	were	VBD	O	be	_	0	SENT_176	[p14l940t47r1146b100],
3	similar	JJ	O	similar	amod	4	SENT_176	[p14l1188t21r1491b99],
4	rates	NNS	O	rate	nsubj	2	SENT_176	[p14l1528t37r1730b99],
5	of	IN	O	of	_	0	SENT_176	[p14l1773t20r1875b99],
6	pneumonitis	NN	O	pneumonitis	prep_of	4	SENT_176	[p14l1895t46r2144b121, p14l12t149r334b227],
7	and	CC	O	and	_	0	SENT_176	[p14l366t149r520b227],
8	pulmonary	JJ	O	pulmonary	amod	9	SENT_176	[p14l548t149r1010b249],
9	ﬁbrosis	NN	O	ﬁbrosis	conj_and	4	SENT_176	[p14l1034t148r1345b227],
10	in	IN	O	in	_	0	SENT_176	[p14l1376t149r1457b226],
11	the	DT	O	the	det	13	SENT_176	[p14l1487t148r1615b227],
12	two	CD	NUMBER	two	num	13	SENT_176	[p14l1645t165r1796b228],
13	groups	NNS	O	group	prep_in	9	SENT_176	[p14l1826t174r2142b249],
14	.	.	O	.	_	0	SENT_176	[p14l1826t174r2142b249],

1	Table	NNP	O	Table	_	0	SENT_177	[p14l61t455r197b503],
2	2	CD	NUMBER	2	dep	1	SENT_177	[p14l214t459r258b503],
3	.	.	O	.	_	0	SENT_177	[p14l214t459r258b503],

1	Analysis	NN	O	analysis	_	0	SENT_178	[p14l276t455r494b518],
2	of	IN	O	of	_	0	SENT_178	[p14l512t454r572b503],
3	Responses	NNS	O	response	prep_of	1	SENT_178	[p14l583t459r862b517],
4	to	TO	O	to	_	0	SENT_178	[p14l878t463r930b503],
5	the	DT	O	the	det	7	SENT_178	[p14l946t455r1031b503],
6	Study	NNP	O	Study	nn	7	SENT_178	[p14l1048t455r1197b518],
7	Treatment	NN	O	treatment	prep_to	1	SENT_178	[p14l1213t457r1528b503],
8	.	.	O	.	_	0	SENT_178	[p14l1213t457r1528b503],

1	*	NN	O	*	_	0	SENT_179	[p14l1213t457r1528b503],

1	No.	NN	O	no.	_	0	SENT_180	[p14l1252t595r1341b639],
2	of	IN	O	of	prep	1	SENT_180	[p14l1360t590r1420b639],

1	No.	NN	O	no.	amod	5	SENT_181	[p14l907t667r996b711],
2	of	IN	O	of	_	0	SENT_181	[p14l1015t662r1075b711],
3	Responses	NNS	O	response	prep_of	1	SENT_181	[p14l1191t667r1469b725],
4	Overall	JJ	O	overall	amod	5	SENT_181	[p14l1559t663r1746b711],
5	Cases	NNS	O	case	nsubj	6	SENT_181	[p14l907t739r1059b783],
6	(	VBP	O	(	_	0	SENT_181	[p14l1196t735r1464b799],
7	Complete	JJ	O	complete	amod	8	SENT_181	[p14l1196t735r1464b799],
8	Response	NN	O	response	dobj	6	SENT_181	[p14l1530t739r1781b797],

1	Factor	NN	O	factor	_	0	SENT_182	[p14l66t812r223b855],
2	Evaluated	VBN	O	evaluate	partmod	1	SENT_182	[p14l859t807r1109b855],
3	and	CC	O	and	_	0	SENT_182	[p14l1178t807r1272b855],
4	Partial	JJ	O	partial	amod	6	SENT_182	[p14l1296t807r1476b871],
5	)	NN	O	)	nn	6	SENT_182	[p14l1296t807r1476b871],
6	Rate	NN	O	rate	conj_and	1	SENT_182	[p14l1545t812r1657b855],
7	(	CD	PERCENT	(	num	8	SENT_182	[p14l1678t810r1762b871],
8	%	NN	PERCENT	%	nn	12	SENT_182	[p14l1678t810r1762b871],
9	)	CD	NUMBER	)	num	11	SENT_182	[p14l1678t810r1762b871],
10	P	NN	O	p	nn	11	SENT_182	[p14l1867t812r1897b855],
11	Value	NNP	O	Value	dep	8	SENT_182	[p14l1912t807r2055b856],
12	Treatment	NN	O	treatment	dep	6	SENT_182	[p14l60t937r329b981],

1	Erlotinib	NN	O	erlotinib	dep	10	SENT_183	[p14l163t1036r380b1085],
2	427	CD	NUMBER	427	number	3	SENT_183	[p14l936t1041r1029b1085],
3	38	CD	NUMBER	38	dep	1	SENT_183	[p14l1300t1040r1358b1085],
4	8.9	CD	NUMBER	8.9	num	5	SENT_183	[p14l1632t1040r1707b1085],
5	<	JJR	O	<	dep	3	SENT_183	[p14l1871t1040r2043b1085],
6	0.001	CD	NUMBER	0.001	num	7	SENT_183	[p14l1871t1040r2043b1085],
7	Placebo	NN	O	placebo	dep	10	SENT_183	[p14l163t1140r362b1189],
8	211	CD	NUMBER	211	number	9	SENT_183	[p14l938t1145r1026b1188],
9	2	CD	NUMBER	2	num	10	SENT_183	[p14l1331t1145r1357b1188],
10	<	JJR	O	<	_	0	SENT_183	[p14l1598t1145r1658b1188],
11	1	CD	NUMBER	1	dep	10	SENT_183	[p14l1598t1145r1658b1188],

1	Age	NN	O	age	_	0	SENT_184	[p14l61t1247r159b1308],

1	<	JJR	O	<	dep	4	SENT_185	[p14l159t1351r255b1396],
2	60	CD	DURATION	60	dep	1	SENT_185	[p14l159t1351r255b1396],
3	yr	NN	DURATION	yr	dep	4	SENT_185	[p14l271t1365r319b1411],
4	177	CD	NUMBER	177	dep	9	SENT_185	[p14l941t1352r1029b1396],
5	19	CD	NUMBER	19	number	6	SENT_185	[p14l1302t1352r1358b1396],
6	10.7	CD	NUMBER	10.7	dep	4	SENT_185	[p14l1604t1351r1707b1396],
7	0.30	CD	NUMBER	0.30	num	8	SENT_185	[p14l1904t1351r2013b1396],
8	260	CD	DURATION	260	dep	6	SENT_185	[p14l159t1455r255b1500],
9	yr	NN	DURATION	yr	dep	12	SENT_185	[p14l272t1469r318b1515],
10	250	CD	NUMBER	250	num	9	SENT_185	[p14l938t1455r1030b1500],
11	19	CD	NUMBER	19	num	12	SENT_185	[p14l1302t1456r1358b1500],
12	7.6	CD	NUMBER	7.6	_	0	SENT_185	[p14l1635t1455r1707b1500],

1	Sex	NN	O	sex	_	0	SENT_186	[p14l63t1559r150b1603],

1	Male	JJ	O	male	_	0	SENT_187	[p14l163t1659r287b1707],
2	281	CD	NUMBER	281	number	3	SENT_187	[p14l938t1662r1026b1707],
3	17	CD	NUMBER	17	num	5	SENT_187	[p14l1302t1663r1358b1707],
4	6.0	CD	NUMBER	6.0	number	5	SENT_187	[p14l1633t1662r1708b1707],
5	0.006	CD	NUMBER	0.006	npadvmod	6	SENT_187	[p14l1906t1662r2046b1707],
6	Female	JJ	O	female	amod	1	SENT_187	[p14l163t1762r346b1811],
7	146	CD	NUMBER	146	dep	1	SENT_187	[p14l941t1767r1029b1811],
8	21	CD	NUMBER	21	number	9	SENT_187	[p14l1299t1767r1356b1810],
9	14.4	CD	NUMBER	14.4	dep	7	SENT_187	[p14l1604t1767r1707b1811],

1	Pathological	JJ	O	pathological	amod	2	SENT_188	[p14l67t1866r383b1930],
2	subtype	NN	O	subtype	_	0	SENT_188	[p14l406t1866r608b1929],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_189	[p14l157t1970r605b2018],
2	209	CD	NUMBER	209	num	1	SENT_189	[p14l938t1973r1028b2018],
3	29	CD	NUMBER	29	number	4	SENT_189	[p14l1299t1974r1358b2018],
4	13.9	CD	NUMBER	13.9	npadvmod	5	SENT_189	[p14l1604t1974r1707b2018],
5	<	JJR	O	<	amod	1	SENT_189	[p14l1871t1973r2043b2018],
6	0.001	CD	NUMBER	0.001	dep	1	SENT_189	[p14l1871t1973r2043b2018],
7	Other	JJ	O	other	amod	8	SENT_189	[p14l159t2074r312b2122],
8	218	CD	NUMBER	218	dep	6	SENT_189	[p14l938t2077r1028b2122],
9	9	CD	NUMBER	9	number	10	SENT_189	[p14l1331t2078r1358b2122],
10	4.1	CD	NUMBER	4.1	amod	8	SENT_189	[p14l1631t2078r1705b2122],

1	Performance	NNP	O	Performance	_	0	SENT_190	[p14l67t2177r398b2226],
2	status	NN	O	status	dep	1	SENT_190	[p14l419t2186r574b2226],

1	o	NN	O	o	_	0	SENT_191	[p14l158t2284r187b2329],
2	or	CC	O	or	_	0	SENT_191	[p14l206t2298r260b2329],
3	1	CD	NUMBER	1	number	4	SENT_191	[p14l280t2285r302b2328],
4	274	CD	NUMBER	274	num	6	SENT_191	[p14l938t2285r1029b2329],
5	21	CD	NUMBER	21	number	6	SENT_191	[p14l1299t2285r1356b2328],
6	7.7	CD	NUMBER	7.7	conj_or	1	SENT_191	[p14l1635t2285r1707b2329],
7	0.29	CD	NUMBER	0.29	number	12	SENT_191	[p14l1904t2284r2012b2329],
8	2	CD	NUMBER	2	number	12	SENT_191	[p14l159t2389r185b2432],
9	or	CC	O	or	_	0	SENT_191	[p14l206t2402r260b2433],
10	3	CD	NUMBER	3	conj_or	12	SENT_191	[p14l278t2389r301b2433],
11	153	CD	NUMBER	153	number	12	SENT_191	[p14l941t2389r1026b2433],
12	17	CD	NUMBER	17	dep	1	SENT_191	[p14l1302t2389r1358b2433],
13	11.1	CD	NUMBER	11.1	dep	12	SENT_191	[p14l1604t2389r1705b2433],

1	Response	NN	O	response	_	0	SENT_192	[p14l67t2493r317b2551],
2	to	TO	O	to	_	0	SENT_192	[p14l335t2498r386b2537],
3	prior	JJ	O	prior	amod	4	SENT_192	[p14l408t2493r532b2551],
4	therapy	NN	O	therapy	prep_to	1	SENT_192	[p14l547t2488r744b2552],

1	Complete	JJ	O	complete	_	0	SENT_193	[p14l159t2592r411b2655],
2	and	CC	O	and	_	0	SENT_193	[p14l431t2592r523b2640],
3	partial	JJ	O	partial	amod	4	SENT_193	[p14l548t2592r706b2655],
4	174	CD	NUMBER	174	conj_and	1	SENT_193	[p14l941t2596r1029b2640],
5	13	CD	NUMBER	13	dep	1	SENT_193	[p14l1302t2596r1355b2640],
6	7.5	CD	NUMBER	7.5	number	7	SENT_193	[p14l1635t2596r1704b2640],
7	0.65	CD	NUMBER	0.65	dep	5	SENT_193	[p14l1904t2595r2009b2640],

1	responses	NNS	O	response	_	0	SENT_194	[p14l258t2681r521b2727],

1	Progressive	JJ	O	progressive	amod	2	SENT_195	[p14l163t2773r463b2832],
2	disease	NN	O	disease	_	0	SENT_195	[p14l482t2768r676b2816],
3	87	CD	NUMBER	87	num	7	SENT_195	[p14l970t2771r1029b2817],
4	9	CD	NUMBER	9	number	5	SENT_195	[p14l1331t2772r1358b2816],
5	10.3	CD	NUMBER	10.3	amod	7	SENT_195	[p14l1603t2771r1704b2816],
6	Stable	JJ	O	stable	amod	7	SENT_195	[p14l160t2872r318b2920],
7	disease	NN	O	disease	dep	2	SENT_195	[p14l338t2872r532b2920],
8	166	CD	NUMBER	166	number	9	SENT_195	[p14l941t2876r1029b2920],
9	16	CD	NUMBER	16	dep	2	SENT_195	[p14l1302t2876r1358b2920],
10	9.6	CD	NUMBER	9.6	dep	9	SENT_195	[p14l1632t2876r1707b2920],

1	Prior	RB	O	prior	_	0	SENT_196	[p14l67t2980r189b3023],
2	regimens	NNS	O	regimen	pobj	1	SENT_196	[p14l209t2980r449b3039],

1	1	CD	NUMBER	1	num	2	SENT_197	[p14l163t3084r184b3127],
2	214	CD	NUMBER	214	_	0	SENT_197	[p14l938t3084r1029b3126],
3	19	CD	NUMBER	19	num	4	SENT_197	[p14l1302t3083r1358b3127],
4	8.9	CD	NUMBER	8.9	dep	2	SENT_197	[p14l1632t3082r1707b3128],
5	1.00	CD	NUMBER	1.00	number	11	SENT_197	[p14l1908t3082r2013b3127],
6	2	CD	NUMBER	2	number	11	SENT_197	[p14l159t3187r185b3230],
7	or	CC	O	or	_	0	SENT_197	[p14l206t3200r260b3231],
8	3	CD	NUMBER	3	conj_or	11	SENT_197	[p14l278t3187r301b3231],
9	213	CD	NUMBER	213	number	11	SENT_197	[p14l938t3187r1026b3231],
10	19	CD	NUMBER	19	number	11	SENT_197	[p14l1302t3187r1358b3231],
11	8.9	CD	NUMBER	8.9	dep	4	SENT_197	[p14l1632t3186r1707b3231],

1	Prior	RB	O	prior	_	0	SENT_198	[p14l67t3291r189b3334],
2	platinum-based	JJ	O	platinum-based	amod	3	SENT_198	[p14l209t3286r615b3349],
3	therapy	NN	O	therapy	pobj	1	SENT_198	[p14l253t3358r450b3422],

1	Yes	UH	O	yes	dep	3	SENT_199	[p14l157t3467r241b3511],
2	396	CD	NUMBER	396	number	3	SENT_199	[p14l938t3466r1029b3511],
3	36	CD	NUMBER	36	num	5	SENT_199	[p14l1300t3466r1358b3511],
4	9.1	CD	NUMBER	9.1	number	5	SENT_199	[p14l1632t3467r1705b3511],
5	1.00	CD	NUMBER	1.00	_	0	SENT_199	[p14l1908t3465r2013b3511],
6	No	DT	O	no	dep	8	SENT_199	[p14l163t3570r237b3614],
7	31	CD	NUMBER	31	number	8	SENT_199	[p14l971t3570r1026b3614],
8	2	CD	NUMBER	2	dep	5	SENT_199	[p14l1331t3570r1357b3614],
9	6.5	CD	NUMBER	6.5	dep	5	SENT_199	[p14l1633t3570r1704b3615],

1	EG	NN	O	eg	nn	2	SENT_200	[p14l67t3673r135b3718],
2	FR	NN	O	fr	nsubj	3	SENT_200	[p14l147t3674r209b3717],
3	expression	NN	O	expression	_	0	SENT_200	[p14l229t3674r545b3733],
4	'	''	O	'	_	0	SENT_200	[p14l229t3674r545b3733],
5	i	FW	O	i	dobj	3	SENT_200	[p14l229t3674r545b3733],
6	'	''	O	'	_	0	SENT_200	[p14l229t3674r545b3733],

1	Positive	JJ	O	positive	amod	2	SENT_201	[p14l163t3778r364b3822],
2	106	CD	NUMBER	106	_	0	SENT_201	[p14l941t3777r1029b3822],
3	12	CD	NUMBER	12	number	4	SENT_201	[p14l1302t3778r1357b3821],
4	11.3	CD	NUMBER	11.3	dep	2	SENT_201	[p14l1604t3777r1704b3822],
5	0.10	CD	NUMBER	0.10	dep	4	SENT_201	[p14l1904t3777r2013b3822],

1	Negative	JJ	O	negative	amod	3	SENT_202	[p15l163t53r391b113],
2	80	CD	NUMBER	80	number	3	SENT_202	[p15l970t52r1030b98],
3	3	CD	NUMBER	3	_	0	SENT_202	[p15l1332t53r1355b97],
4	3.8	CD	NUMBER	3.8	number	5	SENT_202	[p15l1633t52r1707b98],
5	Unknown	JJ	O	unknown	amod	3	SENT_202	[p15l162t153r408b201],
6	241	CD	NUMBER	241	number	7	SENT_202	[p15l938t157r1026b200],
7	23	CD	NUMBER	23	dep	3	SENT_202	[p15l1299t157r1355b201],
8	9.5	CD	NUMBER	9.5	dep	7	SENT_202	[p15l1632t157r1704b201],

1	Smoking	NN	O	smoking	nn	2	SENT_203	[p15l64t256r295b320],
2	status	NN	O	status	_	0	SENT_203	[p15l314t266r470b305],

1	Current	JJ	DATE	current	amod	2	SENT_204	[p15l159t364r358b409],
2	smoker	NN	O	smoker	_	0	SENT_204	[p15l377t360r572b409],
3	or	CC	O	or	_	0	SENT_204	[p15l589t377r642b409],
4	ever	RB	O	ever	advmod	2	SENT_204	[p15l660t377r768b409],
5	311	CD	NUMBER	311	pobj	4	SENT_204	[p15l938t364r1026b408],
6	12	CD	NUMBER	12	number	7	SENT_204	[p15l1302t364r1357b408],
7	3.9	CD	NUMBER	3.9	num	8	SENT_204	[p15l1633t364r1707b409],
8	<	JJR	O	<	conj_or	2	SENT_204	[p15l1871t363r2043b409],
9	0.001	CD	NUMBER	0.001	dep	2	SENT_204	[p15l1871t363r2043b409],

1	smoked	VBN	O	smoke	_	0	SENT_205	[p15l256t433r459b481],

1	Never	RB	O	never	neg	2	SENT_206	[p15l163t540r316b584],
2	smoked	VBN	O	smoke	_	0	SENT_206	[p15l334t536r537b584],
3	93	CD	NUMBER	93	number	4	SENT_206	[p15l970t540r1026b584],
4	23	CD	NUMBER	23	num	5	SENT_206	[p15l1299t540r1355b584],
5	24.7	CD	NUMBER	24.7	dobj	2	SENT_206	[p15l1600t540r1707b584],

1	Unknown	JJ	O	unknown	dep	4	SENT_207	[p15l162t640r408b688],
2	23	CD	NUMBER	23	dep	1	SENT_207	[p15l970t644r1026b688],
3	3	CD	NUMBER	3	num	4	SENT_207	[p15l1331t644r1355b688],
4	13.0	CD	NUMBER	13.0	_	0	SENT_207	[p15l1604t643r1708b688],

1	Race	NN	O	race	_	0	SENT_208	[p15l67t748r185b792],
2	or	CC	O	or	_	0	SENT_208	[p15l204t760r258b792],
3	ethnic	JJ	O	ethnic	amod	4	SENT_208	[p15l275t744r436b792],
4	group	NN	O	group	conj_or	1	SENT_208	[p15l454t760r607b807],

1	Asian	JJ	MISC	asian	amod	2	SENT_209	[p15l157t850r300b895],
2	53	CD	NUMBER	53	_	0	SENT_209	[p15l970t851r1026b895],
3	10	CD	NUMBER	10	number	4	SENT_209	[p15l1302t850r1359b895],
4	18.9	CD	NUMBER	18.9	dep	2	SENT_209	[p15l1604t850r1707b896],
5	0.02	CD	NUMBER	0.02	dep	4	SENT_209	[p15l1904t850r2012b895],

1	Other	JJ	O	other	_	0	SENT_210	[p15l159t951r312b999],
2	374	CD	NUMBER	374	number	3	SENT_210	[p15l938t955r1029b999],
3	28	CD	NUMBER	28	dep	1	SENT_210	[p15l1299t954r1358b1000],
4	7.5	CD	NUMBER	7.5	dep	3	SENT_210	[p15l1635t955r1704b999],

1	7	CD	NUMBER	7	nsubjpass	6	SENT_211	[p15l10t1132r38b1159],
2	'	''	O	'	_	0	SENT_211	[p15l10t1132r38b1159],
3	‘	CD	NUMBER	‘	num	4	SENT_211	[p15l10t1132r38b1159],
4	Responses	NNS	O	response	dep	1	SENT_211	[p15l63t1132r340b1190],
5	were	VBD	O	be	auxpass	6	SENT_211	[p15l359t1144r482b1176],
6	assessed	VBN	O	assess	_	0	SENT_211	[p15l502t1127r734b1175],
7	according	VBG	O	accord	_	0	SENT_211	[p15l757t1127r1015b1191],
8	to	TO	O	to	prepc_according_to	6	SENT_211	[p15l1031t1137r1082b1175],
9	the	DT	O	the	det	12	SENT_211	[p15l1100t1127r1182b1175],
10	Response	NN	O	response	nn	12	SENT_211	[p15l1205t1132r1456b1190],
11	Evaluation	NN	O	evaluation	nn	12	SENT_211	[p15l1479t1127r1746b1176],
12	Criteria	NNS	O	criterion	pobj	6	SENT_211	[p15l1769t1131r1954b1175],
13	in	IN	O	in	prep	12	SENT_211	[p15l1977t1132r2018b1175],

1	Solid	JJ	O	solid	amod	2	SENT_212	[p15l60t1199r186b1248],
2	Tumors	NNS	O	tumor	nsubj	9	SENT_212	[p15l205t1204r403b1248],
3	in	IN	O	in	_	0	SENT_212	[p15l426t1204r467b1247],
4	patients	NNS	O	patient	prep_in	2	SENT_212	[p15l491t1204r697b1262],
5	with	IN	O	with	_	0	SENT_212	[p15l716t1199r823b1248],
6	one	CD	NUMBER	one	prep_with	4	SENT_212	[p15l845t1217r940b1248],
7	or	CC	O	or	_	0	SENT_212	[p15l959t1217r1012b1248],
8	more	JJR	O	more	prep_with	4	SENT_212	[p15l1032t1217r1165b1248],
9	confirmed	VBD	O	confirm	_	0	SENT_212	[p15l1183t1199r1448b1248],
10	lesions	NNS	O	lesion	dobj	9	SENT_212	[p15l1473t1199r1652b1248],
11	and	CC	O	and	_	0	SENT_212	[p15l1673t1199r1765b1248],
12	at	IN	O	at	quantmod	14	SENT_212	[p15l1788t1209r1834b1248],
13	least	JJS	O	least	mwe	12	SENT_212	[p15l1854t1199r1972b1248],
14	one	CD	NUMBER	one	dobj	9	SENT_212	[p15l1990t1217r2085b1248],
15	follow-up	NN	O	follow-up	nn	17	SENT_212	[p15l57t1272r301b1335],
16	radiologic	JJ	O	radiologic	amod	17	SENT_212	[p15l324t1272r581b1336],
17	examination	NN	O	examination	dep	14	SENT_212	[p15l599t1277r936b1321],
18	.	.	O	.	_	0	SENT_212	[p15l599t1277r936b1321],

1	1	CD	NUMBER	1	_	0	SENT_213	[p15l12t1350r41b1409],
2	'	''	O	'	_	0	SENT_213	[p15l12t1350r41b1409],
3	Epidermal	JJ	O	epidermal	amod	8	SENT_213	[p15l63t1345r323b1408],
4	growth	NN	O	growth	nn	8	SENT_213	[p15l346t1345r524b1409],
5	factor	NN	O	factor	nn	8	SENT_213	[p15l545t1345r697b1394],
6	receptor	NN	O	receptor	nn	8	SENT_213	[p15l717t1354r932b1408],
7	(	NN	O	(	nn	8	SENT_213	[p15l955t1349r1045b1409],
8	EG	NN	O	eg	nsubjpass	13	SENT_213	[p15l955t1349r1045b1409],
9	FR	NN	O	fr	nn	11	SENT_213	[p15l1057t1349r1138b1409],
10	)	NN	O	)	nn	11	SENT_213	[p15l1057t1349r1138b1409],
11	expression	NN	O	expression	dep	8	SENT_213	[p15l1163t1350r1440b1408],
12	was	VBD	O	be	auxpass	13	SENT_213	[p15l1460t1362r1559b1394],
13	assessed	VBN	O	assess	rcmod	1	SENT_213	[p15l1580t1345r1812b1394],
14	by	IN	O	by	_	0	SENT_213	[p15l1837t1345r1891b1409],
15	immunohistochemistry	NN	O	immunohistochemistry	agent	13	SENT_213	[p15l1912t1350r2082b1394, p15l61t1418r525b1482],
16	.	.	O	.	_	0	SENT_213	[p15l1912t1350r2082b1394, p15l61t1418r525b1482],

1	N	NN	O	n	nn	2	SENT_214	[p15l526t1618r540b1633],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_214	[p15l556t1617r639b1639],
3	MED	VBD	O	med	_	0	SENT_214	[p15l654t1618r707b1633],
4	353:2	CD	NUMBER	353:2	num	6	SENT_214	[p15l719t1617r783b1639],
5	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	6	SENT_214	[p15l818t1617r1029b1639],
6	JULY	NNP	DATE	JULY	dobj	3	SENT_214	[p15l1063t1618r1123b1639],
7	14	CD	DATE	14	num	6	SENT_214	[p15l1136t1617r1170b1639],
8	,	,	DATE	,	_	0	SENT_214	[p15l1136t1617r1170b1639],
9	2005	CD	DATE	2005	num	10	SENT_214	[p15l1183t1617r1246b1639],
10	127	CD	NUMBER	127	appos	6	SENT_214	[p15l1960t1616r2016b1637],

1	The	DT	O	the	det	5	SENT_215	[p15l702t1650r752b1674],
2	New	NNP	O	New	nn	5	SENT_215	[p15l762t1651r824b1674],
3	England	NNP	O	England	nn	5	SENT_215	[p15l833t1650r944b1681],
4	J	NNP	O	J	nn	5	SENT_215	[p15l952t1651r965b1674],
5	oumal	NN	O	oumal	_	0	SENT_215	[p15l966t1650r1050b1674],
6	of	IN	O	of	_	0	SENT_215	[p15l1060t1650r1088b1674],
7	Medicine	NN	O	medicine	prep_of	5	SENT_215	[p15l1095t1650r1220b1674],

1	The	DT	O	the	det	4	SENT_216	[p15l715t1838r752b1859],
2	NEW	NNP	O	NEW	nn	4	SENT_216	[p15l764t1840r845b1859],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_216	[p15l859t1840r1034b1859],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_216	[p15l1048t1840r1214b1866],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_216	[p15l1228t1838r1444b1865],

1	A	DT	O	a	det	3	SENT_217	[p16l41t63r84b112],
2	Overall	JJ	O	overall	amod	3	SENT_217	[p16l127t67r302b112],
3	Survival	NN	O	survival	_	0	SENT_217	[p16l321t67r516b112],

1	100	CD	NUMBER	100	num	2	SENT_218	[p16l440t161r517b200],
2	P	NN	O	p	npadvmod	3	SENT_218	[p16l674t184r859b223],
3	<	JJR	O	<	amod	8	SENT_218	[p16l674t184r859b223],
4	0.001	CD	NUMBER	0.001	dep	3	SENT_218	[p16l674t184r859b223],
5	by	IN	O	by	dep	4	SENT_218	[p16l881t181r929b237],
6	stratified	JJ	O	stratified	pobj	5	SENT_218	[p16l946t181r1145b223],
7	log-rank	JJ	O	log-rank	amod	8	SENT_218	[p16l1167t181r1351b237],
8	test	NN	O	test	_	0	SENT_218	[p16l1367t189r1451b223],

1	\	NN	O	\	_	0	SENT_219	[p16l593t228r602b242],
2	.	.	O	.	_	0	SENT_219	[p16l618t285r634b316],

1	‘	NN	O	‘	nn	3	SENT_220	[p16l618t285r634b316],
2	Hazard	NN	O	hazard	nn	3	SENT_220	[p16l674t258r836b300],
3	ratio	NN	O	ratio	_	0	SENT_220	[p16l859t262r971b307],
4	,	,	O	,	_	0	SENT_220	[p16l859t262r971b307],
5	0.70	CD	PERCENT	0.70	number	6	SENT_220	[p16l991t260r1087b300],
6	(	CD	PERCENT	(	appos	3	SENT_220	[p16l1109t260r1225b313],
7	95	CD	PERCENT	95	number	8	SENT_220	[p16l1109t260r1225b313],
8	%	NN	PERCENT	%	amod	9	SENT_220	[p16l1109t260r1225b313],
9	CI	NN	O	ci	dep	3	SENT_220	[p16l1243t261r1301b307],
10	,	,	O	,	_	0	SENT_220	[p16l1243t261r1301b307],
11	0.58-0	CD	NUMBER	0.58-0	num	13	SENT_220	[p16l1321t260r1558b313],
12	.85	CD	NUMBER	.85	num	13	SENT_220	[p16l1321t260r1558b313],
13	)	NN	O	)	appos	9	SENT_220	[p16l1321t260r1558b313],

1	Ch	NNP	O	Ch	_	0	SENT_221	[p16l465t589r488b628],
2	9	CD	NUMBER	9	dep	1	SENT_221	[p16l492t588r517b628],

1	Patients	NNS	O	patient	_	0	SENT_222	[p16l323t669r367b864],
2	(	CD	PERCENT	(	num	3	SENT_222	[p16l325t568r382b647],
3	%	NN	PERCENT	%	dep	1	SENT_222	[p16l325t568r382b647],
4	)	CD	NUMBER	)	dep	1	SENT_222	[p16l325t568r382b647],

1	-	:	O	-	_	0	SENT_223	[p16l463t803r488b841],
2	h	NN	O	h	dep	3	SENT_223	[p16l463t803r488b841],
3	C	NN	O	c	_	0	SENT_223	[p16l492t802r517b841],

1	No.	NN	O	no.	_	0	SENT_224	[p16l98t1495r182b1536],
2	at	IN	O	at	_	0	SENT_224	[p16l202t1498r247b1536],
3	Risk	NN	O	risk	prep_at	1	SENT_224	[p16l267t1491r367b1536],
4	Placebo	NN	O	placebo	dep	1	SENT_224	[p16l99t1562r273b1604],
5	243	CD	NUMBER	243	number	6	SENT_224	[p16l503t1566r580b1604],
6	107	CD	NUMBER	107	num	7	SENT_224	[p16l800t1565r877b1604],
7	Erlotinib	NN	O	erlotinib	dep	4	SENT_224	[p16l99t1630r289b1673],
8	488	CD	NUMBER	488	number	9	SENT_224	[p16l502t1629r582b1669],
9	255	CD	NUMBER	255	num	7	SENT_224	[p16l797t1630r874b1669],

1	B	NN	O	b	_	0	SENT_225	[p16l47t1784r82b1833],
2	Progression-free	JJ	O	progression-free	amod	3	SENT_225	[p16l130t1787r531b1847],
3	Survival	NN	O	survival	dep	1	SENT_225	[p16l549t1788r743b1834],

1	100	CD	NUMBER	100	num	2	SENT_226	[p16l440t1885r517b1924],
2	P	NN	O	p	_	0	SENT_226	[p16l674t1906r858b1945],
3	<	JJR	O	<	dep	2	SENT_226	[p16l674t1906r858b1945],
4	0.001	CD	NUMBER	0.001	dep	2	SENT_226	[p16l674t1906r858b1945],
5	by	IN	O	by	_	0	SENT_226	[p16l881t1903r928b1958],
6	Stratiﬁed	JJ	O	stratiﬁed	amod	8	SENT_226	[p16l946t1903r1145b1945],
7	log-rank	JJ	O	log-rank	amod	8	SENT_226	[p16l1167t1903r1351b1959],
8	test	NN	O	test	prep_by	4	SENT_226	[p16l1367t1911r1451b1945],

1	Hazard	NN	O	hazard	nn	2	SENT_227	[p16l674t1979r836b2022],
2	ratio	NN	O	ratio	_	0	SENT_227	[p16l859t1983r971b2029],
3	,	,	O	,	_	0	SENT_227	[p16l859t1983r971b2029],
4	0.61	CD	PERCENT	0.61	number	5	SENT_227	[p16l991t1982r1083b2022],
5	(	CD	PERCENT	(	appos	2	SENT_227	[p16l1109t1981r1224b2034],
6	95	CD	PERCENT	95	number	7	SENT_227	[p16l1109t1981r1224b2034],
7	%	NN	PERCENT	%	amod	8	SENT_227	[p16l1109t1981r1224b2034],
8	CI	NN	O	ci	dep	2	SENT_227	[p16l1243t1983r1301b2029],
9	,	,	O	,	_	0	SENT_227	[p16l1243t1983r1301b2029],
10	0.51-0	CD	NUMBER	0.51-0	num	12	SENT_227	[p16l1321t1982r1558b2034],
11	.74	CD	NUMBER	.74	num	12	SENT_227	[p16l1321t1982r1558b2034],
12	)	NN	O	)	appos	8	SENT_227	[p16l1321t1982r1558b2034],

1	Patients	NNS	O	patient	_	0	SENT_228	[p16l323t2393r367b2588],
2	(	CD	PERCENT	(	num	3	SENT_228	[p16l325t2292r382b2371],
3	%	NN	PERCENT	%	dep	1	SENT_228	[p16l325t2292r382b2371],
4	)	CD	NUMBER	)	dep	1	SENT_228	[p16l325t2292r382b2371],

1	Erlotinib	NN	O	erlotinib	_	0	SENT_229	[p16l1204t2846r1394b2888],

1	No.	NN	O	no.	_	0	SENT_230	[p16l98t3219r182b3260],
2	at	IN	O	at	_	0	SENT_230	[p16l202t3222r247b3260],
3	Risk	NN	O	risk	nn	5	SENT_230	[p16l267t3215r367b3260],
4	Placebo	NN	O	placebo	nn	5	SENT_230	[p16l99t3286r273b3328],
5	Erlotinib	NN	O	erlotinib	prep_at	1	SENT_230	[p16l99t3354r289b3396],

1	Figure	NNP	O	Figure	_	0	SENT_231	[p16l64t3525r226b3587],
2	1	CD	NUMBER	1	dep	1	SENT_231	[p16l244t3528r285b3572],
3	.	.	O	.	_	0	SENT_231	[p16l244t3528r285b3572],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_232	[p16l306t3524r670b3586],
2	.	.	O	.	_	0	SENT_232	[p16l306t3524r670b3586],

1	—	NN	O	—	_	0	SENT_233	[p16l306t3524r670b3586],
2	.	.	O	.	_	0	SENT_233	[p16l306t3524r670b3586],

1	Meier	NNP	O	Meier	nn	2	SENT_234	[p16l306t3524r670b3586],
2	Curves	NNP	O	Curves	nsubj	21	SENT_234	[p16l684t3528r864b3572],
3	for	IN	O	for	_	0	SENT_234	[p16l879t3523r953b3572],
4	Overall	JJ	O	overall	amod	7	SENT_234	[p16l967t3524r1153b3572],
5	Survival	NN	O	survival	nn	7	SENT_234	[p16l1171t3524r1379b3572],
6	(	CD	NUMBER	(	num	7	SENT_234	[p16l1400t3524r1558b3588],
7	Panel	NN	O	panel	prep_for	2	SENT_234	[p16l1400t3524r1558b3588],
8	A	DT	O	a	det	9	SENT_234	[p16l1574t3528r1627b3588],
9	)	NN	O	)	dep	2	SENT_234	[p16l1574t3528r1627b3588],
10	and	CC	O	and	_	0	SENT_234	[p16l1647t3524r1741b3572],
11	Progressionfree	NNP	O	Progressionfree	nn	16	SENT_234	[p16l1763t3525r2089b3587, p16l59t3603r158b3652],
12	Survival	NNP	O	Survival	nn	16	SENT_234	[p16l175t3604r383b3652],
13	(	NNP	O	(	nn	16	SENT_234	[p16l406t3604r564b3668],
14	Panel	NN	O	panel	nn	16	SENT_234	[p16l406t3604r564b3668],
15	B	NN	O	b	nn	16	SENT_234	[p16l587t3608r636b3668],
16	)	NN	O	)	conj_and	2	SENT_234	[p16l587t3608r636b3668],
17	among	IN	O	among	_	0	SENT_234	[p16l657t3620r840b3667],
18	All	DT	O	all	det	19	SENT_234	[p16l855t3604r920b3651],
19	Patients	NNS	O	patient	prep_among	16	SENT_234	[p16l944t3605r1152b3652],
20	Randomly	RB	O	randomly	advmod	21	SENT_234	[p16l1174t3604r1436b3667],
21	Assigned	VBN	O	assign	_	0	SENT_234	[p16l1451t3604r1691b3667],
22	to	TO	O	to	_	0	SENT_234	[p16l1709t3612r1761b3652],
23	Erlotinib	NNP	O	Erlotinib	prep_to	21	SENT_234	[p16l1782t3604r2000b3652],
24	or	CC	O	or	_	0	SENT_234	[p16l60t3700r114b3732],
25	Placebo	NNP	O	Placebo	prep_to	21	SENT_234	[p16l134t3684r348b3733],
26	.	.	O	.	_	0	SENT_234	[p16l134t3684r348b3733],

1	P	NN	O	p	nn	2	SENT_235	[p16l65t3785r93b3828],
2	values	NNS	O	value	nsubj	3	SENT_235	[p16l108t3781r271b3829],
3	were	VBD	O	be	_	0	SENT_235	[p16l288t3797r410b3829],
4	adiusted	VBN	O	adiust	dep	3	SENT_235	[p16l428t3781r649b3834],
5	for	IN	O	for	mark	8	SENT_235	[p16l667t3780r740b3829],
6	stratification	NN	O	stratification	nn	7	SENT_235	[p16l755t3780r1081b3829],
7	factors	NNS	O	factor	nsubj	8	SENT_235	[p16l1100t3780r1277b3829],
8	(	VBP	O	(	advcl	4	SENT_235	[p16l1301t3785r1484b3834],
9	except	IN	O	except	_	0	SENT_235	[p16l1301t3785r1484b3834],
10	center	NN	O	center	nn	11	SENT_235	[p16l1500t3785r1679b3834],
11	)	NN	O	)	prep_except	8	SENT_235	[p16l1500t3785r1679b3834],
12	and	CC	O	and	_	0	SENT_235	[p16l1702t3781r1794b3829],
13	epidermal	JJ	O	epidermal	dep	3	SENT_235	[p16l1814t3781r2074b3834],

1	|	NN	O	|	_	0	SENT_236	[p17l7t6r15b170],
2	growth	NN	O	growth	nn	5	SENT_236	[p17l62t33r239b97],
3	factor	NN	O	factor	nn	5	SENT_236	[p17l260t32r412b81],
4	receptor	NN	O	receptor	nn	5	SENT_236	[p17l432t42r648b96],
5	expression	NN	O	expression	dep	1	SENT_236	[p17l665t38r960b96],
6	.	.	O	.	_	0	SENT_236	[p17l665t38r960b96],

1	|	SYM	O	|	_	0	SENT_237	[p17l2141t6r2149b170],

1	Two	CD	NUMBER	two	num	2	SENT_238	[p17l561t307r692b362],
2	patients	NNS	O	patient	nsubj	3	SENT_238	[p17l730t303r980b377],
3	died	VBD	O	die	_	0	SENT_238	[p17l1020t302r1153b361],
4	of	IN	O	of	_	0	SENT_238	[p17l1192t302r1267b361],
5	pneumonitis	NN	O	pneumonitis	prep_of	7	SENT_238	[p17l1290t303r1692b377],
6	(	CD	NUMBER	(	number	7	SENT_238	[p17l1735t308r1871b370],
7	one	CD	NUMBER	one	dobj	3	SENT_238	[p17l1735t308r1871b370],
8	in	IN	O	in	_	0	SENT_238	[p17l1908t303r1969b360],
9	each	DT	O	each	det	11	SENT_238	[p17l2007t303r2149b361],
10	group	NN	O	group	nn	11	SENT_238	[p17l563t403r794b472],
11	)	NN	O	)	prep_in	7	SENT_238	[p17l563t403r794b472],
12	.	.	O	.	_	0	SENT_238	[p17l563t403r794b472],

1	QUALITY	NN	O	quality	nn	4	SENT_239	[p17l564t609r830b657],
2	or	CC	O	or	_	0	SENT_239	[p17l858t609r936b646],
3	LIFE	NN	O	life	nn	4	SENT_239	[p17l969t609r1092b645],
4	Compliance	NN	O	compliance	nsubj	6	SENT_239	[p17l563t684r943b758],
5	was	VBD	O	be	cop	6	SENT_239	[p17l955t703r1075b742],
6	similar	JJ	O	similar	_	0	SENT_239	[p17l1094t684r1314b742],
7	in	IN	O	in	_	0	SENT_239	[p17l1327t684r1388b741],
8	the	DT	O	the	det	10	SENT_239	[p17l1404t684r1500b742],
9	two	CD	NUMBER	two	num	10	SENT_239	[p17l1516t696r1630b743],
10	groups	NNS	O	group	prep_in	6	SENT_239	[p17l1646t702r1884b758],
11	.	.	O	.	_	0	SENT_239	[p17l1646t702r1884b758],

1	Patients	NNS	O	patient	nsubjpass	17	SENT_240	[p17l1903t684r2148b742],
2	who	WP	O	who	nsubj	12	SENT_240	[p17l560t779r695b837],
3	had	VBD	O	have	aux	4	SENT_240	[p17l720t778r835b837],
4	responded	VBN	O	respond	rcmod	1	SENT_240	[p17l858t778r1186b853],
5	to	TO	O	to	_	0	SENT_240	[p17l1210t791r1269b837],
6	the	DT	O	the	det	8	SENT_240	[p17l1294t779r1389b837],
7	quality-of-life	JJ	O	quality-of-life	amod	8	SENT_240	[p17l1413t778r1831b853],
8	questionnaire	NN	O	questionnaire	prep_to	4	SENT_240	[p17l1856t779r2148b853, p17l563t874r719b932],
9	at	IN	O	at	_	0	SENT_240	[p17l735t886r794b932],
10	baseline	NN	O	baseline	prep_at	8	SENT_240	[p17l807t873r1062b932],
11	and	CC	O	and	_	0	SENT_240	[p17l1078t873r1193b932],
12	had	VBD	O	have	rcmod	1	SENT_240	[p17l1210t873r1325b932],
13	one	CD	NUMBER	one	num	15	SENT_240	[p17l1342t892r1455b932],
14	follow-up	NN	O	follow-up	nn	15	SENT_240	[p17l1471t873r1774b948],
15	assessment	NN	O	assessment	dobj	12	SENT_240	[p17l1791t886r2153b932],
16	were	VBD	O	be	auxpass	17	SENT_240	[p17l560t988r710b1027],
17	included	VBN	O	include	_	0	SENT_240	[p17l733t968r1006b1027],
18	in	IN	O	in	_	0	SENT_240	[p17l1029t969r1089b1026],
19	the	DT	O	the	det	20	SENT_240	[p17l1113t969r1209b1027],
20	analysis	NN	O	analysis	prep_in	17	SENT_240	[p17l1232t969r1498b1043],
21	.	.	O	.	_	0	SENT_240	[p17l1232t969r1498b1043],

1	The	DT	O	the	det	3	SENT_241	[p17l1523t968r1643b1027],
2	median	JJ	O	median	amod	3	SENT_241	[p17l1667t969r1903b1027],
3	time	NN	O	time	nsubj	62	SENT_241	[p17l1926t969r2066b1027],
4	to	TO	O	to	_	0	SENT_241	[p17l2089t981r2148b1027],
5	deterioration	NN	O	deterioration	prep_to	3	SENT_241	[p17l564t1064r986b1122],
6	with	IN	O	with	_	0	SENT_241	[p17l1011t1063r1156b1123],
7	regard	NN	O	regard	prep_with	5	SENT_241	[p17l1185t1063r1395b1138],
8	to	TO	O	to	aux	9	SENT_241	[p17l1424t1076r1484b1122],
9	cough	VB	O	cough	infmod	5	SENT_241	[p17l1514t1064r1714b1138],
10	(	CD	NUMBER	(	number	11	SENT_241	[p17l1746t1068r1868b1131],
11	4.9	CD	DURATION	4.9	num	12	SENT_241	[p17l1746t1068r1868b1131],
12	months	NNS	NUMBER	month	tmod	9	SENT_241	[p17l1898t1064r2146b1122],
13	among	IN	O	among	_	0	SENT_241	[p17l10t1357r316b1432],
14	patients	NNS	O	patient	prep_among	9	SENT_241	[p17l334t1332r668b1432],
15	receiving	VBG	O	receive	partmod	14	SENT_241	[p17l693t1332r1076b1432],
16	erlotinib	NN	O	erlotinib	dobj	15	SENT_241	[p17l1096t1332r1454b1410],
17	and	CC	O	and	_	0	SENT_241	[p17l1478t1332r1633b1410],
18	3.7	CD	DURATION	3.7	num	19	SENT_241	[p17l1656t1337r1785b1410],
19	months	NNS	NUMBER	month	conj_and	16	SENT_241	[p17l1808t1331r2133b1410],
20	among	IN	O	among	_	0	SENT_241	[p17l10t1485r307b1560],
21	those	DT	O	those	nsubj	22	SENT_241	[p17l326t1460r549b1538],
22	receiving	VBG	O	receive	prepc_among	15	SENT_241	[p17l572t1460r948b1560],
23	placebo	NN	O	placebo	dobj	22	SENT_241	[p17l966t1460r1312b1560],
24	,	,	O	,	_	0	SENT_241	[p17l966t1460r1312b1560],
25	P	NN	O	p	dep	15	SENT_241	[p17l1339t1465r1646b1538],
26	=	JJ	O	=	amod	25	SENT_241	[p17l1339t1465r1646b1538],
27	0.04	CD	NUMBER	0.04	tmod	26	SENT_241	[p17l1339t1465r1646b1538],
28	With	IN	O	with	dep	25	SENT_241	[p17l1664t1460r1851b1539],
29	Hoch	NNP	PERSON	Hoch	nn	30	SENT_241	[p17l1873t1459r2132b1538],
30	—	NNP	O	—	pobj	28	SENT_241	[p17l1873t1459r2132b1538],
31	berg	NN	O	berg	nn	33	SENT_241	[p17l11t1588r205b1688],
32	adjustment	NN	O	adjustment	nn	33	SENT_241	[p17l242t1588r785b1688],
33	)	NN	O	)	dep	30	SENT_241	[p17l242t1588r785b1688],
34	,	,	O	,	_	0	SENT_241	[p17l242t1588r785b1688],
35	dyspnea	NN	O	dyspnea	nn	36	SENT_241	[p17l832t1588r1183b1688],
36	(	NN	O	(	conj_and	30	SENT_241	[p17l1227t1593r1389b1679],
37	4.7	CD	DURATION	4.7	num	38	SENT_241	[p17l1227t1593r1389b1679],
38	months	NNS	NUMBER	month	tmod	36	SENT_241	[p17l1430t1588r1761b1666],
39	and	CC	O	and	_	0	SENT_241	[p17l1803t1588r1961b1666],
40	2.9	CD	DURATION	2.9	num	41	SENT_241	[p17l2002t1593r2133b1666],
41	months	NNS	NUMBER	month	conj_and	30	SENT_241	[p17l10t1716r366b1811],
42	,	,	O	,	_	0	SENT_241	[p17l10t1716r366b1811],
43	respectively	RB	O	respectively	advmod	41	SENT_241	[p17l401t1716r926b1816],
44	;	:	O	;	_	0	SENT_241	[p17l401t1716r926b1816],
45	adjusted	VBN	O	adjust	partmod	3	SENT_241	[p17l958t1716r1319b1816],
46	P	NN	O	p	dobj	45	SENT_241	[p17l1346t1721r1727b1811],
47	=	JJ	O	=	amod	49	SENT_241	[p17l1346t1721r1727b1811],
48	0.03	CD	NUMBER	0.03	tmod	47	SENT_241	[p17l1346t1721r1727b1811],
49	)	NN	O	)	dep	46	SENT_241	[p17l1346t1721r1727b1811],
50	,	,	O	,	_	0	SENT_241	[p17l1346t1721r1727b1811],
51	and	CC	O	and	_	0	SENT_241	[p17l1761t1716r1918b1794],
52	pain	NN	O	pain	conj_and	46	SENT_241	[p17l1945t1716r2134b1816],
53	(	CD	NUMBER	(	number	54	SENT_241	[p17l15t1849r176b1935],
54	2.8	CD	DURATION	2.8	num	55	SENT_241	[p17l15t1849r176b1935],
55	months	NNS	NUMBER	month	tmod	52	SENT_241	[p17l203t1844r533b1922],
56	and	CC	O	and	_	0	SENT_241	[p17l560t1844r718b1922],
57	1.9	CD	DURATION	1.9	num	58	SENT_241	[p17l746t1849r874b1922],
58	months	NNS	NUMBER	month	conj_and	46	SENT_241	[p17l900t1844r1256b1939],
59	,	,	O	,	_	0	SENT_241	[p17l900t1844r1256b1939],
60	respectively	RB	O	respectively	advmod	58	SENT_241	[p17l1287t1844r1813b1944],
61	;	:	O	;	_	0	SENT_241	[p17l1287t1844r1813b1944],
62	adjusted	VBN	O	adjust	_	0	SENT_241	[p17l1842t1844r2133b1944, p17l11t1973r108b2051],
63	P	NN	O	p	nsubj	64	SENT_241	[p17l135t1978r486b2064],
64	=	JJ	O	=	ccomp	62	SENT_241	[p17l135t1978r486b2064],
65	0.04	CD	NUMBER	0.04	num	66	SENT_241	[p17l135t1978r486b2064],
66	)	NN	O	)	dobj	64	SENT_241	[p17l135t1978r486b2064],
67	in	IN	O	in	_	0	SENT_241	[p17l519t1973r601b2050],
68	favor	NN	O	favor	nn	69	SENT_241	[p17l629t1972r846b2052],
69	oferlotinib	NN	O	oferlotinib	prep_in	66	SENT_241	[p17l873t1972r1378b2051],
70	.	.	O	.	_	0	SENT_241	[p17l873t1972r1378b2051],

1	These	DT	O	these	det	2	SENT_242	[p17l1408t1973r1664b2051],
2	results	NNS	O	result	nsubj	4	SENT_242	[p17l1692t1973r1975b2052],
3	are	VBP	O	be	cop	4	SENT_242	[p17l2006t1999r2134b2051],
4	consistent	JJ	O	consistent	_	0	SENT_242	[p17l11t2101r458b2179],
5	with	IN	O	with	_	0	SENT_242	[p17l497t2101r690b2180],
6	response	NN	O	response	nn	7	SENT_242	[p17l739t2101r1414b2201],
7	—	NN	O	—	prep_with	4	SENT_242	[p17l739t2101r1414b2201],
8	based	VBN	O	base	partmod	7	SENT_242	[p17l739t2101r1414b2201],
9	analyses	NNS	O	analysis	dobj	8	SENT_242	[p17l1462t2100r1818b2201],
10	of	IN	O	of	_	0	SENT_242	[p17l1870t2100r1971b2179],
11	the	DT	O	the	det	12	SENT_242	[p17l2002t2101r2134b2179],
12	quality	NN	O	quality	prep_of	9	SENT_242	[p17l11t2229r303b2329],
13	of	IN	O	of	_	0	SENT_242	[p17l326t2228r428b2307],
14	life	NN	O	life	prep_of	12	SENT_242	[p17l434t2228r593b2324],
15	,	,	O	,	_	0	SENT_242	[p17l434t2228r593b2324],
16	which	WDT	O	which	nsubj	17	SENT_242	[p17l621t2229r886b2308],
17	found	VBD	O	find	rcmod	14	SENT_242	[p17l912t2228r1169b2308],
18	that	IN	O	that	complm	23	SENT_242	[p17l1197t2229r1368b2307],
19	more	JJR	O	more	amod	20	SENT_242	[p17l1390t2254r1615b2307],
20	patients	NNS	O	patient	nsubj	23	SENT_242	[p17l1642t2229r1988b2329],
21	receiving	VBG	O	receive	partmod	20	SENT_242	[p17l2017t2255r2132b2307, p17l11t2357r309b2457],
22	erlotinib	NN	O	erlotinib	dobj	21	SENT_242	[p17l334t2357r692b2435],
23	had	VBD	O	have	ccomp	17	SENT_242	[p17l721t2356r876b2435],
24	improvement	NN	O	improvement	dobj	23	SENT_242	[p17l901t2357r1476b2457],
25	in	IN	O	in	_	0	SENT_242	[p17l1497t2357r1578b2434],
26	cough	NN	O	cough	prep_in	24	SENT_242	[p17l1606t2357r1890b2457],
27	,	,	O	,	_	0	SENT_242	[p17l1606t2357r1890b2457],
28	pain	NN	O	pain	conj_and	26	SENT_242	[p17l1921t2357r2130b2457],
29	,	,	O	,	_	0	SENT_242	[p17l1921t2357r2130b2457],
30	and	CC	O	and	_	0	SENT_242	[p17l10t2485r167b2563],
31	dyspnea	NN	O	dyspnea	prep_in	24	SENT_242	[p17l193t2485r543b2585],
32	and	CC	O	and	_	0	SENT_242	[p17l566t2484r724b2563],
33	in	IN	O	in	_	0	SENT_242	[p17l748t2485r829b2562],
34	the	DT	O	the	det	35	SENT_242	[p17l855t2485r986b2563],
35	domain	NN	O	domain	prep_in	49	SENT_242	[p17l1012t2485r1341b2563],
36	of	IN	O	of	_	0	SENT_242	[p17l1366t2484r1468b2563],
37	overall	JJ	O	overall	amod	39	SENT_242	[p17l1475t2485r1760b2564],
38	physical	JJ	O	physical	amod	39	SENT_242	[p17l1783t2485r2134b2585],
39	function	NN	O	function	prep_of	35	SENT_242	[p17l10t2612r363b2692],
40	(	CD	NUMBER	(	num	42	SENT_242	[p17l395t2612r716b2704],
41	further	JJ	O	further	amod	42	SENT_242	[p17l395t2612r716b2704],
42	information	NN	O	information	nsubj	49	SENT_242	[p17l739t2612r1245b2691],
43	is	VBZ	O	be	cop	49	SENT_242	[p17l1272t2613r1335b2691],
44	in	IN	O	in	_	0	SENT_242	[p17l1364t2613r1445b2690],
45	the	DT	O	the	det	47	SENT_242	[p17l1472t2612r1600b2691],
46	Supplementary	NNP	MISC	Supplementary	nn	47	SENT_242	[p17l1629t2612r2134b2713, p17l11t2757r169b2841],
47	Appendix	NNP	MISC	Appendix	prep_in	49	SENT_242	[p17l191t2740r636b2841],
48	,	,	O	,	_	0	SENT_242	[p17l191t2740r636b2841],
49	available	JJ	O	available	ccomp	17	SENT_242	[p17l673t2741r1043b2820],
50	With	IN	O	with	_	0	SENT_242	[p17l1066t2740r1256b2820],
51	the	DT	O	the	det	53	SENT_242	[p17l1287t2741r1419b2819],
52	complete	JJ	O	complete	amod	53	SENT_242	[p17l1451t2740r1844b2841],
53	text	NN	O	text	prep_with	23	SENT_242	[p17l1873t2757r2028b2819],
54	of	IN	O	of	_	0	SENT_242	[p17l2053t2740r2153b2819],
55	this	DT	O	this	det	56	SENT_242	[p17l11t2869r163b2947],
56	article	NN	O	article	prep_of	53	SENT_242	[p17l190t2869r447b2947],
57	at	IN	O	at	_	0	SENT_242	[p17l472t2885r551b2947],
58	WvvW.nejm.org	NNP	O	WvvW.nejm.org	prep_at	56	SENT_242	[p17l567t2869r1200b2969],
59	)	CD	NUMBER	)	num	58	SENT_242	[p17l1221t2876r1275b2960],
60	.	.	O	.	_	0	SENT_242	[p17l1221t2876r1275b2960],

1	DISCUSSION	NN	O	discussion	_	0	SENT_243	[p17l717t3184r1415b3243],

1	Docetaxel	NNP	O	Docetaxel	nsubj	5	SENT_244	[p17l9t3379r426b3457],
2	is	VBZ	O	be	cop	5	SENT_244	[p17l453t3379r518b3457],
3	the	DT	O	the	det	5	SENT_244	[p17l549t3379r678b3457],
4	only	JJ	O	only	amod	5	SENT_244	[p17l709t3379r890b3479],
5	agent	NN	O	agent	_	0	SENT_244	[p17l914t3395r1151b3479],
6	known	VBN	O	know	partmod	5	SENT_244	[p17l1174t3378r1465b3458],
7	to	TO	O	to	aux	8	SENT_244	[p17l1495t3395r1574b3457],
8	prolong	VB	O	prolong	xcomp	6	SENT_244	[p17l1602t3379r1944b3479],
9	sur	NN	O	sur	nn	11	SENT_244	[p17l1971t3405r2134b3458],
10	—	CD	NUMBER	—	num	11	SENT_244	[p17l1971t3405r2134b3458],
11	vival	NN	O	vival	dobj	8	SENT_244	[p17l6t3507r194b3586],
12	among	IN	O	among	_	0	SENT_244	[p17l227t3532r526b3607],
13	patients	NNS	O	patient	prep_among	8	SENT_244	[p17l556t3507r890b3607],
14	with	IN	O	with	_	0	SENT_244	[p17l922t3507r1112b3586],
15	disease	NN	O	disease	nn	16	SENT_244	[p17l1146t3506r1450b3585],
16	progression	NN	O	progression	prep_with	13	SENT_244	[p17l1482t3507r1991b3607],
17	after	IN	O	after	_	0	SENT_244	[p17l2025t3506r2134b3585, p17l11t3651r123b3713],
18	cisplatin	NN	O	cisplatin	nn	19	SENT_244	[p17l162t3635r802b3735],
19	—	NN	O	—	prep_after	8	SENT_244	[p17l162t3635r802b3735],
20	based	VBN	O	base	partmod	19	SENT_244	[p17l162t3635r802b3735],
21	chemotherapy	NN	O	chemotherapy	dobj	20	SENT_244	[p17l844t3635r1451b3735],
22	for	IN	O	for	_	0	SENT_244	[p17l1488t3634r1611b3713],
23	non	JJ	O	non	amod	26	SENT_244	[p17l1650t3635r2134b3713],
24	—	JJ	O	—	amod	26	SENT_244	[p17l1650t3635r2134b3713],
25	small	JJ	O	small	amod	26	SENT_244	[p17l1650t3635r2134b3713],
26	—	NN	O	—	prep_for	21	SENT_244	[p17l1650t3635r2134b3713],

1	cell	NN	O	cell	nn	4	SENT_245	[p18l11t24r152b102],
2	lung	NN	O	lung	nn	4	SENT_245	[p18l179t24r372b124],
3	cancer	NN	O	cancer	nn	4	SENT_245	[p18l397t18r901b102],
4	.3	NN	NUMBER	.3	nsubj	11	SENT_245	[p18l397t18r901b102],
5	’	CD	NUMBER	’	num	9	SENT_245	[p18l397t18r901b102],
6	4	CD	NUMBER	4	num	9	SENT_245	[p18l397t18r901b102],
7	’17	CD	NUMBER	’17	num	9	SENT_245	[p18l397t18r901b102],
8	Few	JJ	O	few	amod	9	SENT_245	[p18l927t31r1100b103],
9	options	NNS	O	option	dep	4	SENT_245	[p18l1124t24r1441b124],
10	are	VBP	O	be	cop	11	SENT_245	[p18l1470t50r1596b102],
11	available	JJ	O	available	ccomp	41	SENT_245	[p18l1623t24r1987b103],
12	for	IN	O	for	_	0	SENT_245	[p18l2015t23r2138b102],
13	the	DT	O	the	det	14	SENT_245	[p18l11t152r139b230],
14	treatment	NN	O	treatment	prep_for	11	SENT_245	[p18l169t168r583b230],
15	of	IN	O	of	_	0	SENT_245	[p18l607t151r708b230],
16	patients	NNS	O	patient	prep_of	14	SENT_245	[p18l717t152r1051b252],
17	with	IN	O	with	_	0	SENT_245	[p18l1077t152r1267b231],
18	disease	NN	O	disease	nn	19	SENT_245	[p18l1296t152r1599b230],
19	progression	NN	O	progression	prep_with	16	SENT_245	[p18l1626t152r2135b252],
20	after	IN	O	after	_	0	SENT_245	[p18l10t279r201b358],
21	docetaxel	NN	O	docetaxel	prep_after	11	SENT_245	[p18l222t280r613b358],
22	or	CC	O	or	_	0	SENT_245	[p18l637t305r725b358],
23	those	DT	O	those	prep_after	11	SENT_245	[p18l747t279r970b358],
24	who	WP	O	who	nsubj	27	SENT_245	[p18l990t279r1172b359],
25	are	VBP	O	be	cop	27	SENT_245	[p18l1197t306r1321b358],
26	not	RB	O	not	neg	27	SENT_245	[p18l1345t296r1487b358],
27	eligible	JJ	O	eligible	rcmod	23	SENT_245	[p18l1507t279r1807b380],
28	for	IN	O	for	_	0	SENT_245	[p18l1832t279r1953b358],
29	second	JJ	ORDINAL	second	amod	34	SENT_245	[p18l1976t306r2134b358, p18l11t407r364b485],
30	—	NN	O	—	nn	34	SENT_245	[p18l1976t306r2134b358, p18l11t407r364b485],
31	line	NN	O	line	nn	34	SENT_245	[p18l1976t306r2134b358, p18l11t407r364b485],
32	chemotherapy	NN	O	chemotherapy	nn	34	SENT_245	[p18l392t400r1118b507],
33	.5	CD	NUMBER	.5	num	34	SENT_245	[p18l392t400r1118b507],
34	’	NN	O	’	prep_for	27	SENT_245	[p18l392t400r1118b507],
35	6	CD	NUMBER	6	npadvmod	36	SENT_245	[p18l392t400r1118b507],
36	Clearly	RB	O	clearly	advmod	27	SENT_245	[p18l1146t407r1451b507],
37	,	,	O	,	_	0	SENT_245	[p18l1146t407r1451b507],
38	new	JJ	O	new	amod	39	SENT_245	[p18l1483t432r1659b486],
39	treatments	NNS	O	treatment	nsubjpass	41	SENT_245	[p18l1682t423r2133b485],
40	are	VBP	O	be	auxpass	41	SENT_245	[p18l10t562r135b614],
41	needed	VBN	O	need	_	0	SENT_245	[p18l161t535r462b614],
42	for	IN	O	for	_	0	SENT_245	[p18l487t535r610b614],
43	such	JJ	O	such	amod	44	SENT_245	[p18l634t536r828b615],
44	patients	NNS	O	patient	prep_for	41	SENT_245	[p18l852t536r1212b636],
45	.	.	O	.	_	0	SENT_245	[p18l852t536r1212b636],

1	Expression	NN	O	expression	nsubjpass	43	SENT_246	[p18l138t664r615b764],
2	of	IN	O	of	_	0	SENT_246	[p18l641t663r743b742],
3	EGFRis	NNP	O	EGFRis	prep_of	1	SENT_246	[p18l749t664r1092b747],
4	common	JJ	O	common	amod	3	SENT_246	[p18l1121t689r1507b742],
5	in	IN	O	in	_	0	SENT_246	[p18l1531t664r1614b741],
6	non	JJ	O	non	amod	14	SENT_246	[p18l1639t663r2133b742],
7	—	JJ	O	—	amod	14	SENT_246	[p18l1639t663r2133b742],
8	small	JJ	O	small	amod	14	SENT_246	[p18l1639t663r2133b742],
9	—	NN	O	—	nn	14	SENT_246	[p18l1639t663r2133b742],
10	cell	NN	O	cell	nn	14	SENT_246	[p18l11t792r156b870],
11	lung	NN	O	lung	nn	14	SENT_246	[p18l200t792r397b892],
12	cancer	NN	O	cancer	nn	14	SENT_246	[p18l441t786r941b870],
13	.18	CD	NUMBER	.18	num	14	SENT_246	[p18l441t786r941b870],
14	‘	NN	O	‘	prep_in	43	SENT_246	[p18l441t786r941b870],
15	2	CD	NUMBER	2	number	16	SENT_246	[p18l441t786r941b870],
16	°	CD	NUMBER	°	num	18	SENT_246	[p18l441t786r941b870],
17	Several	JJ	O	several	amod	18	SENT_246	[p18l989t792r1292b871],
18	agents	NNS	O	agent	nsubjpass	43	SENT_246	[p18l1337t808r1618b892],
19	that	WDT	O	that	nsubj	20	SENT_246	[p18l1668t792r1838b870],
20	target	VBP	O	target	rcmod	18	SENT_246	[p18l1881t808r2138b892],
21	EGFR	NN	ORGANIZATION	egfr	nsubj	36	SENT_246	[p18l9t925r275b1003],
22	are	VBP	O	be	cop	36	SENT_246	[p18l311t946r441b998],
23	in	IN	O	in	_	0	SENT_246	[p18l488t920r571b997],
24	various	JJ	O	various	amod	25	SENT_246	[p18l615t920r933b999],
25	phases	NNS	O	phase	prep_in	36	SENT_246	[p18l981t920r1280b1020],
26	of	IN	O	of	_	0	SENT_246	[p18l1330t919r1433b998],
27	clinical	JJ	O	clinical	amod	28	SENT_246	[p18l1463t919r1779b998],
28	evaluation	NN	O	evaluation	prep_of	25	SENT_246	[p18l1826t919r2133b999, p18l11t1042r358b1126],
29	.9	CD	NUMBER	.9	number	30	SENT_246	[p18l1826t919r2133b999, p18l11t1042r358b1126],
30	’21	CD	NUMBER	’21	num	36	SENT_246	[p18l1826t919r2133b999, p18l11t1042r358b1126],
31	The	DT	O	the	det	36	SENT_246	[p18l381t1048r544b1126],
32	orally	RB	O	orally	advmod	33	SENT_246	[p18l573t1048r811b1148],
33	active	JJ	O	active	amod	36	SENT_246	[p18l831t1049r1067b1127],
34	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_246	[p18l1090t1053r1349b1131],
35	tyrosine	NN	O	tyrosine	nn	36	SENT_246	[p18l1364t1049r1699b1148],
36	kinase	NN	O	kinase	ccomp	20	SENT_246	[p18l1724t1048r1994b1127],
37	inhibitors	NNS	O	inhibitor	nn	38	SENT_246	[p18l2020t1049r2133b1125, p18l10t1176r338b1254],
38	geﬁtinib	NN	O	geﬁtinib	dep	36	SENT_246	[p18l363t1175r718b1276],
39	and	CC	O	and	_	0	SENT_246	[p18l743t1175r899b1254],
40	erlotinib	NN	O	erlotinib	conj_and	38	SENT_246	[p18l923t1176r1281b1254],
41	have	VBP	O	have	aux	43	SENT_246	[p18l1306t1175r1494b1255],
42	been	VBN	O	be	auxpass	43	SENT_246	[p18l1519t1176r1718b1254],
43	evaluated	VBN	O	evaluate	_	0	SENT_246	[p18l1742t1176r2135b1255],
44	in	IN	O	in	_	0	SENT_246	[p18l10t1305r91b1381],
45	several	JJ	O	several	amod	46	SENT_246	[p18l116t1304r396b1383],
46	trials	NNS	O	trial	prep_in	43	SENT_246	[p18l419t1304r647b1382],
47	.	.	O	.	_	0	SENT_246	[p18l419t1304r647b1382],

1	In	IN	O	in	_	0	SENT_247	[p18l675t1311r761b1381],
2	the	DT	O	the	det	5	SENT_247	[p18l785t1304r913b1382],
3	IDEAL	NNP	O	IDEAL	nn	5	SENT_247	[p18l936t1311r1211b1382],
4	1	CD	NUMBER	1	num	5	SENT_247	[p18l1236t1309r1280b1381],
5	trial	NN	O	trial	prep_in	27	SENT_247	[p18l1305t1298r1575b1399],
6	,	,	O	,	_	0	SENT_247	[p18l1305t1298r1575b1399],
7	“	CD	NUMBER	“	num	8	SENT_247	[p18l1305t1298r1575b1399],
8	patients	NNS	O	patient	nsubjpass	27	SENT_247	[p18l1598t1305r1927b1404],
9	with	IN	O	with	_	0	SENT_247	[p18l1949t1304r2135b1383],
10	non	JJ	O	non	amod	16	SENT_247	[p18l10t1431r654b1510],
11	—	JJ	O	—	amod	16	SENT_247	[p18l10t1431r654b1510],
12	small	JJ	O	small	amod	16	SENT_247	[p18l10t1431r654b1510],
13	—	NN	O	—	nn	16	SENT_247	[p18l10t1431r654b1510],
14	cell	NN	O	cell	nn	16	SENT_247	[p18l10t1431r654b1510],
15	lung	NN	O	lung	nn	16	SENT_247	[p18l682t1432r879b1532],
16	cancer	NN	O	cancer	prep_with	8	SENT_247	[p18l905t1457r1186b1510],
17	with	IN	O	with	_	0	SENT_247	[p18l1207t1431r1400b1511],
18	disease	NN	O	disease	nn	19	SENT_247	[p18l1429t1432r1739b1510],
19	progression	NN	O	progression	prep_with	16	SENT_247	[p18l1767t1457r2132b1532, p18l12t1560r191b1638],
20	after	IN	O	after	_	0	SENT_247	[p18l214t1559r407b1638],
21	platinum	NN	O	platinum	nn	22	SENT_247	[p18l426t1559r1094b1660],
22	—	NN	O	—	prep_after	19	SENT_247	[p18l426t1559r1094b1660],
23	based	VBN	O	base	partmod	22	SENT_247	[p18l426t1559r1094b1660],
24	chemotherapy	NN	O	chemotherapy	dobj	23	SENT_247	[p18l1118t1560r1725b1660],
25	were	VBD	O	be	auxpass	27	SENT_247	[p18l1739t1586r1940b1639],
26	randomly	RB	O	randomly	advmod	27	SENT_247	[p18l1963t1585r2133b1638, p18l11t1687r281b1788],
27	assigned	VBN	O	assign	_	0	SENT_247	[p18l314t1687r693b1788],
28	to	TO	O	to	aux	29	SENT_247	[p18l732t1704r812b1766],
29	receive	VB	O	receive	xcomp	27	SENT_247	[p18l853t1688r1145b1767],
30	geﬁtinib	NN	O	geﬁtinib	dobj	29	SENT_247	[p18l1184t1687r1574b1788],
31	,	,	O	,	_	0	SENT_247	[p18l1184t1687r1574b1788],
32	at	IN	O	at	_	0	SENT_247	[p18l1617t1704r1698b1766],
33	a	DT	O	a	det	34	SENT_247	[p18l1731t1714r1776b1766],
34	dose	NN	O	dose	prep_at	29	SENT_247	[p18l1814t1688r2010b1766],
35	of	IN	O	of	_	0	SENT_247	[p18l2051t1687r2152b1766],
36	250	CD	NUMBER	250	num	37	SENT_247	[p18l10t1821r166b1894],
37	mg	NN	O	mg	prep_of	34	SENT_247	[p18l194t1842r335b1916],
38	or	CC	O	or	_	0	SENT_247	[p18l361t1841r450b1894],
39	500	CD	NUMBER	500	num	40	SENT_247	[p18l477t1821r631b1894],
40	mg	NN	O	mg	conj_or	37	SENT_247	[p18l659t1842r800b1916],
41	daily	RB	SET	daily	advmod	29	SENT_247	[p18l825t1816r1042b1916],
42	.	.	O	.	_	0	SENT_247	[p18l825t1816r1042b1916],

1	There	EX	O	there	expl	2	SENT_248	[p18l1072t1816r1321b1894],
2	were	VBD	O	be	_	0	SENT_248	[p18l1344t1842r1549b1895],
3	no	DT	O	no	det	4	SENT_248	[p18l1577t1841r1684b1894],
4	differences	NNS	O	difference	nsubj	2	SENT_248	[p18l1714t1815r2132b1894, p18l11t1970r94b2022],
5	between	IN	O	between	_	0	SENT_248	[p18l126t1944r481b2023],
6	the	DT	O	the	det	8	SENT_248	[p18l508t1944r637b2022],
7	tvvo	NN	O	tvvo	nn	8	SENT_248	[p18l664t1960r816b2023],
8	doses	NNS	O	dose	prep_between	4	SENT_248	[p18l846t1944r1081b2022],
9	with	IN	O	with	_	0	SENT_248	[p18l1105t1944r1294b2023],
10	respect	NN	O	respect	_	0	SENT_248	[p18l1321t1960r1626b2044],
11	to	TO	O	to	_	0	SENT_248	[p18l1648t1960r1727b2022],
12	response	NN	O	response	nn	13	SENT_248	[p18l1755t1969r2135b2044],
13	rate	NN	O	rate	prep_with_respect_to	8	SENT_248	[p18l10t2088r191b2167],
14	,	,	O	,	_	0	SENT_248	[p18l10t2088r191b2167],
15	time	NN	O	time	nsubj	2	SENT_248	[p18l222t2072r411b2150],
16	to	TO	O	to	_	0	SENT_248	[p18l439t2088r519b2150],
17	progression	NN	O	progression	prep_to	15	SENT_248	[p18l547t2072r1091b2172],
18	,	,	O	,	_	0	SENT_248	[p18l547t2072r1091b2172],
19	or	CC	O	or	_	0	SENT_248	[p18l1125t2097r1215b2150],
20	median	JJ	O	median	amod	21	SENT_248	[p18l1240t2072r1561b2150],
21	survival	NN	O	survival	nsubj	2	SENT_248	[p18l1590t2072r1940b2151],
22	.	.	O	.	_	0	SENT_248	[p18l1590t2072r1940b2151],

1	The	DT	O	the	det	3	SENT_249	[p18l1970t2072r2134b2150],
2	response	NN	O	response	nn	3	SENT_249	[p18l10t2225r397b2300],
3	rates	NNS	O	rate	nsubj	6	SENT_249	[p18l429t2216r628b2278],
4	were	VBD	O	be	cop	6	SENT_249	[p18l655t2226r856b2279],
5	also	RB	O	also	advmod	6	SENT_249	[p18l886t2200r1052b2278],
6	similar	JJ	O	similar	_	0	SENT_249	[p18l1085t2200r1379b2278],
7	whether	IN	O	whether	complm	10	SENT_249	[p18l1402t2200r1753b2279],
8	geﬁtinib	NN	O	geﬁtinib	nsubjpass	10	SENT_249	[p18l1779t2199r2134b2300],
9	was	VBD	O	be	auxpass	10	SENT_249	[p18l6t2354r166b2407],
10	used	VBN	O	use	ccomp	6	SENT_249	[p18l193t2327r388b2407],
11	as	IN	O	as	_	0	SENT_249	[p18l412t2354r496b2406],
12	second	JJ	ORDINAL	second	amod	15	SENT_249	[p18l524t2327r1013b2406],
13	—	NN	O	—	nn	15	SENT_249	[p18l524t2327r1013b2406],
14	line	NN	O	line	nn	15	SENT_249	[p18l524t2327r1013b2406],
15	treatment	NN	O	treatment	prep_as	10	SENT_249	[p18l1038t2344r1452b2406],
16	(	CD	PERCENT	(	number	17	SENT_249	[p18l1477t2333r1688b2419],
17	17.9	CD	PERCENT	17.9	num	18	SENT_249	[p18l1477t2333r1688b2419],
18	percent	NN	PERCENT	percent	dep	29	SENT_249	[p18l1713t2344r2033b2428],
19	of	IN	O	of	_	0	SENT_249	[p18l2053t2327r2153b2406],
20	patients	NNS	O	patient	prep_of	18	SENT_249	[p18l9t2456r375b2556],
21	)	CD	NUMBER	)	num	20	SENT_249	[p18l9t2456r375b2556],
22	or	CC	O	or	_	0	SENT_249	[p18l422t2481r511b2534],
23	third	JJ	ORDINAL	third	amod	24	SENT_249	[p18l549t2456r947b2534],
24	—	NN	O	—	conj_or	20	SENT_249	[p18l549t2456r947b2534],
25	line	NN	O	line	nn	26	SENT_249	[p18l549t2456r947b2534],
26	treatment	NN	O	treatment	dep	29	SENT_249	[p18l988t2472r1402b2534],
27	(	CD	PERCENT	(	number	28	SENT_249	[p18l1443t2461r1654b2547],
28	19.8	CD	PERCENT	19.8	num	29	SENT_249	[p18l1443t2461r1654b2547],
29	percent	NN	PERCENT	percent	dep	32	SENT_249	[p18l1696t2472r2016b2556],
30	of	IN	O	of	_	0	SENT_249	[p18l2053t2455r2153b2534],
31	patients	NNS	O	patient	prep_of	29	SENT_249	[p18l9t2584r418b2684],
32	)	CD	NUMBER	)	dep	15	SENT_249	[p18l9t2584r418b2684],
33	.	.	O	.	_	0	SENT_249	[p18l9t2584r418b2684],

1	In	IN	O	in	_	0	SENT_250	[p18l458t2591r547b2661],
2	the	DT	O	the	det	5	SENT_250	[p18l583t2584r716b2662],
3	IDEAL	NNP	O	IDEAL	nn	5	SENT_250	[p18l750t2591r1036b2662],
4	2	CD	NUMBER	2	num	5	SENT_250	[p18l1069t2589r1116b2661],
5	trial	NN	O	trial	prep_in	31	SENT_250	[p18l1153t2578r1440b2679],
6	,	,	O	,	_	0	SENT_250	[p18l1153t2578r1440b2679],
7	“	NN	O	“	appos	5	SENT_250	[p18l1153t2578r1440b2679],
8	which	WDT	O	which	nsubj	9	SENT_250	[p18l1472t2584r1738b2663],
9	enrolled	VBD	O	enrol	rcmod	7	SENT_250	[p18l1775t2584r2133b2662],
10	symptomatic	JJ	O	symptomatic	amod	11	SENT_250	[p18l12t2712r566b2812],
11	patients	NNS	O	patient	dobj	9	SENT_250	[p18l599t2712r934b2812],
12	in	IN	O	in	_	0	SENT_250	[p18l971t2712r1052b2789],
13	whom	WP	O	whom	rel	24	SENT_250	[p18l1083t2712r1355b2791],
14	two	CD	NUMBER	two	num	18	SENT_250	[p18l1390t2728r1543b2791],
15	or	CC	O	or	_	0	SENT_250	[p18l1580t2737r1669b2790],
16	more	JJR	O	more	conj_or	14	SENT_250	[p18l1701t2737r1921b2790],
17	chemotherapy	NN	O	chemotherapy	nn	18	SENT_250	[p18l1958t2712r2134b2790, p18l10t2839r463b2940],
18	regimens	NNS	O	regimen	nsubj	24	SENT_250	[p18l483t2840r869b2940],
19	containing	VBG	O	contain	partmod	18	SENT_250	[p18l897t2840r1351b2940],
20	platinum	NN	O	platinum	dobj	19	SENT_250	[p18l1371t2840r1751b2940],
21	and	CC	O	and	_	0	SENT_250	[p18l1775t2839r1929b2918],
22	docetaxel	NN	O	docetaxel	dobj	19	SENT_250	[p18l1955t2840r2134b2918, p18l11t2968r251b3046],
23	had	VBD	O	have	aux	24	SENT_250	[p18l287t2967r441b3046],
24	failed	VBN	O	fail	rcmod	11	SENT_250	[p18l477t2967r733b3063],
25	,	,	O	,	_	0	SENT_250	[p18l477t2967r733b3063],
26	the	DT	O	the	det	28	SENT_250	[p18l775t2968r904b3046],
27	response	NN	O	response	nn	28	SENT_250	[p18l941t2993r1321b3068],
28	rates	NNS	O	rate	nsubj	31	SENT_250	[p18l1357t2984r1556b3046],
29	were	VBD	O	be	cop	31	SENT_250	[p18l1589t2994r1792b3047],
30	12	CD	PERCENT	12	num	31	SENT_250	[p18l1832t2973r1928b3045],
31	percent	NN	PERCENT	percent	_	0	SENT_250	[p18l1964t2994r2133b3068, p18l11t3112r193b3174],
32	and	CC	O	and	_	0	SENT_250	[p18l220t3095r378b3174],
33	9	CD	PERCENT	9	num	34	SENT_250	[p18l411t3101r458b3174],
34	percent	NN	PERCENT	percent	conj_and	31	SENT_250	[p18l490t3112r836b3196],
35	,	,	O	,	_	0	SENT_250	[p18l490t3112r836b3196],
36	respectively	RB	O	respectively	advmod	34	SENT_250	[p18l874t3096r1391b3196],
37	,	,	O	,	_	0	SENT_250	[p18l874t3096r1391b3196],
38	for	IN	O	for	_	0	SENT_250	[p18l1428t3095r1553b3174],
39	the	DT	O	the	det	42	SENT_250	[p18l1584t3096r1715b3174],
40	two	CD	NUMBER	two	num	42	SENT_250	[p18l1748t3112r1903b3175],
41	dose	NN	O	dose	nn	42	SENT_250	[p18l1937t3096r2134b3174],
42	levels	NNS	O	level	prep_for	34	SENT_250	[p18l9t3223r269b3303],
43	.	.	O	.	_	0	SENT_250	[p18l9t3223r269b3303],

1	More	RBR	O	more	advmod	2	SENT_251	[p18l295t3231r517b3302],
2	adverse	JJ	O	adverse	amod	3	SENT_251	[p18l538t3223r851b3303],
3	events	NNS	O	event	nsubjpass	5	SENT_251	[p18l874t3240r1133b3303],
4	were	VBD	O	be	auxpass	5	SENT_251	[p18l1152t3250r1353b3303],
5	seen	VBN	O	see	_	0	SENT_251	[p18l1376t3249r1563b3302],
6	with	IN	O	with	_	0	SENT_251	[p18l1579t3224r1769b3303],
7	the	DT	O	the	det	8	SENT_251	[p18l1790t3224r1919b3302],
8	dose	NN	O	dose	prep_with	5	SENT_251	[p18l1941t3223r2135b3302],
9	of	IN	O	of	_	0	SENT_251	[p18l11t3351r113b3430],
10	500	CD	NUMBER	500	num	11	SENT_251	[p18l134t3357r289b3430],
11	mg	NN	O	mg	prep_of	8	SENT_251	[p18l327t3378r468b3452],
12	in	IN	O	in	prep	5	SENT_251	[p18l501t3352r584b3429],
13	both	CC	O	both	dep	12	SENT_251	[p18l623t3351r820b3430],
14	trials	NNS	O	trial	conj	12	SENT_251	[p18l859t3352r1100b3447],
15	,	,	O	,	_	0	SENT_251	[p18l859t3352r1100b3447],
16	but	CC	O	but	_	0	SENT_251	[p18l1144t3351r1289b3431],
17	discontinuation	NN	O	discontinuation	nsubj	25	SENT_251	[p18l1322t3352r2012b3431],
18	of	IN	O	of	_	0	SENT_251	[p18l2050t3351r2152b3430],
19	treatment	NN	O	treatment	prep_of	17	SENT_251	[p18l11t3496r433b3558],
20	because	IN	O	because	_	0	SENT_251	[p18l456t3480r788b3559],
21	of	IN	O	of	_	0	SENT_251	[p18l817t3479r917b3558],
22	toxic	JJ	O	toxic	amod	23	SENT_251	[p18l927t3480r1127b3558],
23	effects	NNS	O	effect	prep_because_of	19	SENT_251	[p18l1155t3479r1425b3558],
24	was	VBD	O	be	cop	25	SENT_251	[p18l1451t3506r1611b3559],
25	uncommon	JJ	O	uncommon	conj_but	5	SENT_251	[p18l1642t3505r2135b3559],
26	at	IN	O	at	prep	25	SENT_251	[p18l10t3624r89b3686],
27	either	CC	O	either	prep	25	SENT_251	[p18l110t3608r353b3686],
28	dose	NN	O	dose	dep	27	SENT_251	[p18l377t3608r594b3686],
29	.	.	O	.	_	0	SENT_251	[p18l377t3608r594b3686],

1	In	IN	O	in	dep	5	SENT_252	[p18l624t3615r711b3685],
2	a	DT	O	a	det	3	SENT_252	[p18l736t3634r780b3686],
3	phase	NN	O	phase	pobj	1	SENT_252	[p18l803t3608r1050b3708],
4	2	CD	NUMBER	2	num	5	SENT_252	[p18l1076t3613r1124b3685],
5	trial	NN	O	trial	_	0	SENT_252	[p18l1150t3607r1317b3686],
6	of	IN	O	of	_	0	SENT_252	[p18l1343t3607r1444b3686],
7	erlotinib	NN	O	erlotinib	prep_of	5	SENT_252	[p18l1452t3608r1835b3703],
8	,	,	O	,	_	0	SENT_252	[p18l1452t3608r1835b3703],
9	the	DT	O	the	det	10	SENT_252	[p18l1867t3608r1996b3686],
10	response	NN	O	response	appos	7	SENT_252	[p18l2022t3634r2134b3686, p19l12t46r306b121],

1	rate	NN	O	rate	nsubj	4	SENT_253	[p19l339t37r495b99],
2	was	VBD	O	be	cop	4	SENT_253	[p19l524t47r685b100],
3	12	CD	PERCENT	12	num	4	SENT_253	[p19l723t26r820b98],
4	percent	NN	PERCENT	percent	_	0	SENT_253	[p19l853t37r1192b121],
5	,	,	O	,	_	0	SENT_253	[p19l853t37r1192b121],
6	and	CC	O	and	_	0	SENT_253	[p19l1229t21r1385b99],
7	response	NN	O	response	nsubj	10	SENT_253	[p19l1418t46r1797b121],
8	did	VBD	O	do	aux	10	SENT_253	[p19l1831t21r1964b99],
9	not	RB	O	not	neg	10	SENT_253	[p19l1997t37r2140b99],
10	correlate	VB	O	correlate	conj_and	4	SENT_253	[p19l11t149r378b227],
11	with	IN	O	with	_	0	SENT_253	[p19l398t149r587b228],
12	level	NN	O	level	prep_with	10	SENT_253	[p19l611t149r798b228],
13	of	IN	O	of	_	0	SENT_253	[p19l824t148r924b227],
14	EGFR	NN	ORGANIZATION	egfr	prep_of	12	SENT_253	[p19l930t154r1188b232],
15	in	IN	O	in	_	0	SENT_253	[p19l1202t149r1284b226],
16	the	DT	O	the	det	17	SENT_253	[p19l1309t149r1438b227],
17	tumor	NN	O	tumor	prep_in	10	SENT_253	[p19l1464t143r1829b228],
18	.	.	O	.	_	0	SENT_253	[p19l1464t143r1829b228],

1	”	NN	O	”	_	0	SENT_254	[p19l1464t143r1829b228],

1	In	IN	O	in	_	0	SENT_255	[p19l138t284r225b354],
2	our	PRP$	O	we	poss	3	SENT_255	[p19l268t302r414b356],
3	trial	NN	O	trial	prep_in	12	SENT_255	[p19l456t277r650b372],
4	,	,	O	,	_	0	SENT_255	[p19l456t277r650b372],
5	the	DT	O	the	det	7	SENT_255	[p19l700t277r832b355],
6	response	NN	O	response	nn	7	SENT_255	[p19l875t302r1262b377],
7	rate	NN	O	rate	nsubj	12	SENT_255	[p19l1306t293r1466b355],
8	of	IN	O	of	_	0	SENT_255	[p19l1510t276r1612b355],
9	8.9	CD	PERCENT	8.9	num	10	SENT_255	[p19l1638t282r1769b355],
10	percent	NN	PERCENT	percent	prep_of	7	SENT_255	[p19l1812t293r2139b377],
11	was	VBD	O	be	cop	12	SENT_255	[p19l6t431r169b484],
12	similar	JJ	O	similar	_	0	SENT_255	[p19l202t404r503b483],
13	to	TO	O	to	_	0	SENT_255	[p19l529t421r609b483],
14	rates	NNS	O	rate	prep_to	12	SENT_255	[p19l639t421r841b483],
15	reported	VBN	O	report	partmod	14	SENT_255	[p19l873t405r1239b505],
16	for	IN	O	for	_	0	SENT_255	[p19l1268t404r1393b483],
17	erlotinib	NN	O	erlotinib	prep_for	15	SENT_255	[p19l1419t405r1786b483],
18	and	CC	O	and	_	0	SENT_255	[p19l1816t405r1974b483],
19	ge12s	NNS	O	ge12	prep_for	15	SENT_255	[p19l2002t431r2133b505, p19l149t580r204b601],

1	N	NN	O	n	nn	2	SENT_256	[p19l918t582r932b597],
2	ENGLJ	NN	O	englj	dep	3	SENT_256	[p19l947t581r1031b603],
3	MED	VBD	O	med	_	0	SENT_256	[p19l1046t582r1099b597],
4	353:2	CD	NUMBER	353:2	num	6	SENT_256	[p19l1111t581r1175b603],
5	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	6	SENT_256	[p19l1210t581r1421b603],
6	jULY14	NN	O	july14	dobj	3	SENT_256	[p19l1455t581r1638b603],
7	,2005	CD	NUMBER	,2005	nsubj	3	SENT_256	[p19l1455t581r1638b603],

1	The	DT	O	the	det	4	SENT_257	[p19l935t614r986b638],
2	New	NNP	O	New	nn	4	SENT_257	[p19l995t615r1057b638],
3	England	NNP	O	England	nn	4	SENT_257	[p19l1066t614r1177b645],
4	Journal	NNP	O	Journal	_	0	SENT_257	[p19l1186t614r1283b638],
5	of	IN	O	of	_	0	SENT_257	[p19l1293t614r1322b638],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_257	[p19l1329t614r1454b638],

1	ERLOTINIB	NNP	O	ERLOTINIB	nsubj	4	SENT_258	[p19l336t740r523b759],
2	IN	IN	O	in	prep	1	SENT_258	[p19l538t740r577b759],
3	PREVIOUSLY	RB	DATE	previously	pcomp	2	SENT_258	[p19l592t740r797b759],
4	TREATED	VBN	O	treat	_	0	SENT_258	[p19l808t740r959b759],
5	NON	NN	O	non	dobj	4	SENT_258	[p19l974t740r1279b759],
6	.	.	O	.	_	0	SENT_258	[p19l974t740r1279b759],

1	—	NN	O	—	_	0	SENT_259	[p19l974t740r1279b759],
2	.	.	O	.	_	0	SENT_259	[p19l974t740r1279b759],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_260	[p19l974t740r1279b759],
2	LUNG	NN	O	lung	_	0	SENT_260	[p19l1293t740r1387b759],
3	CANCER	NNP	O	CANCER	dep	2	SENT_260	[p19l1400t740r1536b759],

1	Table	NNP	O	Table	_	0	SENT_261	[p19l120t867r191b892],
2	3	CD	NUMBER	3	dep	1	SENT_261	[p19l200t869r223b892],
3	.	.	O	.	_	0	SENT_261	[p19l200t869r223b892],

1	Analysis	NN	O	analysis	_	0	SENT_262	[p19l232t867r345b900],
2	of	IN	O	of	_	0	SENT_262	[p19l355t866r523b892],
3	'	''	O	'	_	0	SENT_262	[p19l355t866r523b892],
4	Surviva	FW	O	surviva	nn	5	SENT_262	[p19l355t866r523b892],
5	|	FW	O	|	prep_of	1	SENT_262	[p19l355t866r523b892],
6	.	.	O	.	_	0	SENT_262	[p19l355t866r523b892],

1	*	NN	O	*	_	0	SENT_263	[p19l355t866r523b892],

1	Univariate	NNP	O	Univariate	_	0	SENT_264	[p19l895t939r1035b963],

1	No.	NN	O	no.	_	0	SENT_265	[p19l660t978r706b1001],
2	of	IN	O	of	_	0	SENT_265	[p19l716t975r747b1001],
3	Hazard	NNP	O	Hazard	nn	5	SENT_265	[p19l877t976r973b1001],
4	Ratio	NNP	O	Ratio	nn	5	SENT_265	[p19l985t976r1053b1001],
5	Multivariate	NNP	O	Multivariate	prep_of	1	SENT_265	[p19l1380t976r1543b1001],

1	Factor	NN	O	factor	nn	2	SENT_266	[p19l123t1016r205b1039],
2	Patients	NNS	O	patient	nsubj	3	SENT_266	[p19l646t1014r754b1039],
3	(	VBP	O	(	_	0	SENT_266	[p19l897t1015r965b1047],
4	95	CD	PERCENT	95	num	5	SENT_266	[p19l897t1015r965b1047],
5	%	NN	PERCENT	%	dobj	3	SENT_266	[p19l897t1015r965b1047],
6	C	NN	O	c	prep	5	SENT_266	[p19l975t1015r1032b1046],
7	|	CD	NUMBER	|	num	8	SENT_266	[p19l975t1015r1032b1046],
8	)	NN	O	)	dep	6	SENT_266	[p19l975t1015r1032b1046],
9	'	''	O	'	_	0	SENT_266	[p19l975t1015r1032b1046],
10	i	FW	O	i	nn	13	SENT_266	[p19l975t1015r1032b1046],
11	‘	FW	O	‘	nn	13	SENT_266	[p19l975t1015r1032b1046],
12	P	NN	O	p	nn	13	SENT_266	[p19l1168t1016r1184b1038],
13	Value	NN	O	value	dep	5	SENT_266	[p19l1192t1013r1266b1039],
14	Hazard	NN	O	hazard	nn	15	SENT_266	[p19l1334t1013r1430b1038],
15	Ratio	NN	O	ratio	dep	13	SENT_266	[p19l1443t1014r1510b1038],
16	(	CD	NUMBER	(	num	17	SENT_266	[p19l1521t1015r1587b1046],
17	Cl	NN	O	cl	dep	3	SENT_266	[p19l1521t1015r1587b1046],
18	)	CD	NUMBER	)	dep	17	SENT_266	[p19l1521t1015r1587b1046],
19	:	:	O	:	_	0	SENT_266	[p19l1521t1015r1587b1046],
20	§	CD	NUMBER	§	dep	17	SENT_266	[p19l1521t1015r1587b1046],
21	:	:	O	:	_	0	SENT_266	[p19l1521t1015r1587b1046],
22	P	NN	O	p	nn	24	SENT_266	[p19l1625t1016r1640b1038],
23	Valueﬁ	NNP	O	Valueﬁ	nn	24	SENT_266	[p19l1648t1013r1739b1047],
24	Treatment	NNP	O	Treatment	dep	20	SENT_266	[p19l120t1082r260b1105],
25	group	NN	O	group	dep	24	SENT_266	[p19l269t1089r349b1113],

1	Erlotinib	NNP	O	Erlotinib	dep	9	SENT_267	[p19l173t1135r286b1160],
2	0.7	CD	NUMBER	0.7	num	1	SENT_267	[p19l878t1136r918b1160],
3	(	CD	NUMBER	(	num	4	SENT_267	[p19l931t1136r1047b1168],
4	0.6	CD	NUMBER	0.6	dep	1	SENT_267	[p19l931t1136r1047b1168],
5	—	NN	O	—	dep	9	SENT_267	[p19l931t1136r1047b1168],
6	0.9	CD	NUMBER	0.9	num	5	SENT_267	[p19l931t1136r1047b1168],
7	)	CD	NUMBER	)	num	9	SENT_267	[p19l931t1136r1047b1168],
8	0.7	CD	NUMBER	0.7	num	9	SENT_267	[p19l1374t1136r1414b1160],
9	(	NN	O	(	dep	15	SENT_267	[p19l1427t1136r1543b1168],
10	0.6	CD	NUMBER	0.6	num	11	SENT_267	[p19l1427t1136r1543b1168],
11	—	NN	O	—	dep	9	SENT_267	[p19l1427t1136r1543b1168],
12	0.9	CD	NUMBER	0.9	number	13	SENT_267	[p19l1427t1136r1543b1168],
13	)	CD	NUMBER	)	dep	11	SENT_267	[p19l1427t1136r1543b1168],
14	0.002	CD	NUMBER	0.002	num	15	SENT_267	[p19l1644t1136r1717b1160],
15	Placebo	NN	O	placebo	_	0	SENT_267	[p19l174t1190r277b1215],

1	Age	NNP	O	Age	nn	2	SENT_268	[p19l120t1247r171b1278],
2	NI	NNP	MISC	NI	_	0	SENT_268	[p19l1446t1247r1474b1270],

1	<	JJR	O	<	dep	10	SENT_269	[p19l171t1302r221b1325],
2	60	CD	DURATION	60	num	3	SENT_269	[p19l171t1302r221b1325],
3	yr	NN	DURATION	yr	dep	1	SENT_269	[p19l230t1309r254b1333],
4	0.8	CD	NUMBER	0.8	number	5	SENT_269	[p19l878t1302r917b1325],
5	(	CD	NUMBER	(	num	6	SENT_269	[p19l931t1302r1047b1333],
6	0.6-1	CD	NUMBER	0.6-1	dep	3	SENT_269	[p19l931t1302r1047b1333],
7	.0	CD	NUMBER	.0	num	8	SENT_269	[p19l931t1302r1047b1333],
8	)	NN	O	)	dep	10	SENT_269	[p19l931t1302r1047b1333],
9	260	CD	DURATION	260	num	10	SENT_269	[p19l171t1357r221b1380],
10	yr	NN	DURATION	yr	dep	16	SENT_269	[p19l230t1364r254b1388],
11	0.8	CD	NUMBER	0.8	number	12	SENT_269	[p19l878t1357r917b1380],
12	(	CD	NUMBER	(	dep	10	SENT_269	[p19l931t1357r1047b1388],
13	0.6-1	CD	NUMBER	0.6-1	num	14	SENT_269	[p19l931t1357r1047b1388],
14	.0	CD	NUMBER	.0	dep	12	SENT_269	[p19l931t1357r1047b1388],
15	)	CD	NUMBER	)	num	16	SENT_269	[p19l931t1357r1047b1388],
16	Sex	NN	O	sex	_	0	SENT_269	[p19l122t1412r167b1435],

1	Male	JJ	O	male	amod	2	SENT_270	[p19l173t1465r238b1490],
2	0.8	CD	NUMBER	0.8	dep	7	SENT_270	[p19l878t1467r917b1490],
3	(	CD	NUMBER	(	num	4	SENT_270	[p19l931t1467r1047b1498],
4	0.6	CD	NUMBER	0.6	dep	2	SENT_270	[p19l931t1467r1047b1498],
5	—	NN	O	—	dep	7	SENT_270	[p19l931t1467r1047b1498],
6	0.9	CD	NUMBER	0.9	num	5	SENT_270	[p19l931t1467r1047b1498],
7	)	CD	NUMBER	)	dep	14	SENT_270	[p19l931t1467r1047b1498],
8	Female	JJ	O	female	amod	10	SENT_270	[p19l174t1520r269b1545],
9	0.8	CD	NUMBER	0.8	number	10	SENT_270	[p19l878t1522r917b1545],
10	(	CD	NUMBER	(	dep	7	SENT_270	[p19l931t1522r1047b1553],
11	0.6	CD	NUMBER	0.6	num	12	SENT_270	[p19l931t1522r1047b1553],
12	—	NN	O	—	dep	10	SENT_270	[p19l931t1522r1047b1553],
13	1.1	CD	NUMBER	1.1	num	14	SENT_270	[p19l931t1522r1047b1553],
14	)	NN	O	)	_	0	SENT_270	[p19l931t1522r1047b1553],

1	Pathological	JJ	O	pathological	amod	3	SENT_271	[p19l123t1575r288b1608],
2	subtype	NN	O	subtype	nn	3	SENT_271	[p19l300t1575r405b1608],
3	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_271	[p19l170t1630r403b1655],
4	0.7	CD	NUMBER	0.7	num	5	SENT_271	[p19l878t1632r918b1655],
5	(	NN	O	(	dep	3	SENT_271	[p19l931t1632r1047b1663],
6	0.6	CD	NUMBER	0.6	num	7	SENT_271	[p19l931t1632r1047b1663],
7	—	CD	NUMBER	—	dep	5	SENT_271	[p19l931t1632r1047b1663],
8	0.9	CD	NUMBER	0.9	num	9	SENT_271	[p19l931t1632r1047b1663],
9	)	NN	O	)	dep	3	SENT_271	[p19l931t1632r1047b1663],
10	0.8	CD	NUMBER	0.8	number	11	SENT_271	[p19l1374t1632r1413b1655],
11	(	CD	NUMBER	(	dep	9	SENT_271	[p19l1427t1632r1543b1663],
12	0.6	CD	NUMBER	0.6	num	13	SENT_271	[p19l1427t1632r1543b1663],
13	—	NN	O	—	dep	3	SENT_271	[p19l1427t1632r1543b1663],
14	0.9	CD	NUMBER	0.9	number	15	SENT_271	[p19l1427t1632r1543b1663],
15	)	CD	NUMBER	)	num	16	SENT_271	[p19l1427t1632r1543b1663],
16	Other	JJ	O	other	dep	13	SENT_271	[p19l172t1685r251b1710],
17	0.8	CD	NUMBER	0.8	number	18	SENT_271	[p19l878t1687r917b1710],
18	(	CD	NUMBER	(	dep	3	SENT_271	[p19l931t1687r1047b1718],
19	0.6-1	CD	NUMBER	0.6-1	num	20	SENT_271	[p19l931t1687r1047b1718],
20	.0	CD	NUMBER	.0	dep	18	SENT_271	[p19l931t1687r1047b1718],
21	)	CD	NUMBER	)	num	24	SENT_271	[p19l931t1687r1047b1718],
22	Performance	NNP	O	Performance	nn	24	SENT_271	[p19l123t1740r296b1765],
23	status	NN	O	status	nn	24	SENT_271	[p19l306t1745r387b1765],
24	NA	NN	O	na	dep	3	SENT_271	[p19l1441t1742r1482b1765],
25	o	NN	O	o	nn	48	SENT_271	[p19l171t1797r186b1820],
26	or	CC	O	or	_	0	SENT_271	[p19l196t1804r224b1820],
27	1	CD	NUMBER	1	conj_or	25	SENT_271	[p19l234t1797r246b1820],
28	0.7	CD	NUMBER	0.7	num	48	SENT_271	[p19l878t1797r918b1820],
29	(	NN	O	(	nn	48	SENT_271	[p19l931t1797r1047b1828],
30	0.6	CD	NUMBER	0.6	num	48	SENT_271	[p19l931t1797r1047b1828],
31	—	CD	NUMBER	—	num	48	SENT_271	[p19l931t1797r1047b1828],
32	0.9	CD	NUMBER	0.9	num	48	SENT_271	[p19l931t1797r1047b1828],
33	)	NN	O	)	nn	48	SENT_271	[p19l931t1797r1047b1828],
34	2	CD	NUMBER	2	num	48	SENT_271	[p19l171t1852r185b1875],
35	0.8	CD	NUMBER	0.8	num	48	SENT_271	[p19l878t1852r917b1875],
36	(	NN	O	(	nn	48	SENT_271	[p19l931t1852r1047b1883],
37	0.5	CD	NUMBER	0.5	num	48	SENT_271	[p19l931t1852r1047b1883],
38	—	NN	O	—	nn	48	SENT_271	[p19l931t1852r1047b1883],
39	1.1	CD	NUMBER	1.1	num	48	SENT_271	[p19l931t1852r1047b1883],
40	)	NN	O	)	nn	48	SENT_271	[p19l931t1852r1047b1883],
41	3	CD	NUMBER	3	num	48	SENT_271	[p19l172t1907r184b1930],
42	0.8	CD	NUMBER	0.8	num	48	SENT_271	[p19l878t1907r917b1930],
43	(	NN	O	(	nn	48	SENT_271	[p19l931t1907r1047b1938],
44	0.4	CD	NUMBER	0.4	num	48	SENT_271	[p19l931t1907r1047b1938],
45	—	CD	NUMBER	—	num	48	SENT_271	[p19l931t1907r1047b1938],
46	1.3	CD	NUMBER	1.3	num	48	SENT_271	[p19l931t1907r1047b1938],
47	)	NN	O	)	nn	48	SENT_271	[p19l931t1907r1047b1938],
48	Response	NN	O	response	dep	24	SENT_271	[p19l123t1962r254b1993],
49	to	TO	O	to	_	0	SENT_271	[p19l263t1965r289b1985],
50	prior	JJ	O	prior	amod	51	SENT_271	[p19l301t1962r365b1993],
51	therapy	NN	O	therapy	prep_to	48	SENT_271	[p19l373t1960r475b1993],
52	Complete	JJ	O	complete	amod	53	SENT_271	[p19l172t2015r302b2048],
53	response	NN	O	response	dep	3	SENT_271	[p19l313t2024r436b2048],
54	or	CC	O	or	_	0	SENT_271	[p19l446t2024r474b2040],
55	partial	JJ	O	partial	amod	56	SENT_271	[p19l484t2015r567b2048],
56	0.7	CD	NUMBER	0.7	conj_or	53	SENT_271	[p19l878t2017r918b2040],
57	(	CD	NUMBER	(	dep	3	SENT_271	[p19l931t2017r1047b2048],
58	O.	NNP	O	O.	dep	57	SENT_271	[p19l931t2017r1047b2048],
59	5	CD	NUMBER	5	num	58	SENT_271	[p19l931t2017r1047b2048],
60	.	.	O	.	_	0	SENT_271	[p19l931t2017r1047b2048],

1	—	NN	O	—	_	0	SENT_272	[p19l931t2017r1047b2048],
2	.	.	O	.	_	0	SENT_272	[p19l931t2017r1047b2048],

1	O.	NNP	O	O.	_	0	SENT_273	[p19l931t2017r1047b2048],
2	9	CD	NUMBER	9	num	3	SENT_273	[p19l931t2017r1047b2048],
3	)	NN	O	)	dep	1	SENT_273	[p19l931t2017r1047b2048],

1	response	NN	O	response	_	0	SENT_274	[p19l223t2061r346b2085],

1	Stable	JJ	O	stable	amod	2	SENT_275	[p19l172t2108r254b2133],
2	disease	NN	O	disease	dep	10	SENT_275	[p19l264t2108r365b2133],
3	0.8	CD	NUMBER	0.8	number	4	SENT_275	[p19l878t2109r917b2133],
4	(	CD	NUMBER	(	dep	2	SENT_275	[p19l931t2109r1047b2141],
5	0.6	CD	NUMBER	0.6	dep	4	SENT_275	[p19l931t2109r1047b2141],
6	—	NN	O	—	dep	10	SENT_275	[p19l931t2109r1047b2141],
7	1.1	CD	NUMBER	1.1	num	6	SENT_275	[p19l931t2109r1047b2141],
8	)	CD	NUMBER	)	num	10	SENT_275	[p19l931t2109r1047b2141],
9	Progressive	JJ	O	progressive	amod	10	SENT_275	[p19l173t2165r329b2196],
10	disease	NN	O	disease	dep	16	SENT_275	[p19l339t2163r440b2188],
11	0.9	CD	NUMBER	0.9	number	12	SENT_275	[p19l878t2164r917b2188],
12	(	CD	NUMBER	(	dep	10	SENT_275	[p19l931t2164r1047b2196],
13	0.6	CD	NUMBER	0.6	num	14	SENT_275	[p19l931t2164r1047b2196],
14	—	NN	O	—	dep	12	SENT_275	[p19l931t2164r1047b2196],
15	1.2	CD	NUMBER	1.2	num	16	SENT_275	[p19l931t2164r1047b2196],
16	)	NN	O	)	_	0	SENT_275	[p19l931t2164r1047b2196],

1	Prior	RB	O	prior	_	0	SENT_276	[p19l123t2220r187b2243],
2	regimens	NNS	O	regimen	pobj	1	SENT_276	[p19l198t2220r322b2251],

1	1	CD	NUMBER	1	num	3	SENT_277	[p19l173t2275r184b2298],
2	0.8	CD	NUMBER	0.8	num	3	SENT_277	[p19l878t2274r917b2298],
3	(	NN	O	(	dep	16	SENT_277	[p19l931t2274r1047b2306],
4	0.5	CD	NUMBER	0.5	num	5	SENT_277	[p19l931t2274r1047b2306],
5	—	NN	O	—	dep	3	SENT_277	[p19l931t2274r1047b2306],
6	1.1	CD	NUMBER	1.1	num	7	SENT_277	[p19l931t2274r1047b2306],
7	)	NN	O	)	dep	5	SENT_277	[p19l931t2274r1047b2306],
8	2	CD	NUMBER	2	number	11	SENT_277	[p19l171t2330r185b2353],
9	or	CC	O	or	_	0	SENT_277	[p19l196t2337r223b2353],
10	3	CD	NUMBER	3	num	12	SENT_277	[p19l233t2330r245b2353],
11	0.8	CD	NUMBER	0.8	num	12	SENT_277	[p19l878t2329r917b2353],
12	(	NN	O	(	dep	7	SENT_277	[p19l931t2329r1047b2361],
13	0.6	CD	NUMBER	0.6	num	14	SENT_277	[p19l931t2329r1047b2361],
14	—	NN	O	—	dep	16	SENT_277	[p19l931t2329r1047b2361],
15	1.1	CD	NUMBER	1.1	num	16	SENT_277	[p19l931t2329r1047b2361],
16	)	CD	NUMBER	)	dep	25	SENT_277	[p19l931t2329r1047b2361],
17	Prior	JJ	O	prior	amod	19	SENT_277	[p19l123t2385r187b2408],
18	platinum-based	JJ	O	platinum-based	amod	19	SENT_277	[p19l198t2383r408b2416],
19	therapy	NN	O	therapy	dep	16	SENT_277	[p19l419t2383r521b2416],
20	Yes	UH	O	yes	dep	22	SENT_277	[p19l170t2440r214b2463],
21	0.7	CD	NUMBER	0.7	num	22	SENT_277	[p19l878t2439r918b2463],
22	(	CD	NUMBER	(	rcmod	19	SENT_277	[p19l931t2439r1047b2471],
23	0.5	CD	NUMBER	0.5	num	25	SENT_277	[p19l931t2439r1047b2471],
24	—	CD	NUMBER	—	num	25	SENT_277	[p19l931t2439r1047b2471],
25	o.	NN	O	o.	dep	33	SENT_277	[p19l931t2439r1047b2471],
26	9	CD	NUMBER	9	num	27	SENT_277	[p19l931t2439r1047b2471],
27	)	CD	NUMBER	)	dep	25	SENT_277	[p19l931t2439r1047b2471],
28	No	DT	O	no	det	31	SENT_277	[p19l173t2495r212b2518],
29	1.7	CD	NUMBER	1.7	number	30	SENT_277	[p19l880t2495r918b2518],
30	(	CD	NUMBER	(	num	31	SENT_277	[p19l931t2494r1047b2526],
31	o.	NN	O	o.	dep	27	SENT_277	[p19l931t2494r1047b2526],
32	7	CD	NUMBER	7	num	33	SENT_277	[p19l931t2494r1047b2526],
33	—	NN	O	—	dep	35	SENT_277	[p19l931t2494r1047b2526],
34	2.7	CD	NUMBER	2.7	num	35	SENT_277	[p19l931t2494r1047b2526],
35	)	NN	O	)	_	0	SENT_277	[p19l931t2494r1047b2526],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_278	[p19l123t2550r197b2573],
2	expression	NN	O	expression	_	0	SENT_278	[p19l208t2550r352b2581],

1	Positive	JJ	O	positive	amod	2	SENT_279	[p19l173t2605r278b2628],
2	0.7	CD	NUMBER	0.7	dep	11	SENT_279	[p19l878t2605r918b2628],
3	(	CD	NUMBER	(	num	4	SENT_279	[p19l931t2605r1047b2636],
4	o.	NN	O	o.	dep	2	SENT_279	[p19l931t2605r1047b2636],
5	5	CD	NUMBER	5	number	6	SENT_279	[p19l931t2605r1047b2636],
6	—	CD	NUMBER	—	num	7	SENT_279	[p19l931t2605r1047b2636],
7	o.	NN	O	o.	dep	4	SENT_279	[p19l931t2605r1047b2636],
8	9	CD	NUMBER	9	num	9	SENT_279	[p19l931t2605r1047b2636],
9	)	NN	O	)	dep	11	SENT_279	[p19l931t2605r1047b2636],
10	Negative	JJ	O	negative	amod	11	SENT_279	[p19l174t2660r292b2691],
11	0.9	CD	NUMBER	0.9	dep	20	SENT_279	[p19l878t2660r917b2683],
12	(	CD	NUMBER	(	num	14	SENT_279	[p19l931t2660r1047b2691],
13	0.6	CD	NUMBER	0.6	num	14	SENT_279	[p19l931t2660r1047b2691],
14	—	NN	O	—	dep	11	SENT_279	[p19l931t2660r1047b2691],
15	1.4	CD	NUMBER	1.4	num	16	SENT_279	[p19l931t2660r1047b2691],
16	)	NN	O	)	dep	14	SENT_279	[p19l931t2660r1047b2691],
17	Unknown	JJ	O	unknown	amod	16	SENT_279	[p19l173t2713r301b2738],
18	0.8	CD	NUMBER	0.8	number	19	SENT_279	[p19l878t2715r917b2738],
19	(	CD	NUMBER	(	dep	17	SENT_279	[p19l931t2715r1047b2746],
20	0.6-1	CD	NUMBER	0.6-1	dep	22	SENT_279	[p19l931t2715r1047b2746],
21	.0	CD	NUMBER	.0	num	22	SENT_279	[p19l931t2715r1047b2746],
22	)	NN	O	)	_	0	SENT_279	[p19l931t2715r1047b2746],

1	Smoking	NN	O	smoking	nn	2	SENT_280	[p19l122t2768r242b2801],
2	status	NN	O	status	_	0	SENT_280	[p19l252t2773r333b2793],

1	Current	JJ	DATE	current	amod	2	SENT_281	[p19l172t2825r274b2848],
2	smoker	NN	O	smoker	_	0	SENT_281	[p19l284t2823r385b2848],
3	or	CC	O	or	_	0	SENT_281	[p19l394t2832r421b2848],
4	ever	RB	O	ever	advmod	5	SENT_281	[p19l430t2832r486b2848],
5	smoked	VBN	O	smoke	conj_or	2	SENT_281	[p19l495t2823r601b2848],
6	0.9	CD	NUMBER	0.9	num	7	SENT_281	[p19l878t2825r917b2848],
7	(	CD	NUMBER	(	dep	5	SENT_281	[p19l931t2825r1047b2856],
8	0.7	CD	NUMBER	0.7	num	9	SENT_281	[p19l931t2825r1047b2856],
9	—	NN	O	—	dep	7	SENT_281	[p19l931t2825r1047b2856],
10	1.0	CD	NUMBER	1.0	number	11	SENT_281	[p19l931t2825r1047b2856],
11	)	CD	NUMBER	)	dep	7	SENT_281	[p19l931t2825r1047b2856],
12	Reference	NNP	O	Reference	nn	13	SENT_281	[p19l1351t2823r1482b2848],
13	group	NN	O	group	dep	11	SENT_281	[p19l1492t2832r1571b2856],
14	Never	RB	O	never	neg	15	SENT_281	[p19l174t2880r253b2903],
15	smoked	VBD	O	smoke	dep	5	SENT_281	[p19l262t2878r368b2903],
16	0.4	CD	NUMBER	0.4	num	17	SENT_281	[p19l878t2880r918b2903],
17	(	CD	NUMBER	(	dobj	15	SENT_281	[p19l931t2880r1047b2911],
18	0.3	CD	NUMBER	0.3	num	19	SENT_281	[p19l931t2880r1047b2911],
19	—	NN	O	—	dep	17	SENT_281	[p19l931t2880r1047b2911],
20	0.6	CD	NUMBER	0.6	num	21	SENT_281	[p19l931t2880r1047b2911],
21	)	NN	O	)	dep	33	SENT_281	[p19l931t2880r1047b2911],
22	0.8	CD	NUMBER	0.8	number	23	SENT_281	[p19l1374t2880r1413b2903],
23	(	CD	NUMBER	(	dep	21	SENT_281	[p19l1427t2880r1543b2911],
24	0.6-1	CD	NUMBER	0.6-1	num	26	SENT_281	[p19l1427t2880r1543b2911],
25	.0	CD	NUMBER	.0	num	26	SENT_281	[p19l1427t2880r1543b2911],
26	)	NN	O	)	dep	23	SENT_281	[p19l1427t2880r1543b2911],
27	Unknown	JJ	O	unknown	amod	23	SENT_281	[p19l173t2933r301b2958],
28	1.1	CD	NUMBER	1.1	number	29	SENT_281	[p19l880t2935r916b2958],
29	(	CD	NUMBER	(	dep	27	SENT_281	[p19l931t2935r1047b2966],
30	0.5	CD	NUMBER	0.5	num	31	SENT_281	[p19l931t2935r1047b2966],
31	—	NN	O	—	dep	33	SENT_281	[p19l931t2935r1047b2966],
32	2.6	CD	NUMBER	2.6	num	33	SENT_281	[p19l931t2935r1047b2966],
33	)	NN	O	)	dep	17	SENT_281	[p19l931t2935r1047b2966],
34	1.0	CD	NUMBER	1.0	num	36	SENT_281	[p19l1376t2935r1414b2958],
35	(	CD	NUMBER	(	num	36	SENT_281	[p19l1427t2935r1543b2966],
36	o.	NN	O	o.	dep	33	SENT_281	[p19l1427t2935r1543b2966],
37	7	CD	NUMBER	7	num	40	SENT_281	[p19l1427t2935r1543b2966],
38	—	NN	O	—	nn	40	SENT_281	[p19l1427t2935r1543b2966],
39	1.5	CD	NUMBER	1.5	num	40	SENT_281	[p19l1427t2935r1543b2966],
40	)	NN	O	)	nsubj	5	SENT_281	[p19l1427t2935r1543b2966],

1	Race	NN	O	race	nn	4	SENT_282	[p19l123t2990r185b3013],
2	or	CC	O	or	_	0	SENT_282	[p19l195t2997r223b3013],
3	ethnic	JJ	O	ethnic	nn	4	SENT_282	[p19l232t2988r315b3013],
4	group	NN	O	group	_	0	SENT_282	[p19l325t2997r404b3021],
5	Asian	JJ	MISC	asian	amod	6	SENT_282	[p19l170t3045r245b3068],
6	0.6	CD	NUMBER	0.6	dep	4	SENT_282	[p19l878t3045r918b3068],
7	(	CD	NUMBER	(	num	8	SENT_282	[p19l931t3045r1047b3076],
8	o.	NN	O	o.	dep	6	SENT_282	[p19l931t3045r1047b3076],
9	4	CD	NUMBER	4	num	10	SENT_282	[p19l931t3045r1047b3076],
10	—	NN	O	—	dep	4	SENT_282	[p19l931t3045r1047b3076],
11	1	CD	NUMBER	1	dep	10	SENT_282	[p19l931t3045r1047b3076],
12	.	.	O	.	_	0	SENT_282	[p19l931t3045r1047b3076],

1	o	NN	O	o	nn	3	SENT_283	[p19l931t3045r1047b3076],
2	)	CD	NUMBER	)	num	3	SENT_283	[p19l931t3045r1047b3076],
3	o.	NN	O	o.	dep	13	SENT_283	[p19l1374t3045r1414b3068],
4	7	CD	NUMBER	7	number	5	SENT_283	[p19l1374t3045r1414b3068],
5	(	CD	NUMBER	(	num	6	SENT_283	[p19l1427t3045r1543b3076],
6	o.	NN	O	o.	dep	3	SENT_283	[p19l1427t3045r1543b3076],
7	5	CD	NUMBER	5	number	8	SENT_283	[p19l1427t3045r1543b3076],
8	—	CD	NUMBER	—	num	9	SENT_283	[p19l1427t3045r1543b3076],
9	o.	NN	O	o.	dep	6	SENT_283	[p19l1427t3045r1543b3076],
10	9	CD	NUMBER	9	num	11	SENT_283	[p19l1427t3045r1543b3076],
11	)	NN	O	)	dep	13	SENT_283	[p19l1427t3045r1543b3076],
12	Other	JJ	O	other	amod	13	SENT_283	[p19l172t3098r251b3123],
13	0.3	CD	NUMBER	0.3	dep	20	SENT_283	[p19l878t3100r917b3123],
14	(	CD	NUMBER	(	num	15	SENT_283	[p19l931t3100r1047b3131],
15	o.	NN	O	o.	dep	13	SENT_283	[p19l931t3100r1047b3131],
16	7	CD	NUMBER	7	number	17	SENT_283	[p19l931t3100r1047b3131],
17	—	CD	NUMBER	—	num	18	SENT_283	[p19l931t3100r1047b3131],
18	o.	NN	O	o.	dep	15	SENT_283	[p19l931t3100r1047b3131],
19	9	CD	NUMBER	9	num	20	SENT_283	[p19l931t3100r1047b3131],
20	)	NN	O	)	_	0	SENT_283	[p19l931t3100r1047b3131],

1	*	NN	O	*	nn	2	SENT_284	[p19l94t3193r109b3207],
2	CI	NN	O	ci	nsubj	18	SENT_284	[p19l119t3192r145b3215],
3	denotes	VBZ	O	denote	_	0	SENT_284	[p19l157t3190r265b3215],
4	confidence	NN	O	confidence	nn	5	SENT_284	[p19l275t3190r424b3215],
5	interval	NN	O	interval	dobj	3	SENT_284	[p19l435t3190r541b3220],
6	,	,	O	,	_	0	SENT_284	[p19l435t3190r541b3220],
7	NI	NNP	O	NI	nsubj	9	SENT_284	[p19l554t3193r583b3215],
8	not	RB	O	not	neg	9	SENT_284	[p19l597t3195r640b3215],
9	included	VBD	O	include	ccomp	3	SENT_284	[p19l650t3190r764b3215],
10	in	IN	O	in	_	0	SENT_284	[p19l777t3193r798b3215],
11	the	DT	O	the	det	13	SENT_284	[p19l809t3190r852b3215],
12	ﬁnal	JJ	O	ﬁnal	amod	13	SENT_284	[p19l861t3190r917b3215],
13	model	NN	O	model	prep_in	9	SENT_284	[p19l930t3190r1021b3220],
14	,	,	O	,	_	0	SENT_284	[p19l930t3190r1021b3220],
15	and	CC	O	and	_	0	SENT_284	[p19l1033t3190r1081b3215],
16	NA	NNP	O	NA	dep	18	SENT_284	[p19l1095t3192r1136b3215],
17	not	RB	O	not	neg	18	SENT_284	[p19l1147t3195r1190b3215],
18	applicable	JJ	O	applicable	conj_and	3	SENT_284	[p19l1200t3190r1337b3223],
19	as	IN	O	as	_	0	SENT_284	[p19l1348t3199r1375b3215],
20	a	DT	O	a	det	22	SENT_284	[p19l1386t3199r1399b3215],
21	stratification	NN	O	stratification	nn	22	SENT_284	[p19l1410t3190r1579b3215],
22	factor	NN	O	factor	prep_as	18	SENT_284	[p19l1590t3190r1672b3215],
23	.	.	O	.	_	0	SENT_284	[p19l1590t3190r1672b3215],

1	1	CD	NUMBER	1	dep	8	SENT_285	[p19l95t3230r110b3261],
2	'	''	O	'	_	0	SENT_285	[p19l95t3230r110b3261],
3	The	DT	O	the	det	6	SENT_285	[p19l118t3228r168b3253],
4	univariate	JJ	O	univariate	amod	6	SENT_285	[p19l180t3230r313b3253],
5	hazard	NN	O	hazard	nn	6	SENT_285	[p19l324t3228r413b3253],
6	ratio	NN	O	ratio	nsubjpass	8	SENT_285	[p19l426t3230r486b3253],
7	was	VBD	O	be	auxpass	8	SENT_285	[p19l495t3237r546b3253],
8	derived	VBN	O	derive	_	0	SENT_285	[p19l557t3228r655b3253],
9	from	IN	O	from	_	0	SENT_285	[p19l665t3227r729b3253],
10	a	DT	O	a	det	12	SENT_285	[p19l741t3237r753b3253],
11	Cox	NN	ORGANIZATION	cox	nn	12	SENT_285	[p19l764t3230r813b3253],
12	model	NN	O	model	prep_from	8	SENT_285	[p19l824t3228r906b3253],
13	with	IN	O	with	_	0	SENT_285	[p19l916t3228r973b3253],
14	a	DT	O	a	det	17	SENT_285	[p19l984t3237r997b3253],
15	single	JJ	O	single	amod	17	SENT_285	[p19l1008t3228r1087b3261],
16	treatment	NN	O	treatment	nn	17	SENT_285	[p19l1096t3233r1231b3253],
17	covariate	NN	O	covariate	prep_with	8	SENT_285	[p19l1241t3230r1370b3253],
18	.	.	O	.	_	0	SENT_285	[p19l1241t3230r1370b3253],

1	1	CD	NUMBER	1	num	4	SENT_286	[p19l95t3268r110b3298],
2	The	DT	O	the	det	4	SENT_286	[p19l118t3265r168b3290],
3	hazard	NN	O	hazard	nn	4	SENT_286	[p19l180t3265r269b3290],
4	ratio	NN	O	ratio	nsubjpass	11	SENT_286	[p19l282t3268r341b3290],
5	between	IN	O	between	_	0	SENT_286	[p19l353t3265r463b3290],
6	levels	NNS	O	level	prep_between	4	SENT_286	[p19l476t3265r548b3290],
7	of	IN	O	of	_	0	SENT_286	[p19l559t3265r589b3290],
8	respective	JJ	O	respective	amod	9	SENT_286	[p19l596t3268r731b3298],
9	covariates	NNS	O	covariate	prep_of	6	SENT_286	[p19l741t3268r878b3290],
10	was	VBD	O	be	auxpass	11	SENT_286	[p19l888t3274r939b3290],
11	derived	VBN	O	derive	_	0	SENT_286	[p19l949t3265r1047b3290],
12	from	IN	O	from	_	0	SENT_286	[p19l1058t3265r1122b3290],
13	the	DT	O	the	det	18	SENT_286	[p19l1132t3265r1175b3290],
14	ﬁnal	JJ	O	ﬁnal	amod	15	SENT_286	[p19l1184t3265r1241b3290],
15	stratified	JJ	O	stratified	amod	18	SENT_286	[p19l1253t3265r1371b3290],
16	Cox	NN	O	cox	nn	18	SENT_286	[p19l1382t3267r1431b3290],
17	regression	NN	O	regression	nn	18	SENT_286	[p19l1442t3268r1581b3298],
18	model	NN	O	model	prep_from	11	SENT_286	[p19l1594t3265r1685b3290],
19	.	.	O	.	_	0	SENT_286	[p19l1594t3265r1685b3290],

1	_	NN	O	_	dep	6	SENT_287	[p19l94t3303r105b3336],
2	f	SYM	O	f	dep	6	SENT_287	[p19l94t3303r105b3336],
3	\	CD	NUMBER	\	num	5	SENT_287	[p19l94t3303r105b3336],
4	P	NN	O	p	nn	5	SENT_287	[p19l121t3305r136b3328],
5	values	NNS	O	value	nsubj	6	SENT_287	[p19l145t3303r230b3328],
6	are	VBP	O	be	_	0	SENT_287	[p19l241t3312r281b3328],
7	for	IN	O	for	_	0	SENT_287	[p19l290t3302r328b3328],
8	the	DT	O	the	det	9	SENT_287	[p19l336t3303r379b3328],
9	comparison	NN	O	comparison	prep_for	6	SENT_287	[p19l389t3305r550b3335],
10	of	IN	O	of	_	0	SENT_287	[p19l562t3302r591b3328],
11	patients	NNS	O	patient	prep_of	9	SENT_287	[p19l598t3305r705b3335],
12	who	WP	O	who	nsubj	15	SENT_287	[p19l715t3303r771b3328],
13	had	VBD	O	have	aux	15	SENT_287	[p19l783t3303r830b3328],
14	never	RB	O	never	neg	15	SENT_287	[p19l842t3312r915b3328],
15	smoked	VBN	O	smoke	rcmod	11	SENT_287	[p19l925t3303r1030b3328],
16	and	CC	O	and	_	0	SENT_287	[p19l1042t3303r1090b3328],
17	those	DT	O	those	conj_and	11	SENT_287	[p19l1101t3303r1176b3328],
18	whose	WP$	O	whose	dep	22	SENT_287	[p19l1185t3303r1272b3328],
19	history	NN	O	history	nn	20	SENT_287	[p19l1283t3303r1374b3336],
20	ofsmoking	NN	O	ofsmoking	nsubj	22	SENT_287	[p19l1384t3302r1536b3336],
21	was	VBD	O	be	cop	22	SENT_287	[p19l1545t3312r1596b3328],
22	unknown	JJ	O	unknown	dep	17	SENT_287	[p19l1608t3303r1730b3328],
23	with	IN	O	with	_	0	SENT_287	[p19l118t3340r174b3365],
24	those	DT	O	those	prep_with	22	SENT_287	[p19l185t3340r260b3365],
25	who	WP	O	who	nsubj	27	SENT_287	[p19l269t3340r325b3365],
26	were	VBD	O	be	cop	27	SENT_287	[p19l334t3349r398b3365],
27	smokers	NNS	O	smoker	rcmod	24	SENT_287	[p19l409t3340r531b3365],
28	.	.	O	.	_	0	SENT_287	[p19l409t3340r531b3365],

1	N	NN	O	n	nn	3	SENT_288	[p19l577t3479r591b3494],
2	ENGLJ	NN	O	englj	nn	3	SENT_288	[p19l607t3478r690b3500],
3	MED	NN	O	med	_	0	SENT_288	[p19l705t3479r758b3494],
4	353	CD	NUMBER	353	dep	3	SENT_288	[p19l770t3478r834b3500],
5	;	:	O	;	_	0	SENT_288	[p19l770t3478r834b3500],
6	2	CD	NUMBER	2	num	8	SENT_288	[p19l770t3478r834b3500],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_288	[p19l869t3478r1080b3500],
8	JULY14	NN	O	july14	dep	4	SENT_288	[p19l1114t3478r1297b3500],
9	,2005	CD	NUMBER	,2005	num	10	SENT_288	[p19l1114t3478r1297b3500],
10	129	CD	NUMBER	129	dep	8	SENT_288	[p19l2011t3477r2067b3499],

1	The	DT	O	the	det	4	SENT_289	[p19l753t3575r803b3599],
2	New	NNP	O	New	nn	4	SENT_289	[p19l813t3576r875b3599],
3	England	NNP	O	England	nn	4	SENT_289	[p19l884t3575r995b3606],
4	Journal	NNP	O	Journal	_	0	SENT_289	[p19l1003t3575r1101b3599],
5	of	IN	O	of	_	0	SENT_289	[p19l1111t3575r1139b3599],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_289	[p19l1146t3575r1271b3599],

1	Copyright	NN	O	copyright	_	0	SENT_290	[p19l545t3657r679b3688],
2	©	CD	NUMBER	©	num	6	SENT_290	[p19l689t3657r712b3681],
3	2005	CD	DATE	2005	num	6	SENT_290	[p19l722t3657r786b3681],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_290	[p19l797t3657r988b3681],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_290	[p19l998t3657r1106b3681],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_290	[p19l1116t3657r1221b3688],
7	.	.	O	.	_	0	SENT_290	[p19l1116t3657r1221b3688],

1	All	DT	O	all	det	2	SENT_291	[p19l1232t3657r1273b3681],
2	rights	NNS	O	rights	nsubj	3	SENT_291	[p19l1283t3657r1357b3688],
3	reserved	VBN	O	reserve	_	0	SENT_291	[p19l1367t3657r1486b3681],
4	.	.	O	.	_	0	SENT_291	[p19l1367t3657r1486b3681],

1	The	DT	O	the	det	4	SENT_292	[p19l715t3699r752b3721],
2	NEW	NNP	O	NEW	nn	4	SENT_292	[p19l764t3701r844b3721],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_292	[p19l858t3701r1033b3721],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_292	[p19l1047t3701r1213b3728],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_292	[p19l1227t3699r1443b3727],

1	Table	NNP	O	Table	_	0	SENT_293	[p20l264t76r334b101],
2	4	CD	NUMBER	4	dep	1	SENT_293	[p20l343t79r366b101],
3	.	.	O	.	_	0	SENT_293	[p20l343t79r366b101],

1	Toxic	JJ	O	toxic	amod	2	SENT_294	[p20l375t77r445b101],
2	Effects	NNS	O	effect	_	0	SENT_294	[p20l456t76r545b101],
3	and	CC	O	and	_	0	SENT_294	[p20l555t76r604b101],
4	Dose	NN	O	dose	nn	5	SENT_294	[p20l616t78r684b101],
5	Modiﬁcations	NNS	O	modiﬁcations	conj_and	2	SENT_294	[p20l695t76r881b101],
6	among	IN	O	among	_	0	SENT_294	[p20l891t85r986b109],
7	727	CD	NUMBER	727	num	8	SENT_294	[p20l995t78r1042b101],
8	Patients	NNS	O	patient	prep_among	2	SENT_294	[p20l1054t77r1162b101],
9	Receiving	VBG	O	receive	partmod	2	SENT_294	[p20l1173t77r1303b109],
10	the	DT	O	the	det	12	SENT_294	[p20l1311t76r1355b101],
11	Study	NN	O	study	nn	12	SENT_294	[p20l1363t76r1441b109],
12	Drugs	NNS	O	drug	dobj	9	SENT_294	[p20l1451t78r1541b109],
13	.	.	O	.	_	0	SENT_294	[p20l1451t78r1541b109],

1	Toxic	JJ	O	toxic	amod	3	SENT_295	[p20l263t148r333b172],
2	Effect	NN	O	effect	nn	3	SENT_295	[p20l344t147r419b172],
3	Erlotinib	NN	O	erlotinib	_	0	SENT_295	[p20l809t147r922b172],
4	(	CD	NUMBER	(	num	5	SENT_295	[p20l933t149r963b180],
5	N	NN	O	n	npadvmod	6	SENT_295	[p20l933t149r963b180],
6	=	JJ	O	=	amod	3	SENT_295	[p20l969t149r1048b180],
7	485	CD	NUMBER	485	number	8	SENT_295	[p20l969t149r1048b180],
8	)	CD	NUMBER	)	num	11	SENT_295	[p20l969t149r1048b180],
9	Placebo	NNP	O	Placebo	nn	11	SENT_295	[p20l1172t147r1275b172],
10	(	CD	NUMBER	(	num	11	SENT_295	[p20l1286t149r1316b180],
11	N	NN	O	n	dep	3	SENT_295	[p20l1286t149r1316b180],
12	=	JJ	O	=	amod	11	SENT_295	[p20l1323t149r1401b180],
13	242	CD	NUMBER	242	number	14	SENT_295	[p20l1323t149r1401b180],
14	)	CD	NUMBER	)	dep	12	SENT_295	[p20l1323t149r1401b180],
15	Grades	NNP	O	Grades	nn	17	SENT_295	[p20l969t213r1065b238],
16	Grades	NNP	O	Grades	nn	17	SENT_295	[p20l1328t213r1424b238],
17	All	NNP	O	All	dep	11	SENT_295	[p20l821t250r854b275],
18	3	CD	NUMBER	3	number	20	SENT_295	[p20l981t252r993b275],
19	to	TO	O	to	dep	20	SENT_295	[p20l1004t255r1030b275],
20	5	CD	NUMBER	5	num	24	SENT_295	[p20l1041t252r1053b275],
21	All	DT	O	all	det	24	SENT_295	[p20l1179t250r1212b275],
22	3	CD	NUMBER	3	number	24	SENT_295	[p20l1339t252r1351b275],
23	to	TO	O	to	dep	24	SENT_295	[p20l1362t255r1389b275],
24	5	CD	NUMBER	5	dep	17	SENT_295	[p20l1399t252r1412b275],

1	percent	NN	O	percent	_	0	SENT_296	[p20l1059t309r1155b337],

1	Rash	NNP	O	Rash	dep	11	SENT_297	[p20l267t358r329b384],
2	76	CD	NUMBER	76	num	1	SENT_297	[p20l824t361r854b384],
3	Anorexia	NNP	O	Anorexia	nn	5	SENT_297	[p20l264t414r382b438],
4	69	CD	NUMBER	69	num	5	SENT_297	[p20l824t415r854b438],
5	Nausea	NN	O	nausea	dep	1	SENT_297	[p20l267t469r367b492],
6	40	CD	NUMBER	40	num	7	SENT_297	[p20l822t468r854b492],
7	Vomiting	NN	O	vomiting	dep	11	SENT_297	[p20l264t523r388b554],
8	25	CD	NUMBER	25	num	11	SENT_297	[p20l823t523r852b546],
9	Stomatitis	NNP	ORGANIZATION	Stomatitis	nn	11	SENT_297	[p20l265t577r404b600],
10	19	CD	NUMBER	19	num	11	SENT_297	[p20l825t577r854b600],
11	Diarrhea	NNP	O	Diarrhea	dep	17	SENT_297	[p20l267t629r381b654],
12	55	CD	NUMBER	55	num	13	SENT_297	[p20l823t632r852b654],
13	Dehydration	NN	O	dehydration	dep	11	SENT_297	[p20l267t683r431b716],
14	7	CD	NUMBER	7	num	17	SENT_297	[p20l841t686r854b708],
15	Ocular	JJ	O	ocular	amod	17	SENT_297	[p20l265t738r357b763],
16	toxic	JJ	O	toxic	amod	17	SENT_297	[p20l365t740r428b763],
17	effect	NN	O	effect	dep	21	SENT_297	[p20l438t737r511b763],
18	28	CD	NUMBER	28	num	19	SENT_297	[p20l823t739r854b763],
19	Fatigue	NN	O	fatigue	dep	17	SENT_297	[p20l267t794r362b825],
20	79	CD	NUMBER	79	num	21	SENT_297	[p20l824t794r854b817],
21	Infection	NN	O	infection	dep	23	SENT_297	[p20l267t846r383b871],
22	34	CD	NUMBER	34	num	23	SENT_297	[p20l824t848r854b871],
23	Puimonaryfibrosis	NN	ORGANIZATION	puimonaryfibrosis	dep	25	SENT_297	[p20l267t900r521b933],
24	3	CD	NUMBER	3	num	25	SENT_297	[p20l840t902r852b925],
25	Pneumonitis	NN	O	pneumonitis	_	0	SENT_297	[p20l267t957r438b979],
26	or	CC	O	or	_	0	SENT_297	[p20l449t963r476b979],
27	pulmonary	JJ	O	pulmonary	amod	28	SENT_297	[p20l487t954r633b987],
28	3	CD	NUMBER	3	conj_or	25	SENT_297	[p20l840t956r852b979],

1	infiltrates	NNS	O	infiltrate	nsubj	2	SENT_298	[p20l366t991r510b1017],
2	*	VBP	O	*	_	0	SENT_298	[p20l366t991r510b1017],

1	Death	NN	O	death	_	0	SENT_299	[p20l267t1046r344b1071],
2	from	IN	O	from	_	0	SENT_299	[p20l355t1046r419b1071],
3	pneumonitis	NN	O	pneumonitis	prep_from	1	SENT_299	[p20l432t1048r603b1079],
4	1	CD	NUMBER	1	num	5	SENT_299	[p20l960t1048r971b1071],
5	patient	NN	O	patient	dep	1	SENT_299	[p20l984t1048r1078b1079],

1	17	CD	NUMBER	17	num	2	SENT_300	[p20l1183t361r1212b383],
2	o	NN	O	o	dep	13	SENT_300	[p20l1369t360r1384b384],
3	56	CD	NUMBER	56	number	4	SENT_300	[p20l1182t415r1212b438],
4	5	CD	NUMBER	5	num	6	SENT_300	[p20l1369t415r1382b438],
5	34	CD	NUMBER	34	number	6	SENT_300	[p20l1182t469r1212b492],
6	23	CD	NUMBER	23	dep	2	SENT_300	[p20l1181t523r1211b546],
7	3	CD	DATE	3	number	8	SENT_300	[p20l1198t577r1211b600],
8	19	CD	DATE	19	amod	6	SENT_300	[p20l1183t631r1212b655],
9	6	CD	DATE	6	dep	13	SENT_300	[p20l1199t686r1212b709],
10	9	CD	DATE	9	number	11	SENT_300	[p20l1198t740r1212b763],
11	74	CD	DATE	74	num	13	SENT_300	[p20l1183t794r1212b817],
12	21	CD	NUMBER	21	number	13	SENT_300	[p20l1181t848r1211b871],
13	3	CD	NUMBER	3	dep	17	SENT_300	[p20l1198t902r1211b925],
14	3	CD	NUMBER	3	dep	13	SENT_300	[p20l1198t956r1211b979],
15	/	:	O	/	punct	17	SENT_300	[p20l993t584r1009b600],
16	\	CD	NUMBER	\	num	17	SENT_300	[p20l993t584r1009b600],
17	I-u4uJLDLO	NN	O	i-u4ujldlo	_	0	SENT_300	[p20l1011t361r1025b600],
18	/	:	O	/	punct	17	SENT_300	[p20l993t909r1009b979],
19	\	CD	NUMBER	\	dep	17	SENT_300	[p20l993t909r1009b979],
20	A	DT	O	a	det	21	SENT_300	[p20l993t909r1009b979],
21	II-I-NLDDA-l	NN	O	ii-i-nldda-l	dep	19	SENT_300	[p20l996t794r1007b817, p20l1010t631r1025b979],
22	>	JJR	O	>	amod	23	SENT_300	[p20l996t794r1007b817, p20l1010t631r1025b979],
23	O	NN	O	o	dep	21	SENT_300	[p20l996t794r1007b817, p20l1010t631r1025b979],
24	\	IN	O	\	amod	23	SENT_300	[p20l996t794r1007b817, p20l1010t631r1025b979],

1	Reason	NN	O	reason	dep	13	SENT_301	[p20l267t1102r363b1125],
2	for	IN	O	for	_	0	SENT_301	[p20l374t1100r411b1125],
3	dose	NN	O	dose	nn	4	SENT_301	[p20l420t1100r484b1125],
4	reduction	NN	O	reduction	prep_for	1	SENT_301	[p20l496t1100r623b1125],
5	Any	DT	O	any	det	7	SENT_301	[p20l314t1156r365b1187],
6	toxic	JJ	O	toxic	amod	7	SENT_301	[p20l373t1157r437b1179],
7	effect	NN	O	effect	dep	13	SENT_301	[p20l446t1154r520b1179],
8	Diarrhea	NNP	O	Diarrhea	nn	13	SENT_301	[p20l317t1208r431b1234],
9	Rash	NNP	O	Rash	nn	13	SENT_301	[p20l317t1263r379b1288],
10	Conjunctivitis	NNP	O	Conjunctivitis	nn	13	SENT_301	[p20l315t1319r501b1350],
11	Vomiting	NNP	O	Vomiting	nn	13	SENT_301	[p20l314t1373r438b1404],
12	Stomatitis	NNP	O	Stomatitis	nn	13	SENT_301	[p20l315t1427r454b1450],
13	Reason	NNP	O	Reason	dep	19	SENT_301	[p20l267t1482r363b1504],
14	for	IN	O	for	_	0	SENT_301	[p20l374t1479r411b1504],
15	treatment	NN	O	treatment	nn	16	SENT_301	[p20l419t1484r554b1504],
16	interruption	NN	O	interruption	prep_for	13	SENT_301	[p20l565t1482r725b1512],
17	Any	DT	O	any	det	19	SENT_301	[p20l314t1535r365b1566],
18	toxic	JJ	O	toxic	amod	19	SENT_301	[p20l373t1536r437b1559],
19	effect	NN	O	effect	dep	24	SENT_301	[p20l446t1533r520b1559],
20	Diarrhea	NNP	O	Diarrhea	nn	24	SENT_301	[p20l317t1588r431b1613],
21	Rash	NNP	O	Rash	nn	24	SENT_301	[p20l317t1642r379b1667],
22	Conjunctivitis	NNP	O	Conjunctivitis	nn	24	SENT_301	[p20l315t1698r501b1729],
23	Vomiting	NNP	O	Vomiting	nn	24	SENT_301	[p20l314t1752r438b1783],
24	Stomatitis	NNP	O	Stomatitis	_	0	SENT_301	[p20l315t1806r454b1829],

1	Treatment	NN	O	treatment	nsubj	2	SENT_302	[p20l263t1861r403b1884],
2	discontinued	VBN	O	discontinue	_	0	SENT_302	[p20l412t1858r589b1884],
3	because	IN	O	because	_	0	SENT_302	[p20l602t1858r711b1884],
4	of	IN	O	of	prepc_because_of	2	SENT_302	[p20l365t1896r394b1921],
5	any	DT	O	any	det	7	SENT_302	[p20l400t1905r446b1929],
6	toxic	JJ	O	toxic	amod	7	SENT_302	[p20l454t1898r518b1921],
7	effect	NN	O	effect	pobj	2	SENT_302	[p20l527t1896r601b1921],

1	*	NN	O	*	nsubjpass	10	SENT_303	[p20l237t1990r252b2004],
2	All	DT	O	all	det	3	SENT_303	[p20l262t1988r295b2012],
3	cases	NNS	O	case	dep	1	SENT_303	[p20l306t1996r379b2013],
4	designated	VBN	O	designate	partmod	1	SENT_303	[p20l390t1988r538b2021],
5	“	NN	O	“	nn	8	SENT_303	[p20l550t1990r561b1999],
6	n	NN	O	n	nn	8	SENT_303	[p20l583t1997r596b2012],
7	umonitis	NN	O	umonitis	nn	8	SENT_303	[p20l617t1990r751b2013],
8	”	NN	O	”	dobj	4	SENT_303	[p20l617t1990r751b2013],
9	were	VBD	O	be	auxpass	10	SENT_303	[p20l761t1996r824b2013],
10	reviewed	VBN	O	review	_	0	SENT_303	[p20l836t1988r952b2013],
11	by	IN	O	by	_	0	SENT_303	[p20l965t1988r993b2021],
12	a	DT	O	a	det	14	SENT_303	[p20l1003t1996r1015b2013],
13	study	NN	O	study	nn	14	SENT_303	[p20l1027t1988r1099b2020],
14	physician	NN	O	physician	agent	10	SENT_303	[p20l1110t1988r1243b2021],
15	.	.	O	.	_	0	SENT_303	[p20l1110t1988r1243b2021],

1	Cases	NNS	O	case	nsubjpass	8	SENT_304	[p20l1255t1990r1332b2013],
2	of	IN	O	of	_	0	SENT_304	[p20l1343t1987r1372b2013],
3	“	CD	NUMBER	“	num	5	SENT_304	[p20l1379t1990r1561b2020],
4	pneumonia	NN	O	pneumonia	nn	5	SENT_304	[p20l1379t1990r1561b2020],
5	”	NN	O	”	prep_of	1	SENT_304	[p20l1379t1990r1561b2020],
6	were	VBD	O	be	auxpass	8	SENT_304	[p20l1571t1997r1635b2013],
7	also	RB	O	also	advmod	8	SENT_304	[p20l1645t1988r1699b2013],
8	reviewed	VBN	O	review	_	0	SENT_304	[p20l1711t1988r1827b2013],
9	and	CC	O	and	_	0	SENT_304	[p20l1839t1988r1887b2013],
10	reclassiﬁed	VBN	O	reclassiﬁed	conj_and	8	SENT_304	[p20l264t2025r414b2050],
11	as	IN	O	as	_	0	SENT_304	[p20l425t2034r453b2050],
12	pneum	NN	O	pneum	prep_as	10	SENT_304	[p20l465t2034r558b2058],
13	'	''	O	'	_	0	SENT_304	[p20l599t2028r602b2031],
14	'	''	O	'	_	0	SENT_304	[p20l617t2028r644b2055],
15	5	CD	NUMBER	5	tmod	10	SENT_304	[p20l617t2028r644b2055],
16	,	,	O	,	_	0	SENT_304	[p20l617t2028r644b2055],
17	ifappropriate	NN	O	ifappropriate	conj_and	8	SENT_304	[p20l657t2025r846b2058],
18	.	.	O	.	_	0	SENT_304	[p20l657t2025r846b2058],

1	ﬁtinib	NN	O	ﬁtinib	nsubj	8	SENT_305	[p20l11t2223r500b2307],
2	.1	CD	NUMBER	.1	dep	1	SENT_305	[p20l11t2223r500b2307],
3	°	CD	NUMBER	°	number	4	SENT_305	[p20l11t2223r500b2307],
4	'12	CD	NUMBER	'12	dep	1	SENT_305	[p20l11t2223r500b2307],
5	Some	DT	O	some	det	6	SENT_305	[p20l527t2234r764b2307],
6	investigators	NNS	O	investigator	dep	4	SENT_305	[p20l789t2230r1343b2329],
7	have	VBP	O	have	aux	8	SENT_305	[p20l1370t2229r1563b2308],
8	reported	VBN	O	report	_	0	SENT_305	[p20l1588t2229r1957b2329],
9	that	IN	O	that	complm	14	SENT_305	[p20l1982t2229r2153b2307],
10	responsiveness	NN	O	responsiveness	nsubj	14	SENT_305	[p20l11t2357r663b2457],
11	to	TO	O	to	_	0	SENT_305	[p20l693t2373r772b2435],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_305	[p20l800t2362r1060b2440],
13	inhibitors	NNS	O	inhibitor	prep_to	10	SENT_305	[p20l1077t2356r1493b2435],
14	correlates	VBZ	O	correlate	ccomp	8	SENT_305	[p20l1523t2357r1934b2435],
15	with	IN	O	with	_	0	SENT_305	[p20l1958t2357r2149b2436],
16	sex	NN	O	sex	prep_with	14	SENT_305	[p20l13t2511r171b2580],
17	,	,	O	,	_	0	SENT_305	[p20l13t2511r171b2580],
18	histologic	JJ	O	histologic	amod	19	SENT_305	[p20l227t2484r659b2585],
19	type	NN	O	type	conj_and	16	SENT_305	[p20l709t2501r909b2585],
20	,	,	O	,	_	0	SENT_305	[p20l709t2501r909b2585],
21	race	NN	O	race	nn	24	SENT_305	[p20l965t2511r1139b2563],
22	or	CC	O	or	_	0	SENT_305	[p20l1191t2510r1282b2563],
23	ethnic	JJ	O	ethnic	nn	24	SENT_305	[p20l1331t2484r1598b2563],
24	origin	NN	O	origin	conj_and	16	SENT_305	[p20l1648t2485r1934b2585],
25	,	,	O	,	_	0	SENT_305	[p20l1648t2485r1934b2585],
26	and	CC	O	and	_	0	SENT_305	[p20l1989t2484r2148b2563],
27	smoking	NN	O	smoking	nn	28	SENT_305	[p20l13t2613r381b2713],
28	status	NN	O	status	conj_and	16	SENT_305	[p20l404t2607r956b2692],
29	.1	CD	NUMBER	.1	number	30	SENT_305	[p20l404t2607r956b2692],
30	°	CD	NUMBER	°	num	31	SENT_305	[p20l404t2607r956b2692],
31	’	NN	O	’	dep	28	SENT_305	[p20l404t2607r956b2692],
32	11	CD	NUMBER	11	number	33	SENT_305	[p20l404t2607r956b2692],
33	’21	CD	NUMBER	’21	dobj	14	SENT_305	[p20l404t2607r956b2692],
34	We	PRP	O	we	nsubj	36	SENT_305	[p20l977t2620r1109b2691],
35	also	RB	O	also	advmod	36	SENT_305	[p20l1134t2613r1298b2691],
36	found	VBD	O	find	rcmod	33	SENT_305	[p20l1324t2612r1570b2692],
37	that	IN	O	that	complm	40	SENT_305	[p20l1596t2613r1759b2691],
38	response	NN	O	response	nsubj	40	SENT_305	[p20l1779t2638r2150b2713],
39	was	VBD	O	be	cop	40	SENT_305	[p20l7t2767r171b2820],
40	higher	JJR	O	higher	ccomp	36	SENT_305	[p20l205t2740r490b2841],
41	among	IN	O	among	_	0	SENT_305	[p20l518t2766r824b2841],
42	Asians	NNPS	MISC	Asians	prep_among	40	SENT_305	[p20l849t2741r1163b2836],
43	,	,	O	,	_	0	SENT_305	[p20l849t2741r1163b2836],
44	Women	NNS	O	woman	prep_among	40	SENT_305	[p20l1196t2766r1544b2836],
45	,	,	O	,	_	0	SENT_305	[p20l1196t2766r1544b2836],
46	patients	NNS	O	patient	prep_among	40	SENT_305	[p20l1580t2741r1925b2841],
47	with	IN	O	with	_	0	SENT_305	[p20l1954t2741r2148b2820],
48	adenocarcinoma	NN	O	adenocarcinoma	prep_with	46	SENT_305	[p20l11t2868r759b2964],
49	,	,	O	,	_	0	SENT_305	[p20l11t2868r759b2964],
50	and	CC	O	and	_	0	SENT_305	[p20l791t2869r950b2947],
51	lifetime	NN	O	lifetime	nn	52	SENT_305	[p20l976t2868r1308b2947],
52	nonsmokers	NNS	O	nonsmoker	prep_among	40	SENT_305	[p20l1336t2869r1904b2948],
53	.	.	O	.	_	0	SENT_305	[p20l1336t2869r1904b2948],

1	Contrary	JJ	O	contrary	_	0	SENT_306	[p20l1937t2874r2147b2947, p20l12t3014r212b3098],
2	to	TO	O	to	_	0	SENT_306	[p20l234t3014r313b3076],
3	previous	JJ	O	previous	amod	4	SENT_306	[p20l337t2999r696b3098],
4	reports	NNS	O	report	prep_contrary_to	14	SENT_306	[p20l722t2992r1135b3098],
5	,	,	O	,	_	0	SENT_306	[p20l722t2992r1135b3098],
6	”	IN	O	”	_	0	SENT_306	[p20l722t2992r1135b3098],
7	the	DT	O	the	det	9	SENT_306	[p20l1160t2998r1290b3076],
8	response	NN	O	response	nn	9	SENT_306	[p20l1314t3023r1696b3098],
9	rate	NN	O	rate	prep_”	14	SENT_306	[p20l1720t3014r1877b3076],
10	in	IN	O	in	_	0	SENT_306	[p20l1901t2998r1982b3075],
11	our	PRP$	O	we	poss	12	SENT_306	[p20l2007t3023r2152b3077],
12	trial	NN	O	trial	prep_in	9	SENT_306	[p20l12t3126r179b3204],
13	was	VBD	O	be	cop	14	SENT_306	[p20l200t3152r362b3205],
14	higher	JJR	O	higher	_	0	SENT_306	[p20l390t3126r670b3226],
15	when	WRB	O	when	advmod	23	SENT_306	[p20l688t3126r924b3205],
16	10	CD	PERCENT	10	num	17	SENT_306	[p20l952t3131r1050b3204],
17	percent	NN	PERCENT	percent	nsubj	23	SENT_306	[p20l1075t3142r1398b3226],
18	or	CC	O	or	_	0	SENT_306	[p20l1419t3151r1508b3204],
19	more	JJR	O	more	nsubj	23	SENT_306	[p20l1531t3151r1752b3204],
20	of	IN	O	of	_	0	SENT_306	[p20l1779t3125r1880b3204],
21	tumor	NN	O	tumor	nn	22	SENT_306	[p20l1888t3142r2152b3205],
22	cells	NNS	O	cell	prep_of	19	SENT_306	[p20l12t3254r195b3332],
23	expressed	VBD	O	express	ccomp	14	SENT_306	[p20l224t3253r641b3354],
24	EGFR	NN	ORGANIZATION	egfr	dobj	23	SENT_306	[p20l665t3259r938b3337],
25	.	.	O	.	_	0	SENT_306	[p20l665t3259r938b3337],

1	Activating	VBG	O	activate	amod	2	SENT_307	[p20l138t3382r571b3482],
2	mutations	NNS	O	mutation	nsubjpass	9	SENT_307	[p20l624t3382r1057b3461],
3	in	IN	O	in	_	0	SENT_307	[p20l1115t3382r1197b3459],
4	the	DT	O	the	det	6	SENT_307	[p20l1254t3382r1383b3460],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_307	[p20l1439t3388r1652b3461],
6	gene	NN	O	gene	prep_in	2	SENT_307	[p20l1702t3407r1902b3482],
7	have	VBP	O	have	aux	9	SENT_307	[p20l1959t3381r2148b3461],
8	been	VBN	O	be	auxpass	9	SENT_307	[p20l11t3511r210b3589],
9	found	VBN	O	find	_	0	SENT_307	[p20l242t3510r493b3590],
10	to	TO	O	to	aux	11	SENT_307	[p20l525t3527r604b3589],
11	predict	VB	O	predict	xcomp	9	SENT_307	[p20l635t3511r935b3611],
12	a	DT	O	a	det	13	SENT_307	[p20l962t3537r1006b3589],
13	response	NN	O	response	dobj	11	SENT_307	[p20l1037t3536r1415b3611],
14	to	TO	O	to	_	0	SENT_307	[p20l1448t3527r1527b3589],
15	geﬁtinib	NN	O	geﬁtinib	prep_to	11	SENT_307	[p20l1560t3506r2134b3611],
16	.22	CD	NUMBER	.22	number	17	SENT_307	[p20l1560t3506r2134b3611],
17	'27	CD	NUMBER	'27	num	19	SENT_307	[p20l1560t3506r2134b3611],
18	The	DT	O	the	det	19	SENT_307	[p20l7t3638r169b3717],
19	results	NNS	O	result	nsubjpass	36	SENT_307	[p20l198t3639r476b3718],
20	of	IN	O	of	_	0	SENT_307	[p20l508t3638r608b3717],
21	our	PRP$	O	we	poss	22	SENT_307	[p20l620t3664r764b3718],
22	assays	NNS	O	assay	prep_of	19	SENT_307	[p20l790t3665r1051b3739],
23	for	IN	O	for	_	0	SENT_307	[p20l1082t3638r1206b3717],
24	the	DT	O	the	det	25	SENT_307	[p20l1233t3639r1362b3717],
25	number	NN	O	number	prep_for	22	SENT_307	[p20l1392t3638r1728b3718],
26	of	IN	O	of	_	0	SENT_307	[p20l1755t3638r1856b3717],
27	copies	NNS	O	copy	prep_of	25	SENT_307	[p20l1868t3639r2133b3739],
28	and	CC	O	and	_	0	SENT_307	[p21l10t20r165b99],
29	mutation	NN	O	mutation	nn	30	SENT_307	[p21l187t21r576b100],
30	status	NN	O	status	prep_of	25	SENT_307	[p21l600t37r845b100],
31	of	IN	O	of	_	0	SENT_307	[p21l870t20r970b99],
32	the	DT	O	the	det	34	SENT_307	[p21l975t21r1103b99],
33	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_307	[p21l1123t27r1336b100],
34	gene	NN	O	gene	prep_of	19	SENT_307	[p21l1351t46r1550b121],
35	are	VBP	O	be	auxpass	36	SENT_307	[p21l1571t47r1698b99],
36	published	VBN	O	publish	dep	11	SENT_307	[p21l1718t20r2135b121],
37	in	IN	O	in	_	0	SENT_307	[p21l10t150r90b227],
38	this	DT	O	this	det	39	SENT_307	[p21l119t150r270b228],
39	issue	NN	O	issue	prep_in	36	SENT_307	[p21l300t150r509b229],
40	of	IN	O	of	_	0	SENT_307	[p21l539t149r638b228],
41	the	DT	O	the	det	42	SENT_307	[p21l650t145r1182b250],
42	]	NN	O	]	prep_of	39	SENT_307	[p21l650t145r1182b250],
43	ournal	JJ	O	ournal	amod	42	SENT_307	[p21l650t145r1182b250],
44	.28	CD	NUMBER	.28	tmod	43	SENT_307	[p21l650t145r1182b250],
45	Higher	JJR	O	higher	amod	47	SENT_307	[p21l1211t150r1507b250],
46	response	NN	O	response	nn	47	SENT_307	[p21l1533t175r1908b250],
47	rates	NNS	O	rate	nsubjpass	49	SENT_307	[p21l1937t166r2133b228],
48	were	VBD	O	be	auxpass	49	SENT_307	[p21l6t304r207b357],
49	found	VBN	O	find	dep	11	SENT_307	[p21l237t277r487b357],
50	among	IN	O	among	_	0	SENT_307	[p21l517t303r815b378],
51	patients	NNS	O	patient	prep_among	49	SENT_307	[p21l841t278r1175b378],
52	with	IN	O	with	_	0	SENT_307	[p21l1203t278r1392b357],
53	high	JJ	O	high	amod	54	SENT_307	[p21l1422t278r1615b378],
54	numbers	NNS	O	number	prep_with	51	SENT_307	[p21l1645t278r2019b357],
55	of	IN	O	of	_	0	SENT_307	[p21l2053t277r2153b356],
56	gene	NN	O	gene	nn	57	SENT_307	[p21l10t431r209b506],
57	copies	NNS	O	copy	prep_of	54	SENT_307	[p21l231t406r500b506],
58	and	CC	O	and	_	0	SENT_307	[p21l525t406r683b484],
59	mutations	NNS	O	mutation	prep_of	54	SENT_307	[p21l706t406r1172b501],
60	,	,	O	,	_	0	SENT_307	[p21l706t406r1172b501],
61	but	CC	O	but	_	0	SENT_307	[p21l1202t406r1344b485],
62	the	DT	O	the	det	63	SENT_307	[p21l1363t405r1494b484],
63	difference	NN	O	difference	nsubj	65	SENT_307	[p21l1518t405r1949b484],
64	was	VBD	O	be	cop	65	SENT_307	[p21l1968t432r2131b485],
65	signiﬁcant	JJ	O	signiﬁcant	conj_but	49	SENT_307	[p21l12t533r473b634],
66	only	RB	O	only	advmod	65	SENT_307	[p21l495t534r676b634],
67	for	IN	O	for	_	0	SENT_307	[p21l696t533r819b612],
68	gene	NN	O	gene	nn	69	SENT_307	[p21l841t559r1040b634],
69	copies	NNS	O	copy	prep_for	65	SENT_307	[p21l1066t534r1357b634],
70	.	.	O	.	_	0	SENT_307	[p21l1066t534r1357b634],

1	Because	IN	O	because	mark	9	SENT_308	[p21l138t669r477b741],
2	none	NN	O	none	nsubj	9	SENT_308	[p21l513t687r724b740],
3	of	IN	O	of	_	0	SENT_308	[p21l759t661r860b740],
4	the	DT	O	the	det	6	SENT_308	[p21l877t662r1006b740],
5	early	JJ	O	early	amod	6	SENT_308	[p21l1042t662r1242b762],
6	trials1	NN	O	trials1	prep_of	2	SENT_308	[p21l1273t656r1671b740],
7	°	CD	NUMBER	°	number	8	SENT_308	[p21l1273t656r1671b740],
8	'12	CD	NUMBER	'12	num	6	SENT_308	[p21l1273t656r1671b740],
9	had	VBD	O	have	advcl	18	SENT_308	[p21l1707t662r1862b740],
10	a	DT	O	a	det	13	SENT_308	[p21l1896t688r1940b740],
11	placebo	NN	O	placebo	nn	13	SENT_308	[p21l1972t662r2133b762, p21l11t790r205b868],
12	control	NN	O	control	nn	13	SENT_308	[p21l235t790r538b868],
13	group	NN	O	group	dobj	9	SENT_308	[p21l566t815r841b890],
14	,	,	O	,	_	0	SENT_308	[p21l566t815r841b890],
15	it	PRP	O	it	nsubj	18	SENT_308	[p21l874t790r934b868],
16	is	VBZ	O	be	cop	18	SENT_308	[p21l957t790r1022b868],
17	not	RB	O	not	neg	18	SENT_308	[p21l1052t806r1196b868],
18	possible	JJ	O	possible	_	0	SENT_308	[p21l1217t790r1568b890],
19	to	TO	O	to	aux	20	SENT_308	[p21l1597t806r1676b868],
20	determine	VB	O	determine	xcomp	18	SENT_308	[p21l1706t789r2135b868],
21	whether	IN	O	whether	complm	27	SENT_308	[p21l6t918r357b997],
22	EGFR	NN	ORGANIZATION	egfr	nsubj	27	SENT_308	[p21l397t917r1055b1001],
23	—	CD	NUMBER	—	num	25	SENT_308	[p21l397t917r1055b1001],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_308	[p21l397t917r1055b1001],
25	therapy	NN	O	therapy	dep	22	SENT_308	[p21l1096t918r1414b1018],
26	was	VBD	O	be	cop	27	SENT_308	[p21l1449t944r1610b997],
27	superior	JJ	O	superior	ccomp	20	SENT_308	[p21l1659t918r2013b1018],
28	to	TO	O	to	prep	27	SENT_308	[p21l2055t934r2134b996],

1	130	CD	NUMBER	130	num	3	SENT_309	[p21l149t1093r205b1115],
2	N	NN	O	n	nn	3	SENT_309	[p21l918t1095r932b1110],
3	ENGLJ	NN	O	englj	nsubj	4	SENT_309	[p21l947t1094r1031b1116],
4	MED	VBD	O	med	_	0	SENT_309	[p21l1046t1095r1099b1110],
5	35	CD	NUMBER	35	number	6	SENT_309	[p21l1111t1094r1136b1116],
6	:2	CD	NUMBER	:2	num	8	SENT_309	[p21l1155t1094r1175b1114],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_309	[p21l1210t1094r1421b1116],
8	JULY14	NN	O	july14	dobj	4	SENT_309	[p21l1455t1094r1562b1116],
9	,	,	O	,	_	0	SENT_309	[p21l1455t1094r1562b1116],
10	2005	CD	DATE	2005	appos	8	SENT_309	[p21l1575t1094r1638b1116],

1	The	DT	O	the	det	4	SENT_310	[p21l935t1127r986b1151],
2	New	NNP	O	New	nn	4	SENT_310	[p21l995t1128r1057b1151],
3	Englan	NNP	O	Englan	nn	4	SENT_310	[p21l1066t1127r1160b1158],
4	oumal	NN	O	oumal	_	0	SENT_310	[p21l1200t1127r1283b1151],
5	of	IN	O	of	_	0	SENT_310	[p21l1293t1127r1322b1151],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_310	[p21l1329t1127r1454b1151],

1	ERLOTINIB	NNP	O	ERLOTINIB	nsubj	4	SENT_311	[p21l480t1315r667b1334],
2	IN	IN	O	in	prep	1	SENT_311	[p21l682t1315r720b1334],
3	PREVIOUSLY	RB	DATE	previously	pcomp	2	SENT_311	[p21l736t1315r941b1334],
4	TREATED	VBN	O	treat	_	0	SENT_311	[p21l952t1315r1103b1334],
5	NON	NN	O	non	dobj	4	SENT_311	[p21l1118t1315r1422b1334],
6	.	.	O	.	_	0	SENT_311	[p21l1118t1315r1422b1334],

1	—	NN	O	—	_	0	SENT_312	[p21l1118t1315r1422b1334],
2	.	.	O	.	_	0	SENT_312	[p21l1118t1315r1422b1334],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_313	[p21l1118t1315r1422b1334],
2	LUNG	NN	O	lung	_	0	SENT_313	[p21l1436t1315r1530b1334],
3	CANCER	NNP	O	CANCER	dep	2	SENT_313	[p21l1544t1315r1680b1334],

1	palliative	JJ	O	palliative	amod	2	SENT_314	[p21l9t1530r381b1630],
2	treatment	NN	O	treatment	_	0	SENT_314	[p21l407t1546r835b1608],
3	.	.	O	.	_	0	SENT_314	[p21l407t1546r835b1608],

1	In	IN	O	in	_	0	SENT_315	[p21l865t1537r951b1607],
2	our	PRP$	O	we	poss	4	SENT_315	[p21l978t1555r1121b1609],
3	placebo	NN	O	placebo	nn	4	SENT_315	[p21l1142t1529r1931b1630],
4	—	NN	O	—	prep_in	10	SENT_315	[p21l1142t1529r1931b1630],
5	controlled	VBN	O	control	partmod	4	SENT_315	[p21l1142t1529r1931b1630],
6	trial	NN	O	trial	dobj	5	SENT_315	[p21l1957t1530r2144b1625],
7	,	,	O	,	_	0	SENT_315	[p21l1957t1530r2144b1625],
8	erlotinib	NN	O	erlotinib	nsubj	10	SENT_315	[p21l11t1657r371b1736],
9	did	VBD	O	do	aux	10	SENT_315	[p21l402t1658r535b1736],
10	provide	VB	O	provide	_	0	SENT_315	[p21l561t1657r880b1758],
11	clinically	RB	O	clinically	advmod	12	SENT_315	[p21l908t1657r1286b1758],
12	meaningful	JJ	O	meaningful	amod	13	SENT_315	[p21l1309t1657r1801b1758],
13	prolongation	NN	O	prolongation	dobj	10	SENT_315	[p21l1828t1658r2147b1758, p21l10t1786r280b1886],
14	of	IN	O	of	_	0	SENT_315	[p21l311t1785r413b1864],
15	survival	NN	O	survival	prep_of	13	SENT_315	[p21l426t1786r769b1865],
16	.	.	O	.	_	0	SENT_315	[p21l426t1786r769b1865],

1	According	VBG	O	accord	_	0	SENT_316	[p21l803t1786r1248b1886],
2	to	TO	O	to	pcomp	1	SENT_316	[p21l1276t1802r1356b1864],
3	the	DT	O	the	det	4	SENT_316	[p21l1388t1785r1518b1864],
4	Kaplan	NNP	PERSON	Kaplan	pobj	2	SENT_316	[p21l1549t1786r2151b1886],
5	.	.	O	.	_	0	SENT_316	[p21l1549t1786r2151b1886],

1	—	NN	O	—	_	0	SENT_317	[p21l1549t1786r2151b1886],
2	.	.	O	.	_	0	SENT_317	[p21l1549t1786r2151b1886],

1	Meier	JJR	PERSON	meier	amod	2	SENT_318	[p21l1549t1786r2151b1886],
2	estimates	NNS	O	estimate	nsubjpass	8	SENT_318	[p21l11t1914r436b2009],
3	,	,	O	,	_	0	SENT_318	[p21l11t1914r436b2009],
4	the	DT	O	the	det	6	SENT_318	[p21l482t1913r611b1992],
5	median	JJ	O	median	amod	6	SENT_318	[p21l652t1913r971b1992],
6	survival	NN	O	survival	appos	2	SENT_318	[p21l1013t1914r1333b1993],
7	Was	VBD	O	be	auxpass	8	SENT_318	[p21l1368t1940r1530b1993],
8	prolonged	VBN	O	prolong	_	0	SENT_318	[p21l1571t1914r2014b2014],
9	by	IN	O	by	_	0	SENT_318	[p21l2055t1914r2153b2014],
10	two	CD	DURATION	two	num	11	SENT_318	[p21l11t2058r163b2121],
11	months	NNS	NUMBER	month	agent	8	SENT_318	[p21l188t2042r534b2137],
12	,	,	O	,	_	0	SENT_318	[p21l188t2042r534b2137],
13	and	CC	O	and	_	0	SENT_318	[p21l563t2042r717b2120],
14	31	CD	PERCENT	31	num	15	SENT_318	[p21l741t2047r841b2120],
15	percent	NN	PERCENT	percent	nsubj	22	SENT_318	[p21l863t2058r1180b2142],
16	of	IN	O	of	_	0	SENT_318	[p21l1199t2041r1299b2120],
17	patients	NNS	O	patient	prep_of	15	SENT_318	[p21l1301t2042r1632b2142],
18	treated	VBN	O	treat	partmod	17	SENT_318	[p21l1657t2041r1943b2120],
19	with	IN	O	with	_	0	SENT_318	[p21l1961t2042r2149b2121],
20	erlotinib	NN	O	erlotinib	prep_with	18	SENT_318	[p21l11t2170r370b2248],
21	Were	VBD	O	be	cop	22	SENT_318	[p21l401t2196r604b2249],
22	alive	JJ	O	alive	conj_and	8	SENT_318	[p21l637t2170r825b2249],
23	at	IN	O	at	_	0	SENT_318	[p21l859t2186r938b2248],
24	one	CD	DURATION	one	prep_at	22	SENT_318	[p21l968t2195r1121b2248],
25	year	NN	NUMBER	year	tmod	22	SENT_318	[p21l1151t2196r1343b2270],
26	,	,	O	,	_	0	SENT_318	[p21l1151t2196r1343b2270],
27	as	IN	O	as	_	0	SENT_318	[p21l1382t2196r1466b2248],
28	compared	VBN	O	compare	prepc_as	22	SENT_318	[p21l1504t2170r1929b2270],
29	with	IN	O	with	pcomp	28	SENT_318	[p21l1958t2169r2148b2249],
30	22	CD	PERCENT	22	num	31	SENT_318	[p21l10t2303r113b2375],
31	percent	NN	PERCENT	percent	pobj	29	SENT_318	[p21l144t2314r473b2398],
32	in	IN	O	in	_	0	SENT_318	[p21l499t2298r582b2375],
33	the	DT	O	the	det	35	SENT_318	[p21l615t2298r746b2376],
34	placebo	NN	O	placebo	nn	35	SENT_318	[p21l777t2298r1112b2398],
35	group	NN	O	group	prep_in	31	SENT_318	[p21l1146t2323r1428b2398],
36	.	.	O	.	_	0	SENT_318	[p21l1146t2323r1428b2398],

1	The	DT	O	the	det	5	SENT_319	[p21l1462t2298r1627b2376],
2	tWo	NN	NUMBER	two	nn	5	SENT_319	[p21l1660t2298r2147b2377],
3	—	CD	NUMBER	—	num	5	SENT_319	[p21l1660t2298r2147b2377],
4	month	NN	NUMBER	month	nn	5	SENT_319	[p21l1660t2298r2147b2377],
5	prolongation	NN	O	prolongation	nsubj	9	SENT_319	[p21l9t2426r578b2526],
6	of	IN	O	of	_	0	SENT_319	[p21l607t2425r707b2504],
7	survival	NN	O	survival	prep_of	5	SENT_319	[p21l718t2425r1038b2505],
8	is	VBZ	O	be	cop	9	SENT_319	[p21l1065t2426r1130b2504],
9	similar	JJ	O	similar	_	0	SENT_319	[p21l1162t2426r1459b2504],
10	to	TO	O	to	_	0	SENT_319	[p21l1484t2442r1564b2504],
11	that	DT	O	that	prep_to	9	SENT_319	[p21l1593t2425r1761b2504],
12	achieved	VBN	O	achieve	partmod	11	SENT_319	[p21l1783t2425r2148b2505],
13	with	IN	O	with	_	0	SENT_319	[p21l6t2554r197b2633],
14	docetaxel	NN	O	docetaxel	prep_with	12	SENT_319	[p21l219t2554r619b2632],
15	in	IN	O	in	_	0	SENT_319	[p21l640t2554r721b2631],
16	the	DT	O	the	det	17	SENT_319	[p21l744t2553r874b2632],
17	setting	NN	O	setting	prep_in	14	SENT_319	[p21l898t2554r1187b2654],
18	of	IN	O	of	_	0	SENT_319	[p21l1207t2553r1308b2632],
19	second	JJ	ORDINAL	second	amod	24	SENT_319	[p21l1313t2554r1804b2632],
20	—	NN	O	—	nn	24	SENT_319	[p21l1313t2554r1804b2632],
21	line	NN	O	line	nn	24	SENT_319	[p21l1313t2554r1804b2632],
22	chemotherapy	NN	O	chemotherapy	nn	24	SENT_319	[p21l1827t2553r2147b2632, p21l11t2678r453b2783],
23	,3	CD	NUMBER	,3	num	24	SENT_319	[p21l1827t2553r2147b2632, p21l11t2678r453b2783],
24	’	NN	O	’	prep_of	17	SENT_319	[p21l1827t2553r2147b2632, p21l11t2678r453b2783],
25	4	CD	NUMBER	4	tmod	12	SENT_319	[p21l1827t2553r2147b2632, p21l11t2678r453b2783],
26	even	RB	O	even	advmod	35	SENT_319	[p21l475t2708r663b2762],
27	though	IN	O	though	dep	35	SENT_319	[p21l686t2683r992b2783],
28	half	PDT	O	half	predet	30	SENT_319	[p21l1014t2682r1195b2761],
29	the	DT	O	the	det	30	SENT_319	[p21l1199t2683r1329b2761],
30	patients	NNS	O	patient	nsubjpass	35	SENT_319	[p21l1351t2683r1687b2783],
31	in	IN	O	in	_	0	SENT_319	[p21l1711t2683r1793b2760],
32	our	PRP$	O	we	poss	33	SENT_319	[p21l1816t2708r1961b2762],
33	trial	NN	O	trial	prep_in	30	SENT_319	[p21l1981t2683r2149b2761],
34	Were	VBD	O	be	auxpass	35	SENT_319	[p21l6t2837r209b2890],
35	treated	VBN	O	treat	ccomp	12	SENT_319	[p21l251t2810r542b2889],
36	after	IN	O	after	_	0	SENT_319	[p21l582t2810r777b2889],
37	both	DT	O	both	preconj	40	SENT_319	[p21l816t2810r1011b2889],
38	ﬁrst	FW	O	ﬁrst	nn	40	SENT_319	[p21l1052t2810r1416b2889],
39	—	FW	O	—	nn	40	SENT_319	[p21l1052t2810r1416b2889],
40	line	NN	O	line	prep_after	35	SENT_319	[p21l1052t2810r1416b2889],
41	and	CC	O	and	_	0	SENT_319	[p21l1457t2810r1613b2889],
42	second	JJ	ORDINAL	second	amod	45	SENT_319	[p21l1656t2810r2148b2889],
43	—	NN	O	—	nn	45	SENT_319	[p21l1656t2810r2148b2889],
44	line	NN	O	line	nn	45	SENT_319	[p21l1656t2810r2148b2889],
45	chemotherapy	NN	O	chemotherapy	prep_after	35	SENT_319	[p21l11t2939r633b3040],
46	.	.	O	.	_	0	SENT_319	[p21l11t2939r633b3040],

1	In	IN	O	in	_	0	SENT_320	[p21l660t2947r747b3017],
2	this	DT	O	this	det	3	SENT_320	[p21l770t2940r924b3018],
3	trial	NN	O	trial	prep_in	14	SENT_320	[p21l949t2940r1116b3018],
4	and	CC	O	and	_	0	SENT_320	[p21l1138t2939r1295b3018],
5	another	DT	O	another	det	6	SENT_320	[p21l1316t2940r1648b3018],
6	trial	NN	O	trial	prep_in	14	SENT_320	[p21l1668t2935r1902b3035],
7	,3	CD	NUMBER	,3	num	6	SENT_320	[p21l1668t2935r1902b3035],
8	a	DT	O	a	det	10	SENT_320	[p21l1926t2966r1971b3018],
9	signiﬁcant	NN	O	signiﬁcant	nn	10	SENT_320	[p21l1993t2940r2146b3040, p21l11t3067r340b3146],
10	prolongation	NN	O	prolongation	nsubjpass	14	SENT_320	[p21l366t3068r925b3168],
11	of	IN	O	of	_	0	SENT_320	[p21l959t3067r1060b3146],
12	survival	NN	O	survival	prep_of	10	SENT_320	[p21l1075t3068r1395b3147],
13	was	VBD	O	be	auxpass	14	SENT_320	[p21l1423t3094r1585b3147],
14	achieved	VBN	O	achieve	_	0	SENT_320	[p21l1619t3068r1984b3147],
15	despite	IN	O	despite	_	0	SENT_320	[p21l2018t3068r2147b3146, p21l12t3196r209b3296],
16	response	NN	O	response	nn	17	SENT_320	[p21l230t3221r605b3296],
17	rates	NNS	O	rate	prep_despite	14	SENT_320	[p21l626t3212r822b3274],
18	of	IN	O	of	_	0	SENT_320	[p21l846t3195r946b3274],
19	less	JJR	O	less	mwe	20	SENT_320	[p21l947t3196r1101b3274],
20	than	IN	O	than	quantmod	21	SENT_320	[p21l1125t3196r1311b3274],
21	10	CD	PERCENT	10	num	22	SENT_320	[p21l1335t3201r1432b3274],
22	percent	NN	PERCENT	percent	prep_of	17	SENT_320	[p21l1452t3212r1787b3296],
23	,	,	O	,	_	0	SENT_320	[p21l1452t3212r1787b3296],
24	perhaps	RB	O	perhaps	advmod	14	SENT_320	[p21l1813t3196r2147b3296],
25	because	IN	O	because	mark	32	SENT_320	[p21l11t3323r350b3403],
26	a	DT	O	a	det	28	SENT_320	[p21l377t3350r422b3402],
27	high	JJ	O	high	amod	28	SENT_320	[p21l448t3323r645b3424],
28	proportion	NN	O	proportion	nsubj	32	SENT_320	[p21l670t3324r1146b3424],
29	of	IN	O	of	_	0	SENT_320	[p21l1175t3323r1277b3402],
30	the	DT	O	the	det	31	SENT_320	[p21l1286t3324r1418b3402],
31	patients	NNS	O	patient	prep_of	28	SENT_320	[p21l1445t3324r1789b3424],
32	had	VBD	O	have	dep	24	SENT_320	[p21l1819t3323r1977b3402],
33	durable	JJ	O	durable	amod	35	SENT_320	[p21l2005t3324r2145b3403, p21l11t3452r224b3530],
34	stable	JJ	O	stable	amod	35	SENT_320	[p21l251t3452r502b3530],
35	disease	NN	O	disease	dobj	32	SENT_320	[p21l526t3452r831b3530],
36	While	IN	O	while	mark	37	SENT_320	[p21l849t3451r1082b3531],
37	receiving	VBG	O	receive	dep	24	SENT_320	[p21l1105t3452r1490b3552],
38	treatment	NN	O	treatment	dobj	37	SENT_320	[p21l1509t3468r1945b3530],
39	.	.	O	.	_	0	SENT_320	[p21l1509t3468r1945b3530],

1	Survival	NN	O	survival	nsubj	5	SENT_321	[p21l1975t3457r2147b3531, p21l6t3580r196b3659],
2	in	IN	O	in	_	0	SENT_321	[p21l215t3580r297b3657],
3	this	DT	O	this	det	4	SENT_321	[p21l319t3580r472b3658],
4	trial	NN	O	trial	prep_in	1	SENT_321	[p21l496t3580r663b3658],
5	appears	VBZ	O	appear	_	0	SENT_321	[p21l684t3606r1012b3680],
6	to	TO	O	to	aux	8	SENT_321	[p21l1036t3596r1115b3658],
7	be	VB	O	be	cop	8	SENT_321	[p21l1139t3580r1234b3658],
8	longer	JJR	O	longer	xcomp	5	SENT_321	[p21l1255t3580r1533b3680],
9	than	IN	O	than	_	0	SENT_321	[p21l1552t3580r1741b3658],
10	what	WP	O	what	nsubjpass	12	SENT_321	[p21l1758t3580r1973b3659],
11	was	VBD	O	be	auxpass	12	SENT_321	[p21l1984t3606r2146b3659],
12	achieved	VBN	O	achieve	prepc_than	8	SENT_321	[p21l10t3707r376b3787],
13	in	IN	O	in	_	0	SENT_321	[p21l400t3708r482b3785],
14	a	DT	O	a	det	16	SENT_321	[p21l507t3734r551b3786],
15	similar	JJ	O	similar	amod	16	SENT_321	[p21l577t3707r873b3786],
16	trial	NN	O	trial	prep_in	12	SENT_321	[p21l896t3707r1064b3786],
17	of	IN	O	of	_	0	SENT_321	[p21l1090t3707r1190b3786],
18	geﬁtinib	NN	O	geﬁtinib	prep_of	16	SENT_321	[p21l1197t3707r1579b3808],
19	,	,	O	,	_	0	SENT_321	[p21l1197t3707r1579b3808],
20	although	IN	O	although	mark	25	SENT_321	[p21l1609t3708r1992b3808],
21	the	DT	O	the	det	23	SENT_321	[p21l2018t3708r2148b3786],
22	response	NN	O	response	nn	23	SENT_321	[p22l11t47r403b122],
23	rates	NNS	O	rate	nsubj	25	SENT_321	[p22l438t38r644b100],
24	were	VBD	O	be	cop	25	SENT_321	[p22l676t48r884b101],
25	similar	JJ	O	similar	advcl	5	SENT_321	[p22l921t22r1227b100],
26	in	IN	O	in	prep	25	SENT_321	[p22l1258t22r1341b99],
27	both	CC	O	both	prep	25	SENT_321	[p22l1377t22r1575b100],
28	studies	NNS	O	study	dep	27	SENT_321	[p22l1611t22r1944b101],
29	.	.	O	.	_	0	SENT_321	[p22l1611t22r1944b101],

1	The	DT	O	the	det	2	SENT_322	[p22l1981t21r2146b100],
2	characteristics	NNS	O	characteristic	nsubj	15	SENT_322	[p22l11t150r629b228],
3	of	IN	O	of	_	0	SENT_322	[p22l670t149r772b228],
4	the	DT	O	the	det	5	SENT_322	[p22l792t150r921b228],
5	patients	NNS	O	patient	prep_of	2	SENT_322	[p22l959t150r1295b250],
6	in	IN	O	in	_	0	SENT_322	[p22l1335t150r1417b227],
7	these	DT	O	these	det	9	SENT_322	[p22l1456t150r1676b228],
8	two	CD	NUMBER	two	num	9	SENT_322	[p22l1715t166r1868b229],
9	trials	NNS	O	trial	prep_in	5	SENT_322	[p22l1909t150r2143b245],
10	,	,	O	,	_	0	SENT_322	[p22l1909t150r2143b245],
11	however	RB	O	however	advmod	15	SENT_322	[p22l11t279r384b374],
12	,	,	O	,	_	0	SENT_322	[p22l11t279r384b374],
13	may	MD	O	may	aux	15	SENT_322	[p22l415t305r593b379],
14	have	VB	O	have	aux	15	SENT_322	[p22l613t279r803b358],
15	differed	VBN	O	differ	_	0	SENT_322	[p22l829t278r1159b357],
16	somewhat	RB	O	somewhat	advmod	15	SENT_322	[p22l1186t274r1733b358],
17	.	.	O	.	_	0	SENT_322	[p22l1186t274r1733b358],

1	”	NN	O	”	_	0	SENT_323	[p22l1186t274r1733b358],

1	Exploratory	JJ	O	exploratory	amod	3	SENT_324	[p22l139t407r636b507],
2	multivariate	JJ	O	multivariate	amod	3	SENT_324	[p22l673t407r1180b486],
3	analyses	NNS	O	analysis	nsubj	4	SENT_324	[p22l1221t407r1572b507],
4	showed	VBD	O	show	_	0	SENT_324	[p22l1618t406r1943b486],
5	that	IN	O	that	complm	24	SENT_324	[p22l1985t406r2153b485],
6	only	JJ	O	only	amod	8	SENT_324	[p22l11t534r192b635],
7	Asian	JJ	MISC	asian	amod	8	SENT_324	[p22l228t535r466b613],
8	origin	NN	O	origin	nsubj	24	SENT_324	[p22l510t535r785b635],
9	,	,	O	,	_	0	SENT_324	[p22l510t535r785b635],
10	adenocarcinoma	NN	O	adenocarcinoma	appos	8	SENT_324	[p22l834t534r1538b613],
11	on	IN	O	on	_	0	SENT_324	[p22l1580t560r1687b613],
12	histologic	JJ	O	histologic	amod	13	SENT_324	[p22l1730t535r2148b635],
13	examination	NN	O	examination	prep_on	10	SENT_324	[p22l11t663r576b758],
14	,	,	O	,	_	0	SENT_324	[p22l11t663r576b758],
15	and	CC	O	and	_	0	SENT_324	[p22l617t662r776b741],
16	a	DT	O	a	det	17	SENT_324	[p22l812t689r857b741],
17	history	NN	O	history	conj_and	10	SENT_324	[p22l892t662r1195b763],
18	of	IN	O	of	_	0	SENT_324	[p22l1227t662r1330b741],
19	not	RB	O	not	neg	20	SENT_324	[p22l1348t679r1495b741],
20	smoking	NN	O	smoking	prep_of	17	SENT_324	[p22l1528t662r1912b763],
21	were	VBD	O	be	cop	24	SENT_324	[p22l1941t689r2147b742],
22	signiﬁcant	JJ	O	signiﬁcant	amod	24	SENT_324	[p22l12t790r477b891],
23	independent	JJ	O	independent	amod	24	SENT_324	[p22l508t790r1059b891],
24	predictors	NNS	O	predictor	ccomp	4	SENT_324	[p22l1088t791r1529b891],
25	of	IN	O	of	_	0	SENT_324	[p22l1567t790r1668b869],
26	survival	NN	O	survival	prep_of	24	SENT_324	[p22l1684t791r2004b870],
27	after	IN	O	after	_	0	SENT_324	[p22l2037t790r2147b869, p22l11t935r124b997],
28	adjustment	NN	O	adjustment	prep_after	24	SENT_324	[p22l164t919r646b1019],
29	for	IN	O	for	_	0	SENT_324	[p22l685t918r808b997],
30	treatment	NN	O	treatment	nn	34	SENT_324	[p22l850t935r1267b997],
31	and	CC	O	and	_	0	SENT_324	[p22l1304t919r1461b997],
32	other	JJ	O	other	conj_and	30	SENT_324	[p22l1506t919r1731b997],
33	potential	JJ	O	potential	amod	34	SENT_324	[p22l1770t918r2149b1019],
34	predictors	NNS	O	predictor	prep_for	28	SENT_324	[p22l10t1046r466b1147],
35	.	.	O	.	_	0	SENT_324	[p22l10t1046r466b1147],

1	Erlotinib	NNP	O	Erlotinib	nsubj	2	SENT_325	[p22l499t1046r873b1125],
2	had	VBD	O	have	_	0	SENT_325	[p22l904t1046r1061b1125],
3	a	DT	O	a	det	5	SENT_325	[p22l1090t1073r1134b1125],
4	beneﬁcial	JJ	O	beneﬁcial	amod	5	SENT_325	[p22l1163t1046r1569b1125],
5	effect	NN	O	effect	dobj	2	SENT_325	[p22l1597t1046r1828b1125],
6	on	IN	O	on	_	0	SENT_325	[p22l1852t1072r1957b1125],
7	survival	NN	O	survival	prep_on	5	SENT_325	[p22l1987t1073r2148b1126, p22l6t1175r192b1254],
8	in	IN	O	in	_	0	SENT_325	[p22l214t1175r295b1252],
9	almost	RB	O	almost	quantmod	10	SENT_325	[p22l317t1175r607b1253],
10	all	DT	O	all	num	11	SENT_325	[p22l624t1175r722b1253],
11	subgroups	NNS	O	subgroup	prep_in	2	SENT_325	[p22l746t1175r1187b1275],
12	tested	VBN	O	test	partmod	11	SENT_325	[p22l1213t1174r1482b1270],
13	,	,	O	,	_	0	SENT_325	[p22l1213t1174r1482b1270],
14	but	CC	O	but	_	0	SENT_325	[p22l1512t1174r1654b1254],
15	only	RB	O	only	advmod	17	SENT_325	[p22l1674t1175r1857b1275],
16	the	DT	O	the	det	17	SENT_325	[p22l1878t1175r2008b1253],
17	interaction	NN	O	interaction	nsubj	25	SENT_325	[p22l2032t1175r2147b1252, p22l11t1303r385b1381],
18	between	IN	O	between	_	0	SENT_325	[p22l424t1302r776b1382],
19	smoking	NN	O	smoking	nn	20	SENT_325	[p22l815t1303r1192b1403],
20	status	NN	O	status	prep_between	17	SENT_325	[p22l1228t1319r1477b1382],
21	and	CC	O	and	_	0	SENT_325	[p22l1519t1302r1679b1381],
22	treatment	NN	O	treatment	prep_between	17	SENT_325	[p22l1722t1319r2152b1381],
23	was	VBD	O	be	cop	25	SENT_325	[p22l6t1457r171b1510],
24	significantly	RB	O	significantly	advmod	25	SENT_325	[p22l204t1430r747b1531],
25	predictive	JJ	O	predictive	conj_but	2	SENT_325	[p22l770t1430r1199b1531],
26	of	IN	O	of	_	0	SENT_325	[p22l1229t1430r1331b1509],
27	a	DT	O	a	det	29	SENT_325	[p22l1341t1457r1386b1509],
28	differential	JJ	O	differential	amod	29	SENT_325	[p22l1413t1430r1892b1509],
29	effect	NN	O	effect	prep_of	25	SENT_325	[p22l1918t1430r2153b1509],
30	on	IN	O	on	_	0	SENT_325	[p22l11t1584r119b1637],
31	survival	NN	O	survival	prep_on	29	SENT_325	[p22l167t1559r510b1638],
32	.	.	O	.	_	0	SENT_325	[p22l167t1559r510b1638],

1	Notably	RB	O	notably	advmod	11	SENT_326	[p22l560t1558r913b1659],
2	,	,	O	,	_	0	SENT_326	[p22l560t1558r913b1659],
3	the	DT	O	the	det	4	SENT_326	[p22l966t1558r1096b1637],
4	presence	NN	O	presence	nsubj	11	SENT_326	[p22l1142t1584r1517b1659],
5	of	IN	O	of	_	0	SENT_326	[p22l1566t1558r1667b1637],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_326	[p22l1693t1565r1907b1638],
7	gene	NN	O	gene	nn	8	SENT_326	[p22l1948t1584r2147b1659],
8	mutations	NNS	O	mutation	prep_of	4	SENT_326	[p22l11t1687r444b1766],
9	was	VBD	O	be	cop	11	SENT_326	[p22l477t1713r640b1766],
10	not	RB	O	not	neg	11	SENT_326	[p22l677t1703r821b1765],
11	predictive	JJ	O	predictive	_	0	SENT_326	[p22l851t1687r1264b1787],
12	of	IN	O	of	_	0	SENT_326	[p22l1301t1686r1403b1765],
13	a	DT	O	a	det	15	SENT_326	[p22l1419t1713r1464b1765],
14	survival	NN	O	survival	nn	15	SENT_326	[p22l1499t1687r1819b1766],
15	beneﬁt	NN	O	beneﬁt	prep_of	11	SENT_326	[p22l1855t1686r2153b1765],
16	from	IN	O	from	_	0	SENT_326	[p22l11t1815r219b1894],
17	erlotinib	NN	O	erlotinib	prep_from	15	SENT_326	[p22l245t1816r606b1894],
18	in	IN	O	in	_	0	SENT_326	[p22l631t1816r713b1893],
19	our	PRP$	O	we	poss	20	SENT_326	[p22l739t1841r884b1895],
20	study	NN	O	study	prep_in	17	SENT_326	[p22l908t1811r1232b1916],
21	.28	CD	NUMBER	.28	tmod	11	SENT_326	[p22l908t1811r1232b1916],

1	In	IN	O	in	_	0	SENT_327	[p22l140t1951r227b2021],
2	the	DT	O	the	det	5	SENT_327	[p22l256t1944r385b2022],
3	IDEAL	NNP	O	IDEAL	nn	5	SENT_327	[p22l412t1951r692b2022],
4	2	CD	NUMBER	2	num	5	SENT_327	[p22l717t1949r765b2021],
5	trial	NN	O	trial	prep_in	10	SENT_327	[p22l795t1938r1071b2039],
6	,	,	O	,	_	0	SENT_327	[p22l795t1938r1071b2039],
7	“	NN	O	“	nn	8	SENT_327	[p22l795t1938r1071b2039],
8	geﬁtinib	NN	O	geﬁtinib	nsubj	10	SENT_327	[p22l1099t1943r1455b2044],
9	rapidly	RB	O	rapidly	advmod	10	SENT_327	[p22l1485t1944r1779b2044],
10	reduced	VBD	O	reduce	_	0	SENT_327	[p22l1803t1944r2138b2023],
11	symptoms	NNS	O	symptom	dobj	10	SENT_327	[p22l13t2088r450b2172],
12	in	IN	O	in	_	0	SENT_327	[p22l483t2072r564b2149],
13	35	CD	PERCENT	35	num	14	SENT_327	[p22l596t2077r692b2150],
14	percent	NN	PERCENT	percent	prep_in	10	SENT_327	[p22l725t2088r1046b2172],
15	to	TO	O	to	_	0	SENT_327	[p22l1072t2088r1151b2150],
16	43	CD	PERCENT	43	num	17	SENT_327	[p22l1182t2077r1281b2150],
17	percent	NN	PERCENT	percent	prep_to	10	SENT_327	[p22l1314t2088r1634b2172],
18	of	IN	O	of	_	0	SENT_327	[p22l1661t2071r1761b2150],
19	patients	NNS	O	patient	prep_of	17	SENT_327	[p22l1772t2072r2133b2172],
20	.	.	O	.	_	0	SENT_327	[p22l1772t2072r2133b2172],

1	In	IN	O	in	_	0	SENT_328	[p22l10t2207r98b2277],
2	our	PRP$	O	we	poss	3	SENT_328	[p22l120t2225r267b2279],
3	trial	NN	O	trial	prep_in	17	SENT_328	[p22l287t2200r482b2295],
4	,	,	O	,	_	0	SENT_328	[p22l287t2200r482b2295],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_328	[p22l512t2199r1047b2300],
6	more	RBR	O	more	amod	7	SENT_328	[p22l1065t2225r1288b2278],
7	patients	NNS	O	patient	nsubj	17	SENT_328	[p22l1310t2200r1652b2300],
8	in	IN	O	in	_	0	SENT_328	[p22l1678t2200r1760b2277],
9	the	DT	O	the	det	11	SENT_328	[p22l1783t2200r1914b2278],
10	erlotinib	JJ	O	erlotinib	amod	11	SENT_328	[p22l1939t2200r2136b2278, p22l12t2327r211b2406],
11	group	NN	O	group	prep_in	7	SENT_328	[p22l241t2353r499b2428],
12	than	IN	O	than	prep	11	SENT_328	[p22l529t2328r722b2406],
13	in	IN	O	in	pcomp	12	SENT_328	[p22l749t2328r832b2405],
14	the	DT	O	the	det	16	SENT_328	[p22l861t2328r993b2406],
15	placebo	NN	O	placebo	nn	16	SENT_328	[p22l1021t2328r1357b2428],
16	group	NN	O	group	pobj	13	SENT_328	[p22l1386t2353r1644b2428],
17	had	VBD	O	have	_	0	SENT_328	[p22l1674t2327r1832b2406],
18	reductions	NNS	O	reduction	dobj	17	SENT_328	[p22l1860t2327r2135b2407, p22l12t2456r216b2534],
19	in	IN	O	in	_	0	SENT_328	[p22l237t2456r317b2533],
20	dyspnea	NN	O	dyspnea	prep_in	18	SENT_328	[p22l339t2455r698b2556],
21	,	,	O	,	_	0	SENT_328	[p22l339t2455r698b2556],
22	pain	NN	O	pain	conj_and	20	SENT_328	[p22l723t2456r928b2556],
23	,	,	O	,	_	0	SENT_328	[p22l723t2456r928b2556],
24	and	CC	O	and	_	0	SENT_328	[p22l953t2456r1107b2534],
25	cough	NN	O	cough	conj_and	20	SENT_328	[p22l1128t2456r1407b2556],
26	.	.	O	.	_	0	SENT_328	[p22l1128t2456r1407b2556],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_329	[p22l1432t2456r1985b2551],
2	,	,	O	,	_	0	SENT_329	[p22l1432t2456r1985b2551],
3	the	DT	O	the	det	4	SENT_329	[p22l2011t2456r2139b2534],
4	time	NN	O	time	nsubj	10	SENT_329	[p22l12t2584r201b2662],
5	to	TO	O	to	_	0	SENT_329	[p22l234t2600r315b2662],
6	exacerbation	NN	O	exacerbation	prep_to	4	SENT_329	[p22l349t2584r898b2662],
7	of	IN	O	of	_	0	SENT_329	[p22l931t2583r1033b2662],
8	these	DT	O	these	det	9	SENT_329	[p22l1048t2584r1270b2662],
9	symptoms	NNS	O	symptom	prep_of	6	SENT_329	[p22l1305t2600r1750b2684],
10	was	VBD	O	be	_	0	SENT_329	[p22l1781t2610r1944b2663],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_329	[p22l1980t2584r2136b2684, p22l12t2711r415b2812],
12	longer	RBR	O	longer	advmod	10	SENT_329	[p22l437t2712r713b2812],
13	in	IN	O	in	_	0	SENT_329	[p22l737t2712r818b2789],
14	the	DT	O	the	det	16	SENT_329	[p22l846t2712r976b2790],
15	erlotinib	JJ	O	erlotinib	amod	16	SENT_329	[p22l1004t2711r1363b2790],
16	group	NN	O	group	prep_in	12	SENT_329	[p22l1391t2737r1667b2812],
17	.	.	O	.	_	0	SENT_329	[p22l1391t2737r1667b2812],

1	The	DT	O	the	det	2	SENT_330	[p22l1697t2711r1858b2790],
2	analysis	NN	O	analysis	nsubj	8	SENT_330	[p22l1886t2712r2137b2812, p22l13t2840r120b2918],
3	of	IN	O	of	_	0	SENT_330	[p22l153t2839r254b2918],
4	the	DT	O	the	det	5	SENT_330	[p22l267t2840r396b2918],
5	quality	NN	O	quality	prep_of	2	SENT_330	[p22l428t2840r714b2940],
6	of	IN	O	of	_	0	SENT_330	[p22l742t2839r842b2918],
7	life	NN	O	life	prep_of	5	SENT_330	[p22l853t2839r984b2918],
8	showed	VBD	O	show	_	0	SENT_330	[p22l1017t2839r1341b2919],
9	that	IN	O	that	complm	14	SENT_330	[p22l1372t2840r1539b2918],
10	symptom	NN	O	symptom	nn	11	SENT_330	[p22l1567t2856r1962b2940],
11	improvement	NN	O	improvement	nsubjpass	14	SENT_330	[p22l1993t2840r2137b2917, p22l11t2984r478b3068],
12	was	VBD	O	be	auxpass	14	SENT_330	[p22l502t2994r666b3047],
13	also	RB	O	also	advmod	14	SENT_330	[p22l700t2968r871b3046],
14	associated	VBN	O	associate	ccomp	8	SENT_330	[p22l904t2968r1351b3046],
15	with	IN	O	with	_	0	SENT_330	[p22l1380t2967r1572b3047],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_330	[p22l1607t2967r2142b3068],
17	improved	VBN	O	improve	amod	19	SENT_330	[p22l11t3095r418b3196],
18	physical	JJ	O	physical	amod	19	SENT_330	[p22l441t3095r786b3196],
19	function	NN	O	function	prep_with	14	SENT_330	[p22l810t3095r1190b3175],
20	.	.	O	.	_	0	SENT_330	[p22l810t3095r1190b3175],

1	Rash3	NN	O	rash3	nn	2	SENT_331	[p22l140t3219r436b3307],
2	°	NN	O	°	nsubj	9	SENT_331	[p22l140t3219r436b3307],
3	and	CC	O	and	_	0	SENT_331	[p22l468t3224r626b3302],
4	diarrhea	NN	O	diarrhea	nsubj	9	SENT_331	[p22l658t3223r1017b3302],
5	are	VBP	O	be	cop	9	SENT_331	[p22l1046t3250r1175b3302],
6	the	DT	O	the	det	9	SENT_331	[p22l1207t3224r1339b3302],
7	main	JJ	O	main	amod	9	SENT_331	[p22l1370t3224r1589b3302],
8	toxic	JJ	O	toxic	amod	9	SENT_331	[p22l1621t3224r1826b3302],
9	effects	NNS	O	effect	_	0	SENT_331	[p22l1858t3223r2135b3302],
10	of	IN	O	of	_	0	SENT_331	[p22l12t3352r114b3431],
11	EGFRinhibitors	NNS	O	egfrinhibitor	prep_of	9	SENT_331	[p22l118t3348r889b3436],
12	.9	CD	NUMBER	.9	num	11	SENT_331	[p22l118t3348r889b3436],
13	They	PRP	O	they	nsubj	14	SENT_331	[p22l911t3353r1123b3453],
14	led	VBD	O	lead	rcmod	11	SENT_331	[p22l1141t3352r1268b3431],
15	to	TO	O	to	_	0	SENT_331	[p22l1292t3369r1372b3431],
16	dose	NN	O	dose	nn	17	SENT_331	[p22l1398t3352r1594b3431],
17	reduction	NN	O	reduction	prep_to	14	SENT_331	[p22l1618t3353r2032b3432],
18	in	IN	O	in	_	0	SENT_331	[p22l2055t3353r2137b3430],
19	12	CD	PERCENT	12	num	20	SENT_331	[p22l15t3486r113b3558],
20	percent	NN	PERCENT	percent	prep_in	17	SENT_331	[p22l147t3497r468b3581],
21	and	CC	O	and	_	0	SENT_331	[p22l496t3480r652b3559],
22	5	CD	PERCENT	5	num	23	SENT_331	[p22l687t3488r729b3559],
23	percent	NN	PERCENT	percent	prep_to	14	SENT_331	[p22l765t3497r1086b3581],
24	of	IN	O	of	_	0	SENT_331	[p22l1115t3480r1216b3559],
25	patients	NNS	O	patient	prep_of	23	SENT_331	[p22l1230t3481r1590b3581],
26	,	,	O	,	_	0	SENT_331	[p22l1230t3481r1590b3581],
27	respectively	RB	O	respectively	advmod	14	SENT_331	[p22l1629t3481r2133b3581],
28	,	,	O	,	_	0	SENT_331	[p22l1629t3481r2133b3581],
29	in	IN	O	in	_	0	SENT_331	[p22l11t3609r92b3686],
30	our	PRP$	O	we	poss	31	SENT_331	[p22l119t3634r264b3688],
31	trial	NN	O	trial	prep_in	14	SENT_331	[p22l287t3608r476b3687],
32	.	.	O	.	_	0	SENT_331	[p22l287t3608r476b3687],

1	Pneumonitis	NN	O	pneumonitis	nsubjpass	4	SENT_332	[p22l507t3609r1043b3688],
2	has	VBZ	O	have	aux	4	SENT_332	[p22l1072t3608r1213b3687],
3	been	VBN	O	be	auxpass	4	SENT_332	[p22l1242t3609r1442b3687],
4	reported	VBN	O	report	dep	32	SENT_332	[p22l1467t3608r1827b3709],
5	mainly	RB	O	mainly	advmod	4	SENT_332	[p22l1852t3609r2143b3709],
6	in	IN	O	in	_	0	SENT_332	[p23l11t25r91b101],
7	Japan	NNP	LOCATION	Japan	prep_in	4	SENT_332	[p23l105t31r345b124],
8	following	VBG	O	follow	_	0	SENT_332	[p23l369t23r771b124],
9	treatment	NN	O	treatment	prep_following	7	SENT_332	[p23l792t40r1200b102],
10	with	IN	O	with	_	0	SENT_332	[p23l1214t24r1401b103],
11	geﬁtinib	NN	O	geﬁtinib	prep_with	9	SENT_332	[p23l1425t18r1882b124],
12	.31	CD	NUMBER	.31	num	11	SENT_332	[p23l1425t18r1882b124],
13	However	RB	O	however	advmod	11	SENT_332	[p23l1905t31r2137b103, p23l12t178r202b247],
14	,	,	O	,	_	0	SENT_332	[p23l1905t31r2137b103, p23l12t178r202b247],
15	four	CD	NUMBER	four	num	16	SENT_332	[p23l237t151r418b231],
16	trials	NNS	O	trial	conj_or	7	SENT_332	[p23l443t151r656b230],
17	of	IN	O	of	_	0	SENT_332	[p23l687t151r789b230],
18	gefitinib	NN	O	gefitinib	prep_of	16	SENT_332	[p23l798t151r1162b252],
19	or	CC	O	or	_	0	SENT_332	[p23l1192t177r1283b230],
20	erlotinib	NN	O	erlotinib	conj_or	7	SENT_332	[p23l1309t151r1676b230],
21	combined	VBN	O	combine	partmod	20	SENT_332	[p23l1706t151r2138b230],
22	with	IN	O	with	_	0	SENT_332	[p23l7t280r198b359],
23	chemotherapy	NN	O	chemotherapy	prep_with	21	SENT_332	[p23l223t279r830b380],
24	for	IN	O	for	_	0	SENT_332	[p23l850t279r973b358],
25	non	JJ	O	non	amod	31	SENT_332	[p23l995t280r1627b358],
26	—	JJ	O	—	amod	31	SENT_332	[p23l995t280r1627b358],
27	small	JJ	O	small	amod	31	SENT_332	[p23l995t280r1627b358],
28	—	NN	O	—	nn	31	SENT_332	[p23l995t280r1627b358],
29	cell	NN	O	cell	nn	31	SENT_332	[p23l995t280r1627b358],
30	lung	NN	O	lung	nn	31	SENT_332	[p23l1650t280r1844b380],
31	cancer	NN	O	cancer	prep_for	23	SENT_332	[p23l1866t305r2141b358],
32	reported	VBD	O	report	_	0	SENT_332	[p23l12t408r378b508],
33	similar	JJ	O	similar	amod	34	SENT_332	[p23l423t408r725b486],
34	rates	NNS	O	rate	dobj	32	SENT_332	[p23l765t424r968b486],
35	of	IN	O	of	_	0	SENT_332	[p23l1014t407r1116b486],
36	pneumonitis	NN	O	pneumonitis	prep_of	34	SENT_332	[p23l1140t408r1690b508],
37	in	IN	O	in	_	0	SENT_332	[p23l1735t408r1818b485],
38	activetreatment	NN	O	activetreatment	nn	41	SENT_332	[p23l1860t408r2136b487, p23l12t553r435b615],
39	and	CC	O	and	_	0	SENT_332	[p23l464t537r621b615],
40	placebo	NN	O	placebo	nn	41	SENT_332	[p23l655t537r982b637],
41	groups	NNS	O	group	prep_in	32	SENT_332	[p23l1019t532r1530b637],
42	.32	CD	NUMBER	.32	number	43	SENT_332	[p23l1019t532r1530b637],
43	'35	CD	NUMBER	'35	nsubj	32	SENT_332	[p23l1019t532r1530b637],
44	We	PRP	O	we	nsubj	46	SENT_332	[p23l1566t544r1699b615],
45	rarely	RB	O	rarely	advmod	46	SENT_332	[p23l1735t537r1973b637],
46	encountered	VBD	O	encounter	rcmod	43	SENT_332	[p23l2005t562r2137b615, p23l12t664r435b744],
47	pneumonitis	NN	O	pneumonitis	dobj	46	SENT_332	[p23l459t665r998b765],
48	or	CC	O	or	_	0	SENT_332	[p23l1026t690r1114b743],
49	pulmonary	JJ	O	pulmonary	amod	50	SENT_332	[p23l1135t665r1602b765],
50	ﬁbrosis	NN	O	ﬁbrosis	dobj	46	SENT_332	[p23l1622t664r1964b743],
51	.	.	O	.	_	0	SENT_332	[p23l1622t664r1964b743],

1	In	IN	O	in	_	0	SENT_333	[p23l140t800r228b870],
2	summary	NN	O	summary	prep_in	6	SENT_333	[p23l260t819r677b893],
3	,	,	O	,	_	0	SENT_333	[p23l260t819r677b893],
4	this	DT	O	this	det	5	SENT_333	[p23l715t793r871b871],
5	trial	NN	O	trial	nsubj	6	SENT_333	[p23l904t793r1075b871],
6	shows	VBZ	O	show	_	0	SENT_333	[p23l1108t793r1376b872],
7	that	IN	O	that	complm	18	SENT_333	[p23l1409t792r1580b871],
8	erlotinib	NN	O	erlotinib	nsubj	21	SENT_333	[p23l1607t793r2000b888],
9	,	,	O	,	_	0	SENT_333	[p23l1607t793r2000b888],
10	an	DT	O	a	det	14	SENT_333	[p23l2036t818r2137b871],
11	oral	JJ	O	oral	amod	14	SENT_333	[p23l12t920r179b999],
12	tyrosine	NN	O	tyrosine	nn	14	SENT_333	[p23l210t921r556b1021],
13	kinase	NN	O	kinase	nn	14	SENT_333	[p23l588t921r867b1000],
14	inhibitor	NN	O	inhibitor	appos	8	SENT_333	[p23l898t920r1287b999],
15	of	IN	O	of	_	0	SENT_333	[p23l1315t920r1417b999],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_333	[p23l1429t926r1708b1016],
17	,	,	O	,	_	0	SENT_333	[p23l1429t926r1708b1016],
18	prolongs	VBZ	O	prolong	ccomp	6	SENT_333	[p23l1744t921r2134b1021],
19	survival	NN	O	survival	dobj	18	SENT_333	[p23l13t1049r323b1128],
20	and	CC	O	and	_	0	SENT_333	[p23l343t1049r497b1127],
21	decreases	VBZ	O	decrease	conj_and	18	SENT_333	[p23l518t1048r911b1127],
22	symptoms	NNS	O	symptom	dobj	21	SENT_333	[p23l935t1065r1389b1149],
23	,	,	O	,	_	0	SENT_333	[p23l935t1065r1389b1149],
24	as	IN	O	as	conj_and	18	SENT_333	[p23l1415t1075r1498b1127],
25	compared	VBN	O	compare	pcomp	24	SENT_333	[p23l1523t1048r1937b1149],
26	with	IN	O	with	pcomp	25	SENT_333	[p23l1954t1048r2139b1128],
27	placebo	NN	O	placebo	pobj	26	SENT_333	[p23l10t1177r369b1277],
28	,	,	O	,	_	0	SENT_333	[p23l10t1177r369b1277],
29	in	IN	O	in	_	0	SENT_333	[p23l406t1177r489b1254],
30	previously	RB	DATE	previously	advmod	31	SENT_333	[p23l520t1176r964b1277],
31	treated	VBN	O	treat	amod	32	SENT_333	[p23l992t1177r1288b1255],
32	patients	NNS	O	patient	prep_in	6	SENT_333	[p23l1319t1177r1661b1277],
33	with	IN	O	with	_	0	SENT_333	[p23l1692t1177r1884b1256],
34	nonsmall	JJ	O	nonsmall	amod	38	SENT_333	[p23l1917t1202r2140b1255, p23l13t1305r427b1383],
35	—	NN	O	—	nn	38	SENT_333	[p23l1917t1202r2140b1255, p23l13t1305r427b1383],
36	cell	NN	O	cell	nn	38	SENT_333	[p23l1917t1202r2140b1255, p23l13t1305r427b1383],
37	lung	NN	O	lung	nn	38	SENT_333	[p23l451t1304r645b1405],
38	cancer	NN	O	cancer	prep_with	32	SENT_333	[p23l668t1330r959b1383],
39	.	.	O	.	_	0	SENT_333	[p23l668t1330r959b1383],

1	Supported	VBN	O	support	_	0	SENT_334	[p23l99t1435r427b1510],
2	in	IN	O	in	_	0	SENT_334	[p23l443t1436r504b1493],
3	part	NN	O	part	prep_in	1	SENT_334	[p23l521t1448r652b1510],
4	by	IN	O	by	_	0	SENT_334	[p23l665t1435r738b1510],
5	a	DT	O	a	det	6	SENT_334	[p23l752t1455r786b1494],
6	grant	NN	O	grant	prep_by	1	SENT_334	[p23l801t1448r973b1511],
7	from	IN	O	from	_	0	SENT_334	[p23l987t1435r1142b1494],
8	OSI	NNP	ORGANIZATION	OSI	nn	9	SENT_334	[p23l1160t1440r1276b1494],
9	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_from	6	SENT_334	[p23l1292t1435r1813b1495],
10	to	TO	O	to	_	0	SENT_334	[p23l1832t1448r1891b1494],
11	the	DT	O	the	det	14	SENT_334	[p23l1910t1435r2007b1494],
12	N	NN	O	n	nn	14	SENT_334	[p23l2023t1441r2080b1495],
13	ational	JJ	O	ational	amod	14	SENT_334	[p23l2082t1455r2139b1494, p23l11t1519r193b1578],
14	Cancer	NN	ORGANIZATION	cancer	nn	15	SENT_334	[p23l211t1524r433b1578],
15	Institute	NNP	ORGANIZATION	Institute	prep_to	1	SENT_334	[p23l448t1520r713b1579],
16	of	IN	ORGANIZATION	of	_	0	SENT_334	[p23l733t1519r808b1578],
17	Canada	NNP	ORGANIZATION	Canada	nn	19	SENT_334	[p23l813t1519r1051b1578],
18	Clinical	JJ	ORGANIZATION	clinical	amod	19	SENT_334	[p23l1068t1520r1310b1578],
19	Trials	NNPS	ORGANIZATION	Trials	prep_of	15	SENT_334	[p23l1325t1519r1501b1578],
20	Group	NNP	ORGANIZATION	Group	dep	19	SENT_334	[p23l1522t1524r1745b1595],
21	.	.	O	.	_	0	SENT_334	[p23l1522t1524r1745b1595],

1	We	PRP	O	we	nsubj	3	SENT_335	[p23l94t1610r194b1663],
2	are	VBP	O	be	cop	3	SENT_335	[p23l212t1624r308b1663],
3	indebted	JJ	O	indebted	_	0	SENT_335	[p23l326t1604r610b1663],
4	to	TO	O	to	_	0	SENT_335	[p23l628t1617r689b1663],
5	Dr.	NNP	O	Dr.	nn	7	SENT_335	[p23l707t1609r802b1663],
6	Joseph	NNP	PERSON	Joseph	nn	7	SENT_335	[p23l817t1604r1041b1680],
7	Pater	NNP	PERSON	Pater	prep_to	3	SENT_335	[p23l1058t1609r1222b1663],
8	and	CC	O	and	_	0	SENT_335	[p23l1238t1604r1357b1663],
9	Dr.	NNP	O	Dr.	nn	11	SENT_335	[p23l1373t1609r1469b1663],
10	Keyue	NNP	PERSON	Keyue	nn	11	SENT_335	[p23l1491t1610r1683b1680],
11	Ding	NNP	PERSON	Ding	conj_and	7	SENT_335	[p23l1701t1605r1863b1680],
12	for	IN	O	for	_	0	SENT_335	[p23l1878t1604r1972b1663],
13	their	PRP$	O	they	poss	14	SENT_335	[p23l1988t1604r2140b1663],
14	contribution	NN	O	contribution	prep_for	11	SENT_335	[p23l11t1690r418b1749],
15	to	TO	O	to	_	0	SENT_335	[p23l443t1702r503b1748],
16	the	DT	O	the	det	17	SENT_335	[p23l530t1689r628b1748],
17	trial	NN	O	trial	prep_to	11	SENT_335	[p23l654t1690r802b1761],
18	;	:	O	;	_	0	SENT_335	[p23l654t1690r802b1761],
19	to	TO	O	to	_	0	SENT_335	[p23l830t1702r890b1748],
20	T.	NNP	PERSON	T.	nn	21	SENT_335	[p23l914t1694r970b1748],
21	Masterson	NNP	PERSON	Masterson	prep_to	11	SENT_335	[p23l996t1695r1357b1761],
22	,	,	O	,	_	0	SENT_335	[p23l996t1695r1357b1761],
23	W.	NNP	PERSON	W.	nn	24	SENT_335	[p23l1383t1695r1462b1748],
24	Gollogly	NNP	PERSON	Gollogly	appos	21	SENT_335	[p23l1492t1689r1780b1765],
25	,	,	O	,	_	0	SENT_335	[p23l1492t1689r1780b1765],
26	S.	NNP	PERSON	S.	nn	29	SENT_335	[p23l1811t1694r1864b1748],
27	Meliny	NNP	PERSON	Meliny	nn	29	SENT_335	[p23l1891t1689r2137b1765],
28	—	NN	O	—	nn	29	SENT_335	[p23l1891t1689r2137b1765],
29	shyn	NN	O	shyn	appos	21	SENT_335	[p23l12t1774r179b1850],
30	,	,	O	,	_	0	SENT_335	[p23l12t1774r179b1850],
31	A.	NN	PERSON	a.	nn	32	SENT_335	[p23l200t1780r266b1833],
32	Sadura	NNP	PERSON	Sadura	appos	21	SENT_335	[p23l291t1774r529b1846],
33	,	,	O	,	_	0	SENT_335	[p23l291t1774r529b1846],
34	M.	NNP	PERSON	M.	nn	35	SENT_335	[p23l551t1780r633b1833],
35	Whitehead	NNP	PERSON	Whitehead	appos	21	SENT_335	[p23l655t1774r1026b1846],
36	,	,	O	,	_	0	SENT_335	[p23l655t1774r1026b1846],
37	L.	NNP	PERSON	L.	nn	38	SENT_335	[p23l1049t1780r1105b1833],
38	Lafond	NNP	PERSON	Lafond	appos	21	SENT_335	[p23l1127t1774r1373b1846],
39	,	,	O	,	_	0	SENT_335	[p23l1127t1774r1373b1846],
40	K.	NNP	PERSON	K.	nn	41	SENT_335	[p23l1396t1780r1462b1835],
41	Hann	NNP	PERSON	Hann	appos	21	SENT_335	[p23l1485t1780r1683b1846],
42	,	,	O	,	_	0	SENT_335	[p23l1485t1780r1683b1846],
43	J.	NNP	PERSON	J.	nn	44	SENT_335	[p23l1700t1780r1744b1843],
44	Ottaway	NNP	PERSON	Ottaway	appos	21	SENT_335	[p23l1768t1779r2042b1850],
45	,	,	O	,	_	0	SENT_335	[p23l1768t1779r2042b1850],
46	D.	NNP	PERSON	D.	nn	47	SENT_335	[p23l2065t1779r2133b1833],
47	Voskoglou	NNP	PERSON	Voskoglou	appos	21	SENT_335	[p23l8t1858r702b1934],
48	.	.	O	.	_	0	SENT_335	[p23l8t1858r702b1934],

1	—	NN	O	—	_	0	SENT_336	[p23l8t1858r702b1934],
2	.	.	O	.	_	0	SENT_336	[p23l8t1858r702b1934],

1	Nomikos	NNP	PERSON	Nomikos	_	0	SENT_337	[p23l8t1858r702b1934],
2	,	,	O	,	_	0	SENT_337	[p23l8t1858r702b1934],
3	D.	NNP	PERSON	D.	nn	4	SENT_337	[p23l722t1863r790b1917],
4	Jones	NNP	PERSON	Jones	appos	1	SENT_337	[p23l804t1864r1199b1930],
5	.	.	O	.	_	0	SENT_337	[p23l804t1864r1199b1930],

1	—	NN	O	—	_	0	SENT_338	[p23l804t1864r1199b1930],
2	.	.	O	.	_	0	SENT_338	[p23l804t1864r1199b1930],

1	Moar	NNP	PERSON	Moar	_	0	SENT_339	[p23l804t1864r1199b1930],
2	,	,	O	,	_	0	SENT_339	[p23l804t1864r1199b1930],
3	T.	NNP	PERSON	T.	nn	4	SENT_339	[p23l1218t1863r1275b1917],
4	Boyd	NNP	PERSON	Boyd	appos	1	SENT_339	[p23l1296t1858r1474b1934],
5	,	,	O	,	_	0	SENT_339	[p23l1296t1858r1474b1934],
6	M.	NNP	PERSON	M.	nn	7	SENT_339	[p23l1493t1864r1576b1917],
7	Savoie	NNP	PERSON	Savoie	appos	1	SENT_339	[p23l1600t1859r1820b1930],
8	,	,	O	,	_	0	SENT_339	[p23l1600t1859r1820b1930],
9	A.	NNP	PERSON	A.	nn	10	SENT_339	[p23l1839t1864r1904b1917],
10	Urton	NNP	PERSON	Urton	conj_and	4	SENT_339	[p23l1926t1864r2134b1930],
11	,	,	O	,	_	0	SENT_339	[p23l1926t1864r2134b1930],
12	T.	NNP	PERSON	T.	nn	13	SENT_339	[p23l8t1948r65b2002],
13	Hanna	NNP	PERSON	Hanna	conj_and	4	SENT_339	[p23l88t1949r322b2015],
14	,	,	O	,	_	0	SENT_339	[p23l88t1949r322b2015],
15	T.	NNP	PERSON	T.	nn	16	SENT_339	[p23l343t1948r399b2002],
16	Feener	NNP	PERSON	Feener	conj_and	4	SENT_339	[p23l421t1949r653b2015],
17	,	,	O	,	_	0	SENT_339	[p23l421t1949r653b2015],
18	and	CC	O	and	_	0	SENT_339	[p23l676t1943r794b2002],
19	S.	NNP	PERSON	S.	nn	20	SENT_339	[p23l815t1948r867b2002],
20	Virk	NNP	PERSON	Virk	conj_and	4	SENT_339	[p23l888t1943r1027b2003],
21	of	IN	O	of	_	0	SENT_339	[p23l1044t1943r1120b2002],
22	the	DT	O	the	det	25	SENT_339	[p23l1126t1944r1225b2002],
23	National	NNP	ORGANIZATION	National	nn	25	SENT_339	[p23l1242t1943r1523b2002],
24	Cancer	NNP	ORGANIZATION	Cancer	nn	25	SENT_339	[p23l1542t1948r1769b2002],
25	Institute	NNP	ORGANIZATION	Institute	conj_and	25	SENT_339	[p23l1785t1944r2056b2002],
26	of	IN	ORGANIZATION	of	_	0	SENT_339	[p23l2076t1943r2152b2002],
27	Canada	NNP	ORGANIZATION	Canada	nn	29	SENT_339	[p23l11t2028r252b2087],
28	Clinical	JJ	ORGANIZATION	clinical	amod	29	SENT_339	[p23l269t2028r512b2087],
29	Trials	NNPS	ORGANIZATION	Trials	prep_of	25	SENT_339	[p23l527t2029r703b2087],
30	Group	NNP	ORGANIZATION	Group	dep	29	SENT_339	[p23l723t2033r947b2104],
31	;	:	O	;	_	0	SENT_339	[p23l723t2033r947b2104],
32	and	CC	O	and	_	0	SENT_339	[p23l967t2028r1084b2087],
33	to	TO	O	to	_	0	SENT_339	[p23l1102t2041r1161b2087],
34	M.	NNP	PERSON	M.	nn	35	SENT_339	[p23l1177t2034r1259b2087],
35	Ptaszynski	NNP	PERSON	Ptaszynski	prep_to	25	SENT_339	[p23l1279t2028r1615b2104],
36	and	CC	O	and	_	0	SENT_339	[p23l1631t2029r1748b2087],
37	B.	NNP	PERSON	B.	nn	38	SENT_339	[p23l1764t2033r1825b2087],
38	Geiger	NNP	PERSON	Geiger	prep_to	25	SENT_339	[p23l1847t2029r2062b2104],
39	of	IN	O	of	_	0	SENT_339	[p23l2077t2028r2152b2087],
40	OSI	NNP	ORGANIZATION	OSI	nn	41	SENT_339	[p23l11t2118r127b2172],
41	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_of	38	SENT_339	[p23l145t2113r684b2172],
42	.	.	O	.	_	0	SENT_339	[p23l145t2113r684b2172],

1	APPENDIX	NN	O	appendix	_	0	SENT_340	[p23l862t2247r1010b2263],

1	The	DT	O	the	dep	173	SENT_341	[p23l94t2290r141b2314],
2	following	VBG	O	follow	dep	173	SENT_341	[p23l149t2290r268b2320],
3	investigators	NNS	O	investigator	dep	173	SENT_341	[p23l274t2291r431b2320],
4	and	CC	O	and	dep	173	SENT_341	[p23l439t2290r484b2314],
5	centers	NNS	O	center	dep	173	SENT_341	[p23l492t2295r579b2314],
6	participated	VBD	O	participate	dep	173	SENT_341	[p23l586t2290r733b2320],
7	in	IN	O	in	dep	173	SENT_341	[p23l741t2291r765b2313],
8	this	DT	O	this	dep	173	SENT_341	[p23l772t2290r817b2314],
9	National	NNP	ORGANIZATION	National	dep	173	SENT_341	[p23l824t2290r931b2314],
10	Cancer	NNP	ORGANIZATION	Cancer	dep	173	SENT_341	[p23l938t2292r1025b2314],
11	Institute	NNP	ORGANIZATION	Institute	dep	173	SENT_341	[p23l1031t2291r1134b2314],
12	of	IN	ORGANIZATION	of	dep	173	SENT_341	[p23l1141t2290r1171b2314],
13	Canada	NNP	ORGANIZATION	Canada	dep	173	SENT_341	[p23l1173t2290r1265b2314],
14	Clinical	JJ	ORGANIZATION	clinical	dep	173	SENT_341	[p23l1272t2290r1366b2314],
15	Trials	NNPS	ORGANIZATION	Trials	dep	173	SENT_341	[p23l1372t2290r1440b2314],
16	Group	NNP	ORGANIZATION	Group	dep	173	SENT_341	[p23l1448t2292r1527b2320],
17	study	NN	O	study	dep	173	SENT_341	[p23l1536t2290r1607b2320],
18	:	:	O	:	_	0	SENT_341	[p23l1536t2290r1607b2320],
19	A.M.	NNP	PERSON	A.M.	dep	173	SENT_341	[p23l1615t2292r1674b2314],
20	Alvarez	NNP	PERSON	Alvarez	dep	173	SENT_341	[p23l1682t2290r1780b2319],
21	,	,	O	,	_	0	SENT_341	[p23l1682t2290r1780b2319],
22	J.L.	NNP	PERSON	J.L.	dep	173	SENT_341	[p23l92t2330r133b2354],
23	Martinez	NNP	PERSON	Martinez	dep	173	SENT_341	[p23l140t2328r258b2356],
24	,	,	O	,	_	0	SENT_341	[p23l140t2328r258b2356],
25	M.	NNP	PERSON	M.	dep	173	SENT_341	[p23l265t2330r297b2351],
26	Varela	NNP	PERSON	Varela	dep	173	SENT_341	[p23l304t2328r386b2356],
27	,	,	O	,	_	0	SENT_341	[p23l304t2328r386b2356],
28	M.	NNP	PERSON	M.	dep	173	SENT_341	[p23l393t2330r425b2351],
29	Van	NNP	PERSON	Van	dep	173	SENT_341	[p23l432t2330r478b2351],
30	Kooten	NNP	PERSON	Kooten	dep	173	SENT_341	[p23l484t2330r580b2356],
31	,	,	O	,	_	0	SENT_341	[p23l484t2330r580b2356],
32	S.	NNP	PERSON	S.	dep	173	SENT_341	[p23l589t2330r609b2351],
33	Jovtis	NNP	PERSON	Jovtis	dep	173	SENT_341	[p23l614t2328r689b2356],
34	,	,	O	,	_	0	SENT_341	[p23l614t2328r689b2356],
35	Buenos	NNP	LOCATION	Buenos	dep	173	SENT_341	[p23l697t2330r788b2351],
36	Aires	NNP	LOCATION	Aires	dep	173	SENT_341	[p23l794t2328r864b2355],
37	;	:	O	;	_	0	SENT_341	[p23l794t2328r864b2355],
38	M.	NNP	PERSON	M.	dep	173	SENT_341	[p23l871t2330r903b2351],
39	Freue	NNP	PERSON	Freue	dep	173	SENT_341	[p23l911t2330r986b2356],
40	,	,	O	,	_	0	SENT_341	[p23l911t2330r986b2356],
41	Lanus	NNP	O	Lanus	dep	173	SENT_341	[p23l993t2330r1074b2356],
42	,	,	O	,	_	0	SENT_341	[p23l993t2330r1074b2356],
43	Argentina	NNP	LOCATION	Argentina	dep	173	SENT_341	[p23l1081t2328r1211b2357],
44	;	:	O	;	_	0	SENT_341	[p23l1081t2328r1211b2357],
45	M.	NNP	PERSON	M.	dep	173	SENT_341	[p23l1217t2330r1249b2351],
46	Rosenthal	NNP	PERSON	Rosenthal	dep	173	SENT_341	[p23l1257t2328r1388b2356],
47	,	,	O	,	_	0	SENT_341	[p23l1257t2328r1388b2356],
48	Parkville	NNP	LOCATION	Parkville	dep	173	SENT_341	[p23l1396t2328r1507b2356],
49	,	,	O	,	_	0	SENT_341	[p23l1396t2328r1507b2356],
50	Australia	NNP	LOCATION	Australia	dep	173	SENT_341	[p23l1514t2328r1632b2356],
51	;	:	O	;	_	0	SENT_341	[p23l1514t2328r1632b2356],
52	D.	NNP	PERSON	D.	dep	173	SENT_341	[p23l1639t2330r1664b2351],
53	Yip	NNP	PERSON	Yip	dep	173	SENT_341	[p23l1671t2328r1718b2357],
54	,	,	O	,	_	0	SENT_341	[p23l1671t2328r1718b2357],
55	Garran	NNP	LOCATION	Garran	dep	173	SENT_341	[p23l1726t2330r1781b2351, p23l95t2372r142b2393],
56	,	,	O	,	_	0	SENT_341	[p23l1726t2330r1781b2351, p23l95t2372r142b2393],
57	Australia	NNP	LOCATION	Australia	dep	173	SENT_341	[p23l149t2365r267b2393],
58	;	:	O	;	_	0	SENT_341	[p23l149t2365r267b2393],
59	R.	NNP	PERSON	R.	dep	173	SENT_341	[p23l275t2367r300b2389],
60	De	NNP	PERSON	De	dep	173	SENT_341	[p23l309t2367r342b2388],
61	Boer	NNP	PERSON	Boer	dep	173	SENT_341	[p23l349t2367r411b2393],
62	,	,	O	,	_	0	SENT_341	[p23l349t2367r411b2393],
63	Footscray	NNP	ORGANIZATION	Footscray	dep	173	SENT_341	[p23l420t2367r542b2394],
64	,	,	O	,	_	0	SENT_341	[p23l420t2367r542b2394],
65	Australia	NNP	LOCATION	Australia	dep	173	SENT_341	[p23l550t2365r668b2393],
66	;	:	O	;	_	0	SENT_341	[p23l550t2365r668b2393],
67	S.	NNP	PERSON	S.	dep	173	SENT_341	[p23l677t2367r697b2388],
68	Ackland	NNP	PERSON	Ackland	dep	173	SENT_341	[p23l705t2365r813b2393],
69	,	,	O	,	_	0	SENT_341	[p23l705t2365r813b2393],
70	Waratah	NNP	LOCATION	Waratah	dep	173	SENT_341	[p23l821t2365r931b2393],
71	,	,	O	,	_	0	SENT_341	[p23l821t2365r931b2393],
72	Australia	NNP	LOCATION	Australia	dep	173	SENT_341	[p23l939t2365r1057b2393],
73	;	:	O	;	_	0	SENT_341	[p23l939t2365r1057b2393],
74	P.	NNP	PERSON	P.	dep	173	SENT_341	[p23l1065t2367r1083b2388],
75	Clingan	NNP	PERSON	Clingan	dep	173	SENT_341	[p23l1092t2365r1196b2394],
76	,	,	O	,	_	0	SENT_341	[p23l1092t2365r1196b2394],
77	Wollongong	NNP	LOCATION	Wollongong	dep	173	SENT_341	[p23l1203t2365r1365b2394],
78	,	,	O	,	_	0	SENT_341	[p23l1203t2365r1365b2394],
79	Australia	NNP	LOCATION	Australia	dep	173	SENT_341	[p23l1372t2365r1490b2393],
80	;	:	O	;	_	0	SENT_341	[p23l1372t2365r1490b2393],
81	D.	NNP	PERSON	D.	dep	173	SENT_341	[p23l1498t2367r1524b2388],
82	Campos	NNP	PERSON	Campos	dep	173	SENT_341	[p23l1533t2367r1641b2394],
83	,	,	O	,	_	0	SENT_341	[p23l1533t2367r1641b2394],
84	San	NNP	LOCATION	San	dep	173	SENT_341	[p23l1650t2367r1694b2388],
85	Isidro	NNP	LOCATION	Isidro	dep	173	SENT_341	[p23l1701t2365r1780b2393],
86	,	,	O	,	_	0	SENT_341	[p23l1701t2365r1780b2393],
87	Argentina	NNP	LOCATION	Argentina	dep	173	SENT_341	[p23l94t2402r224b2431],
88	;	:	O	;	_	0	SENT_341	[p23l94t2402r224b2431],
89	A.	NN	PERSON	a.	dep	173	SENT_341	[p23l232t2404r257b2425],
90	del	NNP	PERSON	del	dep	173	SENT_341	[p23l267t2402r303b2425],
91	Giglio	NNP	PERSON	Giglio	dep	173	SENT_341	[p23l311t2402r395b2431],
92	,	,	O	,	_	0	SENT_341	[p23l311t2402r395b2431],
93	Santo	NNP	PERSON	Santo	dep	173	SENT_341	[p23l405t2404r473b2425],
94	Andre	NNP	PERSON	Andre	dep	173	SENT_341	[p23l481t2402r563b2430],
95	,	,	O	,	_	0	SENT_341	[p23l481t2402r563b2430],
96	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l572t2402r651b2430],
97	;	:	O	;	_	0	SENT_341	[p23l572t2402r651b2430],
98	C.	NNP	PERSON	C.	dep	173	SENT_341	[p23l660t2404r685b2425],
99	Mathias	NNP	PERSON	Mathias	dep	173	SENT_341	[p23l693t2402r799b2430],
100	,	,	O	,	_	0	SENT_341	[p23l693t2402r799b2430],
101	Bahia	NNP	LOCATION	Bahia	dep	173	SENT_341	[p23l808t2402r884b2430],
102	,	,	O	,	_	0	SENT_341	[p23l808t2402r884b2430],
103	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l894t2402r972b2430],
104	;	:	O	;	_	0	SENT_341	[p23l894t2402r972b2430],
105	I.L	NNP	O	I.L	dep	173	SENT_341	[p23l981t2404r1014b2425],
106	Santoro	NNP	PERSON	Santoro	dep	173	SENT_341	[p23l1022t2404r1125b2430],
107	,	,	O	,	_	0	SENT_341	[p23l1022t2404r1125b2430],
108	J.R.	NNP	PERSON	J.R.	dep	173	SENT_341	[p23l1131t2404r1176b2428],
109	Pereira	NNP	PERSON	Pereira	dep	173	SENT_341	[p23l1185t2402r1277b2430],
110	,	,	O	,	_	0	SENT_341	[p23l1185t2402r1277b2430],
111	Sao	NNP	LOCATION	Sao	dep	173	SENT_341	[p23l1287t2403r1330b2425],
112	Paulo	NNP	LOCATION	Paulo	dep	173	SENT_341	[p23l1338t2402r1413b2429],
113	;	:	O	;	_	0	SENT_341	[p23l1338t2402r1413b2429],
114	A.M.	NNP	PERSON	A.M.	dep	173	SENT_341	[p23l1422t2404r1481b2425],
115	Murad	NNP	PERSON	Murad	dep	173	SENT_341	[p23l1489t2402r1578b2430],
116	,	,	O	,	_	0	SENT_341	[p23l1489t2402r1578b2430],
117	Belo	NNP	PERSON	Belo	dep	173	SENT_341	[p23l1587t2402r1641b2425],
118	Horizonte	NNP	PERSON	Horizonte	dep	173	SENT_341	[p23l1649t2402r1781b2430],
119	,	,	O	,	_	0	SENT_341	[p23l1649t2402r1781b2430],
120	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l95t2439r173b2466],
121	;	:	O	;	_	0	SENT_341	[p23l95t2439r173b2466],
122	R.D.A.	NNP	PERSON	R.D.A.	dep	173	SENT_341	[p23l181t2441r262b2463],
123	Ribeiro	NNP	PERSON	Ribeiro	dep	173	SENT_341	[p23l270t2439r367b2467],
124	,	,	O	,	_	0	SENT_341	[p23l270t2439r367b2467],
125	Ceara	NNP	LOCATION	Ceara	dep	173	SENT_341	[p23l376t2441r452b2467],
126	,	,	O	,	_	0	SENT_341	[p23l376t2441r452b2467],
127	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l460t2439r539b2467],
128	;	:	O	;	_	0	SENT_341	[p23l460t2439r539b2467],
129	S.	NNP	LOCATION	S.	dep	173	SENT_341	[p23l547t2441r568b2462],
130	Lago	NNP	LOCATION	Lago	dep	173	SENT_341	[p23l576t2441r642b2468],
131	,	,	O	,	_	0	SENT_341	[p23l576t2441r642b2468],
132	Porto	NNP	ORGANIZATION	Porto	dep	173	SENT_341	[p23l651t2441r716b2462],
133	Alegre	NNP	ORGANIZATION	Alegre	dep	173	SENT_341	[p23l723t2439r809b2468],
134	,	,	O	,	_	0	SENT_341	[p23l723t2439r809b2468],
135	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l818t2439r896b2466],
136	;	:	O	;	_	0	SENT_341	[p23l818t2439r896b2466],
137	J.	NNP	PERSON	J.	dep	173	SENT_341	[p23l902t2441r919b2465],
138	Vinholes	NNP	PERSON	Vinholes	dep	173	SENT_341	[p23l926t2439r1042b2467],
139	,	,	O	,	_	0	SENT_341	[p23l926t2439r1042b2467],
140	Porto	NNP	ORGANIZATION	Porto	dep	173	SENT_341	[p23l1050t2441r1116b2462],
141	Alegre	NNP	ORGANIZATION	Alegre	dep	173	SENT_341	[p23l1122t2439r1209b2468],
142	,	,	O	,	_	0	SENT_341	[p23l1122t2439r1209b2468],
143	Brazil	NNP	LOCATION	Brazil	dep	173	SENT_341	[p23l1217t2439r1296b2467],
144	;	:	O	;	_	0	SENT_341	[p23l1217t2439r1296b2467],
145	R.	NNP	PERSON	R.	dep	173	SENT_341	[p23l1304t2441r1329b2463],
146	Martins	NNP	PERSON	Martins	dep	173	SENT_341	[p23l1337t2439r1439b2467],
147	,	,	O	,	_	0	SENT_341	[p23l1337t2439r1439b2467],
148	Rio	NNP	O	Rio	dep	173	SENT_341	[p23l1447t2439r1489b2463],
149	deJaneiro	NNP	O	deJaneiro	dep	173	SENT_341	[p23l1497t2439r1625b2467],
150	;	:	O	;	_	0	SENT_341	[p23l1497t2439r1625b2467],
151	S.	NNP	PERSON	S.	dep	173	SENT_341	[p23l1634t2441r1654b2462],
152	Rorke	NNP	PERSON	Rorke	dep	173	SENT_341	[p23l1662t2439r1743b2467],
153	,	,	O	,	_	0	SENT_341	[p23l1662t2439r1743b2467],
154	St.	NNP	O	St.	dep	173	SENT_341	[p23l1752t2441r1781b2462],
155	John	NNP	PERSON	John	dep	173	SENT_341	[p23l92t2475r179b2504],
156	’s	POS	O	’s	dep	173	SENT_341	[p23l92t2475r179b2504],
157	,	,	O	,	_	0	SENT_341	[p23l92t2475r179b2504],
158	Canada	NNP	LOCATION	Canada	dep	173	SENT_341	[p23l189t2475r287b2503],
159	;	:	O	;	_	0	SENT_341	[p23l189t2475r287b2503],
160	W.	NNP	PERSON	W.	dep	173	SENT_341	[p23l295t2477r326b2499],
161	Morzycki	NNP	PERSON	Morzycki	dep	173	SENT_341	[p23l334t2475r455b2505],
162	,	,	O	,	_	0	SENT_341	[p23l334t2475r455b2505],
163	Halifax	NNP	LOCATION	Halifax	dep	173	SENT_341	[p23l465t2475r560b2504],
164	,	,	O	,	_	0	SENT_341	[p23l465t2475r560b2504],
165	Canada	NNP	LOCATION	Canada	dep	173	SENT_341	[p23l569t2475r668b2504],
166	;	:	O	;	_	0	SENT_341	[p23l569t2475r668b2504],
167	F.	NNP	PERSON	F.	dep	173	SENT_341	[p23l676t2477r695b2499],
168	Laberge	NNP	PERSON	Laberge	dep	173	SENT_341	[p23l704t2475r808b2505],
169	,	,	O	,	_	0	SENT_341	[p23l704t2475r808b2505],
170	R.	NNP	PERSON	R.	dep	173	SENT_341	[p23l817t2477r842b2500],
171	Whittom	NNP	PERSON	Whittom	dep	173	SENT_341	[p23l850t2475r968b2504],
172	,	,	O	,	_	0	SENT_341	[p23l850t2475r968b2504],
173	Ste.	NNP	O	Ste.	_	0	SENT_341	[p23l978t2477r1080b2505],
174	.	.	O	.	_	0	SENT_341	[p23l978t2477r1080b2505],

1	—	NN	O	—	_	0	SENT_342	[p23l978t2477r1080b2505],
2	.	.	O	.	_	0	SENT_342	[p23l978t2477r1080b2505],

1	Foy	NNP	PERSON	Foy	dep	282	SENT_343	[p23l978t2477r1080b2505],
2	,	,	O	,	_	0	SENT_343	[p23l978t2477r1080b2505],
3	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1090t2475r1188b2503],
4	;	:	O	;	_	0	SENT_343	[p23l1090t2475r1188b2503],
5	V.	NNP	PERSON	V.	dep	282	SENT_343	[p23l1196t2477r1217b2499],
6	Hirsh	NNP	PERSON	Hirsh	dep	282	SENT_343	[p23l1226t2475r1302b2504],
7	,	,	O	,	_	0	SENT_343	[p23l1226t2475r1302b2504],
8	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l1309t2477r1326b2502],
9	Ayoub	NNP	PERSON	Ayoub	dep	282	SENT_343	[p23l1334t2475r1420b2505],
10	,	,	O	,	_	0	SENT_343	[p23l1334t2475r1420b2505],
11	Montreal	NNP	LOCATION	Montreal	dep	282	SENT_343	[p23l1428t2475r1548b2503],
12	;	:	O	;	_	0	SENT_343	[p23l1428t2475r1548b2503],
13	R.W.	NNP	PERSON	R.W.	dep	282	SENT_343	[p23l1557t2477r1610b2500],
14	Gregg	NNP	PERSON	Gregg	dep	282	SENT_343	[p23l1620t2477r1703b2505],
15	,	,	O	,	_	0	SENT_343	[p23l1620t2477r1703b2505],
16	Kingston	NNP	LOCATION	Kingston	dep	282	SENT_343	[p23l1712t2476r1781b2505, p23l95t2518r155b2541],
17	,	,	O	,	_	0	SENT_343	[p23l1712t2476r1781b2505, p23l95t2518r155b2541],
18	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l163t2513r261b2541],
19	;	:	O	;	_	0	SENT_343	[p23l163t2513r261b2541],
20	S.	NNP	PERSON	S.	dep	282	SENT_343	[p23l269t2515r289b2536],
21	Laurie	NNP	PERSON	Laurie	dep	282	SENT_343	[p23l297t2513r380b2541],
22	,	,	O	,	_	0	SENT_343	[p23l297t2513r380b2541],
23	Ottawa	NNP	LOCATION	Ottawa	dep	282	SENT_343	[p23l388t2515r483b2541],
24	;	:	O	;	_	0	SENT_343	[p23l388t2515r483b2541],
25	F.	NNP	PERSON	F.	dep	282	SENT_343	[p23l490t2515r508b2536],
26	Wierzbicki	NNP	PERSON	Wierzbicki	dep	282	SENT_343	[p23l515t2513r656b2541],
27	,	,	O	,	_	0	SENT_343	[p23l515t2513r656b2541],
28	Oshawa	NNP	LOCATION	Oshawa	dep	282	SENT_343	[p23l664t2513r769b2541],
29	,	,	O	,	_	0	SENT_343	[p23l664t2513r769b2541],
30	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l777t2513r875b2540],
31	;	:	O	;	_	0	SENT_343	[p23l777t2513r875b2540],
32	B.	NNP	PERSON	B.	dep	282	SENT_343	[p23l882t2515r906b2536],
33	Findlay	NNP	PERSON	Findlay	dep	282	SENT_343	[p23l914t2513r1007b2542],
34	,	,	O	,	_	0	SENT_343	[p23l914t2513r1007b2542],
35	St.	NNP	LOCATION	St.	dep	282	SENT_343	[p23l1016t2515r1045b2536],
36	Catharines	NNP	LOCATION	Catharines	dep	282	SENT_343	[p23l1053t2513r1192b2541],
37	,	,	O	,	_	0	SENT_343	[p23l1053t2513r1192b2541],
38	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1200t2513r1299b2541],
39	;	:	O	;	_	0	SENT_343	[p23l1200t2513r1299b2541],
40	A.	NN	PERSON	a.	dep	282	SENT_343	[p23l1305t2515r1330b2536],
41	Arnold	NNP	PERSON	Arnold	dep	282	SENT_343	[p23l1337t2513r1430b2541],
42	,	,	O	,	_	0	SENT_343	[p23l1337t2513r1430b2541],
43	Hamilton	NNP	LOCATION	Hamilton	dep	282	SENT_343	[p23l1438t2513r1563b2541],
44	,	,	O	,	_	0	SENT_343	[p23l1438t2513r1563b2541],
45	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1570t2513r1669b2541],
46	;	:	O	;	_	0	SENT_343	[p23l1570t2513r1669b2541],
47	L.A.	NNP	LOCATION	L.A.	dep	282	SENT_343	[p23l1676t2515r1725b2536],
48	Zib	NNP	O	Zib	dep	282	SENT_343	[p23l1732t2513r1781b2536],
49	—	NN	O	—	dep	282	SENT_343	[p23l1732t2513r1781b2536],
50	dawi	NN	O	dawus	dep	282	SENT_343	[p23l95t2550r160b2578],
51	,	,	O	,	_	0	SENT_343	[p23l95t2550r160b2578],
52	Newmarket	NNP	LOCATION	Newmarket	dep	282	SENT_343	[p23l168t2550r319b2578],
53	,	,	O	,	_	0	SENT_343	[p23l168t2550r319b2578],
54	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l328t2550r426b2577],
55	;	:	O	;	_	0	SENT_343	[p23l328t2550r426b2577],
56	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l432t2552r449b2576],
57	Meharchand	NNP	PERSON	Meharchand	dep	282	SENT_343	[p23l457t2550r620b2578],
58	,	,	O	,	_	0	SENT_343	[p23l457t2550r620b2578],
59	F.	NNP	PERSON	F.	dep	282	SENT_343	[p23l629t2552r647b2573],
60	Shepherd	NNP	PERSON	Shepherd	dep	282	SENT_343	[p23l656t2550r780b2579],
61	,	,	O	,	_	0	SENT_343	[p23l656t2550r780b2579],
62	R	NNP	O	R	dep	282	SENT_343	[p23l788t2552r837b2574],
63	,	,	O	,	_	0	SENT_343	[p23l788t2552r837b2574],
64	L.	NNP	PERSON	L.	dep	282	SENT_343	[p23l788t2552r837b2574],
65	Burkes	NNPS	PERSON	Burkes	dep	282	SENT_343	[p23l846t2550r938b2578],
66	,	,	O	,	_	0	SENT_343	[p23l846t2550r938b2578],
67	Y.C.	NNP	PERSON	Y.C.	dep	282	SENT_343	[p23l946t2552r992b2573],
68	Ung	NNP	PERSON	Ung	dep	282	SENT_343	[p23l1000t2552r1059b2579],
69	,	,	O	,	_	0	SENT_343	[p23l1000t2552r1059b2579],
70	Toronto	NNP	LOCATION	Toronto	dep	282	SENT_343	[p23l1067t2552r1174b2578],
71	;	:	O	;	_	0	SENT_343	[p23l1067t2552r1174b2578],
72	J.J.	NNP	PERSON	J.J.	dep	282	SENT_343	[p23l1180t2552r1214b2576],
73	Wilson	NNP	PERSON	Wilson	dep	282	SENT_343	[p23l1222t2550r1317b2578],
74	,	,	O	,	_	0	SENT_343	[p23l1222t2550r1317b2578],
75	Weston	NNP	PERSON	Weston	dep	282	SENT_343	[p23l1325t2552r1425b2578],
76	,	,	O	,	_	0	SENT_343	[p23l1325t2552r1425b2578],
77	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1434t2550r1533b2578],
78	;	:	O	;	_	0	SENT_343	[p23l1434t2550r1533b2578],
79	B.	NNP	PERSON	B.	dep	282	SENT_343	[p23l1541t2552r1565b2573],
80	Pressnail	NNP	PERSON	Pressnail	dep	282	SENT_343	[p23l1573t2550r1691b2578],
81	,	,	O	,	_	0	SENT_343	[p23l1573t2550r1691b2578],
82	Barrie	NNP	PERSON	Barrie	dep	282	SENT_343	[p23l1699t2550r1780b2578],
83	,	,	O	,	_	0	SENT_343	[p23l1699t2550r1780b2578],
84	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l95t2587r194b2615],
85	;	:	O	;	_	0	SENT_343	[p23l95t2587r194b2615],
86	R	NN	O	r	dep	282	SENT_343	[p23l201t2589r226b2611],
87	,	,	O	,	_	0	SENT_343	[p23l201t2589r226b2611],
88	Myers	NNP	PERSON	Myers	dep	282	SENT_343	[p23l232t2589r313b2616],
89	,	,	O	,	_	0	SENT_343	[p23l232t2589r313b2616],
90	Mississauga	NNP	LOCATION	Mississauga	dep	282	SENT_343	[p23l320t2587r478b2616],
91	,	,	O	,	_	0	SENT_343	[p23l320t2587r478b2616],
92	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l485t2587r584b2614],
93	;	:	O	;	_	0	SENT_343	[p23l485t2587r584b2614],
94	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l589t2589r606b2613],
95	Noble	NNP	PERSON	Noble	dep	282	SENT_343	[p23l613t2587r695b2615],
96	,	,	O	,	_	0	SENT_343	[p23l613t2587r695b2615],
97	Sudbury	NNP	LOCATION	Sudbury	dep	282	SENT_343	[p23l703t2587r808b2616],
98	,	,	O	,	_	0	SENT_343	[p23l703t2587r808b2616],
99	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l815t2587r914b2615],
100	;	:	O	;	_	0	SENT_343	[p23l815t2587r914b2615],
101	D.	NNP	PERSON	D.	dep	282	SENT_343	[p23l921t2589r947b2610],
102	Walde	NNP	PERSON	Walde	dep	282	SENT_343	[p23l953t2587r1037b2615],
103	,	,	O	,	_	0	SENT_343	[p23l953t2587r1037b2615],
104	Sault	NNP	LOCATION	Sault	dep	282	SENT_343	[p23l1045t2587r1107b2610],
105	Ste.	NNP	O	Ste.	dep	282	SENT_343	[p23l1112t2589r1155b2610],
106	Marie	NNP	PERSON	Marie	dep	282	SENT_343	[p23l1162t2587r1240b2615],
107	,	,	O	,	_	0	SENT_343	[p23l1162t2587r1240b2615],
108	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1247t2587r1346b2615],
109	;	:	O	;	_	0	SENT_343	[p23l1247t2587r1346b2615],
110	S.	NNP	PERSON	S.	dep	282	SENT_343	[p23l1354t2589r1374b2610],
111	Navaratnam	NNP	PERSON	Navaratnam	dep	282	SENT_343	[p23l1381t2589r1539b2615],
112	,	,	O	,	_	0	SENT_343	[p23l1381t2589r1539b2615],
113	Winnipeg	NNP	LOCATION	Winnipeg	dep	282	SENT_343	[p23l1545t2587r1674b2616],
114	,	,	O	,	_	0	SENT_343	[p23l1545t2587r1674b2616],
115	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1682t2587r1781b2614],
116	;	:	O	;	_	0	SENT_343	[p23l1682t2587r1781b2614],
117	H.I.	NNP	PERSON	H.I.	dep	282	SENT_343	[p23l95t2626r141b2647],
118	Chalchal	NNP	PERSON	Chalchal	dep	282	SENT_343	[p23l152t2624r266b2652],
119	,	,	O	,	_	0	SENT_343	[p23l152t2624r266b2652],
120	Regina	NNP	PERSON	Regina	dep	282	SENT_343	[p23l276t2624r369b2653],
121	,	,	O	,	_	0	SENT_343	[p23l276t2624r369b2653],
122	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l379t2624r478b2652],
123	;	:	O	;	_	0	SENT_343	[p23l379t2624r478b2652],
124	D.G.	NNP	ORGANIZATION	D.G.	dep	282	SENT_343	[p23l488t2626r543b2647],
125	Morris	NNP	ORGANIZATION	Morris	dep	282	SENT_343	[p23l553t2624r643b2652],
126	,	,	O	,	_	0	SENT_343	[p23l553t2624r643b2652],
127	Calgary	NNP	LOCATION	Calgary	dep	282	SENT_343	[p23l653t2624r750b2653],
128	,	,	O	,	_	0	SENT_343	[p23l653t2624r750b2653],
129	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l760t2624r859b2652],
130	;	:	O	;	_	0	SENT_343	[p23l760t2624r859b2652],
131	M.	NNP	PERSON	M.	dep	282	SENT_343	[p23l868t2626r900b2647],
132	Smylie	NNP	PERSON	Smylie	dep	282	SENT_343	[p23l911t2624r999b2653],
133	,	,	O	,	_	0	SENT_343	[p23l911t2624r999b2653],
134	Edmonton	NNP	LOCATION	Edmonton	dep	282	SENT_343	[p23l1009t2624r1147b2652],
135	,	,	O	,	_	0	SENT_343	[p23l1009t2624r1147b2652],
136	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1158t2624r1257b2651],
137	;	:	O	;	_	0	SENT_343	[p23l1158t2624r1257b2651],
138	D.	NNP	PERSON	D.	dep	282	SENT_343	[p23l1266t2626r1292b2647],
139	Fenton	NN	PERSON	fenton	dep	282	SENT_343	[p23l1302t2626r1395b2652],
140	,	,	O	,	_	0	SENT_343	[p23l1302t2626r1395b2652],
141	Kelowna	NNP	LOCATION	Kelowna	dep	282	SENT_343	[p23l1406t2624r1520b2652],
142	,	,	O	,	_	0	SENT_343	[p23l1406t2624r1520b2652],
143	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l1530t2624r1629b2652],
144	;	:	O	;	_	0	SENT_343	[p23l1530t2624r1629b2652],
145	H.	NNP	PERSON	H.	dep	282	SENT_343	[p23l1639t2626r1667b2647],
146	Martins	NNP	PERSON	Martins	dep	282	SENT_343	[p23l1677t2624r1780b2652],
147	,	,	O	,	_	0	SENT_343	[p23l1677t2624r1780b2652],
148	Victoria	NNP	LOCATION	Victoria	dep	282	SENT_343	[p23l94t2661r197b2689],
149	,	,	O	,	_	0	SENT_343	[p23l94t2661r197b2689],
150	Canada	NNP	LOCATION	Canada	dep	282	SENT_343	[p23l207t2660r306b2689],
151	;	:	O	;	_	0	SENT_343	[p23l207t2660r306b2689],
152	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l313t2662r330b2687],
153	Gutierrez	NNP	PERSON	Gutierrez	dep	282	SENT_343	[p23l341t2661r464b2689],
154	,	,	O	,	_	0	SENT_343	[p23l341t2661r464b2689],
155	Las	NNP	LOCATION	Las	dep	282	SENT_343	[p23l474t2662r514b2684],
156	Condes	NNP	LOCATION	Condes	dep	282	SENT_343	[p23l524t2660r623b2689],
157	,	,	O	,	_	0	SENT_343	[p23l524t2660r623b2689],
158	Chile	NNP	LOCATION	Chile	dep	282	SENT_343	[p23l633t2660r704b2688],
159	;	:	O	;	_	0	SENT_343	[p23l633t2660r704b2688],
160	U.	NNP	PERSON	U.	dep	282	SENT_343	[p23l714t2662r739b2684],
161	Gatzemeier	NNP	PERSON	Gatzemeier	dep	282	SENT_343	[p23l750t2661r897b2689],
162	,	,	O	,	_	0	SENT_343	[p23l750t2661r897b2689],
163	Grobhansdorf	NNP	LOCATION	Grobhansdorf	dep	282	SENT_343	[p23l907t2660r1090b2689],
164	,	,	O	,	_	0	SENT_343	[p23l907t2660r1090b2689],
165	Germany	NNP	LOCATION	Germany	dep	282	SENT_343	[p23l1101t2662r1221b2690],
166	;	:	O	;	_	0	SENT_343	[p23l1101t2662r1221b2690],
167	I.	NN	PERSON	i.	dep	282	SENT_343	[p23l1228t2662r1245b2687],
168	Von	NNP	PERSON	Von	dep	282	SENT_343	[p23l1255t2668r1300b2684],
169	Pawel	NNP	PERSON	Pawel	dep	282	SENT_343	[p23l1308t2660r1386b2689],
170	,	,	O	,	_	0	SENT_343	[p23l1308t2660r1386b2689],
171	Gauting	NNP	O	Gauting	dep	282	SENT_343	[p23l1397t2661r1503b2690],
172	,	,	O	,	_	0	SENT_343	[p23l1397t2661r1503b2690],
173	Germany	NNP	LOCATION	Germany	dep	282	SENT_343	[p23l1514t2662r1634b2690],
174	;	:	O	;	_	0	SENT_343	[p23l1514t2662r1634b2690],
175	R.	NNP	PERSON	R.	dep	282	SENT_343	[p23l1644t2662r1669b2685],
176	Lodden	NNP	PERSON	Lodden	dep	282	SENT_343	[p23l1679t2660r1781b2684],
177	—	NN	O	—	dep	282	SENT_343	[p23l1679t2660r1781b2684],
178	kemper	NN	O	kemper	dep	282	SENT_343	[p23l95t2697r194b2727],
179	,	,	O	,	_	0	SENT_343	[p23l95t2697r194b2727],
180	Berlin	NNP	LOCATION	Berlin	dep	282	SENT_343	[p23l202t2697r283b2726],
181	;	:	O	;	_	0	SENT_343	[p23l202t2697r283b2726],
182	A.	NN	PERSON	a.	dep	282	SENT_343	[p23l290t2699r315b2721],
183	Gerogianni	NNP	PERSON	Gerogianni	dep	282	SENT_343	[p23l323t2698r470b2727],
184	,	,	O	,	_	0	SENT_343	[p23l323t2698r470b2727],
185	Athens	NNP	LOCATION	Athens	dep	282	SENT_343	[p23l477t2697r571b2726],
186	;	:	O	;	_	0	SENT_343	[p23l477t2697r571b2726],
187	R.	NNP	PERSON	R.	dep	282	SENT_343	[p23l578t2699r603b2722],
188	Chan	NNP	PERSON	Chan	dep	282	SENT_343	[p23l611t2697r683b2726],
189	,	,	O	,	_	0	SENT_343	[p23l611t2697r683b2726],
190	Pokﬁilarn	NNP	O	Pokﬁilarn	dep	282	SENT_343	[p23l691t2697r816b2726],
191	,	,	O	,	_	0	SENT_343	[p23l691t2697r816b2726],
192	Hong	NNP	LOCATION	Hong	dep	282	SENT_343	[p23l824t2699r895b2727],
193	Kong	NNP	LOCATION	Kong	dep	282	SENT_343	[p23l900t2699r974b2727],
194	;	:	O	;	_	0	SENT_343	[p23l900t2699r974b2727],
195	D.	NNP	O	D.	dep	282	SENT_343	[p23l982t2699r1007b2721],
196	Flex	NNP	O	Flex	dep	282	SENT_343	[p23l1015t2697r1071b2726],
197	,	,	O	,	_	0	SENT_343	[p23l1015t2697r1071b2726],
198	Petach	NNP	ORGANIZATION	Petach	dep	282	SENT_343	[p23l1079t2697r1160b2721],
199	Tikva	NNP	ORGANIZATION	Tikva	dep	282	SENT_343	[p23l1166t2697r1239b2726],
200	,	,	O	,	_	0	SENT_343	[p23l1166t2697r1239b2726],
201	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l1247t2697r1322b2726],
202	;	:	O	;	_	0	SENT_343	[p23l1247t2697r1322b2726],
203	D.	NNP	PERSON	D.	dep	282	SENT_343	[p23l1329t2699r1355b2721],
204	Loven	NNP	PERSON	Loven	dep	282	SENT_343	[p23l1362t2699r1442b2726],
205	,	,	O	,	_	0	SENT_343	[p23l1362t2699r1442b2726],
206	Afula	NNP	LOCATION	Afula	dep	282	SENT_343	[p23l1449t2697r1522b2726],
207	,	,	O	,	_	0	SENT_343	[p23l1449t2697r1522b2726],
208	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l1530t2697r1604b2726],
209	;	:	O	;	_	0	SENT_343	[p23l1530t2697r1604b2726],
210	M.C.	NNP	PERSON	M.C.	dep	282	SENT_343	[p23l1611t2699r1668b2721],
211	Wollner	NNP	PERSON	Wollner	dep	282	SENT_343	[p23l1676t2697r1780b2726],
212	,	,	O	,	_	0	SENT_343	[p23l1676t2697r1780b2726],
213	Haifa	NNP	LOCATION	Haifa	dep	282	SENT_343	[p23l95t2734r168b2763],
214	,	,	O	,	_	0	SENT_343	[p23l95t2734r168b2763],
215	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l176t2734r251b2763],
216	;	:	O	;	_	0	SENT_343	[p23l176t2734r251b2763],
217	H.	NNP	PERSON	H.	dep	282	SENT_343	[p23l259t2736r287b2758],
218	Biran	NNP	PERSON	Biran	dep	282	SENT_343	[p23l296t2735r369b2763],
219	,	,	O	,	_	0	SENT_343	[p23l296t2735r369b2763],
220	Rehovot	NNP	LOCATION	Rehovot	dep	282	SENT_343	[p23l377t2734r485b2762],
221	,	,	O	,	_	0	SENT_343	[p23l377t2734r485b2762],
222	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l494t2734r568b2762],
223	;	:	O	;	_	0	SENT_343	[p23l494t2734r568b2762],
224	M.	NNP	PERSON	M.	dep	282	SENT_343	[p23l576t2736r608b2758],
225	Levitt	NNP	PERSON	Levitt	dep	282	SENT_343	[p23l616t2735r689b2763],
226	,	,	O	,	_	0	SENT_343	[p23l616t2735r689b2763],
227	Tel	NNP	LOCATION	Tel	dep	282	SENT_343	[p23l697t2734r733b2758],
228	Hashomer	NNP	LOCATION	Hashomer	dep	282	SENT_343	[p23l740t2734r875b2762],
229	,	,	O	,	_	0	SENT_343	[p23l740t2734r875b2762],
230	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l884t2734r958b2762],
231	;	:	O	;	_	0	SENT_343	[p23l884t2734r958b2762],
232	A.	NN	PERSON	a.	dep	282	SENT_343	[p23l966t2736r991b2758],
233	Cyjon	NNP	PERSON	Cyjon	dep	282	SENT_343	[p23l1000t2735r1076b2764],
234	,	,	O	,	_	0	SENT_343	[p23l1000t2735r1076b2764],
235	Zeriﬂn	NNP	LOCATION	Zeriﬂn	dep	282	SENT_343	[p23l1084t2734r1174b2763],
236	,	,	O	,	_	0	SENT_343	[p23l1084t2734r1174b2763],
237	Israel	NNP	LOCATION	Israel	dep	282	SENT_343	[p23l1182t2734r1279b2762],
238	;	:	O	;	_	0	SENT_343	[p23l1182t2734r1279b2762],
239	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l1182t2734r1279b2762],
240	Lopez	NNP	PERSON	Lopez	dep	282	SENT_343	[p23l1287t2736r1368b2764],
241	,	,	O	,	_	0	SENT_343	[p23l1287t2736r1368b2764],
242	Dviango	NNP	LOCATION	Dviango	dep	282	SENT_343	[p23l1377t2735r1486b2764],
243	,	,	O	,	_	0	SENT_343	[p23l1377t2735r1486b2764],
244	Mexico	NNP	LOCATION	Mexico	dep	282	SENT_343	[p23l1494t2735r1590b2763],
245	;	:	O	;	_	0	SENT_343	[p23l1494t2735r1590b2763],
246	J.	NNP	PERSON	J.	dep	282	SENT_343	[p23l1596t2736r1613b2761],
247	Robles	NNP	PERSON	Robles	dep	282	SENT_343	[p23l1621t2734r1712b2763],
248	,	,	O	,	_	0	SENT_343	[p23l1621t2734r1712b2763],
249	Mexico	NNP	LOCATION	Mexico	dep	282	SENT_343	[p23l1720t2736r1781b2758, p23l95t2772r130b2795],
250	City	NNP	LOCATION	City	dep	282	SENT_343	[p23l137t2772r192b2801],
251	;	:	O	;	_	0	SENT_343	[p23l137t2772r192b2801],
252	G.	NNP	PERSON	G.	dep	282	SENT_343	[p23l200t2774r228b2795],
253	Calderillo	NNP	PERSON	Calderillo	dep	282	SENT_343	[p23l236t2772r363b2800],
254	,	,	O	,	_	0	SENT_343	[p23l236t2772r363b2800],
255	Tlalpan	NNP	LOCATION	Tlalpan	dep	282	SENT_343	[p23l370t2772r471b2801],
256	,	,	O	,	_	0	SENT_343	[p23l370t2772r471b2801],
257	Mexico	NNP	LOCATION	Mexico	dep	282	SENT_343	[p23l478t2772r574b2799],
258	;	:	O	;	_	0	SENT_343	[p23l478t2772r574b2799],
259	T.	NNP	O	T.	dep	282	SENT_343	[p23l581t2774r603b2795],
260	Christmas	NNP	DATE	Christmas	dep	282	SENT_343	[p23l611t2772r745b2800],
261	,	,	O	,	_	0	SENT_343	[p23l611t2772r745b2800],
262	Auckland	NNP	LOCATION	Auckland	dep	282	SENT_343	[p23l752t2772r876b2799],
263	,	,	O	,	_	0	SENT_343	[p23l752t2772r876b2799],
264	New	NNP	LOCATION	New	dep	282	SENT_343	[p23l884t2774r941b2795],
265	Zealand	NNP	LOCATION	Zealand	dep	282	SENT_343	[p23l947t2772r1051b2800],
266	;	:	O	;	_	0	SENT_343	[p23l947t2772r1051b2800],
267	A.B.	NNP	PERSON	A.B.	dep	282	SENT_343	[p23l1058t2774r1110b2795],
268	Simpson	NNP	PERSON	Simpson	dep	282	SENT_343	[p23l1119t2772r1234b2801],
269	,	,	O	,	_	0	SENT_343	[p23l1119t2772r1234b2801],
270	Wellington	NNP	LOCATION	Wellington	dep	282	SENT_343	[p23l1241t2772r1385b2801],
271	,	,	O	,	_	0	SENT_343	[p23l1241t2772r1385b2801],
272	New	NNP	LOCATION	New	dep	282	SENT_343	[p23l1393t2774r1450b2795],
273	Zealand	NNP	LOCATION	Zealand	dep	282	SENT_343	[p23l1455t2772r1560b2800],
274	;	:	O	;	_	0	SENT_343	[p23l1455t2772r1560b2800],
275	M.	NNP	PERSON	M.	dep	282	SENT_343	[p23l1567t2774r1599b2795],
276	Dediu	NNP	PERSON	Dediu	dep	282	SENT_343	[p23l1607t2772r1687b2800],
277	,	,	O	,	_	0	SENT_343	[p23l1607t2772r1687b2800],
278	Bucharest	NNP	LOCATION	Bucharest	dep	282	SENT_343	[p23l1695t2772r1781b2795, p23l95t2814r146b2837],
279	,	,	O	,	_	0	SENT_343	[p23l1695t2772r1781b2795, p23l95t2814r146b2837],
280	Romania	NNP	LOCATION	Romania	dep	282	SENT_343	[p23l155t2809r274b2837],
281	;	:	O	;	_	0	SENT_343	[p23l155t2809r274b2837],
282	T.	NNP	O	T.	_	0	SENT_343	[p23l281t2811r338b2832],
283	.	.	O	.	_	0	SENT_343	[p23l281t2811r338b2832],

1	—	NN	O	—	_	0	SENT_344	[p23l281t2811r338b2832],
2	.	.	O	.	_	0	SENT_344	[p23l281t2811r338b2832],

1	E.	NNP	PERSON	E.	nn	2	SENT_345	[p23l281t2811r338b2832],
2	Ciuleanu	NNP	PERSON	Ciuleanu	_	0	SENT_345	[p23l347t2809r463b2837],
3	,	,	O	,	_	0	SENT_345	[p23l347t2809r463b2837],
4	Cluj	NNP	LOCATION	Cluj	appos	2	SENT_345	[p23l472t2809r630b2838],
5	.	.	O	.	_	0	SENT_345	[p23l472t2809r630b2838],

1	—	NN	O	—	_	0	SENT_346	[p23l472t2809r630b2838],
2	.	.	O	.	_	0	SENT_346	[p23l472t2809r630b2838],

1	Napaca	NNP	PERSON	Napaca	dep	114	SENT_347	[p23l472t2809r630b2838],
2	,	,	O	,	_	0	SENT_347	[p23l472t2809r630b2838],
3	Romania	NNP	LOCATION	Romania	dep	114	SENT_347	[p23l639t2809r758b2837],
4	;	:	O	;	_	0	SENT_347	[p23l639t2809r758b2837],
5	M.	NNP	PERSON	M.	dep	114	SENT_347	[p23l765t2811r797b2832],
6	Patran	NNP	PERSON	Patran	dep	114	SENT_347	[p23l806t2811r891b2837],
7	,	,	O	,	_	0	SENT_347	[p23l806t2811r891b2837],
8	Sibiu	NNP	LOCATION	Sibiu	dep	114	SENT_347	[p23l901t2809r969b2837],
9	,	,	O	,	_	0	SENT_347	[p23l901t2809r969b2837],
10	Romania	NNP	LOCATION	Romania	dep	114	SENT_347	[p23l978t2809r1097b2837],
11	;	:	O	;	_	0	SENT_347	[p23l978t2809r1097b2837],
12	L.	NNP	PERSON	L.	dep	114	SENT_347	[p23l1105t2811r1126b2832],
13	Miron	NNP	PERSON	Miron	dep	114	SENT_347	[p23l1134t2809r1218b2837],
14	,	,	O	,	_	0	SENT_347	[p23l1134t2809r1218b2837],
15	Lasi	NNP	PERSON	Lasi	dep	114	SENT_347	[p23l1226t2809r1282b2837],
16	,	,	O	,	_	0	SENT_347	[p23l1226t2809r1282b2837],
17	Romania	NNP	LOCATION	Romania	dep	114	SENT_347	[p23l1290t2809r1409b2837],
18	;	:	O	;	_	0	SENT_347	[p23l1290t2809r1409b2837],
19	L.	NNP	PERSON	L.	dep	114	SENT_347	[p23l1417t2811r1439b2832],
20	Ek	NNP	PERSON	Ek	dep	114	SENT_347	[p23l1447t2809r1485b2836],
21	,	,	O	,	_	0	SENT_347	[p23l1447t2809r1485b2836],
22	Lund	NNP	PERSON	Lund	dep	114	SENT_347	[p23l1494t2809r1564b2837],
23	,	,	O	,	_	0	SENT_347	[p23l1494t2809r1564b2837],
24	Sweden	NNP	LOCATION	Sweden	dep	114	SENT_347	[p23l1574t2809r1675b2837],
25	;	:	O	;	_	0	SENT_347	[p23l1574t2809r1675b2837],
26	B.	NNP	PERSON	B.	dep	114	SENT_347	[p23l1683t2811r1707b2832],
27	Bergman	NNP	PERSON	Bergman	dep	114	SENT_347	[p23l1716t2811r1782b2838, p23l95t2853r156b2874],
28	,	,	O	,	_	0	SENT_347	[p23l1716t2811r1782b2838, p23l95t2853r156b2874],
29	Gothenburg	NNP	LOCATION	Gothenburg	dep	114	SENT_347	[p23l171t2846r329b2875],
30	,	,	O	,	_	0	SENT_347	[p23l171t2846r329b2875],
31	Sweden	NNP	LOCATION	Sweden	dep	114	SENT_347	[p23l344t2846r445b2874],
32	;	:	O	;	_	0	SENT_347	[p23l344t2846r445b2874],
33	R.	NNP	PERSON	R.	dep	114	SENT_347	[p23l459t2848r484b2870],
34	Soc	NNP	PERSON	Soc	dep	114	SENT_347	[p23l499t2848r551b2874],
35	,	,	O	,	_	0	SENT_347	[p23l499t2848r551b2874],
36	E.H.	NNP	PERSON	E.H.	dep	114	SENT_347	[p23l565t2848r618b2869],
37	Tan	NNP	PERSON	Tan	dep	114	SENT_347	[p23l632t2848r684b2874],
38	,	,	O	,	_	0	SENT_347	[p23l632t2848r684b2874],
39	Singapore	NNP	LOCATION	Singapore	dep	114	SENT_347	[p23l699t2846r830b2875],
40	;	:	O	;	_	0	SENT_347	[p23l699t2846r830b2875],
41	S.	NNP	PERSON	S.	dep	114	SENT_347	[p23l845t2848r865b2869],
42	Maoleekoonpairoj	NNP	PERSON	Maoleekoonpairoj	dep	114	SENT_347	[p23l878t2846r1109b2875],
43	,	,	O	,	_	0	SENT_347	[p23l878t2846r1109b2875],
44	A.	NNP	PERSON	A.	dep	114	SENT_347	[p23l1123t2848r1148b2869],
45	Cheirsilpa	NNP	PERSON	Cheirsilpa	dep	114	SENT_347	[p23l1162t2846r1295b2875],
46	,	,	O	,	_	0	SENT_347	[p23l1162t2846r1295b2875],
47	Bangkok	NNP	LOCATION	Bangkok	dep	114	SENT_347	[p23l1309t2846r1425b2875],
48	,	,	O	,	_	0	SENT_347	[p23l1309t2846r1425b2875],
49	Thailand	NNP	LOCATION	Thailand	dep	114	SENT_347	[p23l1439t2846r1556b2874],
50	;	:	O	;	_	0	SENT_347	[p23l1439t2846r1556b2874],
51	S.	NNP	PERSON	S.	dep	114	SENT_347	[p23l1571t2848r1591b2869],
52	Thongprasert	NNP	PERSON	Thongprasert	dep	114	SENT_347	[p23l1604t2846r1780b2875],
53	,	,	O	,	_	0	SENT_347	[p23l1604t2846r1780b2875],
54	Chiangmai	NNP	LOCATION	Chiangmai	dep	114	SENT_347	[p23l95t2882r237b2912],
55	,	,	O	,	_	0	SENT_347	[p23l95t2882r237b2912],
56	Thailand	NNP	LOCATION	Thailand	dep	114	SENT_347	[p23l245t2882r362b2910],
57	;	:	O	;	_	0	SENT_347	[p23l245t2882r362b2910],
58	C.M.	NNP	PERSON	C.M.	dep	114	SENT_347	[p23l371t2884r429b2906],
59	Rudin	NNP	PERSON	Rudin	dep	114	SENT_347	[p23l437t2882r519b2911],
60	,	,	O	,	_	0	SENT_347	[p23l437t2882r519b2911],
61	Chicago	NNP	LOCATION	Chicago	dep	114	SENT_347	[p23l527t2882r635b2912],
62	;	:	O	;	_	0	SENT_347	[p23l527t2882r635b2912],
63	P.	NNP	PERSON	P.	dep	114	SENT_347	[p23l643t2884r661b2906],
64	Ruﬂf	NNP	PERSON	Ruﬂf	dep	114	SENT_347	[p23l670t2882r730b2911],
65	,	,	O	,	_	0	SENT_347	[p23l670t2882r730b2911],
66	Johannesburg	NNP	LOCATION	Johannesburg	dep	114	SENT_347	[p23l735t2882r917b2912],
67	,	,	O	,	_	0	SENT_347	[p23l735t2882r917b2912],
68	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l926t2882r997b2906],
69	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l1003t2882r1084b2911],
70	;	:	O	;	_	0	SENT_347	[p23l1003t2882r1084b2911],
71	D.J.	NNP	O	D.J.	dep	114	SENT_347	[p23l1092t2884r1134b2909],
72	Hacking	NNP	O	Hacking	dep	114	SENT_347	[p23l1143t2882r1254b2912],
73	,	,	O	,	_	0	SENT_347	[p23l1143t2882r1254b2912],
74	Westridge	NNP	LOCATION	Westridge	dep	114	SENT_347	[p23l1262t2882r1393b2912],
75	,	,	O	,	_	0	SENT_347	[p23l1262t2882r1393b2912],
76	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l1402t2882r1473b2906],
77	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l1479t2882r1560b2911],
78	;	:	O	;	_	0	SENT_347	[p23l1479t2882r1560b2911],
79	S.J.	NNP	PERSON	S.J.	dep	114	SENT_347	[p23l1569t2884r1606b2909],
80	Fourie	NNP	PERSON	Fourie	dep	114	SENT_347	[p23l1614t2883r1699b2911],
81	,	,	O	,	_	0	SENT_347	[p23l1614t2883r1699b2911],
82	Pretoria	NNP	LOCATION	Pretoria	dep	114	SENT_347	[p23l1708t2884r1781b2906, p23l95t2920r133b2948],
83	,	,	O	,	_	0	SENT_347	[p23l1708t2884r1781b2906, p23l95t2920r133b2948],
84	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l143t2919r214b2943],
85	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l220t2919r301b2947],
86	;	:	O	;	_	0	SENT_347	[p23l220t2919r301b2947],
87	C.	NNP	PERSON	C.	dep	114	SENT_347	[p23l310t2921r335b2943],
88	Jacobs	NNP	PERSON	Jacobs	dep	114	SENT_347	[p23l341t2919r430b2948],
89	,	,	O	,	_	0	SENT_347	[p23l341t2919r430b2948],
90	Port	NNP	LOCATION	Port	dep	114	SENT_347	[p23l438t2921r490b2943],
91	Elizabeth	NNP	LOCATION	Elizabeth	dep	114	SENT_347	[p23l496t2919r618b2948],
92	,	,	O	,	_	0	SENT_347	[p23l496t2919r618b2948],
93	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l628t2919r699b2943],
94	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l705t2919r786b2948],
95	;	:	O	;	_	0	SENT_347	[p23l705t2919r786b2948],
96	C.F.	NNP	PERSON	C.F.	dep	114	SENT_347	[p23l795t2921r840b2943],
97	Slabber	NNP	PERSON	Slabber	dep	114	SENT_347	[p23l850t2919r947b2948],
98	,	,	O	,	_	0	SENT_347	[p23l850t2919r947b2948],
99	Brooklyn	NNP	LOCATION	Brooklyn	dep	114	SENT_347	[p23l955t2919r1068b2949],
100	Square	NNP	LOCATION	Square	dep	114	SENT_347	[p23l1076t2921r1166b2949],
101	,	,	O	,	_	0	SENT_347	[p23l1076t2921r1166b2949],
102	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l1176t2919r1247b2943],
103	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l1253t2919r1334b2947],
104	;	:	O	;	_	0	SENT_347	[p23l1253t2919r1334b2947],
105	D.A.	NNP	PERSON	D.A.	dep	114	SENT_347	[p23l1343t2921r1396b2943],
106	Vorobiof	NNP	PERSON	Vorobiof	dep	114	SENT_347	[p23l1404t2919r1518b2947],
107	,	,	O	,	_	0	SENT_347	[p23l1404t2919r1518b2947],
108	Parklands	NNP	O	Parklands	dep	114	SENT_347	[p23l1527t2919r1656b2948],
109	,	,	O	,	_	0	SENT_347	[p23l1527t2919r1656b2948],
110	South	NNP	LOCATION	South	dep	114	SENT_347	[p23l1666t2919r1737b2943],
111	Africa	NNP	LOCATION	Africa	dep	114	SENT_347	[p23l1743t2919r1781b2942, p23l95t2957r147b2984],
112	;	:	O	;	_	0	SENT_347	[p23l1743t2919r1781b2942, p23l95t2957r147b2984],
113	K.	NNP	PERSON	K.	dep	114	SENT_347	[p23l155t2958r180b2980],
114	Chi	NNP	PERSON	Chi	_	0	SENT_347	[p23l189t2956r292b2985],
115	.	.	O	.	_	0	SENT_347	[p23l189t2956r292b2985],

1	—	NN	O	—	_	0	SENT_348	[p23l189t2956r292b2985],
2	.	.	O	.	_	0	SENT_348	[p23l189t2956r292b2985],

1	Hei	NNP	ORGANIZATION	Hei	nn	6	SENT_349	[p23l189t2956r292b2985],
2	,	,	O	,	_	0	SENT_349	[p23l189t2956r292b2985],
3	Pokfulam	NNP	O	Pokfulam	appos	6	SENT_349	[p23l301t2956r426b2985],
4	,	,	O	,	_	0	SENT_349	[p23l301t2956r426b2985],
5	Hong	NNP	LOCATION	Hong	appos	6	SENT_349	[p23l435t2958r506b2986],
6	Kong	NNP	LOCATION	Kong	_	0	SENT_349	[p23l512t2958r586b2986],
7	;	:	O	;	_	0	SENT_349	[p23l512t2958r586b2986],
8	W.	NNP	PERSON	W.	nn	9	SENT_349	[p23l593t2958r623b2980],
9	Arpornwirat	NNP	PERSON	Arpornwirat	dep	6	SENT_349	[p23l631t2957r789b2986],
10	,	,	O	,	_	0	SENT_349	[p23l631t2957r789b2986],
11	Bangkok	NNP	LOCATION	Bangkok	nn	13	SENT_349	[p23l798t2956r915b2986],
12	,	,	O	,	_	0	SENT_349	[p23l798t2956r915b2986],
13	Thailand	NNP	LOCATION	Thailand	appos	9	SENT_349	[p23l922t2956r1040b2985],
14	;	:	O	;	_	0	SENT_349	[p23l922t2956r1040b2985],
15	M.	NNP	PERSON	M.	nn	16	SENT_349	[p23l1047t2958r1079b2980],
16	Zukin	NNP	PERSON	Zukin	dep	6	SENT_349	[p23l1087t2956r1166b2985],
17	,	,	O	,	_	0	SENT_349	[p23l1087t2956r1166b2985],
18	Rio	NNP	LOCATION	Rio	nn	20	SENT_349	[p23l1175t2957r1216b2981],
19	de	IN	LOCATION	de	amod	20	SENT_349	[p23l1224t2956r1252b2980],
20	Janeiro	NNP	LOCATION	Janeiro	appos	16	SENT_349	[p23l1256t2957r1352b2983],
21	.	.	O	.	_	0	SENT_349	[p23l1256t2957r1352b2983],

1	N	NN	O	n	nn	3	SENT_350	[p23l578t3063r592b3078],
2	ENGLJ	NN	O	englj	nn	3	SENT_350	[p23l607t3062r691b3084],
3	MED	NN	O	med	_	0	SENT_350	[p23l706t3063r759b3078],
4	353	CD	NUMBER	353	dep	3	SENT_350	[p23l771t3062r835b3084],
5	;	:	O	;	_	0	SENT_350	[p23l771t3062r835b3084],
6	2	CD	NUMBER	2	num	8	SENT_350	[p23l771t3062r835b3084],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	8	SENT_350	[p23l870t3062r1081b3084],
8	JULY14	NN	O	july14	dep	4	SENT_350	[p23l1114t3063r1221b3084],
9	,	,	O	,	_	0	SENT_350	[p23l1114t3063r1221b3084],
10	2005	CD	DATE	2005	num	11	SENT_350	[p23l1235t3062r1298b3084],
11	131	CD	NUMBER	131	appos	8	SENT_350	[p23l2012t3061r2068b3083],

1	The	DT	O	the	det	4	SENT_351	[p23l753t3159r804b3183],
2	New	NNP	O	New	nn	4	SENT_351	[p23l813t3160r875b3183],
3	England	NNP	O	England	nn	4	SENT_351	[p23l885t3159r995b3190],
4	Journal	NNP	O	Journal	_	0	SENT_351	[p23l1004t3159r1101b3183],
5	of	IN	O	of	_	0	SENT_351	[p23l1111t3159r1140b3183],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_351	[p23l1147t3159r1272b3183],

1	ERLOTINIB	NNP	O	ERLOTINIB	nsubj	4	SENT_352	[p23l480t3347r667b3366],
2	IN	IN	O	in	prep	1	SENT_352	[p23l682t3347r720b3366],
3	PREVIOUSLY	RB	DATE	previously	pcomp	2	SENT_352	[p23l736t3347r941b3366],
4	TREATED	VBN	O	treat	_	0	SENT_352	[p23l952t3347r1103b3366],
5	NON	NN	O	non	dobj	4	SENT_352	[p23l1118t3347r1423b3366],
6	.	.	O	.	_	0	SENT_352	[p23l1118t3347r1423b3366],

1	—	NN	O	—	_	0	SENT_353	[p23l1118t3347r1423b3366],
2	.	.	O	.	_	0	SENT_353	[p23l1118t3347r1423b3366],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_354	[p23l1118t3347r1423b3366],
2	LUNG	NN	O	lung	_	0	SENT_354	[p23l1437t3347r1531b3366],
3	CANCER	NNP	O	CANCER	dep	2	SENT_354	[p23l1544t3347r1680b3366],

1	REFERENCES	NNS	O	reference	_	0	SENT_355	[p23l18t3663r738b3726],

1	1	LS	NUMBER	1	_	0	SENT_356	[p24l16t71r89b150],
2	.	.	O	.	_	0	SENT_356	[p24l16t71r89b150],

1	Jemal	NNP	PERSON	Jemal	nn	2	SENT_357	[p24l198t61r479b164],
2	A	NNP	PERSON	A	_	0	SENT_357	[p24l500t69r599b170],
3	,	,	O	,	_	0	SENT_357	[p24l500t69r599b170],
4	Tiwan	NNP	O	Tiwan	nn	5	SENT_357	[p24l631t61r933b152],
5	RC	NNP	O	RC	appos	2	SENT_357	[p24l959t67r1127b170],
6	,	,	O	,	_	0	SENT_357	[p24l959t67r1127b170],
7	Murray	NNP	PERSON	Murray	nn	8	SENT_357	[p24l1157t69r1513b176],
8	T	NN	O	t	appos	2	SENT_357	[p24l1532t67r1616b170],
9	,	,	O	,	_	0	SENT_357	[p24l1532t67r1616b170],
10	et	FW	O	et	nn	11	SENT_357	[p24l1651t79r1740b150],
11	al.	FW	O	al.	appos	2	SENT_357	[p24l1760t61r1868b150],
12	.	.	O	.	_	0	SENT_357	[p24l1760t61r1868b150],

1	Cancer	NN	O	cancer	nn	2	SENT_358	[p24l1902t67r2130b150, p24l12t239r153b299],
2	statistics	NNS	O	statistics	_	0	SENT_358	[p24l176t210r607b319],
3	,	,	O	,	_	0	SENT_358	[p24l176t210r607b319],
4	2004	CD	DATE	2004	appos	2	SENT_358	[p24l639t216r898b299],
5	.	.	O	.	_	0	SENT_358	[p24l639t216r898b299],

1	CA	NNP	O	CA	nn	3	SENT_359	[p24l929t216r1074b299],
2	Cancerl	NNP	O	Cancerl	nn	3	SENT_359	[p24l1095t216r1479b313],
3	Clin	NNP	O	Clin	_	0	SENT_359	[p24l1502t210r1696b299],
4	2004	CD	DATE	2004	num	3	SENT_359	[p24l1720t216r2129b319],
5	;	:	O	;	_	0	SENT_359	[p24l1720t216r2129b319],
6	54	CD	NUMBER	54	num	8	SENT_359	[p24l1720t216r2129b319],
7	:	:	O	:	_	0	SENT_359	[p24l1720t216r2129b319],
8	8-29	CD	NUMBER	8-29	dep	3	SENT_359	[p24l12t364r251b447],
9	.	.	O	.	_	0	SENT_359	[p24l12t364r251b447],

1	2	LS	NUMBER	2	_	0	SENT_360	[p24l10t517r89b596],
2	.	.	O	.	_	0	SENT_360	[p24l10t517r89b596],

1	Non	JJ	O	non	amod	2	SENT_361	[p24l206t507r736b598],
2	—	NN	O	—	_	0	SENT_361	[p24l206t507r736b598],
3	small	JJ	O	small	amod	6	SENT_361	[p24l206t507r736b598],
4	Cell	NN	O	cell	nn	6	SENT_361	[p24l781t507r973b596],
5	Lung	NN	O	lung	nn	6	SENT_361	[p24l1016t515r1273b622],
6	Cancer	NN	O	cancer	dep	2	SENT_361	[p24l1317t513r1663b596],
7	Collaborative	NNP	O	Collaborative	nn	8	SENT_361	[p24l1706t507r2129b596, p24l12t656r279b747],
8	Group	NNP	O	Group	dep	6	SENT_361	[p24l320t662r668b771],
9	.	.	O	.	_	0	SENT_361	[p24l320t662r668b771],

1	Chemotherapy	NN	O	chemotherapy	_	0	SENT_362	[p24l717t656r1453b771],
2	in	IN	O	in	_	0	SENT_362	[p24l1487t656r1582b744],
3	non	JJ	O	non	amod	8	SENT_362	[p24l1625t656r2132b745],
4	—	JJ	O	—	amod	8	SENT_362	[p24l1625t656r2132b745],
5	small	JJ	O	small	amod	8	SENT_362	[p24l1625t656r2132b745],
6	cell	NN	O	cell	nn	8	SENT_362	[p24l12t805r178b894],
7	lung	NN	O	lung	nn	8	SENT_362	[p24l251t805r479b920],
8	cancer	NN	O	cancer	prep_in	1	SENT_362	[p24l550t834r898b894],
9	:	:	O	:	_	0	SENT_362	[p24l550t834r898b894],
10	a	DT	O	a	det	11	SENT_362	[p24l977t835r1028b894],
11	meta-analysis	NN	O	meta-analysis	dep	1	SENT_362	[p24l1101t805r1780b920],
12	using	VBG	O	use	partmod	11	SENT_362	[p24l1858t805r2135b920],
13	updated	VBN	O	update	amod	14	SENT_362	[p24l12t954r411b1069],
14	data	NNS	O	datum	dobj	12	SENT_362	[p24l463t954r672b1043],
15	on	IN	O	on	_	0	SENT_362	[p24l723t982r846b1043],
16	individual	JJ	O	individual	amod	17	SENT_362	[p24l897t954r1392b1045],
17	patients	NNS	O	patient	prep_on	12	SENT_362	[p24l1441t954r1835b1069],
18	from	IN	O	from	_	0	SENT_362	[p24l1888t952r2131b1043],
19	52	CD	NUMBER	52	prep_from	12	SENT_362	[p24l14t1109r127b1192],
20	randomised	VBN	O	randomise	partmod	19	SENT_362	[p24l188t1103r783b1192],
21	clinical	JJ	O	clinical	amod	22	SENT_362	[p24l842t1103r1198b1192],
22	trials	NNS	O	trial	dobj	20	SENT_362	[p24l1257t1103r1532b1192],
23	.	.	O	.	_	0	SENT_362	[p24l1257t1103r1532b1192],

1	BM	NN	O	bm	_	0	SENT_363	[p24l1596t1109r1801b1206],
2	]	CD	NUMBER	]	num	3	SENT_363	[p24l1596t1109r1801b1206],
3	1995	CD	DATE	1995	dep	1	SENT_363	[p24l1862t1109r2127b1212],
4	;	:	O	;	_	0	SENT_363	[p24l1862t1109r2127b1212],
5	311:899	CD	NUMBER	311:899	num	6	SENT_363	[p24l12t1255r654b1338],
6	-909	CD	NUMBER	-909	dep	1	SENT_363	[p24l12t1255r654b1338],
7	.	.	O	.	_	0	SENT_363	[p24l12t1255r654b1338],

1	3	LS	NUMBER	3	_	0	SENT_364	[p24l12t1410r89b1489],
2	.	.	O	.	_	0	SENT_364	[p24l12t1410r89b1489],

1	Shepherd	NNP	ORGANIZATION	Shepherd	nn	7	SENT_365	[p24l211t1400r673b1515],
2	FA	NNP	ORGANIZATION	FA	nn	7	SENT_365	[p24l702t1408r852b1509],
3	,	,	O	,	_	0	SENT_365	[p24l702t1408r852b1509],
4	Danceyl	NNP	PERSON	Danceyl	appos	7	SENT_365	[p24l888t1406r1327b1515],
5	,	,	O	,	_	0	SENT_365	[p24l888t1406r1327b1515],
6	Ramlau	NNP	PERSON	Ramlau	appos	7	SENT_365	[p24l1364t1400r1740b1495],
7	R	NNP	PERSON	R	_	0	SENT_365	[p24l1767t1406r1866b1509],
8	,	,	O	,	_	0	SENT_365	[p24l1767t1406r1866b1509],
9	et	FW	O	et	nn	10	SENT_365	[p24l1906t1418r1993b1489],
10	al.	FW	O	al.	appos	7	SENT_365	[p24l2017t1400r2125b1489],
11	.	.	O	.	_	0	SENT_365	[p24l2017t1400r2125b1489],

1	A	DT	O	a	det	4	SENT_366	[p24l8t1557r83b1637],
2	prospective	JJ	O	prospective	amod	4	SENT_366	[p24l111t1549r666b1664],
3	randomized	JJ	O	randomized	amod	4	SENT_366	[p24l700t1549r1287b1638],
4	trial	NN	O	trial	_	0	SENT_366	[p24l1322t1549r1513b1638],
5	of	IN	O	of	_	0	SENT_366	[p24l1548t1547r1663b1638],
6	docetaxel	NN	O	docetaxel	prep_of	4	SENT_366	[p24l1676t1549r2131b1638],
7	versus	CC	O	versus	prep	4	SENT_366	[p24l6t1728r311b1789],
8	best	JJS	O	best	dep	9	SENT_366	[p24l352t1698r554b1787],
9	supportive	JJ	O	supportive	amod	10	SENT_366	[p24l587t1698r1096b1813],
10	care	NN	O	care	dep	7	SENT_366	[p24l1135t1728r1329b1787],
11	in	IN	O	in	_	0	SENT_366	[p24l1366t1698r1459b1786],
12	patients	NNS	O	patient	prep_in	4	SENT_366	[p24l1495t1698r1880b1813],
13	with	IN	O	with	_	0	SENT_366	[p24l1915t1698r2133b1789],
14	non-small-cell	JJ	O	non-small-cell	amod	16	SENT_366	[p24l12t1847r704b1936],
15	lung	NN	O	lung	nn	16	SENT_366	[p24l726t1847r947b1962],
16	cancer	NN	O	cancer	prep_with	4	SENT_366	[p24l967t1876r1279b1936],
17	previously	RB	DATE	previously	advmod	18	SENT_366	[p24l1297t1847r1789b1962],
18	treated	VBN	O	treat	partmod	4	SENT_366	[p24l1807t1847r2134b1936],
19	with	IN	O	with	_	0	SENT_366	[p24l6t1996r228b2087],
20	platinum	NN	O	platinum	nn	21	SENT_366	[p24l265t1996r1048b2111],
21	—	NN	O	—	prep_with	18	SENT_366	[p24l265t1996r1048b2111],
22	based	VBN	O	base	partmod	21	SENT_366	[p24l265t1996r1048b2111],
23	chemotherapy	NN	O	chemotherapy	dobj	22	SENT_366	[p24l1089t1996r1813b2111],
24	.	.	O	.	_	0	SENT_366	[p24l1089t1996r1813b2111],

1	J	NNP	O	J	nn	3	SENT_367	[p24l1847t2004r1890b2101],
2	Clin	NNP	O	Clin	nn	3	SENT_367	[p24l1927t1996r2130b2085],
3	Oncol	NNP	O	Oncol	_	0	SENT_367	[p24l12t2145r309b2234],
4	2000	CD	DATE	2000	num	3	SENT_367	[p24l338t2151r1260b2254],
5	;	:	O	;	_	0	SENT_367	[p24l338t2151r1260b2254],
6	18:2095	CD	NUMBER	18:2095	num	7	SENT_367	[p24l338t2151r1260b2254],
7	—	NN	O	—	dep	3	SENT_367	[p24l338t2151r1260b2254],
8	103	CD	NUMBER	103	dep	7	SENT_367	[p24l338t2151r1260b2254],
9	.	.	O	.	_	0	SENT_367	[p24l338t2151r1260b2254],

1	4	LS	NUMBER	4	_	0	SENT_368	[p24l8t2304r89b2383],
2	.	.	O	.	_	0	SENT_368	[p24l8t2304r89b2383],

1	Fossella	NNP	PERSON	Fossella	nn	2	SENT_369	[p24l207t2294r607b2383],
2	FV	NNP	O	FV	_	0	SENT_369	[p24l648t2302r789b2403],
3	,	,	O	,	_	0	SENT_369	[p24l648t2302r789b2403],
4	lDeVore	NN	O	ldevore	nn	5	SENT_369	[p24l839t2300r1198b2383],
5	R	NN	O	r	appos	2	SENT_369	[p24l1241t2300r1341b2403],
6	,	,	O	,	_	0	SENT_369	[p24l1241t2300r1341b2403],
7	Kerr	NNP	PERSON	Kerr	nn	8	SENT_369	[p24l1392t2302r1610b2386],
8	RN	NNP	O	RN	appos	2	SENT_369	[p24l1649t2300r1833b2403],
9	,	,	O	,	_	0	SENT_369	[p24l1649t2300r1833b2403],
10	et	FW	O	et	nn	11	SENT_369	[p24l1886t2312r1975b2383],
11	al.	FW	O	al.	appos	2	SENT_369	[p24l2013t2294r2124b2383],
12	.	.	O	.	_	0	SENT_369	[p24l2013t2294r2124b2383],

1	Randomized	VBN	O	randomize	csubj	20	SENT_370	[p24l10t2443r639b2538],
2	phase	NN	O	phase	nn	5	SENT_370	[p24l666t2443r951b2558],
3	III	CD	NUMBER	iii	num	5	SENT_370	[p24l979t2451r1090b2531],
4	trial	NN	O	trial	nn	5	SENT_370	[p24l1119t2443r1311b2532],
5	ofdocetaxel	NN	O	ofdocetaxel	dobj	1	SENT_370	[p24l1342t2441r1924b2532],
6	versus	CC	O	versus	prep	5	SENT_370	[p24l1947t2473r2129b2534, p24l14t2622r164b2683],
7	vinorelbine	NN	O	vinorelbine	dep	6	SENT_370	[p24l186t2592r728b2683],
8	or	CC	O	or	_	0	SENT_370	[p24l751t2620r854b2681],
9	ifosfamide	NN	O	ifosfamide	dep	6	SENT_370	[p24l872t2590r1382b2681],
10	in	IN	O	in	_	0	SENT_370	[p24l1405t2592r1499b2680],
11	patients	NNS	O	patient	prep_in	1	SENT_370	[p24l1520t2592r1898b2707],
12	with	IN	O	with	_	0	SENT_370	[p24l1919t2592r2133b2683],
13	advanced	JJ	O	advanced	amod	18	SENT_370	[p24l10t2741r459b2832],
14	non-small	JJ	O	non-small	amod	18	SENT_370	[p24l498t2741r1206b2830],
15	—	NN	O	—	nn	18	SENT_370	[p24l498t2741r1206b2830],
16	cell	NN	O	cell	nn	18	SENT_370	[p24l498t2741r1206b2830],
17	lung	NN	O	lung	nn	18	SENT_370	[p24l1243t2741r1467b2856],
18	cancer	NN	O	cancer	prep_with	11	SENT_370	[p24l1504t2770r1821b2830],
19	previously	RB	DATE	previously	advmod	1	SENT_370	[p24l1855t2741r2131b2856, p24l12t2890r267b3005],
20	treated	VBN	O	treat	_	0	SENT_370	[p24l289t2890r621b2979],
21	with	IN	O	with	_	0	SENT_370	[p24l643t2890r860b2981],
22	platinum-containing	JJ	O	platinum-containing	amod	24	SENT_370	[p24l886t2890r1904b3005],
23	chemotherapy	NN	O	chemotherapy	nn	24	SENT_370	[p24l1927t2890r2130b2979, p24l12t3039r540b3154],
24	regimens	NNS	O	regimen	prep_with	20	SENT_370	[p24l567t3039r1048b3154],
25	.	.	O	.	_	0	SENT_370	[p24l567t3039r1048b3154],

1	J	NNP	O	J	nn	3	SENT_371	[p24l1075t3047r1119b3142],
2	Clin	NNP	O	Clin	nn	3	SENT_371	[p24l1149t3039r1349b3128],
3	Oncol	NNP	O	Oncol	_	0	SENT_371	[p24l1380t3039r1674b3128],
4	2000	CD	DATE	2000	num	3	SENT_371	[p24l1706t3045r2128b3148],
5	;	:	O	;	_	0	SENT_371	[p24l1706t3045r2128b3148],
6	18	CD	NUMBER	18	num	8	SENT_371	[p24l1706t3045r2128b3148],
7	:	:	O	:	_	0	SENT_371	[p24l1706t3045r2128b3148],
8	2354-62	CD	NUMBER	2354-62	dep	3	SENT_371	[p24l12t3194r447b3278],
9	.	.	O	.	_	0	SENT_371	[p24l12t3194r447b3278],

1	[	NNP	O	[	nn	6	SENT_372	[p24l508t3196r979b3297],
2	Erratum	NNP	O	Erratum	nn	6	SENT_372	[p24l508t3196r979b3297],
3	,	,	O	,	_	0	SENT_372	[p24l508t3196r979b3297],
4	J	NNP	O	J	appos	6	SENT_372	[p24l1018t3196r1062b3291],
5	Clin	NNP	O	Clin	nn	6	SENT_372	[p24l1105t3188r1309b3277],
6	Oncol	NNP	O	Oncol	_	0	SENT_372	[p24l1354t3188r1651b3277],
7	2004	CD	DATE	2004	num	6	SENT_372	[p24l1696t3194r2127b3297],
8	;	:	O	;	_	0	SENT_372	[p24l1696t3194r2127b3297],
9	22	CD	NUMBER	22	dep	6	SENT_372	[p24l1696t3194r2127b3297],
10	:	:	O	:	_	0	SENT_372	[p24l1696t3194r2127b3297],
11	209	CD	NUMBER	209	dep	9	SENT_372	[p24l12t3342r259b3439],
12	.	.	O	.	_	0	SENT_372	[p24l12t3342r259b3439],
13	]	SYM	O	]	dep	6	SENT_372	[p24l12t3342r259b3439],

1	5	CD	NUMBER	5	_	0	SENT_373	[p24l12t3495r89b3574],
2	.	.	O	.	_	0	SENT_373	[p24l12t3495r89b3574],

1	Massarelli	JJ	PERSON	massarelli	amod	2	SENT_374	[p24l205t3485r714b3574],
2	E	NN	O	e	_	0	SENT_374	[p24l769t3493r858b3594],
3	,	,	O	,	_	0	SENT_374	[p24l769t3493r858b3594],
4	Andre	NNP	PERSON	Andre	nn	5	SENT_374	[p24l917t3485r1220b3574],
5	F	NN	PERSON	f	appos	2	SENT_374	[p24l1275t3493r1350b3594],
6	,	,	O	,	_	0	SENT_374	[p24l1275t3493r1350b3594],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_374	[p24l1411t3485r1566b3576],
8	DD	NNP	O	DD	appos	2	SENT_374	[p24l1621t3491r1809b3594],
9	,	,	O	,	_	0	SENT_374	[p24l1621t3491r1809b3594],
10	et	FW	O	et	nn	11	SENT_374	[p24l1874t3503r1963b3574],
11	al.	FW	O	al.	appos	2	SENT_374	[p24l2013t3485r2123b3574],
12	.	.	O	.	_	0	SENT_374	[p24l2013t3485r2123b3574],

1	A	DT	O	a	det	3	SENT_375	[p24l8t3642r83b3722],
2	retrospective	JJ	O	retrospective	amod	3	SENT_375	[p24l122t3634r752b3749],
3	analysis	NN	O	analysis	_	0	SENT_375	[p24l799t3634r1179b3749],
4	of	IN	O	of	_	0	SENT_375	[p24l1229t3632r1345b3723],
5	the	DT	O	the	det	6	SENT_375	[p24l1370t3634r1519b3723],
6	outcome	NN	O	outcome	prep_of	3	SENT_375	[p24l1568t3652r1989b3725],
7	of	IN	O	of	_	0	SENT_375	[p24l2038t3632r2153b3723],
8	patients	NNS	O	patient	prep_of	6	SENT_375	[p25l10t24r388b139],
9	Who	WP	O	who	nsubj	11	SENT_375	[p25l413t24r621b115],
10	have	VBP	O	have	aux	11	SENT_375	[p25l650t24r864b115],
11	received	VBN	O	receive	rcmod	8	SENT_375	[p25l892t24r1277b115],
12	two	CD	NUMBER	two	num	15	SENT_375	[p25l1305t42r1479b115],
13	prior	JJ	O	prior	amod	15	SENT_375	[p25l1506t24r1746b139],
14	chemotherapy	NN	O	chemotherapy	nn	15	SENT_375	[p25l1771t24r2132b113, p25l12t173r384b288],
15	regimens	NNS	O	regimen	dobj	11	SENT_375	[p25l425t173r884b288],
16	including	VBG	O	include	_	0	SENT_375	[p25l933t173r1411b288],
17	platinum	NN	O	platinum	prep_including	15	SENT_375	[p25l1451t173r1904b288],
18	and	CC	O	and	_	0	SENT_375	[p25l1949t173r2131b262],
19	docetaxel	NN	O	docetaxel	prep_including	15	SENT_375	[p25l12t322r475b411],
20	for	IN	O	for	_	0	SENT_375	[p25l512t320r653b411],
21	recurrent	JJ	O	recurrent	amod	23	SENT_375	[p25l688t340r1139b413],
22	non	JJ	O	non	amod	23	SENT_375	[p25l1170t322r1877b411],
23	—	NN	O	—	prep_for	17	SENT_375	[p25l1170t322r1877b411],
24	small	JJ	O	small	amod	28	SENT_375	[p25l1170t322r1877b411],
25	—	NN	O	—	nn	28	SENT_375	[p25l1170t322r1877b411],
26	cell	NN	O	cell	nn	28	SENT_375	[p25l1170t322r1877b411],
27	lung	NN	O	lung	nn	28	SENT_375	[p25l1913t322r2137b437],
28	cancer	NN	O	cancer	dep	23	SENT_375	[p25l12t499r346b560],
29	.	.	O	.	_	0	SENT_375	[p25l12t499r346b560],

1	Lung	NN	O	lung	nn	2	SENT_376	[p25l380t479r633b586],
2	Cancer	NN	O	cancer	_	0	SENT_376	[p25l658t477r998b560],
3	2003	CD	DATE	2003	dep	2	SENT_376	[p25l1024t477r1760b580],
4	;	:	O	;	_	0	SENT_376	[p25l1024t477r1760b580],
5	39:55	CD	NUMBER	39:55	number	6	SENT_376	[p25l1024t477r1760b580],
6	—	CD	NUMBER	—	dep	2	SENT_376	[p25l1024t477r1760b580],
7	61	CD	NUMBER	61	dep	6	SENT_376	[p25l1024t477r1760b580],
8	.	.	O	.	_	0	SENT_376	[p25l1024t477r1760b580],

1	6	CD	NUMBER	6	_	0	SENT_377	[p25l12t630r89b709],
2	.	.	O	.	_	0	SENT_377	[p25l12t630r89b709],

1	Shepherd	NNP	O	Shepherd	nn	7	SENT_378	[p25l211t620r673b735],
2	FA	NNP	O	FA	nn	7	SENT_378	[p25l702t628r852b729],
3	,	,	O	,	_	0	SENT_378	[p25l702t628r852b729],
4	DanceyJ	NNP	O	DanceyJ	appos	7	SENT_378	[p25l888t626r1327b735],
5	,	,	O	,	_	0	SENT_378	[p25l888t626r1327b735],
6	Ramlau	NNP	PERSON	Ramlau	appos	7	SENT_378	[p25l1364t620r1740b715],
7	R	NNP	PERSON	R	_	0	SENT_378	[p25l1767t626r1866b729],
8	,	,	O	,	_	0	SENT_378	[p25l1767t626r1866b729],
9	et	FW	O	et	nn	10	SENT_378	[p25l1906t638r1993b709],
10	al.	FW	O	al.	appos	7	SENT_378	[p25l2017t620r2125b709],
11	.	.	O	.	_	0	SENT_378	[p25l2017t620r2125b709],

1	Prospective	JJ	O	prospective	amod	3	SENT_379	[p25l10t769r562b884],
2	randomized	JJ	O	randomized	amod	3	SENT_379	[p25l621t769r1210b858],
3	trial	NN	O	trial	nsubj	23	SENT_379	[p25l1269t769r1461b858],
4	of	IN	O	of	_	0	SENT_379	[p25l1520t767r1637b858],
5	docetaxel	NN	O	docetaxel	prep_of	3	SENT_379	[p25l1676t769r2131b858],
6	versus	CC	O	versus	prep	5	SENT_379	[p25l6t948r307b1009],
7	best	JJS	O	best	amod	9	SENT_379	[p25l332t918r530b1007],
8	support	NN	O	support	nn	9	SENT_379	[p25l550t936r926b1033],
9	care	NN	O	care	dep	6	SENT_379	[p25l943t948r1135b1007],
10	in	IN	O	in	_	0	SENT_379	[p25l1158t918r1251b1006],
11	patients	NNS	O	patient	prep_in	9	SENT_379	[p25l1271t918r1649b1033],
12	with	IN	O	with	_	0	SENT_379	[p25l1670t918r1884b1009],
13	nonsmall	JJ	O	nonsmall	amod	17	SENT_379	[p25l1908t946r2132b1007, p25l14t1067r475b1156],
14	—	NN	O	—	nn	17	SENT_379	[p25l1908t946r2132b1007, p25l14t1067r475b1156],
15	cell	NN	O	cell	nn	17	SENT_379	[p25l1908t946r2132b1007, p25l14t1067r475b1156],
16	lung	NN	O	lung	nn	17	SENT_379	[p25l494t1067r716b1182],
17	cancer	NN	O	cancer	prep_with	11	SENT_379	[p25l735t1096r1048b1156],
18	previously	RB	DATE	previously	advmod	19	SENT_379	[p25l1065t1067r1556b1182],
19	treated	VBN	O	treat	partmod	17	SENT_379	[p25l1575t1067r1900b1156],
20	with	IN	O	with	_	0	SENT_379	[p25l1918t1067r2133b1158],
21	platinum	NN	O	platinum	nn	22	SENT_379	[p25l10t1216r791b1331],
22	—	NN	O	—	prep_with	19	SENT_379	[p25l10t1216r791b1331],
23	based	VBN	O	base	_	0	SENT_379	[p25l10t1216r791b1331],
24	chemotherapy	NN	O	chemotherapy	dobj	23	SENT_379	[p25l820t1216r1544b1331],
25	.	.	O	.	_	0	SENT_379	[p25l820t1216r1544b1331],

1	Classic	JJ	MISC	classic	amod	2	SENT_380	[p25l1579t1216r1926b1305],
2	Pap	NN	MISC	pap	_	0	SENT_380	[p25l1951t1224r2129b1331],
3	Curr	NNP	MISC	Curr	nn	4	SENT_380	[p25l12t1371r236b1456],
4	Comment	NN	O	comment	dep	2	SENT_380	[p25l263t1371r759b1454],
5	2001	CD	DATE	2001	num	4	SENT_380	[p25l783t1371r1459b1474],
6	;	:	O	;	_	0	SENT_380	[p25l783t1371r1459b1474],
7	6:87	CD	NUMBER	6:87	number	8	SENT_380	[p25l783t1371r1459b1474],
8	—	CD	NUMBER	—	dep	2	SENT_380	[p25l783t1371r1459b1474],
9	96	CD	NUMBER	96	dep	8	SENT_380	[p25l783t1371r1459b1474],
10	.	.	O	.	_	0	SENT_380	[p25l783t1371r1459b1474],

1	7	CD	NUMBER	7	_	0	SENT_381	[p25l14t1524r89b1603],
2	.	.	O	.	_	0	SENT_381	[p25l14t1524r89b1603],

1	Rusch	NNP	PERSON	Rusch	nn	2	SENT_382	[p25l207t1514r504b1609],
2	V	NNP	O	V	nsubj	33	SENT_382	[p25l522t1522r601b1623],
3	,	,	O	,	_	0	SENT_382	[p25l522t1522r601b1623],
4	Klimstra	NNP	ORGANIZATION	Klimstra	nn	5	SENT_382	[p25l630t1514r1042b1606],
5	D	NNP	ORGANIZATION	D	conj_and	2	SENT_382	[p25l1061t1520r1161b1623],
6	,	,	O	,	_	0	SENT_382	[p25l1061t1520r1161b1623],
7	Venkatraman	NNP	PERSON	Venkatraman	nn	8	SENT_382	[p25l1186t1514r1823b1605],
8	E	NNP	O	E	conj_and	2	SENT_382	[p25l1842t1522r1930b1623],
9	,	,	O	,	_	0	SENT_382	[p25l1842t1522r1930b1623],
10	Pisters	NNP	ORGANIZATION	Pisters	nn	11	SENT_382	[p25l1957t1514r2131b1603, p25l12t1681r180b1752],
11	PW	NNP	ORGANIZATION	PW	conj_and	2	SENT_382	[p25l219t1669r396b1772],
12	,	,	O	,	_	0	SENT_382	[p25l219t1669r396b1772],
13	Langenfeld	NNP	PERSON	Langenfeld	nn	14	SENT_382	[p25l441t1661r987b1778],
14	J	NNP	PERSON	J	conj_and	2	SENT_382	[p25l1016t1671r1083b1772],
15	,	,	O	,	_	0	SENT_382	[p25l1016t1671r1083b1772],
16	Dmitrovsky	NNP	PERSON	Dmitrovsky	nn	18	SENT_382	[p25l1129t1663r1697b1778],
17	E.	NNP	O	E.	nn	18	SENT_382	[p25l1732t1671r1821b1752],
18	Overexpression	NN	O	overexpression	nsubj	33	SENT_382	[p25l1868t1669r2131b1754, p25l12t1812r546b1927],
19	of	IN	O	of	_	0	SENT_382	[p25l585t1810r702b1901],
20	the	DT	O	the	det	24	SENT_382	[p25l721t1812r872b1901],
21	epidermal	JJ	O	epidermal	amod	24	SENT_382	[p25l913t1812r1412b1927],
22	growth	NN	O	growth	nn	24	SENT_382	[p25l1451t1812r1805b1927],
23	factor	NN	O	factor	nn	24	SENT_382	[p25l1845t1810r2135b1901],
24	receptor	NN	O	receptor	prep_of	18	SENT_382	[p25l12t1979r419b2076],
25	and	CC	O	and	_	0	SENT_382	[p25l441t1961r619b2050],
26	its	PRP$	O	its	poss	27	SENT_382	[p25l643t1961r754b2050],
27	ligand	NN	O	ligand	nsubj	33	SENT_382	[p25l781t1961r1087b2076],
28	transforming	VBG	O	transform	partmod	2	SENT_382	[p25l1111t1959r1764b2076],
29	growth	NN	O	growth	nn	30	SENT_382	[p25l1783t1961r2133b2076],
30	factor	NN	O	factor	nsubj	31	SENT_382	[p25l12t2108r301b2199],
31	alpha	NN	O	alpha	xcomp	28	SENT_382	[p25l338t2110r609b2225],
32	is	VBZ	O	be	cop	33	SENT_382	[p25l648t2110r724b2199],
33	frequent	JJ	O	frequent	_	0	SENT_382	[p25l767t2108r1192b2225],
34	in	IN	O	in	_	0	SENT_382	[p25l1226t2110r1321b2198],
35	resectable	JJ	O	resectable	amod	39	SENT_382	[p25l1360t2110r1857b2199],
36	nonsmall	JJ	O	nonsmall	amod	39	SENT_382	[p25l1898t2138r2129b2199, p25l14t2259r279b2348],
37	cell	NN	O	cell	nn	39	SENT_382	[p25l316t2259r483b2348],
38	lung	NN	O	lung	nn	39	SENT_382	[p25l518t2259r741b2374],
39	cancer	NN	O	cancer	prep_in	33	SENT_382	[p25l773t2288r1107b2368],
40	,	,	O	,	_	0	SENT_382	[p25l773t2288r1107b2368],
41	but	CC	O	but	_	0	SENT_382	[p25l1149t2259r1311b2350],
42	does	VBZ	O	do	aux	44	SENT_382	[p25l1342t2259r1562b2348],
43	not	RB	O	not	neg	44	SENT_382	[p25l1599t2277r1764b2348],
44	predict	VB	O	predict	conj_but	33	SENT_382	[p25l1793t2259r2137b2374],
45	tumor	NN	O	tumor	nn	46	SENT_382	[p25l12t2426r314b2499],
46	progression	NN	O	progression	dobj	44	SENT_382	[p25l336t2408r947b2523],
47	.	.	O	.	_	0	SENT_382	[p25l336t2408r947b2523],

1	Clin	NNP	O	Clin	nn	3	SENT_383	[p25l979t2408r1179b2497],
2	Cancer	NNP	O	Cancer	nn	3	SENT_383	[p25l1204t2414r1544b2497],
3	Res	NNP	O	Res	_	0	SENT_383	[p25l1566t2414r1738b2503],
4	1997	CD	DATE	1997	num	3	SENT_383	[p25l1771t2414r2128b2517],
5	;	:	O	;	_	0	SENT_383	[p25l1771t2414r2128b2517],
6	3	CD	NUMBER	3	num	8	SENT_383	[p25l1771t2414r2128b2517],
7	:	:	O	:	_	0	SENT_383	[p25l1771t2414r2128b2517],
8	515-22	CD	NUMBER	515-22	dep	3	SENT_383	[p25l14t2562r376b2645],
9	.	.	O	.	_	0	SENT_383	[p25l14t2562r376b2645],

1	8	CD	NUMBER	8	_	0	SENT_384	[p25l10t2713r89b2796],
2	.	.	O	.	_	0	SENT_384	[p25l10t2713r89b2796],

1	Brabenderl	NNP	PERSON	Brabenderl	_	0	SENT_385	[p25l207t2705r795b2814],
2	,	,	O	,	_	0	SENT_385	[p25l207t2705r795b2814],
3	Danenberg	NNP	PERSON	Danenberg	nn	4	SENT_385	[p25l826t2705r1372b2820],
4	KD	NN	O	kd	appos	1	SENT_385	[p25l1394t2711r1572b2814],
5	,	,	O	,	_	0	SENT_385	[p25l1394t2711r1572b2814],
6	Metzger	NNP	PERSON	Metzger	nn	7	SENT_385	[p25l1601t2713r2005b2820],
7	R	NNP	PERSON	R	appos	1	SENT_385	[p25l2026t2711r2125b2814],
8	,	,	O	,	_	0	SENT_385	[p25l2026t2711r2125b2814],
9	et	FW	O	et	nn	10	SENT_385	[p25l12t2872r101b2943],
10	al.	FW	O	al.	appos	1	SENT_385	[p25l129t2854r237b2943],
11	.	.	O	.	_	0	SENT_385	[p25l129t2854r237b2943],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_386	[p25l279t2854r783b2969],
2	growth	NN	O	growth	nn	4	SENT_386	[p25l818t2854r1167b2969],
3	factor	NN	O	factor	nn	4	SENT_386	[p25l1202t2852r1485b2943],
4	receptor	NN	O	receptor	nsubjpass	15	SENT_386	[p25l1518t2872r1922b2969],
5	and	CC	O	and	_	0	SENT_386	[p25l1953t2854r2133b2943],
6	HER2-neu	NN	O	her2-neu	nn	8	SENT_386	[p25l10t3009r520b3098],
7	mRNA	NN	O	mrna	nn	8	SENT_386	[p25l561t3009r896b3098],
8	expression	NN	O	expression	conj_and	4	SENT_386	[p25l937t3003r1457b3118],
9	in	IN	O	in	_	0	SENT_386	[p25l1499t3003r1593b3091],
10	non-small	JJ	O	non-small	amod	13	SENT_386	[p25l1635t3003r2133b3092],
11	cell	NN	O	cell	nn	13	SENT_386	[p25l12t3152r174b3241],
12	lung	NN	O	lung	nn	13	SENT_386	[p25l215t3152r437b3267],
13	cancer	NN	O	cancer	prep_in	4	SENT_386	[p25l476t3181r793b3241],
14	is	VBZ	O	be	auxpass	15	SENT_386	[p25l830t3152r906b3241],
15	correlated	VBN	O	correlate	_	0	SENT_386	[p25l951t3152r1437b3241],
16	with	IN	O	with	_	0	SENT_386	[p25l1473t3152r1691b3243],
17	survival	NN	O	survival	prep_with	15	SENT_386	[p25l1734t3152r2126b3243],
18	.	.	O	.	_	0	SENT_386	[p25l1734t3152r2126b3243],

1	Clin	NNP	O	Clin	nn	3	SENT_387	[p25l12t3301r210b3390],
2	Cancer	NNP	O	Cancer	nn	3	SENT_387	[p25l239t3307r579b3390],
3	Res	NNP	O	Res	_	0	SENT_387	[p25l603t3307r775b3396],
4	2001	CD	DATE	2001	num	3	SENT_387	[p25l806t3307r1544b3410],
5	;	:	O	;	_	0	SENT_387	[p25l806t3307r1544b3410],
6	7:1850	CD	NUMBER	7:1850	number	7	SENT_387	[p25l806t3307r1544b3410],
7	—	CD	NUMBER	—	dep	3	SENT_387	[p25l806t3307r1544b3410],
8	5	CD	NUMBER	5	dep	7	SENT_387	[p25l806t3307r1544b3410],
9	.	.	O	.	_	0	SENT_387	[p25l806t3307r1544b3410],

1	9	CD	NUMBER	9	_	0	SENT_388	[p25l10t3460r89b3539],
2	.	.	O	.	_	0	SENT_388	[p25l10t3460r89b3539],

1	Sridhar	NNP	O	Sridhar	nn	2	SENT_389	[p25l211t3450r568b3539],
2	SS	NNP	O	SS	_	0	SENT_389	[p25l625t3456r764b3559],
3	,	,	O	,	_	0	SENT_389	[p25l625t3456r764b3559],
4	Seymour	NNP	PERSON	Seymour	nn	5	SENT_389	[p25l830t3456r1257b3565],
5	L	NNP	PERSON	L	appos	2	SENT_389	[p25l1309t3458r1392b3559],
6	,	,	O	,	_	0	SENT_389	[p25l1309t3458r1392b3559],
7	Shepherd	NNP	ORGANIZATION	Shepherd	nn	8	SENT_389	[p25l1459t3450r1920b3565],
8	FA	NNP	ORGANIZATION	FA	appos	5	SENT_389	[p25l1975t3458r2125b3539],
9	.	.	O	.	_	0	SENT_389	[p25l1975t3458r2125b3539],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_390	[p25l10t3599r485b3688],
2	of	IN	O	of	_	0	SENT_390	[p25l512t3597r627b3688],
3	epidermal	JJ	O	epidermal	amod	8	SENT_390	[p25l631t3597r1819b3714],
4	—	NN	O	—	nn	8	SENT_390	[p25l631t3597r1819b3714],
5	growth	NN	O	growth	nn	8	SENT_390	[p25l631t3597r1819b3714],
6	—	NN	O	—	nn	8	SENT_390	[p25l631t3597r1819b3714],
7	factor	NN	O	factor	nn	8	SENT_390	[p25l631t3597r1819b3714],
8	receptors	NNS	O	receptor	prep_of	1	SENT_390	[p25l1839t3628r2131b3714, p26l12t42r222b113],
9	:	:	O	:	_	0	SENT_390	[p25l1839t3628r2131b3714, p26l12t42r222b113],

1	a	DT	O	a	det	2	SENT_391	[p26l251t53r303b113],
2	review	NN	O	review	_	0	SENT_391	[p26l326t24r635b115],
3	of	IN	O	of	_	0	SENT_391	[p26l656t22r771b113],
4	clinical	JJ	O	clinical	amod	5	SENT_391	[p26l777t24r1115b113],
5	research	NN	O	research	prep_of	2	SENT_391	[p26l1141t24r1542b113],
6	with	IN	O	with	_	0	SENT_391	[p26l1562t24r1778b115],
7	a	DT	O	a	det	8	SENT_391	[p26l1803t53r1854b113],
8	focus	NN	O	focus	prep_with	2	SENT_391	[p26l1878t22r2131b115],
9	on	IN	O	on	_	0	SENT_391	[p26l12t201r134b262],
10	non	JJ	O	non	amod	16	SENT_391	[p26l158t173r864b262],
11	—	JJ	O	—	amod	16	SENT_391	[p26l158t173r864b262],
12	small	JJ	O	small	amod	16	SENT_391	[p26l158t173r864b262],
13	—	NN	O	—	nn	16	SENT_391	[p26l158t173r864b262],
14	cell	NN	O	cell	nn	16	SENT_391	[p26l158t173r864b262],
15	lung	NN	O	lung	nn	16	SENT_391	[p26l887t173r1111b288],
16	cancer	NN	O	cancer	prep_on	8	SENT_391	[p26l1133t201r1467b262],
17	.	.	O	.	_	0	SENT_391	[p26l1133t201r1467b262],

1	Lancet	NNP	O	Lancet	nn	2	SENT_392	[p26l1496t181r1821b262],
2	Oncol	NNP	O	Oncol	_	0	SENT_392	[p26l1840t173r2132b262],

1	10	CD	NUMBER	10	_	0	SENT_393	[p26l16t479r147b560],
2	.	.	O	.	_	0	SENT_393	[p26l16t479r147b560],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_394	[p26l207t471r639b562],
2	M	NNP	O	M	_	0	SENT_394	[p26l670t479r797b580],
3	,	,	O	,	_	0	SENT_394	[p26l670t479r797b580],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_394	[p26l836t479r1076b560],
5	S	NNP	O	S	appos	2	SENT_394	[p26l1117t477r1198b580],
6	,	,	O	,	_	0	SENT_394	[p26l1117t477r1198b580],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_394	[p26l1241t471r1702b560],
8	G	NNP	O	G	appos	2	SENT_394	[p26l1740t477r1849b580],
9	,	,	O	,	_	0	SENT_394	[p26l1740t477r1849b580],
10	et	FW	O	et	nn	11	SENT_394	[p26l1894t489r1983b560],
11	al.	FW	O	al.	appos	2	SENT_394	[p26l2014t471r2124b560],
12	.	.	O	.	_	0	SENT_394	[p26l2014t471r2124b560],

1	Multi	JJ	O	multi	amod	2	SENT_395	[p26l8t620r929b711],
2	—	NN	O	—	nsubj	21	SENT_395	[p26l8t620r929b711],
3	institutional	JJ	O	institutional	amod	7	SENT_395	[p26l8t620r929b711],
4	randomized	JJ	O	randomized	amod	7	SENT_395	[p26l1010t620r1610b709],
5	phase	NN	O	phase	nn	7	SENT_395	[p26l1689t620r1977b735],
6	II	CD	NUMBER	ii	num	7	SENT_395	[p26l2058t628r2133b708],
7	trial	NN	O	trial	npadvmod	2	SENT_395	[p26l12t769r208b858],
8	of	IN	O	of	_	0	SENT_395	[p26l293t767r410b858],
9	geﬁtinib	NN	O	geﬁtinib	prep_of	2	SENT_395	[p26l473t767r892b884],
10	for	IN	O	for	_	0	SENT_395	[p26l977t767r1121b858],
11	previously	RB	DATE	previously	advmod	12	SENT_395	[p26l1202t769r1712b884],
12	treated	VBN	O	treat	amod	13	SENT_395	[p26l1791t769r2131b858],
13	patients	NNS	O	patient	prep_for	9	SENT_395	[p26l10t918r403b1033],
14	with	IN	O	with	_	0	SENT_395	[p26l427t918r649b1009],
15	advanced	JJ	O	advanced	amod	20	SENT_395	[p26l674t918r1135b1009],
16	non	JJ	O	non	amod	20	SENT_395	[p26l1161t918r1884b1007],
17	—	NN	O	—	nn	20	SENT_395	[p26l1161t918r1884b1007],
18	small-cell	NN	O	small-cell	nn	20	SENT_395	[p26l1161t918r1884b1007],
19	lung	NN	O	lung	nn	20	SENT_395	[p26l1908t918r2135b1033],
20	cancer	NN	O	cancer	prep_with	13	SENT_395	[p26l12t1096r334b1156],
21	(	VBD	O	(	_	0	SENT_395	[p26l366t1067r552b1170],
22	the	DT	O	the	det	25	SENT_395	[p26l366t1067r552b1170],
23	IDEAL	JJ	O	ideal	amod	25	SENT_395	[p26l579t1073r906b1156],
24	Trial	NN	O	trial	nn	25	SENT_395	[p26l927t1067r1224b1170],
25	)	NN	O	)	dobj	21	SENT_395	[p26l927t1067r1224b1170],
26	.	.	O	.	_	0	SENT_395	[p26l927t1067r1224b1170],

1	J	NNP	O	J	nn	3	SENT_396	[p26l1248t1075r1291b1170],
2	Clin	NNP	O	Clin	nn	3	SENT_396	[p26l1318t1067r1521b1156],
3	Oncol	NNP	O	Oncol	_	0	SENT_396	[p26l1550t1067r1844b1156],
4	2003	CD	DATE	2003	num	3	SENT_396	[p26l1866t1073r2128b1176],
5	;	:	O	;	_	0	SENT_396	[p26l1866t1073r2128b1176],

1	21:2237	CD	NUMBER	21:2237	_	0	SENT_397	[p26l12t1222r579b1306],
2	—	CD	NUMBER	—	number	3	SENT_397	[p26l12t1222r579b1306],
3	46	CD	NUMBER	46	num	1	SENT_397	[p26l12t1222r579b1306],
4	.	.	O	.	_	0	SENT_397	[p26l12t1222r579b1306],

1	[	NNP	O	[	nn	2	SENT_398	[p26l640t1224r1109b1325],
2	Erratum	NNP	O	Erratum	_	0	SENT_398	[p26l640t1224r1109b1325],
3	,	,	O	,	_	0	SENT_398	[p26l640t1224r1109b1325],
4	J	NNP	O	J	nn	6	SENT_398	[p26l1157t1224r1200b1319],
5	Clin	NNP	O	Clin	nn	6	SENT_398	[p26l1249t1216r1453b1305],
6	Oncol	NNP	O	Oncol	appos	2	SENT_398	[p26l1505t1216r1803b1305],
7	2004	CD	DATE	2004	num	6	SENT_398	[p26l1854t1222r2126b1325],
8	;	:	O	;	_	0	SENT_398	[p26l1854t1222r2126b1325],

1	1	CD	NUMBER	1	num	2	SENT_399	[p26l16t1523r58b1601],
2	1	CD	NUMBER	1	_	0	SENT_399	[p26l73t1523r147b1602],
3	.	.	O	.	_	0	SENT_399	[p26l73t1523r147b1602],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_400	[p26l208t1513r400b1605],
2	MG	NN	PERSON	mg	_	0	SENT_400	[p26l421t1519r629b1622],
3	,	,	O	,	_	0	SENT_400	[p26l421t1519r629b1622],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_400	[p26l654t1513r961b1603],
5	RB	NN	O	rb	appos	2	SENT_400	[p26l981t1519r1147b1622],
6	,	,	O	,	_	0	SENT_400	[p26l981t1519r1147b1622],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_400	[p26l1174t1513r1501b1602],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_400	[p26l1514t1519r1671b1622],
9	,	,	O	,	_	0	SENT_400	[p26l1514t1519r1671b1622],
10	et	FW	O	et	nn	11	SENT_400	[p26l1698t1531r1785b1602],
11	al.	FW	O	al.	appos	2	SENT_400	[p26l1799t1513r1904b1602],
12	.	.	O	.	_	0	SENT_400	[p26l1799t1513r1904b1602],

1	Efficacy	NN	O	efficacy	_	0	SENT_401	[p26l1930t1511r2132b1601, p26l12t1692r212b1777],

1	of	IN	O	of	_	0	SENT_402	[p26l235t1660r350b1751],
2	geﬁtinib	NN	O	geﬁtinib	pobj	1	SENT_402	[p26l358t1660r805b1777],
3	,	,	O	,	_	0	SENT_402	[p26l358t1660r805b1777],
4	an	DT	O	a	det	5	SENT_402	[p26l844t1691r961b1751],
5	inhibitor	NN	O	inhibitor	appos	2	SENT_402	[p26l994t1662r1436b1751],
6	of	IN	O	of	_	0	SENT_402	[p26l1467t1660r1584b1751],
7	the	DT	O	the	det	13	SENT_402	[p26l1597t1662r1748b1751],
8	epidermal	JJ	O	epidermal	amod	13	SENT_402	[p26l1781t1662r2129b1777, p26l12t1811r196b1900],
9	growth	NN	O	growth	nn	13	SENT_402	[p26l222t1811r577b1926],
10	factor	NN	O	factor	nn	13	SENT_402	[p26l605t1809r894b1900],
11	receptor	NN	O	receptor	nn	13	SENT_402	[p26l919t1829r1333b1926],
12	tyrosine	NN	O	tyrosine	nn	13	SENT_402	[p26l1358t1811r1752b1926],
13	kinase	NN	O	kinase	prep_of	5	SENT_402	[p26l1779t1811r2125b1920],
14	,	,	O	,	_	0	SENT_402	[p26l1779t1811r2125b1920],

1	in	IN	O	in	dep	14	SENT_403	[p26l8t2071r54b2114],
2	symptomatic	JJ	O	symptomatic	amod	3	SENT_403	[p26l68t2071r374b2127],
3	patients	NNS	O	patient	pobj	1	SENT_403	[p26l386t2071r574b2127],
4	with	IN	O	with	_	0	SENT_403	[p26l586t2071r691b2115],
5	non	JJ	O	non	amod	10	SENT_403	[p26l705t2071r946b2115],
6	—	JJ	O	—	amod	10	SENT_403	[p26l705t2071r946b2115],
7	small	JJ	O	small	amod	10	SENT_403	[p26l705t2071r946b2115],
8	cell	NN	O	cell	nn	10	SENT_403	[p26l960t2071r1039b2115],
9	lung	NN	O	lung	nn	10	SENT_403	[p26l8t2142r117b2198],
10	cancer	NN	O	cancer	prep_with	3	SENT_403	[p26l127t2156r293b2186],
11	:	:	O	:	_	0	SENT_403	[p26l127t2156r293b2186],
12	a	DT	O	a	det	14	SENT_403	[p26l306t2156r331b2186],
13	randomized	JJ	O	randomized	amod	14	SENT_403	[p26l342t2142r628b2186],
14	trial	NN	O	trial	_	0	SENT_403	[p26l640t2142r746b2186],
15	.	.	O	.	_	0	SENT_403	[p26l640t2142r746b2186],

1	JAMA	NNP	O	JAMA	_	0	SENT_404	[p26l755t2146r897b2193],
2	2003	CD	DATE	2003	num	1	SENT_404	[p26l907t2145r1037b2195],
3	;	:	O	;	_	0	SENT_404	[p26l907t2145r1037b2195],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_404	[p26l9t2217r321b2258],
5	—	CD	NUMBER	—	dep	1	SENT_404	[p26l9t2217r321b2258],
6	58	CD	NUMBER	58	dep	5	SENT_404	[p26l9t2217r321b2258],
7	.	.	O	.	_	0	SENT_404	[p26l9t2217r321b2258],

1	12	CD	NUMBER	12	_	0	SENT_405	[p26l11t2290r74b2329],
2	.	.	O	.	_	0	SENT_405	[p26l11t2290r74b2329],

1	Pérez	NNP	PERSON	Pérez	_	0	SENT_406	[p26l104t2283r374b2329],
2	.	.	O	.	_	0	SENT_406	[p26l104t2283r374b2329],

1	—	NN	O	—	_	0	SENT_407	[p26l104t2283r374b2329],
2	.	.	O	.	_	0	SENT_407	[p26l104t2283r374b2329],

1	Soler	NNP	PERSON	Soler	nn	2	SENT_408	[p26l104t2283r374b2329],
2	R	NNP	PERSON	R	_	0	SENT_408	[p26l389t2288r437b2338],
3	,	,	O	,	_	0	SENT_408	[p26l389t2288r437b2338],
4	Chachoua	NNP	O	Chachoua	nn	5	SENT_408	[p26l458t2285r696b2329],
5	A	NNP	O	A	appos	2	SENT_408	[p26l711t2289r760b2338],
6	,	,	O	,	_	0	SENT_408	[p26l711t2289r760b2338],
7	Hammond	NNP	ORGANIZATION	Hammond	nn	8	SENT_408	[p26l781t2285r1039b2329],
8	LA	NNP	ORGANIZATION	LA	appos	2	SENT_408	[p26l8t2360r86b2409],
9	,	,	O	,	_	0	SENT_408	[p26l8t2360r86b2409],
10	et	FW	O	et	nn	11	SENT_408	[p26l108t2365r151b2400],
11	al.	FW	O	al.	appos	2	SENT_408	[p26l166t2356r220b2400],
12	.	.	O	.	_	0	SENT_408	[p26l166t2356r220b2400],

1	Determinants	NNS	O	determinant	_	0	SENT_409	[p26l241t2356r571b2400],
2	of	IN	O	of	_	0	SENT_409	[p26l591t2355r648b2400],
3	tumor	NN	O	tumor	nn	4	SENT_409	[p26l656t2365r805b2400],
4	response	NN	O	response	prep_of	1	SENT_409	[p26l822t2370r1038b2412],
5	and	CC	O	and	_	0	SENT_409	[p26l8t2427r97b2471],
6	survival	NN	O	survival	prep_of	1	SENT_409	[p26l114t2427r297b2471],
7	with	IN	O	with	_	0	SENT_409	[p26l311t2427r419b2471],
8	erlotinib	NN	O	erlotinib	prep_with	1	SENT_409	[p26l436t2427r643b2471],
9	in	IN	O	in	_	0	SENT_409	[p26l660t2427r706b2470],
10	patients	NNS	O	patient	prep_in	1	SENT_409	[p26l721t2427r915b2483],
11	with	IN	O	with	_	0	SENT_409	[p26l930t2427r1038b2471],
12	non	JJ	O	non	amod	18	SENT_409	[p26l9t2498r363b2542],
13	—	JJ	O	—	amod	18	SENT_409	[p26l9t2498r363b2542],
14	small	JJ	O	small	amod	18	SENT_409	[p26l9t2498r363b2542],
15	—	NN	O	—	nn	18	SENT_409	[p26l9t2498r363b2542],
16	cell	NN	O	cell	nn	18	SENT_409	[p26l9t2498r363b2542],
17	lung	NN	O	lung	nn	18	SENT_409	[p26l390t2498r501b2554],
18	cancer	NN	O	cancer	prep_with	10	SENT_409	[p26l526t2512r694b2542],
19	.	.	O	.	_	0	SENT_409	[p26l526t2512r694b2542],

1	J	NNP	O	J	nn	3	SENT_410	[p26l718t2502r740b2549],
2	Clin	NNP	O	Clin	nn	3	SENT_410	[p26l765t2498r865b2542],
3	Oncol	NNP	O	Oncol	_	0	SENT_410	[p26l892t2498r1038b2542],
4	2004	CD	DATE	2004	num	3	SENT_410	[p26l9t2573r430b2623],
5	;	:	O	;	_	0	SENT_410	[p26l9t2573r430b2623],
6	22:3238	CD	NUMBER	22:3238	number	7	SENT_410	[p26l9t2573r430b2623],
7	—	CD	NUMBER	—	dep	3	SENT_410	[p26l9t2573r430b2623],
8	47	CD	NUMBER	47	dep	7	SENT_410	[p26l9t2573r430b2623],
9	.	.	O	.	_	0	SENT_410	[p26l9t2573r430b2623],

1	13	CD	NUMBER	13	_	0	SENT_411	[p26l11t2645r74b2684],
2	.	.	O	.	_	0	SENT_411	[p26l11t2645r74b2684],

1	Tu	NNP	O	Tu	nn	3	SENT_412	[p26l103t2643r164b2684],
2	D.	NNP	O	D.	nn	3	SENT_412	[p26l175t2643r224b2684],
3	Minimization	NNP	O	Minimization	_	0	SENT_412	[p26l237t2640r555b2684],
4	procedure	NN	O	procedure	dep	3	SENT_412	[p26l566t2640r814b2696],
5	.	.	O	.	_	0	SENT_412	[p26l566t2640r814b2696],

1	In	IN	O	in	dep	4	SENT_413	[p26l828t2644r890b2684],
2	:	:	O	:	_	0	SENT_413	[p26l828t2644r890b2684],
3	Chow	NNP	ORGANIZATION	Chow	nn	4	SENT_413	[p26l904t2640r1041b2684],
4	SC	NNP	ORGANIZATION	SC	_	0	SENT_413	[p26l10t2714r87b2764],
5	,	,	O	,	_	0	SENT_413	[p26l10t2714r87b2764],
6	ed	VBD	O	ed	rcmod	4	SENT_413	[p26l113t2711r182b2755],
7	.	.	O	.	_	0	SENT_413	[p26l113t2711r182b2755],

1	Encyclopedia	NN	O	encyclopedia	_	0	SENT_414	[p26l207t2711r534b2767],
2	of	IN	O	of	_	0	SENT_414	[p26l556t2710r614b2755],
3	biopharmaceuti	NN	O	biopharmaceutus	npadvmod	5	SENT_414	[p26l625t2711r1037b2767],
4	—	CD	NUMBER	—	num	3	SENT_414	[p26l625t2711r1037b2767],
5	cal	JJ	O	cal	amod	6	SENT_414	[p26l9t2782r72b2826],
6	statistics	NNS	O	statistics	prep_of	1	SENT_414	[p26l83t2782r294b2826],
7	.	.	O	.	_	0	SENT_414	[p26l83t2782r294b2826],

1	New	NNP	LOCATION	New	nn	2	SENT_415	[p26l307t2786r416b2826],
2	York	NNP	LOCATION	York	_	0	SENT_415	[p26l422t2782r540b2826],
3	:	:	O	:	_	0	SENT_415	[p26l422t2782r540b2826],
4	Marcel	NNP	PERSON	Marcel	nn	5	SENT_415	[p26l551t2782r709b2826],
5	Dekker	NNP	PERSON	Dekker	dep	2	SENT_415	[p26l719t2782r896b2835],
6	,	,	O	,	_	0	SENT_415	[p26l719t2782r896b2835],
7	2003	CD	DATE	2003	appos	5	SENT_415	[p26l910t2785r1037b2826],
8	:	:	O	:	_	0	SENT_415	[p26l910t2785r1037b2826],
9	614	CD	NUMBER	614	dep	2	SENT_415	[p26l9t2856r156b2897],
10	—	CD	NUMBER	—	number	11	SENT_415	[p26l9t2856r156b2897],
11	8	CD	NUMBER	8	dep	9	SENT_415	[p26l9t2856r156b2897],
12	.	.	O	.	_	0	SENT_415	[p26l9t2856r156b2897],

1	14	CD	NUMBER	14	_	0	SENT_416	[p26l11t2929r74b2968],
2	.	.	O	.	_	0	SENT_416	[p26l11t2929r74b2968],

1	Therasse	NN	O	therasse	nn	2	SENT_417	[p26l103t2924r314b2968],
2	P	NN	O	p	_	0	SENT_417	[p26l331t2927r366b2977],
3	,	,	O	,	_	0	SENT_417	[p26l331t2927r366b2977],
4	Arbuck	NNP	O	Arbuck	nn	5	SENT_417	[p26l385t2924r560b2968],
5	SG	NNP	O	SG	appos	2	SENT_417	[p26l576t2927r657b2977],
6	,	,	O	,	_	0	SENT_417	[p26l576t2927r657b2977],
7	Eisenhauer	NNP	PERSON	Eisenhauer	nn	8	SENT_417	[p26l676t2924r941b2968],
8	EA	NN	PERSON	ea	appos	2	SENT_417	[p26l956t2928r1035b2977],
9	,	,	O	,	_	0	SENT_417	[p26l956t2928r1035b2977],
10	et	FW	O	et	nn	11	SENT_417	[p26l9t3004r51b3039],
11	al.	FW	O	al.	appos	2	SENT_417	[p26l60t2995r111b3039],
12	.	.	O	.	_	0	SENT_417	[p26l60t2995r111b3039],

1	New	NNP	O	New	nn	2	SENT_418	[p26l125t2999r233b3039],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_418	[p26l242t2995r481b3051],
3	to	TO	O	to	aux	4	SENT_418	[p26l494t3004r537b3039],
4	evaluate	VB	O	evaluate	_	0	SENT_418	[p26l550t2995r735b3039],
5	the	DT	O	the	det	6	SENT_418	[p26l747t2995r818b3039],
6	response	NN	O	response	dobj	4	SENT_418	[p26l829t3009r1038b3051],
7	to	TO	O	to	_	0	SENT_418	[p26l9t3075r53b3110],
8	treatment	NN	O	treatment	prep_to	4	SENT_418	[p26l73t3075r305b3110],
9	in	IN	O	in	_	0	SENT_418	[p26l321t3066r366b3109],
10	solid	JJ	O	solid	amod	11	SENT_418	[p26l386t3066r500b3110],
11	tumors	NNS	O	tumor	prep_in	8	SENT_418	[p26l519t3075r701b3110],
12	.	.	O	.	_	0	SENT_418	[p26l519t3075r701b3110],

1	J	NNP	O	J	nn	4	SENT_419	[p26l718t3070r739b3117],
2	Natl	NNP	O	Natl	nn	4	SENT_419	[p26l756t3066r856b3110],
3	Cancer	NNP	O	Cancer	nn	4	SENT_419	[p26l875t3069r1041b3110],
4	Inst	NNP	O	Inst	_	0	SENT_419	[p26l8t3141r101b3181],
5	2000	CD	DATE	2000	num	4	SENT_419	[p26l112t3140r500b3190],
6	;	:	O	;	_	0	SENT_419	[p26l112t3140r500b3190],
7	92:205	CD	NUMBER	92:205	number	8	SENT_419	[p26l112t3140r500b3190],
8	—	CD	NUMBER	—	dep	4	SENT_419	[p26l112t3140r500b3190],
9	16	CD	NUMBER	16	dep	8	SENT_419	[p26l112t3140r500b3190],
10	.	.	O	.	_	0	SENT_419	[p26l112t3140r500b3190],

1	15	CD	NUMBER	15	_	0	SENT_420	[p26l11t3213r74b3252],
2	.	.	O	.	_	0	SENT_420	[p26l11t3213r74b3252],

1	Osoba	NNP	PERSON	Osoba	nn	2	SENT_421	[p26l105t3208r258b3252],
2	D	NNP	O	D	_	0	SENT_421	[p26l274t3211r324b3261],
3	,	,	O	,	_	0	SENT_421	[p26l274t3211r324b3261],
4	Rodrigues	NNP	PERSON	Rodrigues	nn	5	SENT_421	[p26l345t3208r592b3264],
5	G	NNP	PERSON	G	appos	2	SENT_421	[p26l611t3211r664b3261],
6	,	,	O	,	_	0	SENT_421	[p26l611t3211r664b3261],
7	Myles	NNP	PERSON	Myles	nn	8	SENT_421	[p26l684t3208r822b3264],
8	J	NNP	PERSON	J	appos	2	SENT_421	[p26l835t3212r869b3261],
9	,	,	O	,	_	0	SENT_421	[p26l835t3212r869b3261],
10	Zee	NN	O	zee	nn	11	SENT_421	[p26l889t3212r972b3252],
11	B	NN	O	b	appos	2	SENT_421	[p26l989t3211r1035b3261],
12	,	,	O	,	_	0	SENT_421	[p26l989t3211r1035b3261],
13	Pater	NNP	O	Pater	nn	15	SENT_421	[p26l8t3282r133b3323],
14	J.	NNP	O	J.	nn	15	SENT_421	[p26l157t3283r191b3330],
15	Interpreting	NNP	O	Interpreting	appos	11	SENT_421	[p26l225t3279r526b3335],
16	the	DT	O	the	det	17	SENT_421	[p26l556t3279r630b3323],
17	significance	NN	O	significance	dep	2	SENT_421	[p26l663t3278r959b3335],
18	of	IN	O	of	_	0	SENT_421	[p26l991t3278r1048b3323],
19	changes	NNS	O	change	prep_of	17	SENT_421	[p26l9t3350r204b3406],
20	in	IN	O	in	_	0	SENT_421	[p26l246t3350r292b3393],
21	health	NN	O	health	nn	22	SENT_421	[p26l333t3350r669b3394],
22	—	NN	O	—	prep_in	19	SENT_421	[p26l333t3350r669b3394],
23	related	JJ	O	related	amod	25	SENT_421	[p26l333t3350r669b3394],
24	quality-of	JJ	O	quality-of	amod	25	SENT_421	[p26l710t3349r1038b3406],
25	—	NN	O	—	dep	2	SENT_421	[p26l710t3349r1038b3406],
26	life	NN	O	life	nn	27	SENT_421	[p26l710t3349r1038b3406],
27	scores	NNS	O	score	dep	25	SENT_421	[p26l10t3436r173b3466],
28	.	.	O	.	_	0	SENT_421	[p26l10t3436r173b3466],

1	J	NNP	O	J	nn	3	SENT_422	[p26l186t3426r207b3472],
2	Clin	NNP	O	Clin	nn	3	SENT_422	[p26l220t3422r317b3466],
3	Oncol	NNP	O	Oncol	_	0	SENT_422	[p26l331t3422r473b3466],
4	1998	CD	DATE	1998	num	3	SENT_422	[p26l489t3425r874b3475],
5	;	:	O	;	_	0	SENT_422	[p26l489t3425r874b3475],
6	16:139	CD	NUMBER	16:139	number	7	SENT_422	[p26l489t3425r874b3475],
7	—	CD	NUMBER	—	dep	3	SENT_422	[p26l489t3425r874b3475],
8	44	CD	NUMBER	44	dep	7	SENT_422	[p26l489t3425r874b3475],
9	.	.	O	.	_	0	SENT_422	[p26l489t3425r874b3475],

1	16	CD	NUMBER	16	_	0	SENT_423	[p26l11t3497r74b3536],
2	.	.	O	.	_	0	SENT_423	[p26l11t3497r74b3536],

1	Hochberg	NNP	PERSON	Hochberg	nn	3	SENT_424	[p26l104t3492r339b3548],
2	Y.	NNP	O	Y.	nn	3	SENT_424	[p26l348t3496r386b3536],
3	A	NNP	O	A	_	0	SENT_424	[p26l400t3496r436b3535],
4	sharper	JJR	O	sharper	amod	5	SENT_424	[p26l448t3492r625b3548],
5	Bonferroni	NNP	PERSON	Bonferroni	poss	7	SENT_424	[p26l636t3491r928b3536],
6	’s	POS	O	’s	_	0	SENT_424	[p26l636t3491r928b3536],
7	procedure	NN	O	procedure	dep	3	SENT_424	[p26l941t3506r1038b3548, p26l9t3563r166b3607],
8	for	IN	O	for	_	0	SENT_424	[p26l194t3562r264b3607],
9	multiple	JJ	O	multiple	amod	10	SENT_424	[p26l290t3563r492b3619],
10	tests	NNS	O	test	prep_for	7	SENT_424	[p26l520t3572r628b3607],
11	of	IN	O	of	_	0	SENT_424	[p26l657t3562r714b3607],
12	signiﬁcance	NN	O	signiﬁcance	prep_of	10	SENT_424	[p26l732t3562r1035b3619],
13	.	.	O	.	_	0	SENT_424	[p26l732t3562r1035b3619],

1	Biometrika	FW	O	biometrika	_	0	SENT_425	[p26l8t3635r275b3679],
2	1988	CD	DATE	1988	dep	1	SENT_425	[p26l289t3638r646b3688],
3	;	:	O	;	_	0	SENT_425	[p26l289t3638r646b3688],
4	75:800	CD	NUMBER	75:800	number	5	SENT_425	[p26l289t3638r646b3688],
5	—	CD	NUMBER	—	dep	1	SENT_425	[p26l289t3638r646b3688],
6	3	CD	NUMBER	3	dep	5	SENT_425	[p26l289t3638r646b3688],
7	.	.	O	.	_	0	SENT_425	[p26l289t3638r646b3688],

1	17	CD	NUMBER	17	_	0	SENT_426	[p26l11t3710r74b3749],
2	.	.	O	.	_	0	SENT_426	[p26l11t3710r74b3749],

1	Pfister	NNP	O	Pfister	nn	2	SENT_427	[p26l104t3704r257b3749],
2	DG	NNS	O	dg	_	0	SENT_427	[p26l270t3708r366b3758],
3	,	,	O	,	_	0	SENT_427	[p26l270t3708r366b3758],
4	Johnson	NNP	PERSON	Johnson	nn	5	SENT_427	[p26l380t3705r586b3756],
5	DH	NNP	O	DH	appos	2	SENT_427	[p26l602t3708r698b3758],
6	,	,	O	,	_	0	SENT_427	[p26l602t3708r698b3758],
7	Azzoli	NNP	PERSON	Azzoli	nn	8	SENT_427	[p26l716t3705r871b3749],
8	CG	NNP	O	CG	appos	2	SENT_427	[p26l886t3708r977b3758],
9	,	,	O	,	_	0	SENT_427	[p26l886t3708r977b3758],
10	et	FW	O	et	nn	11	SENT_427	[p26l997t3714r1041b3749],
11	al.	FW	O	al.	appos	2	SENT_427	[p26l8t3776r62b3820],
12	.	.	O	.	_	0	SENT_427	[p26l8t3776r62b3820],

1	American	NNP	ORGANIZATION	American	nn	2	SENT_428	[p26l86t3776r320b3820],
2	Society	NNP	ORGANIZATION	Society	_	0	SENT_428	[p26l344t3776r514b3832],
3	of	IN	ORGANIZATION	of	_	0	SENT_428	[p26l534t3775r591b3820],
4	Clinical	JJ	ORGANIZATION	clinical	amod	7	SENT_428	[p26l602t3776r786b3820],
5	Oncology	NN	ORGANIZATION	oncology	nn	7	SENT_428	[p26l808t3776r1041b3832],
6	clinical	JJ	O	clinical	amod	7	SENT_428	[p26l1113t2071r1281b2115],
7	response	NN	O	response	prep_of	2	SENT_428	[p26l1308t2085r1519b2127],
8	to	TO	O	to	_	0	SENT_428	[p26l1546t2080r1591b2115],
9	gefitinib	NN	O	gefitinib	nn	10	SENT_428	[p26l1618t2070r1816b2127],
10	therapy	NN	O	therapy	prep_to	2	SENT_428	[p26l1844t2071r2026b2127],
11	.	.	O	.	_	0	SENT_428	[p26l1844t2071r2026b2127],

1	Science	NNP	O	Science	_	0	SENT_429	[p26l2057t2071r2142b2115, p26l1113t2156r1219b2186],
2	2004	CD	DATE	2004	num	1	SENT_429	[p26l1233t2145r1709b2195],
3	;	:	O	;	_	0	SENT_429	[p26l1233t2145r1709b2195],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_429	[p26l1233t2145r1709b2195],
5	—	CD	NUMBER	—	dep	1	SENT_429	[p26l1233t2145r1709b2195],
6	500	CD	NUMBER	500	dep	5	SENT_429	[p26l1233t2145r1709b2195],
7	.	.	O	.	_	0	SENT_429	[p26l1233t2145r1709b2195],

1	25	CD	NUMBER	25	_	0	SENT_430	[p26l1112t2219r1179b2258],
2	.	.	O	.	_	0	SENT_430	[p26l1112t2219r1179b2258],

1	Pao	NNP	O	Pao	nn	2	SENT_431	[p26l1208t2217r1292b2258],
2	W	NNP	O	W	_	0	SENT_431	[p26l1306t2218r1365b2267],
3	,	,	O	,	_	0	SENT_431	[p26l1306t2218r1365b2267],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_431	[p26l1382t2214r1524b2258],
5	V	NNP	O	V	appos	2	SENT_431	[p26l1536t2218r1576b2267],
6	,	,	O	,	_	0	SENT_431	[p26l1536t2218r1576b2267],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_431	[p26l1593t2214r1821b2258],
8	M	NNP	O	M	appos	2	SENT_431	[p26l1835t2218r1896b2267],
9	,	,	O	,	_	0	SENT_431	[p26l1835t2218r1896b2267],
10	et	FW	O	et	nn	11	SENT_431	[p26l1915t2223r1957b2258],
11	al.	FW	O	al.	appos	2	SENT_431	[p26l1970t2214r2023b2258],
12	.	.	O	.	_	0	SENT_431	[p26l1970t2214r2023b2258],

1	EGF	NN	ORGANIZATION	egf	nn	3	SENT_432	[p26l2041t2217r2142b2258],
2	receptor	NN	O	receptor	nn	3	SENT_432	[p26l1113t2294r1312b2341],
3	mutations	NNS	O	mutation	nsubjpass	16	SENT_432	[p26l1339t2285r1585b2329],
4	are	VBP	O	be	cop	5	SENT_432	[p26l1614t2299r1686b2329],
5	common	JJ	O	common	_	0	SENT_432	[p26l1715t2299r1931b2329],
6	in	IN	O	in	_	0	SENT_432	[p26l1960t2285r2005b2328],
7	lung	NN	O	lung	nn	8	SENT_432	[p26l2034t2285r2144b2341],
8	cancers	NNS	O	cancer	prep_in	5	SENT_432	[p26l1113t2370r1288b2400],
9	from	IN	O	from	_	0	SENT_432	[p26l1303t2355r1419b2400],
10	“	CD	NUMBER	“	prep_from	8	SENT_432	[p26l1434t2358r1585b2400],
11	never	RB	O	never	advmod	8	SENT_432	[p26l1434t2358r1585b2400],
12	smokers	NNS	O	smoker	dep	8	SENT_432	[p26l1598t2356r1822b2400],
13	”	CD	NUMBER	”	tmod	5	SENT_432	[p26l1598t2356r1822b2400],
14	and	CC	O	and	_	0	SENT_432	[p26l1838t2356r1925b2400],
15	are	VBP	O	be	auxpass	16	SENT_432	[p26l1938t2370r2008b2400],
16	associated	VBN	O	associate	conj_and	5	SENT_432	[p26l2021t2370r2143b2400, p26l1113t2427r1251b2471],
17	with	IN	O	with	_	0	SENT_432	[p26l1265t2427r1370b2471],
18	sensitivity	NN	O	sensitivity	prep_with	16	SENT_432	[p26l1387t2427r1622b2483],
19	of	IN	O	of	_	0	SENT_432	[p26l1635t2426r1692b2471],
20	tumors	NNS	O	tumor	prep_of	18	SENT_432	[p26l1698t2436r1866b2471],
21	to	TO	O	to	_	0	SENT_432	[p26l1883t2436r1928b2471],
22	geﬁtinib	NN	O	geﬁtinib	prep_to	16	SENT_432	[p26l1944t2426r2143b2483],
23	and	CC	O	and	_	0	SENT_432	[p26l1112t2498r1200b2542],
24	erlotinib	NN	O	erlotinib	prep_to	16	SENT_432	[p26l1212t2498r1426b2542],
25	.	.	O	.	_	0	SENT_432	[p26l1212t2498r1426b2542],

1	Proc	NNP	O	Proc	nn	7	SENT_433	[p26l1441t2501r1546b2542],
2	Natl	NNP	O	Natl	nn	7	SENT_433	[p26l1557t2498r1657b2542],
3	Acad	NNP	O	Acad	nn	7	SENT_433	[p26l1667t2498r1785b2542],
4	Sci	NNP	O	Sci	nn	7	SENT_433	[p26l1798t2498r1865b2542],
5	U	NNP	O	U	nn	7	SENT_433	[p26l1876t2502r1915b2542],
6	S	NNP	O	S	nn	7	SENT_433	[p26l1928t2501r1952b2542],
7	A	NNP	O	A	_	0	SENT_433	[p26l1964t2502r2000b2541],
8	2004	CD	DATE	2004	num	7	SENT_433	[p26l2011t2501r2141b2551],
9	;	:	O	;	_	0	SENT_433	[p26l2011t2501r2141b2551],
10	101:13306	CD	NUMBER	101:13306	number	11	SENT_433	[p26l1115t2573r1455b2614],
11	—	CD	NUMBER	—	dep	7	SENT_433	[p26l1115t2573r1455b2614],
12	11	CD	NUMBER	11	dep	11	SENT_433	[p26l1115t2573r1455b2614],
13	.	.	O	.	_	0	SENT_433	[p26l1115t2573r1455b2614],

1	26	CD	NUMBER	26	_	0	SENT_434	[p26l1112t2645r1179b2684],
2	.	.	O	.	_	0	SENT_434	[p26l1112t2645r1179b2684],

1	Huang	NNP	PERSON	Huang	nsubj	2	SENT_435	[p26l1209t2644r1371b2696],
2	S	NN	O	s	_	0	SENT_435	[p26l1389t2643r1471b2693],
3	.	.	O	.	_	0	SENT_435	[p26l1389t2643r1471b2693],

1	—	NN	O	—	_	0	SENT_436	[p26l1389t2643r1471b2693],
2	.	.	O	.	_	0	SENT_436	[p26l1389t2643r1471b2693],

1	F	NN	O	f	_	0	SENT_437	[p26l1389t2643r1471b2693],
2	,	,	O	,	_	0	SENT_437	[p26l1389t2643r1471b2693],
3	Liu	NNP	PERSON	Liu	nn	4	SENT_437	[p26l1492t2640r1566b2684],
4	H	NNP	O	H	appos	1	SENT_437	[p26l1585t2643r1682b2693],
5	.	.	O	.	_	0	SENT_437	[p26l1585t2643r1682b2693],

1	—	NN	O	—	_	0	SENT_438	[p26l1585t2643r1682b2693],
2	.	.	O	.	_	0	SENT_438	[p26l1585t2643r1682b2693],

1	P	NN	O	p	_	0	SENT_439	[p26l1585t2643r1682b2693],
2	,	,	O	,	_	0	SENT_439	[p26l1585t2643r1682b2693],
3	Li	NNP	PERSON	Li	nn	4	SENT_439	[p26l1704t2640r1747b2683],
4	L	NNP	PERSON	L	appos	1	SENT_439	[p26l1765t2644r1868b2693],
5	.	.	O	.	_	0	SENT_439	[p26l1765t2644r1868b2693],

1	—	NN	O	—	_	0	SENT_440	[p26l1765t2644r1868b2693],
2	.	.	O	.	_	0	SENT_440	[p26l1765t2644r1868b2693],

1	H	NN	O	h	_	0	SENT_441	[p26l1765t2644r1868b2693],
2	,	,	O	,	_	0	SENT_441	[p26l1765t2644r1868b2693],
3	et	FW	O	et	nn	4	SENT_441	[p26l1891t2649r1934b2684],
4	al.	FW	O	al.	appos	1	SENT_441	[p26l1949t2640r2002b2684],
5	.	.	O	.	_	0	SENT_441	[p26l1949t2640r2002b2684],

1	High	JJ	O	high	amod	2	SENT_442	[p26l2024t2640r2143b2696],
2	frequency	NN	O	frequency	nsubj	17	SENT_442	[p26l1113t2710r1346b2767],
3	of	IN	O	of	_	0	SENT_442	[p26l1357t2710r1413b2755],
4	epidermal	JJ	O	epidermal	amod	8	SENT_442	[p26l1416t2711r1654b2767],
5	growth	NN	O	growth	nn	8	SENT_442	[p26l1666t2711r1836b2767],
6	factor	NN	O	factor	nn	8	SENT_442	[p26l1849t2710r1986b2755],
7	receptor	NN	O	receptor	nn	8	SENT_442	[p26l1998t2725r2143b2767, p26l1113t2791r1180b2826],
8	mutations	NNS	O	mutation	prep_of	2	SENT_442	[p26l1190t2782r1431b2826],
9	with	IN	O	with	_	0	SENT_442	[p26l1441t2782r1547b2826],
10	complex	JJ	O	complex	amod	11	SENT_442	[p26l1559t2782r1760b2838],
11	patterns	NNS	O	pattern	prep_with	8	SENT_442	[p26l1770t2791r1962b2838],
12	in	IN	O	in	_	0	SENT_442	[p26l1975t2782r2020b2825],
13	nonsmall	JJ	O	nonsmall	amod	16	SENT_442	[p26l2032t2796r2142b2826, p26l1114t2853r1241b2897],
14	cell	NN	O	cell	nn	16	SENT_442	[p26l1264t2853r1343b2897],
15	lung	NN	O	lung	nn	16	SENT_442	[p26l1365t2853r1473b2909],
16	cancers	NNS	O	cancer	prep_in	11	SENT_442	[p26l1495t2867r1670b2897],
17	related	VBN	O	relate	_	0	SENT_442	[p26l1694t2853r1854b2897],
18	to	TO	O	to	_	0	SENT_442	[p26l1876t2862r1921b2897],
19	geﬁtinib	NN	O	geﬁtinib	nn	20	SENT_442	[p26l1944t2852r2142b2909],
20	responsiveness	NN	O	responsiveness	prep_to	17	SENT_442	[p26l1113t2924r1469b2980],
21	in	IN	O	in	_	0	SENT_442	[p26l1490t2924r1535b2967],
22	Taiwan	NNP	LOCATION	Taiwan	prep_in	20	SENT_442	[p26l1553t2924r1736b2968],
23	.	.	O	.	_	0	SENT_442	[p26l1553t2924r1736b2968],

1	Clin	NNP	O	Clin	nn	3	SENT_443	[p26l1759t2924r1856b2968],
2	Cancer	NNP	O	Cancer	nn	3	SENT_443	[p26l1875t2927r2041b2968],
3	Res	NNP	O	Res	_	0	SENT_443	[p26l2058t2927r2142b2971],
4	2004	CD	DATE	2004	num	3	SENT_443	[p26l1113t2998r1560b3048],
5	;	:	O	;	_	0	SENT_443	[p26l1113t2998r1560b3048],
6	10:8195	CD	NUMBER	10:8195	num	7	SENT_443	[p26l1113t2998r1560b3048],
7	—	NN	O	—	dep	3	SENT_443	[p26l1113t2998r1560b3048],
8	203	CD	NUMBER	203	dep	7	SENT_443	[p26l1113t2998r1560b3048],
9	.	.	O	.	_	0	SENT_443	[p26l1113t2998r1560b3048],

1	27	CD	NUMBER	27	_	0	SENT_444	[p26l1112t3071r1179b3110],
2	.	.	O	.	_	0	SENT_444	[p26l1112t3071r1179b3110],

1	Han	NNP	O	Han	nsubj	2	SENT_445	[p26l1209t3070r1308b3110],
2	S	NN	O	s	_	0	SENT_445	[p26l1322t3069r1422b3119],
3	.	.	O	.	_	0	SENT_445	[p26l1322t3069r1422b3119],

1	—	NN	O	—	_	0	SENT_446	[p26l1322t3069r1422b3119],
2	.	.	O	.	_	0	SENT_446	[p26l1322t3069r1422b3119],

1	VV	NN	O	vv	_	0	SENT_447	[p26l1322t3069r1422b3119],
2	,	,	O	,	_	0	SENT_447	[p26l1322t3069r1422b3119],
3	Kim	NNP	PERSON	Kim	nn	4	SENT_447	[p26l1439t3066r1537b3111],
4	T-Y	NNP	O	T-Y	appos	1	SENT_447	[p26l1549t3069r1633b3119],
5	,	,	O	,	_	0	SENT_447	[p26l1549t3069r1633b3119],
6	Hwang	NNP	PERSON	Hwang	nn	7	SENT_447	[p26l1650t3070r1820b3122],
7	PG	NNP	O	PG	appos	1	SENT_447	[p26l1831t3069r1913b3119],
8	,	,	O	,	_	0	SENT_447	[p26l1831t3069r1913b3119],
9	et	FW	O	et	nn	10	SENT_447	[p26l1930t3075r1973b3110],
10	al.	FW	O	al.	appos	1	SENT_447	[p26l1983t3066r2035b3110],
11	.	.	O	.	_	0	SENT_447	[p26l1983t3066r2035b3110],

1	Predictive	JJ	O	predictive	amod	4	SENT_448	[p26l2051t3069r2143b3110, p26l1113t3137r1261b3181],
2	and	CC	O	and	_	0	SENT_448	[p26l1272t3137r1358b3181],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_448	[p26l1369t3137r1636b3193],
4	impact	NN	O	impact	nsubj	18	SENT_448	[p26l1650t3137r1821b3193],
5	of	IN	O	of	_	0	SENT_448	[p26l1833t3136r1890b3181],
6	epidermal	JJ	O	epidermal	amod	10	SENT_448	[p26l1895t3137r2142b3193],
7	growth	NN	O	growth	nn	10	SENT_448	[p26l1113t3208r1286b3264],
8	factor	NN	O	factor	nn	10	SENT_448	[p26l1313t3207r1455b3252],
9	receptor	NN	O	receptor	nn	10	SENT_448	[p26l1479t3217r1682b3264],
10	mutation	NN	O	mutation	prep_of	4	SENT_448	[p26l1706t3208r1930b3252],
11	in	IN	O	in	_	0	SENT_448	[p26l1955t3208r2002b3251],
12	nonsmall	JJ	O	nonsmall	amod	17	SENT_448	[p26l2028t3222r2141b3252, p26l1114t3279r1347b3323],
13	—	NN	O	—	nn	17	SENT_448	[p26l2028t3222r2141b3252, p26l1114t3279r1347b3323],
14	cell	NN	O	cell	nn	17	SENT_448	[p26l2028t3222r2141b3252, p26l1114t3279r1347b3323],
15	lung	NN	O	lung	nn	17	SENT_448	[p26l1361t3279r1471b3335],
16	cancer	NN	O	cancer	nn	17	SENT_448	[p26l1483t3293r1640b3323],
17	patients	NNS	O	patient	prep_in	10	SENT_448	[p26l1652t3279r1843b3335],
18	treated	VBN	O	treat	_	0	SENT_448	[p26l1858t3279r2023b3323],
19	with	IN	O	with	_	0	SENT_448	[p26l2035t3279r2142b3323],
20	geﬁtinib	NN	O	geﬁtinib	prep_with	18	SENT_448	[p26l1113t3349r1330b3406],
21	.	.	O	.	_	0	SENT_448	[p26l1113t3349r1330b3406],

1	J	NNP	O	J	nn	3	SENT_449	[p26l1342t3354r1364b3401],
2	Clin	NNP	O	Clin	nn	3	SENT_449	[p26l1377t3350r1476b3394],
3	Oncol	NNP	O	Oncol	_	0	SENT_449	[p26l1491t3350r1636b3394],
4	2005	CD	DATE	2005	num	3	SENT_449	[p26l1651t3353r2104b3403],
5	;	:	O	;	_	0	SENT_449	[p26l1651t3353r2104b3403],
6	23:2493	CD	NUMBER	23:2493	num	7	SENT_449	[p26l1651t3353r2104b3403],
7	—	NN	O	—	dep	3	SENT_449	[p26l1651t3353r2104b3403],
8	501	CD	NUMBER	501	dep	7	SENT_449	[p26l1651t3353r2104b3403],
9	.	.	O	.	_	0	SENT_449	[p26l1651t3353r2104b3403],

1	28	CD	NUMBER	28	_	0	SENT_450	[p26l1112t3426r1179b3466],
2	.	.	O	.	_	0	SENT_450	[p26l1112t3426r1179b3466],

1	Tsao	NNP	PERSON	Tsao	nsubj	2	SENT_451	[p26l1207t3425r1318b3466],
2	M	NN	O	m	_	0	SENT_451	[p26l1339t3425r1448b3475],
3	.	.	O	.	_	0	SENT_451	[p26l1339t3425r1448b3475],

1	—	NN	O	—	_	0	SENT_452	[p26l1339t3425r1448b3475],
2	.	.	O	.	_	0	SENT_452	[p26l1339t3425r1448b3475],

1	S	NN	O	s	_	0	SENT_453	[p26l1339t3425r1448b3475],
2	,	,	O	,	_	0	SENT_453	[p26l1339t3425r1448b3475],
3	Sakurada	NNP	ORGANIZATION	Sakurada	nn	4	SENT_453	[p26l1475t3422r1692b3466],
4	A	NNP	ORGANIZATION	A	appos	1	SENT_453	[p26l1712t3426r1760b3475],
5	,	,	O	,	_	0	SENT_453	[p26l1712t3426r1760b3475],
6	Cutz	NNP	O	Cutz	nn	7	SENT_453	[p26l1786t3425r1894b3466],
7	J	NNP	O	J	appos	4	SENT_453	[p26l1911t3425r1999b3475],
8	.	.	O	.	_	0	SENT_453	[p26l1911t3425r1999b3475],

1	—	NN	O	—	_	0	SENT_454	[p26l1911t3425r1999b3475],
2	.	.	O	.	_	0	SENT_454	[p26l1911t3425r1999b3475],

1	C	NN	O	c	_	0	SENT_455	[p26l1911t3425r1999b3475],
2	,	,	O	,	_	0	SENT_455	[p26l1911t3425r1999b3475],
3	et	FW	O	et	nn	4	SENT_455	[p26l2025t3431r2068b3466],
4	al.	FW	O	al.	appos	1	SENT_455	[p26l2087t3422r2140b3466],
5	.	.	O	.	_	0	SENT_455	[p26l2087t3422r2140b3466],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_456	[p26l1112t3492r1320b3536],
2	in	IN	O	in	_	0	SENT_456	[p26l1344t3492r1389b3535],
3	lung	NN	O	lung	nn	4	SENT_456	[p26l1412t3492r1520b3548],
4	cancer	NN	O	cancer	prep_in	1	SENT_456	[p26l1542t3506r1696b3536],
5	—	CD	NUMBER	—	number	6	SENT_456	[p26l1716t3517r1776b3521],
6	molecular	JJ	O	molecular	dep	1	SENT_456	[p26l1797t3492r2035b3536],
7	and	CC	O	and	_	0	SENT_456	[p26l2056t3492r2143b3536],
8	clinical	JJ	O	clinical	amod	9	SENT_456	[p26l1113t3563r1281b3607],
9	predictors	NNS	O	predictor	dep	1	SENT_456	[p26l1293t3563r1532b3619],
10	of	IN	O	of	_	0	SENT_456	[p26l1547t3562r1603b3607],
11	outcome	NN	O	outcome	prep_of	6	SENT_456	[p26l1606t3572r1825b3607],
12	.	.	O	.	_	0	SENT_456	[p26l1606t3572r1825b3607],

1	N	NN	O	n	nn	3	SENT_457	[p26l1839t3567r1881b3607],
2	Engll	NNP	O	Engll	nn	3	SENT_457	[p26l1893t3563r2029b3619],
3	Med	NNP	O	Med	_	0	SENT_457	[p26l2039t3563r2143b3607],
4	2005	CD	DATE	2005	num	3	SENT_457	[p26l1113t3638r1530b3688],
5	;	:	O	;	_	0	SENT_457	[p26l1113t3638r1530b3688],
6	353:133	CD	NUMBER	353:133	number	7	SENT_457	[p26l1113t3638r1530b3688],
7	—	CD	NUMBER	—	dep	3	SENT_457	[p26l1113t3638r1530b3688],
8	44	CD	NUMBER	44	dep	7	SENT_457	[p26l1113t3638r1530b3688],
9	.	.	O	.	_	0	SENT_457	[p26l1113t3638r1530b3688],

1	29	CD	NUMBER	29	_	0	SENT_458	[p26l1112t3710r1179b3749],
2	.	.	O	.	_	0	SENT_458	[p26l1112t3710r1179b3749],

1	Thatcher	NNP	PERSON	Thatcher	nn	2	SENT_459	[p26l1207t3705r1421b3749],
2	N	NNP	O	N	dep	17	SENT_459	[p26l1431t3709r1483b3758],
3	,	,	O	,	_	0	SENT_459	[p26l1431t3709r1483b3758],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_459	[p26l1499t3705r1655b3761],
5	A	NNP	O	A	appos	2	SENT_459	[p26l1664t3709r1712b3758],
6	,	,	O	,	_	0	SENT_459	[p26l1664t3709r1712b3758],
7	Parikh	NNP	ORGANIZATION	Parikh	nn	8	SENT_459	[p26l1728t3705r1880b3749],
8	P	NN	ORGANIZATION	p	appos	2	SENT_459	[p26l1893t3708r1928b3758],
9	,	,	O	,	_	0	SENT_459	[p26l1893t3708r1928b3758],
10	Pember	NNP	PERSON	Pember	appos	2	SENT_459	[p26l1943t3705r2142b3749],
11	—	CD	NUMBER	—	num	13	SENT_459	[p26l1943t3705r2142b3749],
12	ton	NN	O	ton	nn	13	SENT_459	[p26l1113t3785r1190b3820],
13	K	NN	O	k	dep	10	SENT_459	[p26l1210t3780r1259b3829],
14	,	,	O	,	_	0	SENT_459	[p26l1210t3780r1259b3829],
15	Archer	NNP	PERSON	Archer	appos	2	SENT_459	[p26l1280t3776r1442b3820],
16	V.	NNP	PERSON	V.	dep	17	SENT_459	[p26l1458t3780r1497b3820],
17	Results	NNS	PERSON	result	dep	22	SENT_459	[p26l1520t3776r1692b3822],
18	of	IN	O	of	_	0	SENT_459	[p26l1714t3775r1770b3820],
19	a	DT	O	a	det	20	SENT_459	[p26l1779t3790r1805b3820],
20	Phase	NN	O	phase	prep_of	17	SENT_459	[p26l1823t3776r1959b3820],
21	III	CD	NUMBER	iii	num	22	SENT_459	[p26l1979t3780r2033b3819],
22	platreatment	NN	O	platreatment	_	0	SENT_459	[p26l2052t3776r2142b3832, p27l9t30r247b65],

1	of	IN	O	of	_	0	SENT_460	[p27l273t20r330b65],
2	unresectable	JJ	O	unresectable	amod	4	SENT_460	[p27l347t21r655b65],
3	non	JJ	O	non	amod	4	SENT_460	[p27l683t21r1038b65],
4	—	NN	O	—	prep_of	12	SENT_460	[p27l683t21r1038b65],
5	small	JJ	O	small	amod	10	SENT_460	[p27l683t21r1038b65],
6	—	NN	O	—	nn	10	SENT_460	[p27l683t21r1038b65],
7	cell	NN	O	cell	nn	10	SENT_460	[p27l683t21r1038b65],
8	lung	NN	O	lung	nn	10	SENT_460	[p27l8t92r118b148],
9	cancer	NN	O	cancer	nn	10	SENT_460	[p27l139t106r295b136],
10	guideline	NN	O	guideline	dep	4	SENT_460	[p27l315t92r549b148],
11	:	:	O	:	_	0	SENT_460	[p27l315t92r549b148],
12	update	VB	O	update	_	0	SENT_460	[p27l572t92r732b148],
13	2003	CD	DATE	2003	dobj	12	SENT_460	[p27l753t95r882b136],
14	.	.	O	.	_	0	SENT_460	[p27l753t95r882b136],

1	J	NNP	O	J	nn	3	SENT_461	[p27l901t96r922b143],
2	Clin	NNP	O	Clin	nn	3	SENT_461	[p27l942t92r1039b136],
3	Oncol	NNP	O	Oncol	_	0	SENT_461	[p27l9t163r150b207],
4	2004	CD	DATE	2004	num	3	SENT_461	[p27l164t166r552b216],
5	;	:	O	;	_	0	SENT_461	[p27l164t166r552b216],
6	22:330	CD	NUMBER	22:330	number	7	SENT_461	[p27l164t166r552b216],
7	—	CD	NUMBER	—	dep	3	SENT_461	[p27l164t166r552b216],
8	53	CD	NUMBER	53	dep	7	SENT_461	[p27l164t166r552b216],
9	.	.	O	.	_	0	SENT_461	[p27l164t166r552b216],

1	18	CD	NUMBER	18	_	0	SENT_462	[p27l11t238r74b278],
2	.	.	O	.	_	0	SENT_462	[p27l11t238r74b278],

1	Salomon	NNP	O	Salomon	_	0	SENT_463	[p27l106t234r311b278],
2	DS	NN	O	d	dep	1	SENT_463	[p27l322t237r401b287],
3	,	,	O	,	_	0	SENT_463	[p27l322t237r401b287],
4	Brandt	NNP	PERSON	Brandt	nn	5	SENT_463	[p27l416t234r575b278],
5	R	NNP	PERSON	R	dep	1	SENT_463	[p27l584t237r631b287],
6	,	,	O	,	_	0	SENT_463	[p27l584t237r631b287],
7	Ciardiello	NNP	PERSON	Ciardiello	nn	8	SENT_463	[p27l646t234r869b278],
8	F	NN	O	f	conj_and	2	SENT_463	[p27l882t238r915b287],
9	,	,	O	,	_	0	SENT_463	[p27l882t238r915b287],
10	Normanno	NNP	O	Normanno	nn	14	SENT_463	[p27l930t238r1038b278, p27l9t319r172b349],
11	N.	NNP	O	N.	nn	14	SENT_463	[p27l192t309r244b349],
12	Epidermal	NNP	O	Epidermal	nn	14	SENT_463	[p27l266t305r512b361],
13	growth	NN	O	growth	nn	14	SENT_463	[p27l531t305r701b361],
14	factor	NN	O	factor	conj_and	2	SENT_463	[p27l721t304r1039b349],
15	—	CD	NUMBER	—	num	17	SENT_463	[p27l721t304r1039b349],
16	related	JJ	O	related	amod	17	SENT_463	[p27l721t304r1039b349],
17	peptides	NNS	O	peptide	dep	14	SENT_463	[p27l8t376r204b432],
18	and	CC	O	and	_	0	SENT_463	[p27l216t376r302b420],
19	their	PRP$	O	they	poss	20	SENT_463	[p27l313t376r422b420],
20	receptors	NNS	O	receptor	dep	1	SENT_463	[p27l431t385r645b432],
21	in	IN	O	in	_	0	SENT_463	[p27l657t376r701b419],
22	human	JJ	O	human	amod	23	SENT_463	[p27l712t376r878b420],
23	malignancies	NNS	O	malignancy	prep_in	1	SENT_463	[p27l889t376r1038b432, p27l9t448r199b492],
24	.	.	O	.	_	0	SENT_463	[p27l889t376r1038b432, p27l9t448r199b492],

1	Crit	NNP	O	Crit	nn	4	SENT_464	[p27l225t448r315b492],
2	Rev	NN	O	rev	nn	4	SENT_464	[p27l333t451r420b494],
3	Oncol	NNP	O	Oncol	nn	4	SENT_464	[p27l440t448r582b492],
4	Hematol	NNP	O	Hematol	_	0	SENT_464	[p27l604t448r809b492],
5	1995	CD	DATE	1995	num	4	SENT_464	[p27l833t451r1036b501],
6	;	:	O	;	_	0	SENT_464	[p27l833t451r1036b501],
7	19	CD	NUMBER	19	num	9	SENT_464	[p27l833t451r1036b501],
8	:	:	O	:	_	0	SENT_464	[p27l833t451r1036b501],
9	183-232	CD	NUMBER	183-232	dep	4	SENT_464	[p27l11t521r216b562],
10	.	.	O	.	_	0	SENT_464	[p27l11t521r216b562],

1	19	CD	NUMBER	19	_	0	SENT_465	[p27l11t595r74b634],
2	.	.	O	.	_	0	SENT_465	[p27l11t595r74b634],

1	Fontanini	NNP	O	Fontanini	nn	2	SENT_466	[p27l104t590r335b634],
2	G	NNP	O	G	_	0	SENT_466	[p27l347t593r400b643],
3	,	,	O	,	_	0	SENT_466	[p27l347t593r400b643],
4	De	NNP	PERSON	De	nn	6	SENT_466	[p27l415t593r479b634],
5	Laurentiis	NNP	PERSON	Laurentiis	nn	6	SENT_466	[p27l491t590r726b634],
6	M	NN	PERSON	m	appos	2	SENT_466	[p27l739t594r799b643],
7	,	,	O	,	_	0	SENT_466	[p27l739t594r799b643],
8	Vignati	NNP	PERSON	Vignati	nn	9	SENT_466	[p27l813t590r984b646],
9	S	NNP	O	S	appos	2	SENT_466	[p27l997t593r1036b643],
10	,	,	O	,	_	0	SENT_466	[p27l997t593r1036b643],
11	et	FW	O	et	nn	12	SENT_466	[p27l9t670r52b705],
12	al.	FW	O	al.	appos	2	SENT_466	[p27l69t661r122b705],
13	.	.	O	.	_	0	SENT_466	[p27l69t661r122b705],

1	Evaluation	NN	O	evaluation	nsubj	18	SENT_467	[p27l146t661r400b705],
2	of	IN	O	of	_	0	SENT_467	[p27l422t660r479b705],
3	epidermal	JJ	O	epidermal	amod	5	SENT_467	[p27l491t661r734b717],
4	growth	NN	O	growth	nn	5	SENT_467	[p27l756t661r928b717],
5	factor	NN	O	factor	prep_of	1	SENT_467	[p27l950t660r1038b705, p27l9t742r92b777],
6	—	CD	NUMBER	—	num	9	SENT_467	[p27l950t660r1038b705, p27l9t742r92b777],
7	related	JJ	O	related	amod	9	SENT_467	[p27l106t733r262b777],
8	growth	NN	O	growth	nn	9	SENT_467	[p27l276t733r442b789],
9	factors	NNS	O	factor	dep	5	SENT_467	[p27l456t732r612b777],
10	and	CC	O	and	_	0	SENT_467	[p27l626t733r712b777],
11	receptors	NNS	O	receptor	dep	5	SENT_467	[p27l725t742r939b789],
12	and	CC	O	and	_	0	SENT_467	[p27l953t733r1039b777],
13	of	IN	O	of	dep	15	SENT_467	[p27l9t803r66b848],
14	neoangiogenesis	NN	O	neoangiogenesis	pobj	13	SENT_467	[p27l71t804r481b860],
15	in	IN	O	in	dep	5	SENT_467	[p27l497t804r543b847],
16	completely	RB	O	completely	advmod	17	SENT_467	[p27l559t804r826b860],
17	resected	JJ	O	resected	pobj	15	SENT_467	[p27l839t804r1038b848],
18	stage	NN	O	stage	_	0	SENT_467	[p27l9t884r134b931],
19	I	PRP	O	I	dobj	18	SENT_467	[p27l169t879r301b918],
20	.	.	O	.	_	0	SENT_467	[p27l169t879r301b918],

1	—	NN	O	—	_	0	SENT_468	[p27l169t879r301b918],
2	.	.	O	.	_	0	SENT_468	[p27l169t879r301b918],

1	IIIA	NNP	ORGANIZATION	IIIA	nn	3	SENT_469	[p27l169t879r301b918],
2	non	JJ	O	non	amod	3	SENT_469	[p27l335t875r686b919],
3	—	NN	O	—	_	0	SENT_469	[p27l335t875r686b919],
4	small	JJ	O	small	amod	8	SENT_469	[p27l335t875r686b919],
5	—	NN	O	—	nn	8	SENT_469	[p27l335t875r686b919],
6	cell	NN	O	cell	nn	8	SENT_469	[p27l335t875r686b919],
7	lung	NN	O	lung	nn	8	SENT_469	[p27l721t875r832b931],
8	cancer	NN	O	cancer	dep	3	SENT_469	[p27l866t889r1036b919],
9	:	:	O	:	_	0	SENT_469	[p27l866t889r1036b919],
10	amphiregulin	NN	O	amphiregulin	nn	13	SENT_469	[p27l8t946r337b1002],
11	and	CC	O	and	_	0	SENT_469	[p27l368t946r456b990],
12	microvessel	NN	O	microvessel	conj_and	10	SENT_469	[p27l487t946r770b990],
13	count	NN	O	count	dep	3	SENT_469	[p27l801t955r939b990],
14	are	VBP	O	be	cop	17	SENT_469	[p27l966t960r1038b990],
15	independent	JJ	O	independent	amod	17	SENT_469	[p27l8t1017r312b1073],
16	prognostic	JJ	O	prognostic	amod	17	SENT_469	[p27l333t1017r590b1073],
17	indicators	NNS	O	indicator	rcmod	13	SENT_469	[p27l614t1017r849b1061],
18	of	IN	O	of	_	0	SENT_469	[p27l876t1016r932b1061],
19	sur	NN	O	sur	nn	21	SENT_469	[p27l947t1031r1038b1061],
20	—	CD	NUMBER	—	num	21	SENT_469	[p27l947t1031r1038b1061],
21	vival	NN	O	vival	prep_of	17	SENT_469	[p27l6t1088r124b1132],
22	.	.	O	.	_	0	SENT_469	[p27l6t1088r124b1132],

1	Clin	NNP	O	Clin	nn	3	SENT_470	[p27l141t1088r238b1132],
2	Cancer	NNP	O	Cancer	nn	3	SENT_470	[p27l252t1091r417b1132],
3	Res	NNP	O	Res	_	0	SENT_470	[p27l429t1091r512b1135],
4	1998	CD	DATE	1998	num	3	SENT_470	[p27l529t1091r856b1141],
5	;	:	O	;	_	0	SENT_470	[p27l529t1091r856b1141],
6	4:241	CD	NUMBER	4:241	number	7	SENT_470	[p27l529t1091r856b1141],
7	—	CD	NUMBER	—	dep	3	SENT_470	[p27l529t1091r856b1141],
8	9	CD	NUMBER	9	dep	7	SENT_470	[p27l529t1091r856b1141],
9	.	.	O	.	_	0	SENT_470	[p27l529t1091r856b1141],

1	20	CD	NUMBER	20	_	0	SENT_471	[p27l8t1163r74b1203],
2	.	.	O	.	_	0	SENT_471	[p27l8t1163r74b1203],

1	Grunwald	NNP	PERSON	Grunwald	nn	2	SENT_472	[p27l105t1159r348b1203],
2	V	NNP	PERSON	V	_	0	SENT_472	[p27l374t1163r414b1212],
3	,	,	O	,	_	0	SENT_472	[p27l374t1163r414b1212],
4	Hidalgo	NNP	PERSON	Hidalgo	nn	5	SENT_472	[p27l446t1159r641b1215],
5	M.	NNP	O	M.	appos	2	SENT_472	[p27l668t1163r730b1203],
6	Developing	VBG	O	develop	partmod	5	SENT_472	[p27l761t1159r1039b1215],
7	inhibitors	NNS	O	inhibitor	dobj	6	SENT_472	[p27l8t1230r245b1274],
8	of	IN	O	of	_	0	SENT_472	[p27l270t1229r327b1274],
9	the	DT	O	the	det	13	SENT_472	[p27l340t1230r414b1274],
10	epidermal	JJ	O	epidermal	amod	13	SENT_472	[p27l438t1230r680b1286],
11	growth	NN	O	growth	nn	13	SENT_472	[p27l703t1230r876b1286],
12	factor	NN	O	factor	nn	13	SENT_472	[p27l900t1229r1040b1274],
13	receptor	NN	O	receptor	prep_of	7	SENT_472	[p27l9t1310r207b1357],
14	for	IN	O	for	_	0	SENT_472	[p27l221t1300r289b1345],
15	cancer	NN	O	cancer	nn	16	SENT_472	[p27l304t1315r457b1345],
16	treatment	NN	O	treatment	prep_for	13	SENT_472	[p27l471t1310r713b1345],
17	.	.	O	.	_	0	SENT_472	[p27l471t1310r713b1345],

1	J	NNP	O	J	nn	4	SENT_473	[p27l726t1305r747b1352],
2	Natl	NNP	O	Natl	nn	4	SENT_473	[p27l760t1301r860b1345],
3	Cancer	NNP	O	Cancer	nn	4	SENT_473	[p27l875t1304r1040b1345],
4	Inst	NNP	O	Inst	_	0	SENT_473	[p27l8t1377r101b1417],
5	2003	CD	DATE	2003	num	4	SENT_473	[p27l112t1376r500b1426],
6	;	:	O	;	_	0	SENT_473	[p27l112t1376r500b1426],
7	95:851	CD	NUMBER	95:851	number	8	SENT_473	[p27l112t1376r500b1426],
8	—	CD	NUMBER	—	dep	4	SENT_473	[p27l112t1376r500b1426],
9	67	CD	NUMBER	67	dep	8	SENT_473	[p27l112t1376r500b1426],
10	.	.	O	.	_	0	SENT_473	[p27l112t1376r500b1426],

1	21	CD	NUMBER	21	_	0	SENT_474	[p27l8t1448r74b1487],
2	.	.	O	.	_	0	SENT_474	[p27l8t1448r74b1487],

1	Rusch	NNP	PERSON	Rusch	nn	2	SENT_475	[p27l104t1443r251b1489],
2	V	NNP	PERSON	V	_	0	SENT_475	[p27l266t1447r305b1496],
3	,	,	O	,	_	0	SENT_475	[p27l266t1447r305b1496],
4	Baselga	NNP	PERSON	Baselga	nn	5	SENT_475	[p27l325t1443r507b1499],
5	J	NNP	PERSON	J	appos	2	SENT_475	[p27l518t1447r551b1496],
6	,	,	O	,	_	0	SENT_475	[p27l518t1447r551b1496],
7	Cordon	NNP	O	Cordon	appos	5	SENT_475	[p27l571t1443r913b1487],
8	.	.	O	.	_	0	SENT_475	[p27l571t1443r913b1487],

1	—	NN	O	—	_	0	SENT_476	[p27l571t1443r913b1487],
2	.	.	O	.	_	0	SENT_476	[p27l571t1443r913b1487],

1	Cardo	NNP	ORGANIZATION	Cardo	nn	2	SENT_477	[p27l571t1443r913b1487],
2	C	NNP	O	C	_	0	SENT_477	[p27l931t1446r978b1496],
3	,	,	O	,	_	0	SENT_477	[p27l931t1446r978b1496],
4	et	FW	O	et	nn	5	SENT_477	[p27l999t1452r1041b1487],
5	al.	FW	O	al.	appos	2	SENT_477	[p27l8t1514r61b1558],
6	.	.	O	.	_	0	SENT_477	[p27l8t1514r61b1558],

1	Differential	JJ	O	differential	amod	2	SENT_478	[p27l82t1513r353b1558],
2	expression	NN	O	expression	_	0	SENT_478	[p27l372t1514r625b1570],
3	of	IN	O	of	_	0	SENT_478	[p27l645t1513r701b1558],
4	the	DT	O	the	det	8	SENT_478	[p27l710t1514r782b1558],
5	epidermal	JJ	O	epidermal	amod	8	SENT_478	[p27l802t1514r1039b1570],
6	growth	NN	O	growth	nn	8	SENT_478	[p27l9t1585r178b1641],
7	factor	NN	O	factor	nn	8	SENT_478	[p27l190t1584r328b1629],
8	receptor	NN	O	receptor	prep_of	2	SENT_478	[p27l339t1594r535b1641],
9	and	CC	O	and	_	0	SENT_478	[p27l546t1585r633b1629],
10	its	PRP$	O	its	poss	11	SENT_478	[p27l645t1585r699b1629],
11	ligands	NNS	O	ligand	conj_and	8	SENT_478	[p27l712t1585r883b1641],
12	in	IN	O	in	_	0	SENT_478	[p27l897t1585r942b1628],
13	primary	JJ	O	primary	amod	19	SENT_478	[p27l954t1585r1038b1641, p27l9t1670r128b1712],
14	non	JJ	O	non	amod	19	SENT_478	[p27l144t1656r386b1700],
15	—	NN	O	—	nn	19	SENT_478	[p27l144t1656r386b1700],
16	small	JJ	O	small	amod	19	SENT_478	[p27l144t1656r386b1700],
17	cell	NN	O	cell	nn	19	SENT_478	[p27l404t1656r483b1700],
18	lung	NN	O	lung	nn	19	SENT_478	[p27l500t1656r609b1712],
19	cancers	NNS	O	cancer	prep_in	2	SENT_478	[p27l626t1670r801b1700],
20	and	CC	O	and	_	0	SENT_478	[p27l820t1656r907b1700],
21	adjacent	JJ	O	adjacent	amod	23	SENT_478	[p27l925t1656r1038b1712, p27l9t1736r107b1771],
22	benign	JJ	O	benign	amod	23	SENT_478	[p27l116t1727r277b1783],
23	lung	NN	O	lung	conj_and	19	SENT_478	[p27l288t1727r405b1783],
24	.	.	O	.	_	0	SENT_478	[p27l288t1727r405b1783],

1	Cancer	NNP	O	Cancer	nn	2	SENT_479	[p27l420t1730r582b1771],
2	Res	NNP	O	Res	_	0	SENT_479	[p27l592t1730r674b1773],
3	1993	CD	DATE	1993	num	5	SENT_479	[p27l689t1730r799b1771],
4	;	:	O	;	_	0	SENT_479	[p27l806t1727r1037b1783],
5	53	CD	NUMBER	53	dep	2	SENT_479	[p27l806t1727r1037b1783],
6	:	:	O	:	_	0	SENT_479	[p27l806t1727r1037b1783],
7	Suppl	NNP	O	Suppl	dep	2	SENT_479	[p27l806t1727r1037b1783],
8	:	:	O	:	_	0	SENT_479	[p27l806t1727r1037b1783],
9	2379-85	CD	NUMBER	2379-85	dep	7	SENT_479	[p27l9t1801r216b1842],
10	.	.	O	.	_	0	SENT_479	[p27l9t1801r216b1842],

1	22	CD	NUMBER	22	_	0	SENT_480	[p27l8t1874r74b1913],
2	.	.	O	.	_	0	SENT_480	[p27l8t1874r74b1913],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_481	[p27l103t1869r245b1913],
2	VA	NNP	ORGANIZATION	VA	_	0	SENT_481	[p27l256t1873r334b1922],
3	,	,	O	,	_	0	SENT_481	[p27l256t1873r334b1922],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_481	[p27l351t1869r446b1914],
5	MG	NN	PERSON	mg	appos	2	SENT_481	[p27l460t1872r563b1922],
6	,	,	O	,	_	0	SENT_481	[p27l460t1872r563b1922],
7	Shah	NNP	PERSON	Shah	nn	8	SENT_481	[p27l581t1869r697b1913],
8	N	NNP	O	N	appos	2	SENT_481	[p27l711t1873r762b1922],
9	,	,	O	,	_	0	SENT_481	[p27l711t1873r762b1922],
10	et	FW	O	et	nn	11	SENT_481	[p27l780t1878r823b1913],
11	al.	FW	O	al.	appos	2	SENT_481	[p27l834t1869r887b1913],
12	.	.	O	.	_	0	SENT_481	[p27l834t1869r887b1913],

1	Bronchioalveolar	JJ	PERSON	bronchioalveolar	amod	3	SENT_482	[p27l903t1872r1037b1913, p27l9t1940r295b1984],
2	pathologic	JJ	O	pathologic	amod	3	SENT_482	[p27l312t1940r565b1996],
3	subtype	NN	O	subtype	nsubj	9	SENT_482	[p27l585t1940r765b1996],
4	and	CC	O	and	_	0	SENT_482	[p27l784t1940r871b1984],
5	smol	NN	O	smol	dep	6	SENT_482	[p27l891t1940r1037b1984],
6	<	JJR	O	<	conj_and	3	SENT_482	[p27l891t1940r1037b1984],
7	ing	CD	NUMBER	ing	num	8	SENT_482	[p27l8t2011r86b2067],
8	history	NN	O	history	dep	6	SENT_482	[p27l102t2011r266b2067],
9	predict	VBP	O	predict	_	0	SENT_482	[p27l280t2011r448b2067],
10	sensitivity	NN	O	sensitivity	dobj	9	SENT_482	[p27l464t2011r699b2067],
11	to	TO	O	to	_	0	SENT_482	[p27l714t2020r758b2055],
12	geﬁtinib	NN	O	geﬁtinib	prep_to	9	SENT_482	[p27l777t2010r975b2067],
13	in	IN	O	in	_	0	SENT_482	[p27l993t2011r1039b2054],
14	advanced	JJ	O	advanced	amod	16	SENT_482	[p27l8t2082r227b2126],
15	non	JJ	O	non	amod	16	SENT_482	[p27l244t2082r587b2126],
16	—	NN	O	—	prep_in	12	SENT_482	[p27l244t2082r587b2126],
17	small	JJ	O	small	amod	21	SENT_482	[p27l244t2082r587b2126],
18	—	NN	O	—	nn	21	SENT_482	[p27l244t2082r587b2126],
19	cell	NN	O	cell	nn	21	SENT_482	[p27l244t2082r587b2126],
20	lung	NN	O	lung	nn	21	SENT_482	[p27l603t2082r712b2138],
21	cancer	NN	O	cancer	dep	16	SENT_482	[p27l727t2096r890b2126],
22	.	.	O	.	_	0	SENT_482	[p27l727t2096r890b2126],

1	J	NNP	O	J	nn	3	SENT_483	[p27l904t2086r925b2133],
2	Clin	NNP	O	Clin	nn	3	SENT_483	[p27l941t2082r1038b2126],
3	Oncol	NNP	O	Oncol	_	0	SENT_483	[p27l9t2154r151b2198],
4	2004	CD	DATE	2004	num	3	SENT_483	[p27l164t2157r552b2207],
5	;	:	O	;	_	0	SENT_483	[p27l164t2157r552b2207],
6	22:1103	CD	NUMBER	22:1103	number	7	SENT_483	[p27l164t2157r552b2207],
7	—	CD	NUMBER	—	dep	3	SENT_483	[p27l164t2157r552b2207],
8	9	CD	NUMBER	9	dep	7	SENT_483	[p27l164t2157r552b2207],
9	.	.	O	.	_	0	SENT_483	[p27l164t2157r552b2207],

1	23	CD	NUMBER	23	_	0	SENT_484	[p27l8t2229r74b2268],
2	.	.	O	.	_	0	SENT_484	[p27l8t2229r74b2268],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_485	[p27l104t2224r245b2280],
2	T	NN	O	t	nn	3	SENT_485	[p27l255t2227r317b2277],
3	]	NN	O	]	_	0	SENT_485	[p27l255t2227r317b2277],
4	,	,	O	,	_	0	SENT_485	[p27l255t2227r317b2277],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_485	[p27l331t2224r421b2268],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_485	[p27l431t2227r528b2277],
7	,	,	O	,	_	0	SENT_485	[p27l431t2227r528b2277],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_485	[p27l544t2224r736b2268],
9	R	NNP	PERSON	R	appos	3	SENT_485	[p27l746t2227r794b2277],
10	,	,	O	,	_	0	SENT_485	[p27l746t2227r794b2277],
11	et	FW	O	et	nn	12	SENT_485	[p27l809t2233r852b2268],
12	al.	FW	O	al.	appos	3	SENT_485	[p27l860t2224r913b2268],
13	.	.	O	.	_	0	SENT_485	[p27l860t2224r913b2268],

1	Activating	VBG	O	activate	amod	2	SENT_486	[p27l926t2224r1038b2268, p27l6t2295r153b2351],
2	mutations	NNS	O	mutation	_	0	SENT_486	[p27l176t2295r416b2339],
3	in	IN	O	in	_	0	SENT_486	[p27l441t2295r486b2338],
4	the	DT	O	the	det	7	SENT_486	[p27l511t2295r583b2339],
5	epidermal	JJ	O	epidermal	amod	7	SENT_486	[p27l608t2295r845b2351],
6	growth	NN	O	growth	nn	7	SENT_486	[p27l869t2295r1039b2351],
7	factor	NN	O	factor	prep_in	2	SENT_486	[p27l9t2365r146b2410],
8	receptor	NN	O	receptor	nn	10	SENT_486	[p27l174t2375r370b2422],
9	underlying	VBG	O	underlie	amod	10	SENT_486	[p27l397t2366r654b2422],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_486	[p27l681t2366r1037b2422],
11	of	IN	O	of	_	0	SENT_486	[p27l9t2436r65b2481],
12	non	JJ	O	non	amod	18	SENT_486	[p27l77t2437r430b2481],
13	—	JJ	O	—	amod	18	SENT_486	[p27l77t2437r430b2481],
14	small	JJ	O	small	amod	18	SENT_486	[p27l77t2437r430b2481],
15	—	NN	O	—	nn	18	SENT_486	[p27l77t2437r430b2481],
16	cell	NN	O	cell	nn	18	SENT_486	[p27l77t2437r430b2481],
17	lung	NN	O	lung	nn	18	SENT_486	[p27l452t2437r560b2493],
18	cancer	NN	O	cancer	prep_of	10	SENT_486	[p27l581t2451r735b2481],
19	to	TO	O	to	_	0	SENT_486	[p27l757t2446r800b2481],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_486	[p27l824t2436r1036b2493],
21	.	.	O	.	_	0	SENT_486	[p27l824t2436r1036b2493],

1	N	NN	O	n	nn	2	SENT_487	[p27l8t2512r49b2552],
2	EnglJ	NN	O	englj	nsubj	3	SENT_487	[p27l62t2508r200b2564],
3	Med	VBD	O	med	_	0	SENT_487	[p27l210t2508r315b2552],
4	2004	CD	DATE	2004	dobj	3	SENT_487	[p27l328t2511r775b2561],
5	;	:	O	;	_	0	SENT_487	[p27l328t2511r775b2561],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_487	[p27l328t2511r775b2561],
7	—	CD	NUMBER	—	dep	4	SENT_487	[p27l328t2511r775b2561],
8	39	CD	NUMBER	39	dep	7	SENT_487	[p27l328t2511r775b2561],
9	.	.	O	.	_	0	SENT_487	[p27l328t2511r775b2561],

1	24	CD	NUMBER	24	_	0	SENT_488	[p27l8t2585r74b2624],
2	.	.	O	.	_	0	SENT_488	[p27l8t2585r74b2624],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_489	[p27l104t2583r211b2624],
2	JG	NNP	O	JG	_	0	SENT_489	[p27l226t2583r302b2633],
3	,	,	O	,	_	0	SENT_489	[p27l226t2583r302b2633],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_489	[p27l320t2584r456b2631],
5	PA	NN	PERSON	pa	appos	2	SENT_489	[p27l476t2583r551b2633],
6	,	,	O	,	_	0	SENT_489	[p27l476t2583r551b2633],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_489	[p27l574t2584r653b2624],
8	JC	NNP	PERSON	JC	appos	2	SENT_489	[p27l669t2583r738b2633],
9	,	,	O	,	_	0	SENT_489	[p27l669t2583r738b2633],
10	et	FW	O	et	nn	11	SENT_489	[p27l763t2589r806b2624],
11	al.	FW	O	al.	appos	2	SENT_489	[p27l823t2580r876b2624],
12	.	.	O	.	_	0	SENT_489	[p27l823t2580r876b2624],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_490	[p27l900t2583r1044b2626],
2	mutations	NNS	O	mutation	_	0	SENT_490	[p27l9t2650r249b2694],
3	in	IN	O	in	_	0	SENT_490	[p27l272t2650r317b2693],
4	lung	NN	O	lung	nn	5	SENT_490	[p27l338t2650r446b2706],
5	cancer	NN	O	cancer	prep_in	2	SENT_490	[p27l466t2664r632b2694],
6	:	:	O	:	_	0	SENT_490	[p27l466t2664r632b2694],
7	correlation	NN	O	correlation	dep	2	SENT_490	[p27l657t2650r914b2694],
8	with	IN	O	with	_	0	SENT_490	[p27l933t2650r1039b2694],
9	cebo-controlled	JJ	O	cebo-controlled	amod	10	SENT_490	[p27l1113t21r1485b65],
10	study	NN	O	study	prep_with	7	SENT_490	[p27l1522t21r1648b77],
11	(	CD	NUMBER	(	num	13	SENT_490	[p27l1684t24r1824b72],
12	ISEL	NN	O	isel	nn	13	SENT_490	[p27l1684t24r1824b72],
13	)	NN	O	)	dep	17	SENT_490	[p27l1684t24r1824b72],
14	of	IN	O	of	_	0	SENT_490	[p27l1863t20r1919b65],
15	geﬁtinib	NN	O	geﬁtinib	prep_of	13	SENT_490	[p27l1944t20r2142b77],
16	(	CD	NUMBER	(	dep	17	SENT_490	[p27l1116t95r1327b143],
17	IRESSA	NNP	O	IRESSA	dep	25	SENT_490	[p27l1116t95r1327b143],
18	)	CD	NUMBER	)	num	17	SENT_490	[p27l1116t95r1327b143],
19	plus	CC	O	plus	prep	17	SENT_490	[p27l1345t92r1444b148],
20	best	JJS	O	best	dep	21	SENT_490	[p27l1461t92r1559b136],
21	supportive	JJ	O	supportive	amod	22	SENT_490	[p27l1573t92r1820b148],
22	care	NN	O	care	dep	19	SENT_490	[p27l1836t106r1931b136],
23	(	CD	NUMBER	(	num	25	SENT_490	[p27l1950t95r2079b143],
24	BSC	NN	O	bsc	nn	25	SENT_490	[p27l1950t95r2079b143],
25	)	NN	O	)	dep	35	SENT_490	[p27l1950t95r2079b143],
26	in	IN	O	in	_	0	SENT_490	[p27l2098t92r2143b135],
27	patients	NNS	O	patient	prep_in	25	SENT_490	[p27l1112t163r1299b219],
28	with	IN	O	with	_	0	SENT_490	[p27l1316t163r1421b207],
29	advanced	JJ	O	advanced	amod	31	SENT_490	[p27l1439t163r1658b207],
30	non	JJ	O	non	amod	31	SENT_490	[p27l1676t163r2019b207],
31	—	NN	O	—	prep_with	27	SENT_490	[p27l1676t163r2019b207],
32	small	JJ	O	small	amod	35	SENT_490	[p27l1676t163r2019b207],
33	—	NN	O	—	nn	35	SENT_490	[p27l1676t163r2019b207],
34	cell	NN	O	cell	nn	35	SENT_490	[p27l1676t163r2019b207],
35	lung	NN	O	lung	dep	10	SENT_490	[p27l2037t163r2145b219],
36	cancer	NN	O	cancer	nn	39	SENT_490	[p27l1113t248r1265b278],
37	(	CD	NUMBER	(	num	39	SENT_490	[p27l1277t237r1477b285],
38	NSCLC	NN	O	nsclc	nn	39	SENT_490	[p27l1277t237r1477b285],
39	)	NN	O	)	dep	35	SENT_490	[p27l1277t237r1477b285],
40	who	WP	O	who	nsubj	42	SENT_490	[p27l1488t234r1590b278],
41	had	VBD	O	have	aux	42	SENT_490	[p27l1602t234r1687b278],
42	received	VBN	O	receive	rcmod	10	SENT_490	[p27l1698t234r1884b278],
43	1	CD	NUMBER	1	num	48	SENT_490	[p27l1897t237r1922b277],
44	or	CC	O	or	_	0	SENT_490	[p27l1933t248r1983b278],
45	2	CD	NUMBER	2	conj_or	43	SENT_490	[p27l1992t237r2019b277],
46	prior	JJ	O	prior	amod	48	SENT_490	[p27l2029t234r2145b290],
47	chemotherapy	NN	O	chemotherapy	nn	48	SENT_490	[p27l1113t305r1452b361],
48	regimens	NNS	O	regimen	dobj	42	SENT_490	[p27l1464t305r1698b361],
49	.	.	O	.	_	0	SENT_490	[p27l1464t305r1698b361],

1	In	IN	O	in	dep	3	SENT_491	[p27l1715t309r1777b349],
2	:	:	O	:	_	0	SENT_491	[p27l1715t309r1777b349],
3	Proceedings	NNP	O	Proceedings	_	0	SENT_491	[p27l1793t305r2081b361],
4	of	IN	O	of	_	0	SENT_491	[p27l2097t304r2153b349],
5	the	DT	O	the	det	7	SENT_491	[p27l1113t376r1186b420],
6	96th	JJ	ORDINAL	96th	amod	7	SENT_491	[p27l1208t376r1316b420],
7	Annual	JJ	SET	annual	prep_of	3	SENT_491	[p27l1335t376r1510b420],
8	Meeting	VBG	O	meet	partmod	7	SENT_491	[p27l1529t376r1729b432],
9	of	IN	O	of	_	0	SENT_491	[p27l1749t375r1805b420],
10	the	DT	O	the	det	12	SENT_491	[p27l1816t376r1890b420],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_491	[p27l1909t376r2143b420],
12	Association	NNP	ORGANIZATION	Association	prep_of	8	SENT_491	[p27l1111t448r1390b492],
13	for	IN	ORGANIZATION	for	_	0	SENT_491	[p27l1406t447r1474b492],
14	Cancer	NNP	ORGANIZATION	Cancer	nn	19	SENT_491	[p27l1488t451r1654b492],
15	Research	NNP	ORGANIZATION	Research	nn	19	SENT_491	[p27l1667t448r1895b501],
16	,	,	O	,	_	0	SENT_491	[p27l1667t448r1895b501],
17	Anaheim	NNP	LOCATION	Anaheim	appos	19	SENT_491	[p27l1911t448r2140b501],
18	,	,	O	,	_	0	SENT_491	[p27l1911t448r2140b501],
19	Calif.	NNP	LOCATION	Calif.	prep_for	12	SENT_491	[p27l1113t517r1252b571],
20	,	,	O	,	_	0	SENT_491	[p27l1113t517r1252b571],
21	April	NNP	DATE	April	tmod	8	SENT_491	[p27l1267t518r1385b574],
22	16-20	CD	DATE	16-20	num	21	SENT_491	[p27l1401t521r1557b571],
23	,	,	O	,	_	0	SENT_491	[p27l1401t521r1557b571],
24	2005:4	CD	NUMBER	2005:4	num	21	SENT_491	[p27l1574t521r1749b562],
25	.	.	O	.	_	0	SENT_491	[p27l1574t521r1749b562],

1	abstract	JJ	O	abstract	_	0	SENT_492	[p27l1765t518r1965b562],
2	.	.	O	.	_	0	SENT_492	[p27l1765t518r1965b562],

1	30	CD	NUMBER	30	_	0	SENT_493	[p27l1113t594r1179b634],
2	.	.	O	.	_	0	SENT_493	[p27l1113t594r1179b634],

1	Pérez	NNP	PERSON	Pérez	_	0	SENT_494	[p27l1208t588r1478b634],
2	.	.	O	.	_	0	SENT_494	[p27l1208t588r1478b634],

1	—	NN	O	—	_	0	SENT_495	[p27l1208t588r1478b634],
2	.	.	O	.	_	0	SENT_495	[p27l1208t588r1478b634],

1	Soler	NNP	O	Soler	nn	2	SENT_496	[p27l1208t588r1478b634],
2	R.	NNP	O	R.	nsubj	3	SENT_496	[p27l1491t593r1539b637],
3	Can	MD	O	can	_	0	SENT_496	[p27l1557t593r1649b634],
4	rash	NN	O	rash	dep	3	SENT_496	[p27l1664t590r1765b634],
5	associated	VBN	O	associate	partmod	4	SENT_496	[p27l1780t590r2024b634],
6	with	IN	O	with	_	0	SENT_496	[p27l2037t590r2143b634],
7	HER1/EGFR	NN	O	her1/egfr	nn	8	SENT_496	[p27l1113t664r1415b711],
8	inhibition	NN	O	inhibition	prep_with	5	SENT_496	[p27l1425t661r1660b705],
9	be	VB	O	be	auxpass	10	SENT_496	[p27l1676t661r1730b705],
10	used	VBN	O	use	ccomp	5	SENT_496	[p27l1746t661r1854b705],
11	as	IN	O	as	_	0	SENT_496	[p27l1870t675r1917b705],
12	a	DT	O	a	det	13	SENT_496	[p27l1934t675r1958b705],
13	marker	NN	O	marker	prep_as	10	SENT_496	[p27l1973t661r2145b705],
14	of	IN	O	of	_	0	SENT_496	[p27l1113t732r1169b777],
15	treatment	NN	O	treatment	nn	16	SENT_496	[p27l1171t742r1402b777],
16	outcome	NN	O	outcome	prep_of	13	SENT_496	[p27l1412t731r1639b777],
17	?	.	O	?	_	0	SENT_496	[p27l1412t731r1639b777],

1	Oncology	NNP	O	Oncology	_	0	SENT_497	[p27l1650t733r1879b789],
2	(	CD	NUMBER	(	num	1	SENT_497	[p27l1891t733r2140b789],
3	Huntingt	NNP	O	Huntingt	dep	1	SENT_497	[p27l1891t733r2140b789],
4	)	CD	NUMBER	)	num	3	SENT_497	[p27l1891t733r2140b789],
5	2003	CD	DATE	2003	num	7	SENT_497	[p27l1113t804r1458b860],
6	;	:	O	;	_	0	SENT_497	[p27l1113t804r1458b860],
7	17	CD	NUMBER	17	dep	1	SENT_497	[p27l1113t804r1458b860],
8	:	:	O	:	_	0	SENT_497	[p27l1113t804r1458b860],
9	Suppl	NNP	O	Suppl	dep	1	SENT_497	[p27l1113t804r1458b860],
10	12:23	CD	TIME	12:23	num	9	SENT_497	[p27l1474t807r1666b848],
11	—	CD	NUMBER	—	number	12	SENT_497	[p27l1474t807r1666b848],
12	8	CD	NUMBER	8	dep	9	SENT_497	[p27l1474t807r1666b848],
13	.	.	O	.	_	0	SENT_497	[p27l1474t807r1666b848],

1	31	CD	NUMBER	31	_	0	SENT_498	[p27l1113t880r1179b919],
2	.	.	O	.	_	0	SENT_498	[p27l1113t880r1179b919],

1	Inoue	NNP	O	Inoue	nn	2	SENT_499	[p27l1208t879r1345b919],
2	A	NNP	O	A	_	0	SENT_499	[p27l1365t879r1414b928],
3	,	,	O	,	_	0	SENT_499	[p27l1365t879r1414b928],
4	Saijo	NNP	LOCATION	Saijo	nn	5	SENT_499	[p27l1441t875r1554b931],
5	Y	NN	LOCATION	y	appos	2	SENT_499	[p27l1575t879r1614b928],
6	,	,	O	,	_	0	SENT_499	[p27l1575t879r1614b928],
7	Maemondo	NNP	O	Maemondo	nn	8	SENT_499	[p27l1638t875r1913b919],
8	M	NNP	O	M	appos	2	SENT_499	[p27l1935t879r1996b928],
9	,	,	O	,	_	0	SENT_499	[p27l1935t879r1996b928],
10	et	FW	O	et	nn	11	SENT_499	[p27l2022t884r2066b919],
11	al.	FW	O	al.	appos	2	SENT_499	[p27l2085t875r2139b919],
12	.	.	O	.	_	0	SENT_499	[p27l2085t875r2139b919],

1	Severe	JJ	O	severe	_	0	SENT_500	[p27l1114t949r1266b990],
2	acute	JJ	O	acute	amod	4	SENT_500	[p27l1297t955r1425b990],
3	interstitial	JJ	O	interstitial	amod	4	SENT_500	[p27l1456t946r1711b990],
4	pneumonia	NN	O	pneumonia	dep	1	SENT_500	[p27l1741t946r2022b1002],
5	and	CC	O	and	_	0	SENT_500	[p27l2052t946r2142b990],
6	geﬁtinib	NN	O	geﬁtinib	dep	1	SENT_500	[p27l1113t1016r1334b1073],
7	.	.	O	.	_	0	SENT_500	[p27l1113t1016r1334b1073],

1	Lancet	NNP	O	Lancet	_	0	SENT_501	[p27l1352t1021r1512b1061],
2	2003	CD	DATE	2003	num	1	SENT_501	[p27l1523t1020r1910b1070],
3	;	:	O	;	_	0	SENT_501	[p27l1523t1020r1910b1070],
4	361:137	CD	NUMBER	361:137	number	5	SENT_501	[p27l1523t1020r1910b1070],
5	—	CD	NUMBER	—	dep	1	SENT_501	[p27l1523t1020r1910b1070],
6	9	CD	NUMBER	9	dep	5	SENT_501	[p27l1523t1020r1910b1070],
7	.	.	O	.	_	0	SENT_501	[p27l1523t1020r1910b1070],

1	32	CD	NUMBER	32	_	0	SENT_502	[p27l1113t1093r1179b1132],
2	.	.	O	.	_	0	SENT_502	[p27l1113t1093r1179b1132],

1	Giaccone	NNP	PERSON	Giaccone	nn	2	SENT_503	[p27l1209t1088r1429b1132],
2	G	NNP	PERSON	G	_	0	SENT_503	[p27l1444t1091r1497b1141],
3	,	,	O	,	_	0	SENT_503	[p27l1444t1091r1497b1141],
4	Herbst	NNP	ORGANIZATION	Herbst	nn	5	SENT_503	[p27l1515t1088r1678b1132],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_503	[p27l1689t1091r1766b1141],
6	,	,	O	,	_	0	SENT_503	[p27l1689t1091r1766b1141],
7	Manegold	NNP	ORGANIZATION	Manegold	nn	8	SENT_503	[p27l1783t1088r2022b1144],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_503	[p27l2038t1091r2084b1141],
9	,	,	O	,	_	0	SENT_503	[p27l2038t1091r2084b1141],
10	et	FW	O	et	nn	11	SENT_503	[p27l2103t1097r2146b1132],
11	al.	FW	O	al.	appos	2	SENT_503	[p27l1112t1159r1165b1203],
12	.	.	O	.	_	0	SENT_503	[p27l1112t1159r1165b1203],

1	Gefitinib	NNP	O	Gefitinib	_	0	SENT_504	[p27l1189t1158r1400b1203],
2	in	IN	O	in	_	0	SENT_504	[p27l1421t1159r1467b1202],
3	combination	NN	O	combination	prep_in	1	SENT_504	[p27l1489t1159r1790b1203],
4	with	IN	O	with	_	0	SENT_504	[p27l1809t1159r1915b1203],
5	gemcita	NN	O	gemcita	nn	7	SENT_504	[p27l1936t1159r2142b1215],
6	—	CD	NUMBER	—	num	7	SENT_504	[p27l1936t1159r2142b1215],
7	bine	NN	O	bine	prep_with	3	SENT_504	[p27l1113t1230r1214b1274],
8	and	CC	O	and	_	0	SENT_504	[p27l1238t1230r1324b1274],
9	cisplatin	NN	O	cisplatin	conj_and	3	SENT_504	[p27l1348t1230r1548b1286],
10	in	IN	O	in	_	0	SENT_504	[p27l1572t1230r1617b1273],
11	advanced	JJ	O	advanced	amod	16	SENT_504	[p27l1640t1230r1859b1274],
12	non	JJ	O	non	amod	16	SENT_504	[p27l1882t1230r2143b1274, p27l1113t1301r1192b1345],
13	—	NN	O	—	nn	16	SENT_504	[p27l1882t1230r2143b1274, p27l1113t1301r1192b1345],
14	smallcell	NN	O	smallcell	nn	16	SENT_504	[p27l1882t1230r2143b1274, p27l1113t1301r1192b1345],
15	lung	NN	O	lung	nn	16	SENT_504	[p27l1206t1301r1315b1357],
16	cancer	NN	O	cancer	prep_in	9	SENT_504	[p27l1328t1315r1494b1345],
17	:	:	O	:	_	0	SENT_504	[p27l1328t1315r1494b1345],
18	a	DT	O	a	det	21	SENT_504	[p27l1511t1315r1536b1345],
19	phase	NN	O	phase	nn	21	SENT_504	[p27l1550t1301r1688b1357],
20	III	CD	NUMBER	iii	num	21	SENT_504	[p27l1702t1305r1756b1344],
21	trial	NN	O	trial	dep	1	SENT_504	[p27l1771t1301r1864b1345],
22	—	CD	NUMBER	—	dep	21	SENT_504	[p27l1876t1326r1937b1330],
23	IN	IN	O	in	_	0	SENT_504	[p27l1949t1305r2009b1345],
24	TACT	NN	O	tact	prep_in	22	SENT_504	[p27l2009t1304r2144b1345],
25	1	CD	NUMBER	1	num	24	SENT_504	[p27l1115t1376r1153b1417],
26	.	.	O	.	_	0	SENT_504	[p27l1115t1376r1153b1417],

1	J	NNP	O	J	nn	3	SENT_505	[p27l1164t1377r1185b1424],
2	Clin	NNP	O	Clin	nn	3	SENT_505	[p27l1198t1373r1295b1417],
3	Oncol	NNP	O	Oncol	_	0	SENT_505	[p27l1309t1373r1451b1417],
4	2004	CD	DATE	2004	num	3	SENT_505	[p27l1465t1376r1852b1426],
5	;	:	O	;	_	0	SENT_505	[p27l1465t1376r1852b1426],
6	22:777	CD	NUMBER	22:777	number	7	SENT_505	[p27l1465t1376r1852b1426],
7	-84	CD	NUMBER	-84	dep	3	SENT_505	[p27l1465t1376r1852b1426],
8	.	.	O	.	_	0	SENT_505	[p27l1465t1376r1852b1426],

1	33	CD	NUMBER	33	_	0	SENT_506	[p27l1113t1448r1179b1487],
2	.	.	O	.	_	0	SENT_506	[p27l1113t1448r1179b1487],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_507	[p27l1209t1443r1371b1487],
2	RS	NN	ORGANIZATION	r	_	0	SENT_507	[p27l1389t1446r1466b1496],
3	,	,	O	,	_	0	SENT_507	[p27l1389t1446r1466b1496],
4	Giaccone	NNP	PERSON	Giaccone	nn	5	SENT_507	[p27l1490t1443r1710b1487],
5	G	NNP	PERSON	G	appos	2	SENT_507	[p27l1732t1446r1785b1496],
6	,	,	O	,	_	0	SENT_507	[p27l1732t1446r1785b1496],
7	Schiller	NNP	PERSON	Schiller	nn	8	SENT_507	[p27l1811t1443r1988b1487],
8	JH	NNP	O	JH	appos	2	SENT_507	[p27l2002t1447r2078b1496],
9	,	,	O	,	_	0	SENT_507	[p27l2002t1447r2078b1496],
10	et	FW	O	et	nn	11	SENT_507	[p27l2103t1452r2146b1487],
11	al.	FW	O	al.	appos	2	SENT_507	[p27l1112t1514r1165b1558],
12	.	.	O	.	_	0	SENT_507	[p27l1112t1514r1165b1558],

1	Geﬂtinib	NNP	O	Geﬂtinib	_	0	SENT_508	[p27l1186t1513r1396b1558],
2	in	IN	O	in	_	0	SENT_508	[p27l1415t1514r1460b1557],
3	combination	NN	O	combination	prep_in	1	SENT_508	[p27l1479t1514r1780b1558],
4	with	IN	O	with	_	0	SENT_508	[p27l1796t1514r1901b1558],
5	paclitaxel	NN	O	paclitaxel	prep_with	3	SENT_508	[p27l1918t1514r2143b1570],
6	and	CC	O	and	_	0	SENT_508	[p27l1112t1585r1200b1629],
7	carboplatin	NN	O	carboplatin	conj_and	5	SENT_508	[p27l1217t1585r1486b1641],
8	in	IN	O	in	_	0	SENT_508	[p27l1502t1585r1548b1628],
9	advanced	JJ	O	advanced	amod	11	SENT_508	[p27l1564t1585r1783b1629],
10	non	JJ	O	non	amod	11	SENT_508	[p27l1800t1585r2143b1629],
11	—	NN	O	—	prep_in	1	SENT_508	[p27l1800t1585r2143b1629],
12	small	JJ	O	small	amod	16	SENT_508	[p27l1800t1585r2143b1629],
13	—	NN	O	—	nn	16	SENT_508	[p27l1800t1585r2143b1629],
14	cell	NN	O	cell	nn	16	SENT_508	[p27l1800t1585r2143b1629],
15	lung	NN	O	lung	nn	16	SENT_508	[p27l1112t1656r1221b1712],
16	cancer	NN	O	cancer	dep	1	SENT_508	[p27l1239t1670r1405b1700],
17	:	:	O	:	_	0	SENT_508	[p27l1239t1670r1405b1700],
18	a	DT	O	a	det	21	SENT_508	[p27l1426t1670r1451b1700],
19	phase	NN	O	phase	nn	21	SENT_508	[p27l1469t1656r1607b1712],
20	III	CD	NUMBER	iii	num	21	SENT_508	[p27l1626t1660r1680b1699],
21	trial	NN	O	trial	dep	1	SENT_508	[p27l1699t1656r1792b1700],
22	—	CD	NUMBER	—	num	23	SENT_508	[p27l1809t1681r1869b1685],
23	INTACT	NN	O	intact	dep	21	SENT_508	[p27l1886t1659r2081b1700],
24	2	CD	NUMBER	2	dep	23	SENT_508	[p27l2099t1659r2139b1700],
25	.	.	O	.	_	0	SENT_508	[p27l2099t1659r2139b1700],

1	JClin	NN	O	jclin	nn	2	SENT_509	[p27l1107t1727r1238b1778],
2	Oncol	NN	O	oncol	_	0	SENT_509	[p27l1252t1727r1394b1771],
3	2004	CD	DATE	2004	dep	2	SENT_509	[p27l1408t1730r1795b1780],
4	;	:	O	;	_	0	SENT_509	[p27l1408t1730r1795b1780],
5	22:785	CD	NUMBER	22:785	number	6	SENT_509	[p27l1408t1730r1795b1780],
6	—	CD	NUMBER	—	dep	2	SENT_509	[p27l1408t1730r1795b1780],
7	94	CD	NUMBER	94	dep	6	SENT_509	[p27l1408t1730r1795b1780],
8	.	.	O	.	_	0	SENT_509	[p27l1408t1730r1795b1780],

1	34	CD	NUMBER	34	_	0	SENT_510	[p27l1113t1803r1179b1842],
2	.	.	O	.	_	0	SENT_510	[p27l1113t1803r1179b1842],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_511	[p27l1209t1798r1371b1842],
2	RS	NN	ORGANIZATION	r	_	0	SENT_511	[p27l1385t1801r1462b1851],
3	,	,	O	,	_	0	SENT_511	[p27l1385t1801r1462b1851],
4	Prager	NN	PERSON	prager	nn	5	SENT_511	[p27l1481t1801r1635b1854],
5	D	NN	PERSON	d	appos	2	SENT_511	[p27l1650t1801r1699b1851],
6	,	,	O	,	_	0	SENT_511	[p27l1650t1801r1699b1851],
7	Hermann	NNP	PERSON	Hermann	nn	8	SENT_511	[p27l1719t1802r1946b1842],
8	R	NNP	PERSON	R	appos	2	SENT_511	[p27l1962t1801r2010b1851],
9	,	,	O	,	_	0	SENT_511	[p27l1962t1801r2010b1851],
10	et	FW	O	et	nn	11	SENT_511	[p27l2030t1807r2073b1842],
11	al.	FW	O	al.	appos	2	SENT_511	[p27l2087t1798r2140b1842],
12	.	.	O	.	_	0	SENT_511	[p27l2087t1798r2140b1842],

1	TRIBUTE	NN	O	tribute	nsubj	2	SENT_512	[p27l1111t1872r1337b1915],
2	—	VBD	O	—	_	0	SENT_512	[p27l1349t1894r1409b1898],
3	a	DT	O	a	det	6	SENT_512	[p27l1419t1883r1444b1913],
4	phase	NN	O	phase	nn	6	SENT_512	[p27l1455t1869r1593b1925],
5	III	CD	NUMBER	iii	num	6	SENT_512	[p27l1605t1873r1659b1912],
6	trial	NN	O	trial	dobj	2	SENT_512	[p27l1672t1869r1765b1913],
7	of	IN	O	of	_	0	SENT_512	[p27l1778t1868r1834b1913],
8	erlotinib	NN	O	erlotinib	nn	9	SENT_512	[p27l1837t1869r2037b1913],
9	HCl	NN	O	hcl	prep_of	6	SENT_512	[p27l2050t1869r2143b1913],
10	(	CD	NUMBER	(	num	14	SENT_512	[p27l1116t1943r1343b1991],
11	OSI	NNP	O	OSI	amod	14	SENT_512	[p27l1116t1943r1343b1991],
12	—	CD	NUMBER	—	num	11	SENT_512	[p27l1116t1943r1343b1991],
13	774	CD	NUMBER	774	dep	11	SENT_512	[p27l1116t1943r1343b1991],
14	)	NN	O	)	tmod	2	SENT_512	[p27l1116t1943r1343b1991],
15	combined	VBN	O	combine	partmod	14	SENT_512	[p27l1371t1940r1608b1984],
16	with	IN	O	with	_	0	SENT_512	[p27l1631t1940r1736b1984],
17	carboplatin	NN	O	carboplatin	prep_with	15	SENT_512	[p27l1762t1940r2031b1996],
18	and	CC	O	and	_	0	SENT_512	[p27l2056t1940r2143b1984],
19	paclitaxel	NN	O	paclitaxel	prep_with	15	SENT_512	[p27l1112t2011r1342b2067],
20	(	CD	NUMBER	(	num	23	SENT_512	[p27l1366t2014r1464b2062],
21	CP	NN	MISC	cp	nn	23	SENT_512	[p27l1366t2014r1464b2062],
22	)	NN	O	)	nn	23	SENT_512	[p27l1366t2014r1464b2062],
23	chemotherapy	NN	O	chemotherapy	dobj	15	SENT_512	[p27l1489t2011r1834b2067],
24	in	IN	O	in	_	0	SENT_512	[p27l1853t2011r1899b2054],
25	advanced	JJ	O	advanced	amod	27	SENT_512	[p27l1919t2011r2142b2055],
26	non	JJ	O	non	amod	27	SENT_512	[p27l1113t2082r1358b2126],
27	—	NN	O	—	prep_in	23	SENT_512	[p27l1113t2082r1358b2126],
28	small	JJ	O	small	amod	34	SENT_512	[p27l1113t2082r1358b2126],
29	cell	NN	O	cell	nn	34	SENT_512	[p27l1383t2082r1462b2126],
30	lung	NN	O	lung	nn	34	SENT_512	[p27l1484t2082r1593b2138],
31	cancer	NN	O	cancer	nn	34	SENT_512	[p27l1615t2096r1768b2126],
32	(	CD	NUMBER	(	num	34	SENT_512	[p27l1793t2085r2013b2133],
33	NSCLC	NN	O	nsclc	nn	34	SENT_512	[p27l1793t2085r2013b2133],
34	)	NN	O	)	dep	14	SENT_512	[p27l1793t2085r2013b2133],
35	.	.	O	.	_	0	SENT_512	[p27l1793t2085r2013b2133],

1	Proc	NNP	O	Proc	nn	5	SENT_513	[p27l2039t2085r2143b2126],
2	Am	NNP	O	Am	nn	5	SENT_513	[p27l1111t2158r1195b2197],
3	Soc	NNP	O	Soc	nn	5	SENT_513	[p27l1210t2157r1291b2198],
4	Clin	NNP	O	Clin	nn	5	SENT_513	[p27l1304t2154r1401b2198],
5	Oncol	NNP	O	Oncol	_	0	SENT_513	[p27l1415t2154r1557b2198],
6	2004	CD	DATE	2004	num	5	SENT_513	[p27l1571t2157r1880b2207],
7	;	:	O	;	_	0	SENT_513	[p27l1571t2157r1880b2207],
8	23:617	CD	NUMBER	23:617	dep	5	SENT_513	[p27l1571t2157r1880b2207],
9	.	.	O	.	_	0	SENT_513	[p27l1571t2157r1880b2207],

1	abstract	JJ	O	abstract	_	0	SENT_514	[p27l1897t2154r2096b2198],
2	.	.	O	.	_	0	SENT_514	[p27l1897t2154r2096b2198],

1	35	CD	NUMBER	35	_	0	SENT_515	[p27l1113t2229r1179b2268],
2	.	.	O	.	_	0	SENT_515	[p27l1113t2229r1179b2268],

1	Gatzemeier	NNP	PERSON	Gatzemeier	nn	2	SENT_516	[p27l1209t2224r1479b2268],
2	U	NNP	PERSON	U	_	0	SENT_516	[p27l1491t2228r1539b2277],
3	,	,	O	,	_	0	SENT_516	[p27l1491t2228r1539b2277],
4	Pluzanska	NNP	O	Pluzanska	nn	5	SENT_516	[p27l1556t2224r1793b2268],
5	A	NNP	O	A	appos	2	SENT_516	[p27l1804t2228r1852b2277],
6	,	,	O	,	_	0	SENT_516	[p27l1804t2228r1852b2277],
7	Szczesna	NNP	O	Szczesna	nn	8	SENT_516	[p27l1871t2227r2081b2268],
8	A	NNP	O	A	appos	2	SENT_516	[p27l2092t2228r2140b2277],
9	,	,	O	,	_	0	SENT_516	[p27l2092t2228r2140b2277],
10	et	FW	O	et	nn	11	SENT_516	[p27l1113t2304r1157b2339],
11	al.	FW	O	al.	appos	2	SENT_516	[p27l1169t2295r1223b2339],
12	.	.	O	.	_	0	SENT_516	[p27l1169t2295r1223b2339],

1	Results	NNS	O	result	nsubj	14	SENT_517	[p27l1241t2295r1418b2341],
2	of	IN	O	of	_	0	SENT_517	[p27l1434t2294r1491b2339],
3	a	DT	O	a	det	6	SENT_517	[p27l1495t2309r1520b2339],
4	phase	NN	O	phase	nn	6	SENT_517	[p27l1534t2295r1675b2351],
5	III	CD	NUMBER	iii	num	6	SENT_517	[p27l1690t2299r1745b2338],
6	trial	NN	O	trial	prep_of	1	SENT_517	[p27l1760t2295r1857b2339],
7	of	IN	O	of	_	0	SENT_517	[p27l1872t2294r1929b2339],
8	erlotinib	NN	O	erlotinib	nn	10	SENT_517	[p27l1934t2295r2142b2339],
9	(	CD	NUMBER	(	num	10	SENT_517	[p27l1116t2369r1348b2417],
10	OSI	NNP	O	OSI	prep_of	6	SENT_517	[p27l1116t2369r1348b2417],
11	—	CD	NUMBER	—	number	12	SENT_517	[p27l1116t2369r1348b2417],
12	774	CD	NUMBER	774	num	13	SENT_517	[p27l1116t2369r1348b2417],
13	)	NN	O	)	dep	10	SENT_517	[p27l1116t2369r1348b2417],
14	combined	VBN	O	combine	_	0	SENT_517	[p27l1389t2366r1630b2410],
15	with	IN	O	with	_	0	SENT_517	[p27l1665t2366r1773b2410],
16	cisplatin	NN	O	cisplatin	prep_with	14	SENT_517	[p27l1810t2366r2015b2422],
17	and	CC	O	and	_	0	SENT_517	[p27l2052t2366r2141b2410],
18	gemcitabine	NN	O	gemcitabine	conj_and	16	SENT_517	[p27l1113t2437r1398b2493],
19	(	CD	NUMBER	(	num	22	SENT_517	[p27l1411t2440r1518b2488],
20	GC	NN	O	gc	nn	22	SENT_517	[p27l1411t2440r1518b2488],
21	)	NN	O	)	nn	22	SENT_517	[p27l1411t2440r1518b2488],
22	chemotherapy	NN	O	chemotherapy	dobj	14	SENT_517	[p27l1532t2437r1864b2493],
23	in	IN	O	in	_	0	SENT_517	[p27l1872t2437r1917b2480],
24	advanced	JJ	O	advanced	amod	26	SENT_517	[p27l1927t2437r2142b2481],
25	non	JJ	O	non	amod	26	SENT_517	[p27l1113t2508r1359b2552],
26	—	NN	O	—	prep_in	22	SENT_517	[p27l1113t2508r1359b2552],
27	small	JJ	O	small	amod	33	SENT_517	[p27l1113t2508r1359b2552],
28	cell	NN	O	cell	nn	33	SENT_517	[p27l1380t2508r1461b2552],
29	lung	NN	O	lung	nn	33	SENT_517	[p27l1481t2508r1591b2564],
30	cancer	NN	O	cancer	nn	33	SENT_517	[p27l1610t2522r1767b2552],
31	(	CD	NUMBER	(	num	33	SENT_517	[p27l1789t2511r2013b2559],
32	NSCLC	NN	O	nsclc	nn	33	SENT_517	[p27l1789t2511r2013b2559],
33	)	NN	O	)	dep	26	SENT_517	[p27l1789t2511r2013b2559],
34	.	.	O	.	_	0	SENT_517	[p27l1789t2511r2013b2559],

1	Proc	NNP	O	Proc	nn	5	SENT_518	[p27l2036t2511r2143b2552],
2	Am	NNP	O	Am	nn	5	SENT_518	[p27l1111t2584r1195b2623],
3	Soc	NNP	O	Soc	nn	5	SENT_518	[p27l1212t2583r1294b2624],
4	Clin	NNP	O	Clin	nn	5	SENT_518	[p27l1309t2580r1407b2624],
5	Oncol	NNP	O	Oncol	_	0	SENT_518	[p27l1422t2580r1567b2624],
6	2004	CD	DATE	2004	num	5	SENT_518	[p27l1582t2583r1894b2633],
7	;	:	O	;	_	0	SENT_518	[p27l1582t2583r1894b2633],
8	23:617	CD	NUMBER	23:617	dep	5	SENT_518	[p27l1582t2583r1894b2633],
9	.	.	O	.	_	0	SENT_518	[p27l1582t2583r1894b2633],

1	abstract	JJ	O	abstract	_	0	SENT_519	[p27l1911t2580r2110b2624],
2	.	.	O	.	_	0	SENT_519	[p27l1911t2580r2110b2624],

1	Copyright	NN	O	copyright	_	0	SENT_520	[p27l1114t2657r1292b2705],
2	©	CD	NUMBER	©	num	6	SENT_520	[p27l1308t2661r1348b2701],
3	2005	CD	DATE	2005	num	6	SENT_520	[p27l1365t2659r1459b2694],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_520	[p27l1474t2657r1743b2694],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_520	[p27l1759t2657r1906b2694],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_520	[p27l1920t2659r2056b2704],
7	.	.	O	.	_	0	SENT_520	[p27l1920t2659r2056b2704],

1	N	NN	O	n	nn	2	SENT_521	[p27l918t2783r932b2798],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_521	[p27l947t2782r1031b2804],
3	MED	VBD	O	med	_	0	SENT_521	[p27l1046t2783r1099b2798],
4	3532	CD	NUMBER	3532	num	6	SENT_521	[p27l1111t2782r1175b2804],
5	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	6	SENT_521	[p27l1210t2782r1421b2804],
6	JULY14	NN	O	july14	dobj	3	SENT_521	[p27l1455t2782r1562b2804],
7	,	,	O	,	_	0	SENT_521	[p27l1455t2782r1562b2804],
8	2005	CD	DATE	2005	appos	6	SENT_521	[p27l1575t2782r1638b2804],

1	The	DT	O	the	det	4	SENT_522	[p27l935t2815r986b2839],
2	New	NNP	O	New	nn	4	SENT_522	[p27l995t2816r1057b2839],
3	England	NNP	O	England	nn	4	SENT_522	[p27l1066t2815r1177b2846],
4	Journal	NNP	O	Journal	_	0	SENT_522	[p27l1186t2815r1283b2839],
5	of	IN	O	of	_	0	SENT_522	[p27l1293t2815r1322b2839],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_522	[p27l1329t2815r1454b2839],

